data_2d9p_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2d9p _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 83.9 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.886 0.374 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.4 m -108.72 -26.25 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.135 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -65.59 128.57 36.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.508 HD12 ' CE1' ' A' ' 340' ' ' PHE . 38.5 mt -118.93 145.97 45.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -106.12 115.6 30.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 58.8 t -103.04 133.13 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.554 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 22.1 tttm -130.81 166.39 20.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . 0.554 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 6.7 m-20 63.58 54.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 40.9 mt -91.45 105.44 17.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.949 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -51.4 145.05 9.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.859 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -52.08 -34.01 41.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -67.55 -35.16 85.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.443 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.79 123.92 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.836 0.35 . . . . 0.0 111.121 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -116.0 171.32 7.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.827 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -38.02 -68.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -40.88 -56.5 2.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -45.91 -58.51 3.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 64.1 tp -52.7 -62.74 1.45 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -55.86 -24.56 37.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -81.67 -22.2 37.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -96.21 15.12 21.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.1 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.426 ' C ' ' HD2' ' A' ' 316' ' ' PRO . 6.2 m-85 -123.73 -32.38 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.7 OUTLIER -50.36 -45.87 83.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.627 0.727 . . . . 0.0 110.887 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.4 Cg_exo -47.97 -17.34 0.78 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.724 2.282 . . . . 0.0 112.342 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -100.07 -52.32 3.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.07 168.26 37.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.486 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 61.6 m -61.88 147.9 45.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 0.0 111.105 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 30.9 mt -125.1 134.05 67.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 71.8 p -110.72 -33.2 6.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -134.37 109.74 8.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -145.03 122.49 11.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.075 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -160.46 153.33 21.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 93.7 t -111.65 136.86 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 33.4 mmt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 179.875 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 333' ' ' LYS . 68.0 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.92 0.39 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . 0.485 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 11.8 mmtp -35.7 -58.75 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.8 27.79 0.58 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.508 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.485 ' CE1' ' HB3' ' A' ' 333' ' ' LYS . 42.0 p90 -171.32 147.54 2.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.915 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -146.33 -170.37 14.86 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.458 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -134.22 142.09 47.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.899 0.38 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 33.6 t -135.83 132.54 50.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 65.5 m -117.61 145.48 44.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.508 ' CE1' HD12 ' A' ' 296' ' ' LEU . 46.7 m-85 -116.79 174.21 6.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 4.2 t -75.58 -42.41 52.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.829 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 49.2 m -132.3 143.32 48.37 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.635 0.731 . . . . 0.0 110.917 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.16 -58.24 1.85 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.737 2.291 . . . . 0.0 112.344 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -40.6 -56.17 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -53.81 -42.51 68.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.913 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.82 -43.95 91.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.078 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 47.0 m -48.59 -65.21 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.147 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.443 ' O ' ' C ' ' A' ' 349' ' ' ALA . 42.7 tttt -38.6 -64.97 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.888 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -34.52 -55.25 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . 0.469 ' CG2' HD21 ' A' ' 296' ' ' LEU . 58.7 t -38.02 -52.84 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 56.0 m -80.6 -53.72 6.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.144 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -49.94 -19.19 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' MET . . . . . 0.421 ' O ' ' C ' ' A' ' 354' ' ' ASN . 71.8 mmm -107.08 -59.85 1.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 353' ' ' MET . 9.1 t30 -36.3 111.01 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.895 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 99.01 9.62 51.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -95.86 118.84 33.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 110.89 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 11.0 mm -89.27 138.35 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 71.8 t -127.34 -43.64 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -116.43 -73.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.98 -47.62 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.14 156.9 37.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.63 0.728 . . . . 0.0 110.875 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.82 139.34 17.55 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.723 2.282 . . . . 0.0 112.341 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 65.1 mt -69.47 101.08 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.933 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -68.43 96.82 0.71 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.57 131.62 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -157.44 145.33 18.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.084 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 32.2 mt -63.0 138.87 58.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.059 179.837 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.849 0.357 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 343' ' ' PRO . 15.1 m -93.07 -34.99 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -59.01 140.76 55.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.514 HD12 ' CE1' ' A' ' 340' ' ' PHE . 35.6 mt -130.4 135.58 48.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -96.13 106.14 18.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 49.0 t -89.77 131.13 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.118 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.457 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 20.5 tttt -135.22 161.82 34.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . 0.457 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 11.1 t-20 74.5 37.87 0.53 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 46.8 mt -79.98 91.32 5.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -46.26 148.62 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.42 -36.49 9.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.96 -40.62 98.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 41.6 mt -65.99 140.81 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.855 0.359 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -134.15 177.71 7.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -52.45 -41.66 63.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -65.96 -61.8 1.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 64.8 mtt-85 -49.3 -34.14 14.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.423 ' CD1' ' CE1' ' A' ' 314' ' ' PHE . 61.5 tp -67.61 -71.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 45.3 ttt-85 -50.44 -25.45 3.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -73.89 -30.26 62.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -94.16 20.28 8.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.128 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.445 ' CB ' ' CD1' ' A' ' 320' ' ' ILE . 7.0 m-85 -126.17 -30.77 2.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.1 t -56.12 -45.32 99.92 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.688 0.756 . . . . 0.0 110.878 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 315' ' ' SER . 66.1 Cg_exo -48.02 -17.04 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.718 2.279 . . . . 0.0 112.324 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 60.0 m-85 -99.93 -52.39 3.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.62 165.91 35.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.418 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.5 m -62.85 138.23 58.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.761 0.315 . . . . 0.0 111.145 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.445 ' CD1' ' CB ' ' A' ' 314' ' ' PHE . 82.0 mt -118.32 132.1 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 67.2 p -105.77 -40.48 5.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -126.51 111.14 14.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.81 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -142.6 119.83 11.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.1 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -153.56 162.36 41.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 78.4 t -121.72 142.98 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.136 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 34.1 mmt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.942 0.401 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.2 -47.65 65.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 123.62 29.93 1.12 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -171.32 158.07 5.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.372 . . . . 0.0 110.868 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -161.45 -166.88 21.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.501 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -139.04 143.89 38.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 22.7 t -138.96 140.04 39.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 23.7 m -117.54 149.33 40.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.514 ' CE1' HD12 ' A' ' 296' ' ' LEU . 10.4 m-85 -122.84 176.92 5.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.835 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 32.6 t -78.45 -39.2 39.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.885 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 27.2 m -136.87 143.19 41.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.683 0.754 . . . . 0.0 110.843 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.455 ' N ' HG13 ' A' ' 294' ' ' VAL . 73.2 Cg_exo -47.35 -59.15 1.35 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 2.243 . . . . 0.0 112.347 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 343' ' ' PRO . 30.9 tt0 -37.63 -59.76 0.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -49.33 -41.39 38.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.08 -42.72 93.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.109 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.4 m -50.72 -67.81 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.167 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -40.55 -56.53 2.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 350' ' ' VAL . . . -44.4 -55.51 4.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.097 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . 0.445 ' HA ' ' CG1' ' A' ' 365' ' ' VAL . 84.3 t -36.6 -58.48 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.136 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 353' ' ' MET . 35.2 m -75.94 -60.35 2.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . 0.511 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 3.7 mm-40 -39.99 -27.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' MET . . . . . 0.491 ' HG2' ' CE2' ' A' ' 317' ' ' PHE . 77.6 mmm -101.29 -42.33 6.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 26.1 t30 -60.15 106.28 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.859 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 113.92 -3.66 24.23 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.469 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -98.88 144.24 28.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.894 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . 0.449 HG21 ' N ' ' A' ' 358' ' ' VAL . 8.3 mm -95.23 152.01 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.129 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.449 ' N ' HG21 ' A' ' 357' ' ' ILE . 45.1 t -131.95 -40.9 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.081 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -130.21 -66.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.0 -54.52 0.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.15 154.92 36.89 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.564 0.697 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.43 134.07 15.13 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 35.7 mt -66.16 123.92 21.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -95.96 89.44 5.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.445 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 2.9 t -90.78 134.53 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.061 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -153.87 142.87 21.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.068 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 27.9 mt -60.79 144.88 51.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 179.742 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 84.0 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.882 0.372 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.8 m -93.25 -30.65 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -67.99 133.11 48.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.46 HD22 ' CG2' ' A' ' 350' ' ' VAL . 65.6 mt -121.94 135.84 54.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -94.27 119.93 33.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 59.3 t -104.14 137.71 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.163 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 10.8 tttp -137.22 161.78 35.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.938 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . 0.471 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.1 m120 63.79 53.84 1.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.464 HD23 ' CD2' ' A' ' 363' ' ' LEU . 32.0 mt -86.67 94.47 9.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -44.41 149.15 0.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.81 -36.3 62.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.91 -38.36 95.97 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.468 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 81.6 mt -73.58 121.9 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.351 . . . . 0.0 111.103 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.43 177.91 4.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -39.28 -46.25 1.52 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 309' ' ' ARG . 0.2 OUTLIER -65.35 -69.57 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 308' ' ' GLU . 10.4 mmt180 -35.19 -36.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.541 HD11 ' CE1' ' A' ' 314' ' ' PHE . 47.8 tp -68.05 -75.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -48.85 -25.06 1.69 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -79.33 -32.64 43.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.99 21.03 2.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.094 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.541 ' CE1' HD11 ' A' ' 310' ' ' LEU . 8.8 m-85 -130.22 -30.41 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.597 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.1 t -53.1 -44.92 98.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.7 0.762 . . . . 0.0 110.872 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.4 Cg_exo -47.95 -17.59 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.685 2.257 . . . . 0.0 112.351 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -100.22 -54.9 2.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -159.28 163.67 33.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.462 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 44.5 m -61.31 143.27 55.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.727 0.298 . . . . 0.0 111.139 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 59.6 mt -117.69 149.37 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.122 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 61.9 p -117.27 -43.83 2.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.157 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 70.8 m -132.69 112.53 12.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -141.01 119.55 12.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.174 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -153.45 147.78 25.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 49.0 t -89.87 118.58 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.121 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' MET . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 335' ' ' PHE . 26.3 mmm . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.852 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.971 0.415 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -38.62 -45.8 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 121.01 43.05 0.46 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.493 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 326' ' ' MET . 2.0 p90 -175.53 160.57 2.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 110.881 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -156.97 177.0 34.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -127.74 132.74 49.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.871 0.367 . . . . 0.0 110.837 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 37.2 t -133.24 135.3 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 9.6 t -117.23 135.96 53.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.459 ' CE1' HD11 ' A' ' 296' ' ' LEU . 10.9 m-85 -107.98 162.19 14.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 12.5 t -58.82 -46.92 86.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.85 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.14 146.1 58.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.654 0.74 . . . . 0.0 110.861 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 344' ' ' GLU . 71.9 Cg_exo -46.16 -57.78 2.02 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.694 2.263 . . . . 0.0 112.356 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 343' ' ' PRO . 17.4 mm-40 -37.09 -64.7 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . 0.413 ' N ' ' CD ' ' A' ' 345' ' ' GLU . 0.2 OUTLIER -49.09 -43.25 41.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.89 -48.05 83.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.102 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 75.1 m -46.08 -63.02 1.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.178 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 349' ' ' ALA . 1.3 ttmp? -40.65 -65.56 0.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.58 -54.93 0.87 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.114 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . 0.498 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 59.3 t -41.43 -51.0 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.163 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 66.1 m -79.37 -58.0 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.118 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -45.78 -25.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.933 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 356' ' ' ARG . 65.3 mmm -102.16 -52.37 3.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 4.7 t-20 -34.25 111.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.916 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.04 20.98 58.28 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.497 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 353' ' ' MET . 17.5 tpp180 -98.05 123.33 42.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.883 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 10.9 mm -93.14 125.35 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.108 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 74.8 t -110.52 -51.63 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.133 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -113.22 -69.48 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.09 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 1.4 p -131.6 -53.23 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.65 153.37 37.95 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.589 0.709 . . . . 0.0 110.861 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.67 145.3 22.97 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.69 2.26 . . . . 0.0 112.344 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.464 ' CD2' HD23 ' A' ' 301' ' ' LEU . 48.4 mt -82.74 92.08 7.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -66.82 100.52 0.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.6 t -106.43 136.35 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -158.32 149.18 20.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 34.4 mt -59.31 137.28 58.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 179.796 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 86.8 t . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.85 0.357 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 29.0 m -95.88 -32.24 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.178 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -69.26 126.12 28.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.401 HD13 ' CE1' ' A' ' 340' ' ' PHE . 39.3 mt -114.6 140.17 49.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -95.59 121.16 36.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 67.0 t -103.01 133.53 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.127 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 26.8 tttm -133.82 162.49 31.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . 0.481 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.4 m120 63.77 48.27 3.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.907 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.462 HD13 ' CA ' ' A' ' 335' ' ' PHE . 28.9 mt -86.81 99.61 11.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -44.79 157.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -59.14 -42.18 90.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.53 -38.96 94.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.511 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 77.9 mt -65.92 132.33 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.896 0.379 . . . . 0.0 111.123 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.68 -174.93 3.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -46.96 -60.86 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 309' ' ' ARG . 12.5 tt0 -49.65 -65.13 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 308' ' ' GLU . 9.8 mmt85 -34.4 -49.08 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.863 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.565 HD12 ' CE1' ' A' ' 314' ' ' PHE . 67.7 tp -55.42 -74.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -49.07 -25.05 1.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -74.47 -40.47 61.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.34 19.01 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.109 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.565 ' CE1' HD12 ' A' ' 310' ' ' LEU . 7.3 m-85 -127.36 -30.16 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.598 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.2 t -54.02 -45.0 99.16 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.688 0.756 . . . . 0.0 110.872 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.8 Cg_exo -48.03 -17.88 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.703 2.268 . . . . 0.0 112.351 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 57.4 m-85 -100.45 -61.09 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.863 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -148.69 159.32 27.99 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.458 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.432 HG23 ' N ' ' A' ' 320' ' ' ILE . 26.2 m -65.36 141.92 58.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.769 0.318 . . . . 0.0 111.157 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.458 HD11 ' CG1' ' A' ' 338' ' ' VAL . 79.8 mt -120.26 135.41 60.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 66.4 p -99.45 -36.55 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.6 t -137.81 122.62 18.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -137.16 124.18 21.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.062 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -150.67 149.81 30.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 79.5 t -115.38 138.87 44.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.099 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 39.3 mmt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.895 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 82.2 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.9 0.381 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . 0.4 ' HE2' ' CZ ' ' A' ' 335' ' ' PHE . 22.7 mtpt -65.24 -47.07 78.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.39 27.45 0.62 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.488 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.462 ' CA ' HD13 ' A' ' 301' ' ' LEU . 7.8 p90 -174.98 165.72 3.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.883 0.373 . . . . 0.0 110.893 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -167.41 -163.31 21.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -144.16 138.98 28.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.377 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.458 ' CG1' HD11 ' A' ' 320' ' ' ILE . 53.7 t -130.73 142.46 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . 0.444 ' N ' HG13 ' A' ' 338' ' ' VAL . 74.0 m -114.29 145.7 41.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.401 ' CE1' HD13 ' A' ' 296' ' ' LEU . 18.1 m-85 -120.83 174.55 6.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.5 t -73.58 -42.0 62.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.85 145.88 38.49 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.645 0.736 . . . . 0.0 110.837 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.402 ' O ' ' C ' ' A' ' 344' ' ' GLU . 71.5 Cg_exo -46.41 -56.18 3.15 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.699 2.266 . . . . 0.0 112.332 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 343' ' ' PRO . 3.6 mm-40 -37.56 -63.52 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -47.75 -45.89 29.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.92 -44.06 97.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 92.8 m -45.9 -61.67 1.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.167 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 349' ' ' ALA . 15.4 ttmt -46.94 -61.95 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -37.52 -50.35 1.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . 0.499 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 57.7 t -41.16 -57.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.113 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 94.2 m -77.48 -55.33 5.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.154 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . 0.558 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 25.6 mm-40 -43.24 -30.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' MET . . . . . 0.448 ' O ' ' C ' ' A' ' 354' ' ' ASN . 72.8 mmm -100.82 -53.66 3.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 2.9 t30 -34.02 115.95 0.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 81.03 27.18 50.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.478 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -99.98 118.24 35.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.868 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . 0.444 HD13 ' CA ' ' A' ' 362' ' ' PRO . 27.0 mm -91.51 117.49 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 97.0 t -106.83 -45.01 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -118.55 -72.83 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.093 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.0 p -132.14 -51.74 0.96 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -100.32 148.84 35.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.549 0.69 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.444 ' CA ' HD13 ' A' ' 357' ' ' ILE . 62.9 Cg_endo -77.97 137.34 15.58 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.702 2.268 . . . . 0.0 112.374 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 62.5 mt -74.5 91.93 2.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -64.19 105.15 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.433 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 47.0 t -108.79 133.11 54.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.094 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -152.48 151.23 30.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.115 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 73.7 mt -58.79 136.49 57.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 179.825 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.909 0.385 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 343' ' ' PRO . 19.2 m -118.45 -25.12 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -77.21 143.85 38.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.417 HD11 ' CE1' ' A' ' 340' ' ' PHE . 35.4 mt -131.3 135.87 47.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -94.93 123.83 38.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.2 t -105.07 130.82 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.139 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 34.4 tttp -129.54 162.24 28.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.872 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . 0.479 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.8 m-20 63.86 52.25 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 27.7 mt -93.51 91.16 6.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -40.52 135.34 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -41.08 -41.62 1.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -57.3 -38.72 88.04 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.506 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 57.8 mt -65.89 127.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.831 0.348 . . . . 0.0 111.168 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.4 178.51 4.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.828 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -54.8 -41.49 70.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.847 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -63.43 -57.61 9.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -42.36 -51.76 4.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 49.5 tp -57.28 -70.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -47.91 -27.63 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 10.7 mtpp -74.3 -32.06 62.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -91.66 18.4 7.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -127.11 -29.56 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.594 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -54.51 -45.35 99.44 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.673 0.749 . . . . 0.0 110.858 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.1 Cg_exo -47.92 -17.1 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.666 2.244 . . . . 0.0 112.38 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . 0.559 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 61.7 m-85 -99.87 -57.6 2.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -155.94 167.66 33.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.479 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 8.1 m -65.82 143.88 57.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.0 111.102 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 80.2 mt -123.81 139.43 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.7 p -110.74 -38.86 5.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.136 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 14.8 m -127.32 111.12 13.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -145.4 126.01 14.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.161 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.449 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 12.5 tptm -165.05 149.73 9.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.449 ' N ' ' HG3' ' A' ' 324' ' ' LYS . 93.7 t -98.13 139.47 20.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' MET . . . . . 0.41 ' N ' HG12 ' A' ' 325' ' ' VAL . 37.7 mmt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 333' ' ' LYS . 37.6 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.904 0.383 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . 0.54 ' HD3' ' CZ ' ' A' ' 335' ' ' PHE . 22.1 mtpp -35.14 -48.01 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 117.38 36.59 0.99 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.46 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.54 ' CZ ' ' HD3' ' A' ' 333' ' ' LYS . 13.3 p90 -174.47 164.45 3.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.896 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -160.99 -166.78 20.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.404 ' C ' HG22 ' A' ' 338' ' ' VAL . 36.9 m-85 -134.4 144.37 48.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.868 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.404 HG22 ' C ' ' A' ' 337' ' ' PHE . 49.0 t -137.08 132.13 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 7.2 t -115.92 134.76 54.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.417 ' CE1' HD11 ' A' ' 296' ' ' LEU . 16.5 m-85 -110.86 170.19 8.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.916 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 47.9 t -79.97 -43.32 22.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.895 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 3.0 m -125.29 138.48 31.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.666 0.746 . . . . 0.0 110.84 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.467 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.1 Cg_exo -47.43 -60.02 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.643 2.229 . . . . 0.0 112.37 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 343' ' ' PRO . 42.6 mt-10 -37.44 -58.7 0.83 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -47.35 -45.06 24.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.41 -43.18 99.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.7 m -51.07 -67.64 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.216 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 349' ' ' ALA . 26.3 tttt -41.32 -63.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.96 -52.93 0.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 60.9 t -40.06 -54.25 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 81.0 m -79.76 -54.49 5.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.149 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . 0.559 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 17.5 mm-40 -46.42 -25.64 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' MET . . . . . 0.435 ' O ' ' C ' ' A' ' 354' ' ' ASN . 73.4 mmm -104.26 -52.23 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 4.2 t-20 -34.89 110.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 91.88 25.88 21.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -99.76 119.99 39.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 8.8 mm -90.66 127.49 43.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.173 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 67.1 t -116.68 -40.98 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.142 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.11 -70.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.128 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.3 p -132.03 -52.91 0.98 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.151 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -99.99 149.44 35.98 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.606 0.717 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.57 136.81 17.69 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.721 2.281 . . . . 0.0 112.295 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 37.0 mt -66.85 100.35 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -73.75 95.4 2.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 52.7 t -96.95 144.05 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.077 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -157.96 171.7 19.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 28.4 mt -81.14 140.77 34.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.868 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.102 179.788 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 81.4 t . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.866 0.365 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.72 -25.22 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -75.38 128.25 34.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.404 HD23 ' CG2' ' A' ' 350' ' ' VAL . 46.1 mt -118.62 147.84 43.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -106.76 115.51 30.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 31.8 t -100.46 127.95 52.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.155 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.445 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 42.9 tttp -129.16 160.88 31.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . 0.445 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.5 m120 63.78 50.48 2.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 24.1 mt -84.28 105.32 15.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -45.19 137.42 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -44.97 -40.58 6.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -65.53 -37.97 94.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.479 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.61 107.6 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.822 0.344 . . . . 0.0 111.12 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -95.78 -176.46 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -51.22 -45.91 62.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -66.11 -54.14 29.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -45.27 -42.99 10.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.837 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.541 HD11 ' CE1' ' A' ' 314' ' ' PHE . 54.0 tp -60.22 -70.29 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.925 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.41 ' NH1' ' HB3' ' A' ' 311' ' ' ARG . 19.3 ttp-105 -53.37 -23.82 10.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -67.96 -35.99 79.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -95.01 20.25 9.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.087 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.541 ' CE1' HD11 ' A' ' 310' ' ' LEU . 7.2 m-85 -126.48 -30.38 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.596 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.0 OUTLIER -57.29 -44.79 99.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.62 0.724 . . . . 0.0 110.829 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.7 Cg_exo -48.07 -17.02 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.683 2.255 . . . . 0.0 112.335 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 53.6 m-85 -100.24 -51.48 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.97 163.9 34.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.4 m -63.99 140.7 58.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.124 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 90.9 mt -121.5 143.15 34.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.129 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 69.2 p -117.74 -42.19 2.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.156 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 65.4 m -115.47 105.89 13.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.845 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -137.52 112.71 9.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.059 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.436 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 33.5 tptt -143.54 145.01 32.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.436 ' N ' ' HG3' ' A' ' 324' ' ' LYS . 49.0 t -110.16 117.48 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 35.8 mmt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.91 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 67.9 p . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.886 0.374 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . 0.552 ' HB3' ' CE2' ' A' ' 335' ' ' PHE . 23.7 mttm -48.59 -52.3 23.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 122.33 33.47 0.89 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.508 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 333' ' ' LYS . 20.1 p90 -173.03 159.67 4.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.924 0.392 . . . . 0.0 110.864 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -162.08 -170.46 26.88 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.401 ' C ' HG22 ' A' ' 338' ' ' VAL . 37.7 m-85 -131.56 141.02 49.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.882 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.401 HG22 ' C ' ' A' ' 337' ' ' PHE . 18.5 t -136.51 125.95 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 10.1 t -110.4 134.88 51.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -107.59 165.6 11.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 5.0 t -73.36 -39.75 64.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 68.4 m -127.01 139.5 35.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.663 0.744 . . . . 0.0 110.878 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.62 -60.5 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.715 2.276 . . . . 0.0 112.341 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -40.31 -57.67 1.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -46.87 -46.77 21.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.65 99.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.081 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 56.5 m -53.2 -63.56 1.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 349' ' ' ALA . 37.8 tttt -43.64 -62.77 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -37.37 -51.65 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 58.0 t -40.53 -55.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.151 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 73.4 m -78.74 -55.44 5.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . 0.501 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 2.5 mm-40 -45.01 -27.86 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' MET . . . . . 0.484 ' O ' ' CB ' ' A' ' 356' ' ' ARG . 82.3 mmm -102.49 -52.24 3.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.838 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 2.5 t30 -33.96 118.66 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 79.5 18.8 72.76 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.453 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 353' ' ' MET . 22.4 tpp180 -100.12 125.79 46.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.752 0.31 . . . . 0.0 110.872 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . 0.441 HD12 ' CA ' ' A' ' 362' ' ' PRO . 29.2 mm -88.59 139.88 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 90.7 t -128.35 -34.74 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.153 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -131.27 -69.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.68 -51.2 0.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.177 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.32 155.84 37.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.603 0.716 . . . . 0.0 110.886 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.441 ' CA ' HD12 ' A' ' 357' ' ' ILE . 63.1 Cg_endo -77.77 142.67 20.4 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.369 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 34.4 mt -79.19 92.97 5.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -65.23 97.69 0.28 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.6 t -101.17 145.11 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.104 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -158.95 154.64 26.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.093 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.63 140.66 58.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 179.761 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 88.1 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.843 0.354 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.409 HG21 ' N ' ' A' ' 295' ' ' ASN . 24.2 m -108.85 -34.72 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.409 ' N ' HG21 ' A' ' 294' ' ' VAL . 2.0 p-10 -59.64 143.74 49.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 20.2 mt -134.7 153.38 52.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -115.3 118.81 34.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.7 t -100.19 137.06 28.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.076 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -138.92 155.71 47.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 74.78 39.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 33.9 mt -73.43 90.66 1.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -40.76 139.92 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.4 -41.58 9.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.862 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.85 -38.97 94.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.44 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 66.7 mt -66.52 143.69 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.856 0.36 . . . . 0.0 111.157 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -132.21 -175.03 3.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -57.79 -42.73 84.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -64.65 -63.81 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 74.5 mtt-85 -46.23 -44.56 16.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.51 HD11 ' CE1' ' A' ' 314' ' ' PHE . 47.5 tp -55.37 -75.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.415 ' HG3' ' CD1' ' A' ' 320' ' ' ILE . 58.7 ttp180 -48.95 -29.53 4.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -72.14 -33.68 67.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -85.98 20.35 2.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.51 ' CE1' HD11 ' A' ' 310' ' ' LEU . 8.4 m-85 -128.99 -30.73 2.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.83 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.81 -45.34 97.25 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.716 0.769 . . . . 0.0 110.882 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.6 Cg_exo -48.03 -16.73 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.664 2.243 . . . . 0.0 112.351 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 57.9 m-85 -99.84 -46.62 5.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -169.0 165.97 39.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.542 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.436 HG23 ' N ' ' A' ' 320' ' ' ILE . 42.0 m -62.59 140.19 58.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.116 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.436 ' N ' HG23 ' A' ' 319' ' ' THR . 74.5 mt -109.92 145.56 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.112 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 82.4 p -109.98 -45.39 3.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 82.7 p -136.3 116.53 13.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.842 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -135.2 123.46 23.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -150.61 152.4 33.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 55.2 t -112.34 130.17 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 37.5 mmt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 179.965 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.895 0.379 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . 0.532 ' HB3' ' CE2' ' A' ' 335' ' ' PHE . 58.2 mttt -52.49 -61.47 2.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 136.9 37.58 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.466 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.532 ' CE2' ' HB3' ' A' ' 333' ' ' LYS . 23.2 p90 -174.82 162.06 3.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 0.0 110.907 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -159.27 -169.16 22.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.477 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -138.8 137.02 36.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.866 0.365 . . . . 0.0 110.912 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 48.8 t -138.04 136.48 44.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.149 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 10.1 t -121.39 133.49 55.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -104.13 158.91 16.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.851 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.4 m -64.04 -43.07 96.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 71.0 m -125.38 136.97 28.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.67 0.748 . . . . 0.0 110.859 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.4 -56.87 2.69 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.648 2.232 . . . . 0.0 112.361 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -43.82 -61.33 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -47.66 -46.05 28.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.75 -41.18 97.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.062 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 31.4 m -51.49 -60.9 2.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.108 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -40.96 -58.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -46.48 -53.14 11.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.101 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . 0.469 ' HA ' ' CG1' ' A' ' 365' ' ' VAL . 98.6 t -38.48 -58.69 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.162 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 72.4 m -75.36 -59.08 2.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . 0.551 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 39.4 mm-40 -41.54 -28.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.9 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' MET . . . . . 0.455 ' HG2' ' CE2' ' A' ' 317' ' ' PHE . 64.1 mmm -100.06 -40.63 7.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -46.1 109.07 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.44 21.93 55.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . 0.42 ' C ' ' HD3' ' A' ' 356' ' ' ARG . 0.0 OUTLIER -98.1 125.19 42.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.762 0.315 . . . . 0.0 110.862 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . 0.455 HD13 ' CA ' ' A' ' 362' ' ' PRO . 27.6 mm -89.42 127.26 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 66.3 t -113.38 -42.89 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -123.0 -74.36 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.089 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 5.2 p -128.9 -49.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.184 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -105.14 150.15 38.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.574 0.702 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.455 ' CA ' HD13 ' A' ' 357' ' ' ILE . 61.5 Cg_endo -76.76 140.98 21.3 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.688 2.259 . . . . 0.0 112.331 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 32.4 mt -80.39 115.87 20.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -83.21 99.66 10.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 39.0 t -103.37 140.83 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -166.41 152.8 8.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.073 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 26.9 mt -65.93 132.48 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.072 179.802 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.857 0.361 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.42 HG11 ' N ' ' A' ' 343' ' ' PRO . 23.1 m -117.88 -26.8 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -74.12 114.94 13.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 38.4 mt -105.45 132.97 50.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.955 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -90.28 120.09 31.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 299' ' ' LYS . 98.6 t -101.05 137.43 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.116 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.466 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 35.8 tttt -137.03 161.46 36.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . 0.466 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.0 m120 63.53 47.69 3.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.439 HD22 ' CD2' ' A' ' 363' ' ' LEU . 28.4 mt -80.23 102.46 9.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -45.9 143.9 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -52.39 -39.45 60.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -61.95 -37.11 93.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.79 148.22 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.852 0.358 . . . . 0.0 111.136 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -137.36 179.78 6.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -52.52 -38.67 60.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 309' ' ' ARG . 16.4 mm-40 -68.63 -72.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.888 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 308' ' ' GLU . 61.0 mtt-85 -36.99 -38.89 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.562 HD12 ' CE1' ' A' ' 314' ' ' PHE . 44.0 tp -63.32 -70.72 0.2 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.437 ' HG3' ' CD1' ' A' ' 320' ' ' ILE . 46.3 ttt180 -50.85 -24.98 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -79.4 -32.96 43.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.47 18.88 3.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.081 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.562 ' CE1' HD12 ' A' ' 310' ' ' LEU . 8.4 m-85 -129.36 -30.92 2.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.874 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.584 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.7 OUTLIER -50.79 -45.65 86.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.634 0.73 . . . . 0.0 110.84 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.7 Cg_exo -47.94 -17.05 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.662 2.241 . . . . 0.0 112.353 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . 0.432 ' CE2' ' HG2' ' A' ' 353' ' ' MET . 54.4 m-85 -99.84 -47.45 5.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -166.14 158.61 31.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.484 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.42 HG23 ' N ' ' A' ' 320' ' ' ILE . 40.8 m -60.7 139.13 57.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.738 0.304 . . . . 0.0 111.163 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 321' ' ' THR . 46.7 mt -110.99 141.69 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.463 ' N ' HG22 ' A' ' 320' ' ' ILE . 67.9 p -110.34 -40.39 4.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.068 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 3.5 m -132.12 121.24 23.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.883 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -132.98 125.18 29.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.102 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 22.2 mtpt -142.48 154.99 45.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 31.5 t -129.96 117.57 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.16 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' MET . . . . . 0.473 ' HE1' ' N ' ' A' ' 326' ' ' MET . 30.0 mmt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.904 0.383 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . 0.46 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 21.2 mtpp -46.96 -53.31 12.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 300' ' ' ASN . . . 132.59 33.36 0.39 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.46 ' CE1' ' HB3' ' A' ' 333' ' ' LYS . 29.4 p90 -175.15 157.29 2.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -156.89 -161.38 10.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -142.46 131.65 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.386 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.43 HG12 ' CE1' ' A' ' 340' ' ' PHE . 61.7 t -127.36 134.25 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 7.3 m -110.26 138.78 46.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.43 ' CE1' HG12 ' A' ' 338' ' ' VAL . 28.8 m-85 -114.14 164.41 13.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.904 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.9 t -67.76 -46.51 71.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 3.5 m -130.69 142.67 46.37 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.638 0.733 . . . . 0.0 110.876 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 344' ' ' GLU . 72.8 Cg_exo -47.05 -59.34 1.28 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.652 2.234 . . . . 0.0 112.36 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 343' ' ' PRO . 39.8 mt-10 -36.09 -61.83 0.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -46.87 -47.28 21.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.89 -41.02 95.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 90.1 m -50.13 -62.8 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 349' ' ' ALA . 27.0 tttm -46.52 -63.94 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.21 -48.96 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.071 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . 0.474 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 47.0 t -41.66 -56.42 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.187 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 92.9 m -79.58 -51.99 8.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . 0.425 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 20.5 mm-40 -46.3 -29.44 1.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' MET . . . . . 0.439 ' O ' ' C ' ' A' ' 354' ' ' ASN . 53.4 mmm -101.51 -52.71 3.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 1.8 t30 -34.22 116.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.921 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 82.7 25.57 49.58 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.523 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -100.05 118.27 36.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.723 0.297 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . 0.446 HD11 ' CA ' ' A' ' 362' ' ' PRO . 29.6 mm -86.73 126.43 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 94.9 t -112.18 -48.49 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.172 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -120.75 -68.24 0.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.067 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 6.0 p -130.88 -54.44 1.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.139 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.43 151.17 37.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.561 0.696 . . . . 0.0 110.882 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.446 ' CA ' HD11 ' A' ' 357' ' ' ILE . 63.0 Cg_endo -77.13 143.78 22.96 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.641 2.227 . . . . 0.0 112.353 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.439 ' CD2' HD22 ' A' ' 301' ' ' LEU . 33.2 mt -78.68 91.97 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -64.32 101.82 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 50.8 t -105.66 134.49 47.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.122 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -154.54 153.65 31.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.26 136.75 58.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.169 179.75 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 99.6 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.857 0.361 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.406 HG11 ' N ' ' A' ' 343' ' ' PRO . 4.6 m -93.85 -32.54 4.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -64.93 135.84 56.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.459 ' CD2' HD21 ' A' ' 367' ' ' LEU . 48.4 mt -122.33 137.73 54.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -98.75 106.56 18.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.2 t -90.3 135.75 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.164 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.492 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 17.3 ttmm -133.25 164.76 26.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . 0.492 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.7 m-20 63.77 45.34 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.462 HD21 ' CD2' ' A' ' 363' ' ' LEU . 28.4 mt -90.61 98.09 11.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -46.35 163.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.32 -36.62 84.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.26 -43.58 97.13 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.533 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 39.6 mt -60.91 147.49 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.336 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -137.31 -176.82 4.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.823 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -60.14 -34.08 73.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -72.13 -62.25 1.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.878 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -46.82 -42.78 17.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.416 ' CD1' ' CE1' ' A' ' 314' ' ' PHE . 61.2 tp -62.38 -71.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.447 ' CG ' HD11 ' A' ' 320' ' ' ILE . 37.2 ttt180 -48.43 -26.58 2.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -70.48 -33.69 71.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -92.35 18.94 7.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.108 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.416 ' CE1' ' CD1' ' A' ' 310' ' ' LEU . 6.3 m-85 -123.76 -31.16 3.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.8 OUTLIER -56.85 -45.48 99.95 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.643 0.735 . . . . 0.0 110.846 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.9 Cg_exo -47.95 -17.06 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 0.0 112.385 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . 0.568 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 62.0 m-85 -99.92 -48.91 4.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.26 168.08 37.11 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.455 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.3 m -64.37 139.39 58.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.787 0.327 . . . . 0.0 111.124 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.447 HD11 ' CG ' ' A' ' 311' ' ' ARG . 42.1 mt -115.85 133.93 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 75.2 p -108.15 -40.62 5.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.127 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.9 m -130.09 112.61 13.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.815 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -138.65 124.31 19.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.122 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 19.2 tptm -163.63 146.55 9.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 326' ' ' MET . 98.9 t -101.05 136.23 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.113 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' MET . . . . . 0.458 ' N ' HG13 ' A' ' 325' ' ' VAL . 37.5 mmt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.963 0.411 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -58.11 -53.62 56.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.899 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 138.78 36.86 0.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.5 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -171.93 152.76 3.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.857 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -154.08 -174.11 23.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.519 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -133.62 143.74 48.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 110.895 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 48.7 t -138.7 147.59 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 62.6 m -124.52 149.03 47.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -125.2 175.96 7.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 90.2 p -75.11 -29.79 60.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 43.4 t -156.75 145.05 14.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.717 0.77 . . . . 0.0 110.789 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 346' ' ' ALA . 71.3 Cg_exo -45.06 -54.01 4.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.693 2.262 . . . . 0.0 112.359 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -39.01 -37.92 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -76.2 -38.64 56.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 343' ' ' PRO . . . -65.79 -45.39 82.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 87.5 m -49.3 -67.82 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.172 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.442 ' HG2' ' CG ' ' A' ' 352' ' ' GLU . 19.7 tttm -41.14 -60.71 1.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -40.8 -52.45 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 66.2 t -39.47 -59.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 353' ' ' MET . 51.9 m -77.51 -59.6 2.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.159 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . 0.568 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 30.9 mm-40 -37.44 -29.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' MET . . . . . 0.468 ' N ' ' O ' ' A' ' 351' ' ' THR . 79.6 mmm -100.24 -61.3 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 353' ' ' MET . 8.0 t30 -36.8 101.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 125.68 -9.26 7.68 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.511 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.42 126.54 35.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 110.878 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . 0.467 HD11 ' CA ' ' A' ' 362' ' ' PRO . 23.4 mm -87.94 135.27 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 65.6 t -113.63 -54.54 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -116.08 -65.39 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.064 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.76 -52.65 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.81 153.67 38.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.548 0.69 . . . . 0.0 110.893 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.467 ' CA ' HD11 ' A' ' 357' ' ' ILE . 60.0 Cg_endo -73.5 148.24 42.31 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.324 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.462 ' CD2' HD21 ' A' ' 301' ' ' LEU . 58.7 mt -70.8 93.61 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -68.08 88.28 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 14.3 t -92.66 140.09 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.09 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -155.96 138.32 14.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . 0.459 HD21 ' CD2' ' A' ' 296' ' ' LEU . 60.2 mt -57.76 141.45 48.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.121 179.763 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 98.6 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.864 0.364 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 343' ' ' PRO . 23.9 m -94.55 -23.82 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.175 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -78.35 137.92 38.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.458 ' CD1' ' CE1' ' A' ' 340' ' ' PHE . 36.2 mt -128.08 142.85 51.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.958 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -99.65 121.87 41.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.57 130.1 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.098 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 16.0 tttm -128.44 157.56 40.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . . . . . . . . . 3.4 m120 63.83 54.94 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.456 HD21 ' CD2' ' A' ' 363' ' ' LEU . 28.3 mt -92.56 98.07 11.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.939 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 303' ' ' ASP . 14.8 t70 -50.24 131.42 23.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 302' ' ' ASP . 12.9 t70 -35.61 -49.86 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -48.35 -44.98 28.45 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.73 143.15 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.826 0.346 . . . . 0.0 111.125 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.8 -175.76 4.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.828 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.74 -42.94 65.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -62.25 -70.25 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 66.7 mtt-85 -41.66 -40.73 2.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.535 HD13 ' CE1' ' A' ' 314' ' ' PHE . 43.2 tp -60.72 -70.92 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.438 ' HG3' ' CD1' ' A' ' 320' ' ' ILE . 54.6 ttt180 -53.2 -23.71 9.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -68.7 -37.97 79.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -91.82 20.09 5.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.098 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.535 ' CE1' HD13 ' A' ' 310' ' ' LEU . 7.1 m-85 -126.19 -30.34 2.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.864 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.589 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.0 OUTLIER -56.9 -45.52 99.95 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.664 0.745 . . . . 0.0 110.822 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 315' ' ' SER . 66.1 Cg_exo -48.0 -17.16 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 0.0 112.354 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . 0.532 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 48.6 m-85 -100.8 -52.84 3.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -145.72 170.62 26.94 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.464 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.4 m -85.93 95.19 9.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 0.0 111.143 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.438 ' CD1' ' HG3' ' A' ' 311' ' ' ARG . 93.4 mt -62.07 143.59 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.181 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 39.1 p -112.13 -28.54 7.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 2.6 t -155.37 109.23 2.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -123.19 135.77 54.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -156.57 152.7 27.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 86.7 t -115.96 139.18 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.101 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 35.9 mmt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 59.2 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.907 0.384 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . 0.416 ' HD3' ' CZ ' ' A' ' 335' ' ' PHE . 19.0 mtpt -75.57 -60.77 2.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 149.14 37.72 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.525 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.416 ' CZ ' ' HD3' ' A' ' 333' ' ' LYS . 34.9 p90 -174.02 150.09 1.56 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.899 0.38 . . . . 0.0 110.891 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -158.12 -169.0 21.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.479 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -136.34 143.22 43.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 0.0 110.882 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.432 HG11 ' CE1' ' A' ' 340' ' ' PHE . 41.2 t -134.05 126.84 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.15 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 74.3 m -101.41 127.56 48.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.458 ' CE1' ' CD1' ' A' ' 296' ' ' LEU . 15.5 m-85 -101.76 168.14 9.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 25.1 t -78.36 -42.24 31.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.9 m -131.24 139.75 36.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.664 0.745 . . . . 0.0 110.875 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.468 ' N ' HG12 ' A' ' 294' ' ' VAL . 72.8 Cg_exo -47.43 -59.01 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.718 2.279 . . . . 0.0 112.332 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 343' ' ' PRO . 27.9 tt0 -36.39 -59.06 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.921 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.43 -48.11 56.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.92 76.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.088 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 99.2 m -52.93 -67.15 0.27 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.19 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 349' ' ' ALA . 15.2 ttmt -40.85 -65.06 0.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.6 -48.24 0.51 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.112 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . 0.492 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 43.4 t -44.38 -52.66 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 53.1 m -81.79 -50.41 9.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . 0.532 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 23.4 mm-40 -49.62 -28.13 5.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 356' ' ' ARG . 83.7 mmm -101.84 -49.0 4.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 3.5 t30 -36.1 110.53 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 87.75 19.83 52.74 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.507 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 353' ' ' MET . 21.8 tpp85 -99.11 120.97 40.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.897 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 9.0 mm -87.11 130.92 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.145 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 85.2 t -116.43 -42.29 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.073 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -126.1 -69.23 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.11 -55.25 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.98 155.68 36.17 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.558 0.694 . . . . 0.0 110.942 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.18 135.55 15.34 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.68 2.253 . . . . 0.0 112.301 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.456 ' CD2' HD21 ' A' ' 301' ' ' LEU . 28.0 mt -71.72 88.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -64.48 100.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.94 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 28.8 t -100.09 135.25 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -153.94 143.16 21.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 71.7 mt -54.14 145.18 17.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.777 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 74.7 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.882 0.372 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 343' ' ' PRO . 16.6 m -87.13 -30.39 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -69.63 123.21 20.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.552 HD13 ' CE1' ' A' ' 340' ' ' PHE . 69.1 mt -112.45 136.84 51.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.966 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -90.21 119.52 30.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.98 129.73 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.119 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.488 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 11.0 tttp -129.61 162.71 27.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . 0.488 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.4 m120 63.8 51.21 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.441 ' CD1' HG11 ' A' ' 325' ' ' VAL . 39.8 mt -85.85 99.41 11.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -46.91 144.26 2.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -47.45 -40.27 17.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -61.28 -36.82 93.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.503 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 66.9 mt -69.11 135.97 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.826 0.346 . . . . 0.0 111.14 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -136.18 -176.36 4.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -43.04 -63.3 0.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -47.06 -63.83 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -39.59 -52.5 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.564 HD12 ' CE1' ' A' ' 314' ' ' PHE . 53.1 tp -50.22 -74.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.96 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.461 ' CG ' HD12 ' A' ' 320' ' ' ILE . 19.3 ttt180 -54.2 -21.45 8.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -78.41 -29.51 47.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -99.91 17.96 19.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.564 ' CE1' HD12 ' A' ' 310' ' ' LEU . 8.0 m-85 -128.59 -30.39 2.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.73 -45.4 96.81 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.644 0.735 . . . . 0.0 110.82 -179.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 315' ' ' SER . 66.0 Cg_exo -48.0 -17.13 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.67 2.247 . . . . 0.0 112.341 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 52.0 m-85 -99.95 -50.11 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -145.91 169.19 27.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 90.4 m -81.86 88.19 6.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.725 0.298 . . . . 0.0 111.136 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.461 HD12 ' CG ' ' A' ' 311' ' ' ARG . 64.8 mt -65.56 131.57 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.151 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 3.1 t -108.75 -29.65 8.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.1 t -139.98 126.17 19.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -140.24 140.93 35.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.093 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -156.43 150.65 25.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 326' ' ' MET . 95.5 t -125.12 135.68 63.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' MET . . . . . 0.45 ' N ' HG13 ' A' ' 325' ' ' VAL . 35.7 mmt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.908 0.385 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -58.22 -56.31 23.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 141.14 36.9 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.471 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -174.2 161.37 3.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.92 0.391 . . . . 0.0 110.846 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -164.85 -167.83 26.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.492 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -144.2 136.13 26.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.902 0.382 . . . . 0.0 110.887 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.415 HG13 ' CE1' ' A' ' 340' ' ' PHE . 60.1 t -123.05 134.82 65.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 64.5 m -107.34 128.58 54.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.552 ' CE1' HD13 ' A' ' 296' ' ' LEU . 21.9 m-85 -105.03 160.86 14.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 95.7 p -67.42 -31.36 71.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.905 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' SER . . . . . 0.419 ' C ' HG13 ' A' ' 294' ' ' VAL . 4.8 t -148.48 143.41 17.33 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.681 0.753 . . . . 0.0 110.842 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.46 ' N ' HG13 ' A' ' 294' ' ' VAL . 72.9 Cg_exo -47.28 -58.97 1.42 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.636 2.224 . . . . 0.0 112.368 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 343' ' ' PRO . 22.4 mp0 -36.09 -64.94 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -44.8 -45.47 10.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.1 -42.51 96.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.137 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 97.2 m -45.8 -62.37 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.095 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 349' ' ' ALA . 44.4 tttp -48.41 -63.74 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.65 -48.06 0.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 48.3 t -43.19 -54.93 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.106 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 85.8 m -80.65 -48.99 11.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . 0.407 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 17.1 mm-40 -50.7 -26.65 5.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' MET . . . . . 0.458 ' O ' ' N ' ' A' ' 356' ' ' ARG . 75.2 mmm -103.31 -50.36 3.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 3.5 t-20 -40.72 105.92 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 95.71 16.78 38.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 353' ' ' MET . 0.0 OUTLIER -98.04 122.0 40.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.762 0.315 . . . . 0.0 110.893 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . 0.441 HD11 ' CA ' ' A' ' 362' ' ' PRO . 23.4 mm -88.76 134.26 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.113 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.86 -59.83 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.13 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -105.72 -70.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.099 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 16.9 p -133.64 -47.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.163 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -104.32 154.85 38.01 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.567 0.698 . . . . 0.0 110.886 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.441 ' CA ' HD11 ' A' ' 357' ' ' ILE . 62.6 Cg_endo -77.7 144.07 21.8 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.674 2.249 . . . . 0.0 112.363 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 37.8 mt -81.02 92.6 6.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -61.45 102.65 0.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 47.4 t -108.84 137.67 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.091 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -163.38 149.05 11.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.087 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 18.0 mt -60.5 148.38 37.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.105 179.792 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 1.3 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.872 0.368 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.42 HG13 ' C ' ' A' ' 342' ' ' SER . 10.1 m -112.12 -22.28 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -75.16 125.9 29.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.439 HD13 ' CE1' ' A' ' 340' ' ' PHE . 49.9 mt -111.37 145.03 39.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -110.99 105.53 14.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 39.1 t -89.5 137.14 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.168 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.559 ' HE2' ' CD1' ' A' ' 364' ' ' TYR . 17.7 ttpt -132.85 162.04 32.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . 0.47 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.8 m-20 64.02 51.72 2.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 30.9 mt -90.39 106.63 18.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -52.31 150.29 4.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.842 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -56.64 -34.3 67.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -64.82 -39.73 96.8 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.497 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 60.7 mt -62.82 139.14 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.829 0.347 . . . . 0.0 111.123 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -128.32 174.74 9.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.83 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -49.12 -43.1 41.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -62.86 -64.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 58.5 mtt-85 -42.81 -34.33 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 59.5 tp -67.74 -75.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -48.28 -25.79 1.7 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -70.51 -36.1 73.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -93.82 20.54 7.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.088 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.401 ' C ' ' HD2' ' A' ' 316' ' ' PRO . 7.3 m-85 -127.06 -29.69 2.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.636 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 2.7 t -58.05 -42.74 96.7 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.665 0.745 . . . . 0.0 110.887 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 315' ' ' SER . 63.4 Cg_exo -47.89 -17.21 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.67 2.247 . . . . 0.0 112.395 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -100.23 -51.94 3.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -158.31 175.65 35.42 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.447 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 92.0 m -77.39 134.25 38.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.728 0.299 . . . . 0.0 111.171 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 321' ' ' THR . 84.3 mt -110.32 138.36 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.13 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.435 ' N ' HG22 ' A' ' 320' ' ' ILE . 82.8 p -108.24 -39.06 5.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 72.7 m -127.56 106.74 9.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.807 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -131.32 114.37 14.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.084 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.441 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 2.9 tppp? -146.82 145.01 29.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.441 ' N ' ' HG3' ' A' ' 324' ' ' LYS . 44.1 t -106.13 140.4 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 33.8 mmt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 333' ' ' LYS . 5.4 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.925 0.393 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 332' ' ' SER . 2.9 mtpm? -34.54 -49.67 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 136.79 33.17 0.23 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -173.35 154.69 2.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -158.95 179.1 34.82 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.452 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -128.34 129.26 46.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 12.7 t -130.56 130.27 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 33.2 t -109.16 154.14 22.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.439 ' CE1' HD13 ' A' ' 296' ' ' LEU . 19.6 m-85 -125.61 177.54 6.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 93.1 p -77.32 -38.08 51.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' SER . . . . . 0.42 ' C ' HG13 ' A' ' 294' ' ' VAL . 27.0 t -142.98 146.5 37.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.689 0.756 . . . . 0.0 110.888 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 344' ' ' GLU . 71.6 Cg_exo -46.56 -60.39 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.717 2.278 . . . . 0.0 112.316 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 343' ' ' PRO . 20.8 mt-10 -35.75 -70.04 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -44.03 -43.86 7.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.827 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.63 98.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.086 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.8 m -52.41 -60.31 3.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.149 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -46.27 -52.4 12.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -53.83 -53.08 57.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . 0.476 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 76.0 t -39.02 -49.58 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 353' ' ' MET . 50.9 m -82.58 -62.18 1.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -41.04 -24.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 351' ' ' THR . 94.4 mmm -102.06 -43.41 5.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 17.2 t-20 -59.22 109.54 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 108.5 -11.99 36.04 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -87.39 147.45 25.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.772 0.32 . . . . 0.0 110.888 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 6.2 mm -97.47 148.98 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.97 -54.01 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.162 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -113.01 -72.72 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.089 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 2.4 t -131.86 -49.08 0.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -101.08 154.0 37.42 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.618 0.723 . . . . 0.0 110.916 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.38 129.14 10.9 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.697 2.265 . . . . 0.0 112.329 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 52.3 mt -67.08 122.55 18.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.914 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . 0.559 ' CD1' ' HE2' ' A' ' 299' ' ' LYS . 25.1 t80 -101.83 93.48 5.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.6 144.22 10.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.126 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -162.43 145.94 11.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.085 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 35.9 mt -53.14 145.9 12.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.943 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.83 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.837 0.351 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.1 m -92.1 -32.5 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.158 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -65.59 136.1 55.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.499 HD12 ' CE1' ' A' ' 340' ' ' PHE . 30.7 mt -123.58 137.2 54.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.967 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -101.62 103.05 13.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 32.2 t -88.45 136.21 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.572 ' HE3' ' CD1' ' A' ' 364' ' ' TYR . 13.2 ttpp -135.41 162.8 31.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . 0.455 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.6 m120 63.97 47.84 3.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 35.7 mt -86.22 98.44 10.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -41.47 134.98 2.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -45.83 -36.4 5.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.15 -42.72 97.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.5 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 63.0 mt -60.44 147.65 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.834 0.349 . . . . 0.0 111.173 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -130.34 -174.61 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.23 -28.47 69.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.48 -55.07 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -51.89 -41.89 62.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.42 HD21 ' CG2' ' A' ' 325' ' ' VAL . 62.9 tp -61.89 -72.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 13.7 ttt-85 -50.38 -24.89 3.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -80.0 -29.02 39.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -93.34 17.65 10.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.096 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.445 ' CB ' HD11 ' A' ' 320' ' ' ILE . 6.9 m-85 -126.01 -31.49 2.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.49 -45.27 95.67 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.648 0.737 . . . . 0.0 110.799 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.5 Cg_exo -48.03 -16.67 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.716 2.277 . . . . 0.0 112.325 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -99.67 -52.17 3.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.835 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.27 166.56 36.51 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.475 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 23.9 m -64.08 144.48 57.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.743 0.306 . . . . 0.0 111.18 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.467 HG21 ' N ' ' A' ' 321' ' ' THR . 49.6 mt -119.75 137.73 52.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.467 ' N ' HG21 ' A' ' 320' ' ' ILE . 68.4 p -100.94 -41.43 6.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.145 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.1 t -142.28 124.53 15.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.825 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -145.57 124.76 12.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.08 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -149.25 159.0 44.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.42 ' CG2' HD21 ' A' ' 310' ' ' LEU . 89.9 t -120.32 123.87 71.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.097 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' MET . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 335' ' ' PHE . 33.5 mmt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.972 0.415 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -69.68 -44.76 69.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 125.39 34.74 0.65 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.439 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.492 ' CZ ' ' HG3' ' A' ' 326' ' ' MET . 2.5 p90 -174.75 161.13 3.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.913 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -164.7 -172.05 31.69 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.519 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -131.21 146.46 52.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.868 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 50.5 t -142.43 131.9 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.091 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 6.5 t -112.94 144.27 42.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.499 ' CE1' HD12 ' A' ' 296' ' ' LEU . 9.0 m-85 -118.52 178.63 4.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.1 t -78.49 -39.88 36.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.3 t -137.53 142.36 36.83 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.671 0.748 . . . . 0.0 110.855 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.99 -54.51 4.9 Favored 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.686 2.258 . . . . 0.0 112.369 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -41.83 -52.05 4.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.93 -46.06 82.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.03 -38.86 80.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.152 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 348' ' ' LYS . 60.9 m -52.04 -74.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 347' ' ' THR . 10.1 ttmm -35.25 -64.8 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.953 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.41 -54.5 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.117 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 33.5 t -47.52 -46.25 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.163 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 27.3 m -77.57 -59.48 2.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.133 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -50.49 -22.08 1.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 90.1 mmm -100.22 -43.34 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 9.2 t-20 -58.98 97.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 123.58 -11.49 8.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.492 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -85.15 122.44 29.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 11.5 mm -84.99 149.63 4.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.24 -49.37 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -120.28 -68.97 0.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.32 -51.25 0.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.185 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.58 151.81 37.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.545 0.688 . . . . 0.0 110.899 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.15 151.98 44.73 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.728 2.285 . . . . 0.0 112.345 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 63.1 mt -77.09 96.51 4.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . 0.572 ' CD1' ' HE3' ' A' ' 299' ' ' LYS . 10.1 t80 -74.48 85.8 2.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.67 144.41 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.131 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -152.09 168.07 26.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.148 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 29.5 mt -72.35 145.95 47.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.099 179.796 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 93.7 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.883 0.373 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 295' ' ' ASN . 24.3 m -87.27 -30.32 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.414 ' N ' HG23 ' A' ' 294' ' ' VAL . 14.4 t-20 -72.69 135.83 45.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.829 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 28.9 mt -129.76 132.99 46.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.916 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -90.81 121.06 32.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.958 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.3 t -104.5 132.49 51.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.112 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.49 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 22.3 tttm -132.86 164.05 27.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.898 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . 0.49 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.8 m120 64.14 45.7 3.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 32.7 mt -84.31 95.26 8.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -41.24 136.76 1.55 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -45.16 -40.54 7.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -58.97 -35.77 85.03 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.525 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 65.7 mt -68.36 126.98 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.785 0.326 . . . . 0.0 111.153 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -115.7 175.67 5.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -42.45 -63.82 0.7 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.802 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -47.48 -55.67 8.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.877 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? -45.05 -51.61 9.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.527 HD11 ' CE1' ' A' ' 314' ' ' PHE . 54.7 tp -53.91 -74.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.927 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.458 ' HG3' ' CD1' ' A' ' 320' ' ' ILE . 31.3 ttt180 -45.84 -27.95 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -68.66 -42.78 77.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -83.93 25.1 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.103 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.527 ' CE1' HD11 ' A' ' 310' ' ' LEU . 10.7 m-85 -133.72 -32.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.599 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -51.82 -45.27 92.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.662 0.744 . . . . 0.0 110.867 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.3 Cg_exo -47.95 -17.17 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.642 2.228 . . . . 0.0 112.367 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . 0.468 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 46.9 m-85 -100.07 -45.83 5.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -167.8 167.01 39.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.466 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.445 HG21 ' N ' ' A' ' 320' ' ' ILE . 35.9 m -68.72 141.16 55.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.785 0.326 . . . . 0.0 111.154 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.458 ' CD1' ' HG3' ' A' ' 311' ' ' ARG . 53.3 mt -113.95 144.09 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.457 ' N ' HG22 ' A' ' 320' ' ' ILE . 61.6 p -114.12 -38.55 4.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.145 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -133.36 111.05 10.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.825 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -135.45 122.98 22.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -147.28 152.99 39.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.459 ' CG2' HD23 ' A' ' 310' ' ' LEU . 81.9 t -119.41 135.85 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.148 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 38.0 mmt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.921 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.956 0.408 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . 0.478 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 55.1 mttp -51.76 -51.25 57.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.936 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 133.02 35.24 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.445 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 333' ' ' LYS . 5.3 p90 -173.04 165.89 5.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.885 0.374 . . . . 0.0 110.906 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -166.71 -171.43 32.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.541 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -136.82 140.03 42.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.883 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.435 HG13 ' CE1' ' A' ' 340' ' ' PHE . 43.9 t -131.28 133.55 62.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.134 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 8.7 m -111.77 133.2 54.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.435 ' CE1' HG13 ' A' ' 338' ' ' VAL . 25.3 m-85 -109.51 173.3 6.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 13.2 t -87.15 -40.68 14.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.833 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 49.7 m -123.66 130.19 24.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.648 0.737 . . . . 0.0 110.846 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -45.88 -58.57 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.678 2.252 . . . . 0.0 112.345 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -38.62 -52.66 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -54.12 -46.78 72.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.54 -42.38 98.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.115 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.4 m -49.95 -60.35 3.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.125 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 349' ' ' ALA . 46.3 tttt -48.13 -62.94 1.22 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.855 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.62 -48.96 0.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . 0.44 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 57.6 t -42.49 -56.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.163 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 61.2 m -78.33 -54.65 5.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.147 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . 0.468 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 2.2 mm-40 -44.22 -29.54 0.66 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' MET . . . . . 0.451 ' O ' ' N ' ' A' ' 356' ' ' ARG . 76.9 mmm -100.06 -51.55 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 1.6 t30 -39.49 103.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 97.66 18.24 28.43 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.501 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 353' ' ' MET . 0.0 OUTLIER -99.04 118.11 35.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.324 . . . . 0.0 110.883 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . 0.42 HD13 ' N ' ' A' ' 362' ' ' PRO . 20.7 mm -85.89 133.75 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.178 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 84.4 t -118.05 -41.99 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -126.26 -65.18 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.065 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.7 p -134.52 -53.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.11 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -101.58 154.22 37.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.569 0.7 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.42 ' N ' HD13 ' A' ' 357' ' ' ILE . 63.1 Cg_endo -78.17 143.46 20.09 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.448 HD11 ' CE ' ' A' ' 353' ' ' MET . 61.8 mt -75.11 90.92 2.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -61.38 99.73 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.427 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 40.8 t -106.8 141.58 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -161.37 157.8 25.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.059 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 30.8 mt -63.58 141.79 58.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.93 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.089 179.809 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 95.9 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.819 0.342 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 343' ' ' PRO . 22.9 m -87.75 -35.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.148 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.423 ' N ' HG23 ' A' ' 294' ' ' VAL . 0.2 OUTLIER -62.42 129.96 43.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.489 HD12 ' CE1' ' A' ' 340' ' ' PHE . 60.1 mt -118.44 136.3 53.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -94.11 125.96 39.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . 0.425 HG11 ' N ' ' A' ' 299' ' ' LYS . 57.7 t -110.29 143.55 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.154 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.519 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 14.1 ttmm -144.49 164.57 30.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . 0.519 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.5 m120 64.14 44.72 4.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.469 HD23 ' CD2' ' A' ' 363' ' ' LEU . 25.5 mt -84.67 99.87 11.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 301' ' ' LEU . 30.0 m-20 -37.52 155.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -31.91 73.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -67.87 -38.32 89.06 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.498 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.434 ' CG2' ' N ' ' A' ' 306' ' ' ASP . 62.8 mt -56.94 162.94 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.851 0.358 . . . . 0.0 111.104 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.434 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 8.7 t0 -149.28 -176.75 5.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -59.68 -41.82 91.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -64.86 -57.46 8.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.88 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 29.5 mtt-85 -47.06 -45.17 21.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.57 HD11 ' CE1' ' A' ' 314' ' ' PHE . 50.4 tp -57.36 -71.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -49.73 -32.19 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -72.14 -33.73 67.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -85.74 19.31 2.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.059 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.57 ' CE1' HD11 ' A' ' 310' ' ' LEU . 8.2 m-85 -129.73 -30.19 2.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.899 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.18 -45.24 94.1 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.645 0.735 . . . . 0.0 110.866 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.1 Cg_exo -47.94 -16.69 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.71 2.273 . . . . 0.0 112.329 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -99.6 -54.35 2.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.871 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -158.37 170.75 35.11 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.446 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 49.4 m -65.2 144.24 57.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 111.113 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.417 HG21 ' N ' ' A' ' 321' ' ' THR . 48.5 mt -124.41 140.91 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.417 ' N ' HG21 ' A' ' 320' ' ' ILE . 82.6 p -114.16 -46.73 2.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -121.55 111.0 16.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -138.92 121.33 16.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -155.4 156.27 35.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 48.0 t -110.56 143.33 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' MET . . . . . 0.55 ' HG3' ' CE2' ' A' ' 335' ' ' PHE . 38.7 mmt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.9 0.381 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . 0.565 ' HD3' ' CZ ' ' A' ' 335' ' ' PHE . 28.9 mttm -50.89 -42.27 58.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 128.76 -31.23 3.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.537 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.565 ' CZ ' ' HD3' ' A' ' 333' ' ' LYS . 5.4 p90 -111.64 161.8 15.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.9 0.381 . . . . 0.0 110.881 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -155.37 -174.24 25.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.522 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -136.51 140.63 43.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.928 0.394 . . . . 0.0 110.841 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 51.5 t -136.93 131.52 46.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.164 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 4.7 m -111.33 141.33 45.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.489 ' CE1' HD12 ' A' ' 296' ' ' LEU . 14.5 m-85 -115.75 171.85 7.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 62.7 p -71.73 -37.01 70.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.854 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 6.2 t -144.44 143.07 20.57 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.668 0.747 . . . . 0.0 110.828 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.463 ' N ' HG13 ' A' ' 294' ' ' VAL . 71.9 Cg_exo -46.49 -56.07 3.25 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.74 2.294 . . . . 0.0 112.317 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 343' ' ' PRO . 1.2 mp0 -37.21 -61.29 0.59 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -50.3 -43.38 53.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.01 98.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 86.2 m -49.29 -60.83 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -47.37 -60.46 2.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -42.51 -48.87 5.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . 0.445 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 47.1 t -41.49 -55.73 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.111 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 82.7 m -78.74 -55.75 4.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -44.18 -28.96 0.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.886 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' MET . . . . . 0.468 ' CE ' HD11 ' A' ' 363' ' ' LEU . 79.3 mmm -100.2 -49.81 4.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 9.4 t30 -40.14 110.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 85.29 20.7 56.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.481 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 353' ' ' MET . 19.7 tpp180 -99.94 112.46 24.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.815 0.341 . . . . 0.0 110.885 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 17.6 mm -77.67 150.49 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 95.3 t -132.52 -48.01 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.8 -68.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 19.0 p -130.79 -53.14 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.106 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -100.05 151.42 37.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.576 0.703 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.58 155.95 35.9 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.706 2.271 . . . . 0.0 112.374 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.469 ' CD2' HD23 ' A' ' 301' ' ' LEU . 32.9 mt -94.49 87.44 5.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.944 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -61.48 106.66 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.964 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.423 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 47.8 t -113.91 134.63 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.104 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -155.27 145.32 21.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.137 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 77.9 mt -54.66 134.18 47.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.757 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 73.8 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.86 0.362 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 343' ' ' PRO . 6.4 m -86.61 -37.11 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -52.27 142.17 17.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.558 HD11 ' CE1' ' A' ' 340' ' ' PHE . 32.5 mt -135.48 132.64 37.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -102.08 113.02 25.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 45.7 t -100.83 145.5 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.132 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 0.0 OUTLIER -132.4 165.84 23.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . 0.537 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 4.0 m-20 63.48 46.57 4.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.92 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 302' ' ' ASP . 32.8 mt -82.43 91.97 6.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 301' ' ' LEU . 86.5 m-20 -36.05 132.09 0.54 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.86 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.58 -41.68 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -60.13 -36.19 89.83 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.468 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . 0.462 HG22 ' CB ' ' A' ' 309' ' ' ARG . 75.5 mt -64.92 118.49 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.143 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -103.55 -175.74 2.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.37 -45.96 76.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -62.76 -48.96 76.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . 0.462 ' CB ' HG22 ' A' ' 305' ' ' ILE . 4.3 mmm180 -46.68 -49.66 18.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.561 HD12 ' CE1' ' A' ' 314' ' ' PHE . 43.2 tp -56.65 -73.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -46.89 -26.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -70.01 -41.72 73.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -88.9 21.35 3.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.058 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.561 ' CE1' HD12 ' A' ' 310' ' ' LEU . 8.2 m-85 -129.41 -29.96 2.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -55.38 -44.95 99.9 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.662 0.744 . . . . 0.0 110.883 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.7 Cg_exo -47.97 -16.57 0.59 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.747 2.298 . . . . 0.0 112.288 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . 0.496 ' CD2' ' HB1' ' A' ' 349' ' ' ALA . 51.5 m-85 -99.64 -51.87 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -163.68 166.07 37.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 64.4 m -67.2 137.91 56.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.785 0.326 . . . . 0.0 111.144 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 321' ' ' THR . 93.3 mt -109.65 142.15 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.165 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.434 ' N ' HG22 ' A' ' 320' ' ' ILE . 70.3 p -111.74 -35.8 5.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.172 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -133.58 104.51 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -134.58 122.48 22.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.084 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.401 ' HG2' ' N ' ' A' ' 325' ' ' VAL . 44.0 tttp -156.72 152.52 27.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.441 HG11 ' N ' ' A' ' 326' ' ' MET . 59.4 t -107.44 140.33 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' MET . . . . . 0.537 ' HG3' ' CE2' ' A' ' 335' ' ' PHE . 34.4 mmt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.918 0.389 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -71.24 -58.13 3.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 139.95 35.76 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.516 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.537 ' CE2' ' HG3' ' A' ' 326' ' ' MET . 25.7 p90 -174.95 163.65 3.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 0.0 110.857 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -162.09 -179.77 36.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -123.88 139.24 54.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 110.897 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.463 ' CG2' HD21 ' A' ' 310' ' ' LEU . 29.9 t -134.59 127.72 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.169 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 68.8 m -111.93 134.38 53.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.558 ' CE1' HD11 ' A' ' 296' ' ' LEU . 43.4 m-85 -111.39 177.18 4.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 6.4 t -78.21 -35.52 48.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.9 t -141.61 141.71 23.56 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.62 0.724 . . . . 0.0 110.885 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.405 ' N ' HG13 ' A' ' 294' ' ' VAL . 72.4 Cg_exo -46.65 -53.65 5.85 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.692 2.261 . . . . 0.0 112.327 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -40.82 -63.74 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -46.09 -44.22 15.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.863 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.15 -59.58 5.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.076 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 28.7 m -41.58 -56.05 2.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.408 ' NZ ' ' HG3' ' A' ' 352' ' ' GLU . 2.3 tmtm? -45.84 -56.31 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.496 ' HB1' ' CD2' ' A' ' 317' ' ' PHE . . . -54.51 -51.12 66.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.068 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . 0.467 ' CG2' HD21 ' A' ' 296' ' ' LEU . 91.9 t -39.38 -53.21 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.143 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 86.7 m -75.29 -59.28 2.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . 0.408 ' HG3' ' NZ ' ' A' ' 348' ' ' LYS . 3.9 mm-40 -49.08 -18.84 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 90.0 mmm -107.28 -35.14 6.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.459 ' OD1' ' C ' ' A' ' 354' ' ' ASN . 5.4 t-20 -59.1 96.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 112.47 -15.86 24.53 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 17.6 tpp85 -73.27 110.19 7.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 20.5 mm -68.12 151.2 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.422 HG11 ' NH2' ' A' ' 309' ' ' ARG . 58.4 t -132.26 -39.46 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.115 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -133.22 -71.36 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.095 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 4.9 p -128.96 -55.05 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.95 153.45 37.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.558 0.694 . . . . 0.0 110.873 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.1 153.49 46.61 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.719 2.279 . . . . 0.0 112.332 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.401 ' CD2' HD21 ' A' ' 301' ' ' LEU . 30.5 mt -87.77 99.44 12.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -79.24 91.39 4.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.96 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.2 t -95.33 141.33 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.127 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -159.84 142.98 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.078 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 24.4 mt -52.99 153.43 3.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.094 179.793 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.855 0.359 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.02 -21.51 5.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.095 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.1 152.05 38.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.529 HD13 ' CE1' ' A' ' 340' ' ' PHE . 14.7 mt -143.87 134.21 24.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -101.85 120.47 40.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.25 145.5 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.113 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.484 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 13.4 ttmm -136.58 162.68 32.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . 0.484 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 6.8 m-20 62.59 51.11 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.467 HD23 ' CD2' ' A' ' 363' ' ' LEU . 28.0 mt -88.86 104.52 17.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -45.92 162.05 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.872 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -64.2 -38.87 92.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.26 -40.59 99.2 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.494 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 59.9 mt -57.41 132.64 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 111.176 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.23 -174.82 3.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -49.86 -46.38 51.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -60.69 -61.13 2.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -41.8 -46.05 3.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.565 HD13 ' CE1' ' A' ' 314' ' ' PHE . 20.4 tp -52.23 -75.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.948 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . 0.492 ' HG3' ' CB ' ' A' ' 323' ' ' ALA . 19.4 mtp180 -53.22 -24.72 11.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -67.58 -39.96 84.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -97.79 19.74 13.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.063 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.565 ' CE1' HD13 ' A' ' 310' ' ' LEU . 7.1 m-85 -127.29 -29.72 2.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.584 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.8 OUTLIER -57.7 -45.61 99.81 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.704 0.764 . . . . 0.0 110.905 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.2 Cg_exo -47.98 -16.63 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.634 2.222 . . . . 0.0 112.377 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . 0.479 ' CE2' ' HG2' ' A' ' 353' ' ' MET . 50.0 m-85 -99.61 -46.92 5.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -165.05 166.31 38.14 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 33.9 m -67.33 133.6 49.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 111.141 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 321' ' ' THR . 37.7 mt -110.37 139.58 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.46 ' N ' HG22 ' A' ' 320' ' ' ILE . 41.6 p -109.85 -36.24 5.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 71.0 m -137.42 126.81 24.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . 0.492 ' CB ' ' HG3' ' A' ' 311' ' ' ARG . . . -156.46 119.25 4.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.068 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -150.24 132.25 15.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 49.9 t -82.22 125.2 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.153 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 20.8 mmm . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.878 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 29.9 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.934 0.397 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -53.72 -52.04 61.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 137.63 34.16 0.2 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.425 ' C ' HD12 ' A' ' 301' ' ' LEU . 4.0 p90 -175.39 156.38 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -154.47 172.45 32.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.508 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -117.22 139.41 50.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.411 ' CG2' HD11 ' A' ' 310' ' ' LEU . 24.1 t -133.85 149.29 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.172 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 20.9 t -132.76 134.23 44.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.838 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.529 ' CE1' HD13 ' A' ' 296' ' ' LEU . 6.5 m-85 -113.24 172.46 6.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.882 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.4 p -78.98 -47.94 15.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 54.8 m -121.37 136.12 25.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.691 0.757 . . . . 0.0 110.83 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 346' ' ' ALA . 71.5 Cg_exo -45.87 -63.01 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.72 2.28 . . . . 0.0 112.357 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 343' ' ' PRO . 49.0 tt0 -36.2 -53.62 0.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -52.36 -44.4 65.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 343' ' ' PRO . . . -64.29 -41.91 96.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.08 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 98.1 m -50.77 -64.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 349' ' ' ALA . 31.8 tttm -43.09 -62.91 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.902 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.27 -53.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.108 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 93.6 t -38.2 -60.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 62.5 m -75.14 -55.27 5.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . 0.431 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 23.5 mm-40 -44.8 -26.26 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' MET . . . . . 0.479 ' HG2' ' CE2' ' A' ' 317' ' ' PHE . 83.3 mmm -102.19 -62.03 1.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -40.66 107.22 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 116.15 -5.88 19.65 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -95.74 125.78 40.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 0.0 110.871 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 358' ' ' VAL . 7.8 mm -85.7 150.31 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.131 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . 0.408 ' N ' HG23 ' A' ' 357' ' ' ILE . 95.6 t -132.23 -41.06 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -126.64 -71.91 0.67 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.093 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 16.5 p -131.63 -50.16 0.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.18 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.86 152.14 39.51 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.555 0.693 . . . . 0.0 110.909 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.48 146.77 35.43 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.699 2.266 . . . . 0.0 112.324 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.467 ' CD2' HD23 ' A' ' 301' ' ' LEU . 37.3 mt -77.22 88.95 3.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -66.34 94.56 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 17.2 t -97.12 150.95 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -164.3 166.24 21.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 58.7 mt -71.32 143.61 50.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.803 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.874 0.368 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 25.2 m -115.79 -23.98 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -67.13 104.13 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.554 HD13 ' CE1' ' A' ' 340' ' ' PHE . 45.6 mt -94.85 133.79 38.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -96.45 114.06 25.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.6 t -98.62 139.44 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.114 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.51 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 24.5 tttt -137.33 163.94 29.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . 0.51 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 6.4 m-20 63.19 49.38 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 25.0 mt -87.8 114.88 24.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.36 140.47 27.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -50.5 -42.31 54.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.812 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.26 -30.08 66.96 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.463 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 95.8 mt -72.62 130.78 35.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.34 . . . . 0.0 111.126 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -114.33 -179.11 3.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.96 -45.71 67.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.4 -54.12 47.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -47.03 -47.59 22.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.553 HD12 ' CE1' ' A' ' 314' ' ' PHE . 16.6 tp -53.96 -75.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -49.2 -25.4 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -78.81 -32.82 46.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.9 15.72 10.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.083 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.6 ' CZ ' ' SD ' ' A' ' 353' ' ' MET . 10.7 m-85 -128.79 -28.49 2.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -50.25 -46.07 83.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.679 0.752 . . . . 0.0 110.859 -179.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 315' ' ' SER . 63.8 Cg_exo -47.92 -16.89 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.688 2.259 . . . . 0.0 112.367 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -99.66 -41.49 7.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.52 169.0 36.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.492 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 97.0 m -83.21 96.48 8.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.81 0.338 . . . . 0.0 111.17 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 321' ' ' THR . 93.5 mt -65.55 145.9 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.423 ' N ' HG23 ' A' ' 320' ' ' ILE . 73.5 p -117.34 -28.52 6.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.125 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 3.0 p -152.83 109.38 3.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -131.72 142.56 49.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.093 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -154.08 170.24 21.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.13 121.55 54.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.145 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' MET . . . . . 0.541 ' HB2' ' CE2' ' A' ' 335' ' ' PHE . 10.2 mmm . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 333' ' ' LYS . 20.2 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.929 0.395 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . 0.472 ' HD3' ' CE1' ' A' ' 335' ' ' PHE . 18.3 mttm -34.57 -55.22 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 128.62 29.95 0.73 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.471 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.541 ' CE2' ' HB2' ' A' ' 326' ' ' MET . 43.7 p90 -164.74 157.15 16.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 0.0 110.907 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -159.63 -167.05 19.73 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.458 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -135.13 122.19 21.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.928 0.394 . . . . 0.0 110.872 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.423 ' CG2' HD13 ' A' ' 310' ' ' LEU . 46.5 t -116.18 98.1 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.122 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 1.7 m -86.9 135.84 33.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.554 ' CE1' HD13 ' A' ' 296' ' ' LEU . 23.1 m-85 -107.88 178.0 4.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 7.2 t -82.69 -36.48 25.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.813 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.9 m -133.57 133.92 23.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.681 0.753 . . . . 0.0 110.85 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.26 -59.58 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.725 2.283 . . . . 0.0 112.337 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -38.75 -57.32 1.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -54.29 -45.93 72.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.89 87.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.066 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 348' ' ' LYS . 14.5 m -45.65 -63.86 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.152 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 347' ' ' THR . 3.9 ttpm? -37.51 -65.93 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -41.13 -53.7 3.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 46.2 t -39.75 -52.24 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.129 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 82.7 m -78.85 -56.91 4.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -46.69 -24.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' MET . . . . . 0.6 ' SD ' ' CZ ' ' A' ' 314' ' ' PHE . 15.7 mtp -104.05 -43.99 5.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 6.8 t-20 -47.91 115.51 1.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 80.76 17.42 72.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.481 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -98.26 121.39 40.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.765 0.317 . . . . 0.0 110.853 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 9.2 mm -87.77 125.7 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.117 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.26 -59.53 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.164 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -109.01 -67.85 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.104 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 2.3 t -134.87 -49.06 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -99.79 151.24 37.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.568 0.699 . . . . 0.0 110.88 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.37 151.59 29.66 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.704 2.269 . . . . 0.0 112.355 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 32.9 mt -89.65 92.97 9.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -70.77 94.74 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.9 t -106.8 141.73 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.086 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -164.69 145.67 7.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 81.3 mt -56.68 137.83 53.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.785 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 97.8 t . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.864 0.364 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 343' ' ' PRO . 25.9 m -86.04 -36.9 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -54.72 136.59 45.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.42 HD23 ' CG2' ' A' ' 350' ' ' VAL . 40.6 mt -127.87 144.34 51.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -106.36 110.41 22.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.936 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.1 t -94.4 129.81 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.149 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.484 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 37.0 tttt -130.49 163.25 27.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . 0.484 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.5 m120 63.83 49.45 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.901 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.462 HD21 ' CD2' ' A' ' 363' ' ' LEU . 19.8 mt -87.12 105.98 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . 0.427 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 21.2 t70 -46.12 158.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.877 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -62.15 -37.52 85.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -67.02 -38.75 92.88 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.459 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 83.1 mt -61.65 112.69 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 111.138 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.19 -176.8 3.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.822 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.24 -62.6 1.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -52.46 -47.53 66.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -47.28 -34.13 6.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.458 HD12 ' CE1' ' A' ' 314' ' ' PHE . 54.0 tp -77.68 -56.22 4.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -58.33 -24.65 60.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -84.78 -22.82 29.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -95.18 16.21 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.125 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.458 ' CE1' HD12 ' A' ' 310' ' ' LEU . 7.9 m-85 -129.16 -29.12 2.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.593 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.8 OUTLIER -50.36 -45.54 83.75 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.65 0.738 . . . . 0.0 110.873 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.1 Cg_exo -48.04 -15.51 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.661 2.24 . . . . 0.0 112.342 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 352' ' ' GLU . 55.0 m-85 -99.13 -53.84 3.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.69 -179.1 37.06 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.437 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 320' ' ' ILE . 28.9 m -74.52 143.39 44.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 111.129 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . 0.467 ' N ' HG22 ' A' ' 319' ' ' THR . 55.3 mt -115.45 152.53 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.149 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 40.9 p -121.11 -41.2 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.5 t -137.38 119.42 15.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -146.35 126.62 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.081 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.466 ' HG2' ' N ' ' A' ' 325' ' ' VAL . 15.7 ttmm -159.99 151.1 19.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.466 ' N ' ' HG2' ' A' ' 324' ' ' LYS . 99.2 t -110.12 132.99 56.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 38.1 mmt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.934 0.397 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . 0.501 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 12.1 mmmt -53.55 -60.95 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.869 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 136.25 34.69 0.22 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.469 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' A' ' 333' ' ' LYS . 12.9 p90 -173.39 159.37 3.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -158.91 -171.95 25.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.498 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . 0.408 ' C ' HG23 ' A' ' 338' ' ' VAL . 87.2 m-85 -135.14 141.1 45.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.36 . . . . 0.0 110.837 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.437 HG13 ' N ' ' A' ' 339' ' ' CYS . 36.5 t -136.56 140.94 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.112 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . 0.437 ' N ' HG13 ' A' ' 338' ' ' VAL . 65.4 m -117.56 156.57 27.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -130.27 173.89 10.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 51.6 p -80.29 -40.99 25.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' SER . . . . . 0.423 ' C ' HG12 ' A' ' 294' ' ' VAL . 22.9 m -130.62 139.23 34.97 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.649 0.738 . . . . 0.0 110.882 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.451 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.3 Cg_exo -47.44 -54.88 4.49 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.688 2.259 . . . . 0.0 112.316 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -41.28 -55.61 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -51.71 -43.75 62.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.862 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.414 ' CB ' HD21 ' A' ' 296' ' ' LEU . . . -64.15 -41.5 97.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.09 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 94.6 m -49.71 -63.6 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -47.07 -61.92 1.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -37.71 -50.25 1.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 57.8 t -41.69 -55.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 90.2 m -78.7 -55.84 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 317' ' ' PHE . 18.8 mm-40 -44.08 -27.79 0.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' MET . . . . . 0.431 ' HE1' ' CD1' ' A' ' 363' ' ' LEU . 86.4 mmm -101.83 -42.59 6.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 12.9 t-20 -58.14 96.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 121.92 -13.97 9.1 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.469 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -77.12 112.93 14.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.898 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . 0.432 HD12 ' CA ' ' A' ' 362' ' ' PRO . 13.3 mm -78.25 138.29 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.096 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.99 -65.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.112 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -100.79 -75.24 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' A' ' 361' ' ' LYS . 1.0 OUTLIER -123.5 -47.34 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.555 ' N ' ' CG2' ' A' ' 360' ' ' THR . 12.1 pttm -109.39 159.0 33.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.553 0.692 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.432 ' CA ' HD12 ' A' ' 357' ' ' ILE . 60.2 Cg_endo -80.24 154.04 21.7 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.671 2.247 . . . . 0.0 112.369 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.462 ' CD2' HD21 ' A' ' 301' ' ' LEU . 31.4 mt -78.13 98.31 5.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -67.8 81.61 0.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 32.2 t -91.14 141.11 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.134 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -160.39 143.33 13.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.096 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 18.8 mt -59.87 141.48 55.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.801 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 70.9 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.882 0.372 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 343' ' ' PRO . 25.8 m -104.02 -35.16 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.54 143.31 57.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.55 HD12 ' CE1' ' A' ' 340' ' ' PHE . 58.2 mt -131.29 144.99 51.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -99.62 123.47 43.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 17.6 t -107.22 134.75 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.163 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' LYS . . . . . 0.545 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 21.9 ttmt -134.3 165.99 23.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' ASN . . . . . 0.545 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.9 m-20 61.16 51.36 4.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.463 HD21 ' CD2' ' A' ' 363' ' ' LEU . 30.9 mt -91.85 107.54 19.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.39 141.36 24.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -48.4 -34.51 10.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.86 -37.06 94.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.538 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 49.5 mt -70.33 136.91 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 111.164 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -126.49 -178.75 4.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 307' ' ' ASP . 21.5 t0 -51.27 -47.29 62.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -58.44 -66.32 0.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -43.58 -42.1 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.471 HD11 ' CE1' ' A' ' 314' ' ' PHE . 63.2 tp -60.59 -69.35 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -52.32 -27.82 16.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -72.7 -27.52 62.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -95.28 19.23 11.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' PHE . . . . . 0.471 ' CE1' HD11 ' A' ' 310' ' ' LEU . 8.6 m-85 -129.69 -31.31 2.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.854 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' SER . . . . . 0.587 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.2 m -50.89 -45.78 87.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.711 0.767 . . . . 0.0 110.874 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.8 Cg_exo -47.99 -17.25 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.683 2.255 . . . . 0.0 112.314 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' PHE . . . . . 0.561 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 55.5 m-85 -100.05 -49.64 4.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -163.04 160.63 33.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.5 m -60.63 138.28 58.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.311 . . . . 0.0 111.18 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 80.3 mt -114.89 130.73 68.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.9 p -103.62 -28.36 11.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 4.7 t -143.19 125.07 15.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -154.64 122.52 5.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' LYS . . . . . 0.42 ' HD3' ' N ' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -151.93 158.21 42.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.0 134.42 53.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' MET . . . . . 0.54 ' HG3' ' CE2' ' A' ' 335' ' ' PHE . 35.5 mmt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.008 0.433 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -46.93 -46.81 21.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.68 -28.46 3.39 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.507 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.54 ' CE2' ' HG3' ' A' ' 326' ' ' MET . 3.2 p90 -118.53 160.79 21.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.928 0.394 . . . . 0.0 110.875 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -153.44 -172.45 21.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.531 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -138.44 138.29 38.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.863 0.363 . . . . 0.0 110.884 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' VAL . . . . . 0.421 HG11 ' N ' ' A' ' 339' ' ' CYS . 30.9 t -130.27 143.79 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.121 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' CYS . . . . . 0.421 ' N ' HG11 ' A' ' 338' ' ' VAL . 84.3 m -121.6 143.09 49.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' PHE . . . . . 0.55 ' CE1' HD12 ' A' ' 296' ' ' LEU . 21.7 m-85 -118.19 175.59 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 23.2 t -83.85 -40.79 18.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' SER . . . . . 0.416 ' C ' HG12 ' A' ' 294' ' ' VAL . 70.7 m -130.37 139.33 35.3 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.898 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' PRO . . . . . 0.433 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.2 Cg_exo -47.43 -56.15 3.32 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.694 2.262 . . . . 0.0 112.332 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -41.49 -54.68 3.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -50.55 -45.35 56.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.56 95.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.086 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 61.0 m -51.25 -65.7 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.166 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 349' ' ' ALA . 28.6 tttt -44.38 -64.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.06 -48.83 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.114 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' VAL . . . . . 0.493 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 49.1 t -42.79 -56.3 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 52.8 m -79.69 -50.71 10.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' GLU . . . . . 0.561 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 24.3 mm-40 -47.66 -29.39 2.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' MET . . . . . 0.453 ' O ' ' N ' ' A' ' 356' ' ' ARG . 75.9 mmm -101.66 -51.75 3.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 7.0 t-20 -35.77 112.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.833 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 87.98 18.87 55.23 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.499 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 353' ' ' MET . 16.5 tpp180 -96.94 126.95 42.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.867 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 11.3 mm -93.27 142.62 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 64.6 t -131.84 -38.81 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.65 -72.68 0.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 2.5 p -131.71 -52.22 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.167 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -101.85 153.91 37.66 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.564 0.697 . . . . 0.0 110.931 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.84 146.38 29.71 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.671 2.248 . . . . 0.0 112.333 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' LEU . . . . . 0.463 ' CD2' HD21 ' A' ' 301' ' ' LEU . 43.1 mt -81.68 96.3 7.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -64.52 97.38 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' VAL . . . . . 0.465 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 37.0 t -103.19 125.35 57.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.153 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -150.6 150.81 31.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 49.5 mt -60.67 139.37 57.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.051 179.824 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.6 m -151.42 123.65 8.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 110.831 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 57.8 m -143.64 174.46 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 174.94 148.77 6.85 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.505 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 2.5 t -104.81 126.23 51.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 110.857 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 58.5 m -132.63 175.26 9.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.73 69.66 0.45 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.5 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 287' ' ' ARG . 1.2 m-20 -64.53 -51.35 63.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.342 . . . . 0.0 110.85 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 286' ' ' ASP . 16.8 ptp180 35.49 38.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . 0.421 ' C ' HD12 ' A' ' 288' ' ' ILE . 2.3 pp -83.92 -2.22 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.3 t -64.21 139.17 58.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.16 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -171.46 150.47 2.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -50.19 168.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.962 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -59.83 95.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.94 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 83.9 t -128.63 103.13 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.4 m -108.72 -26.25 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.135 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -65.59 128.57 36.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.508 HD12 ' CE1' ' A' ' 340' ' ' PHE . 38.5 mt -118.93 145.97 45.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -106.12 115.6 30.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 58.8 t -103.04 133.13 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.554 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 22.1 tttm -130.81 166.39 20.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . 0.554 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 6.7 m-20 63.58 54.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 40.9 mt -91.45 105.44 17.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.949 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -51.4 145.05 9.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.859 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -52.08 -34.01 41.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -67.55 -35.16 85.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.443 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.79 123.92 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.836 0.35 . . . . 0.0 111.121 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -116.0 171.32 7.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.827 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -38.02 -68.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -40.88 -56.5 2.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -45.91 -58.51 3.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 64.1 tp -52.7 -62.74 1.45 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -55.86 -24.56 37.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -81.67 -22.2 37.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -96.21 15.12 21.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.1 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.426 ' C ' ' HD2' ' A' ' 316' ' ' PRO . 6.2 m-85 -123.73 -32.38 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.7 OUTLIER -50.36 -45.87 83.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.627 0.727 . . . . 0.0 110.887 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.4 Cg_exo -47.97 -17.34 0.78 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.724 2.282 . . . . 0.0 112.342 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -100.07 -52.32 3.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.07 168.26 37.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.486 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 61.6 m -61.88 147.9 45.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 0.0 111.105 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 30.9 mt -125.1 134.05 67.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 71.8 p -110.72 -33.2 6.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -134.37 109.74 8.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -145.03 122.49 11.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.075 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -160.46 153.33 21.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 93.7 t -111.65 136.86 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 33.4 mmt -70.04 127.04 31.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 35.1 mmm -125.19 140.8 52.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.67 34.31 1.35 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 68.94 85.63 0.11 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.466 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 111.07 -41.2 2.3 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.474 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 -121.58 167.16 13.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.339 . . . . 0.0 110.845 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 333' ' ' LYS . 68.0 p -101.02 109.11 20.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.485 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 11.8 mmtp -35.7 -58.75 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.8 27.79 0.58 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.508 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.485 ' CE1' ' HB3' ' A' ' 333' ' ' LYS . 42.0 p90 -171.32 147.54 2.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.915 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -146.33 -170.37 14.86 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.458 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -134.22 142.09 47.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.899 0.38 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 33.6 t -135.83 132.54 50.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 65.5 m -117.61 145.48 44.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.892 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.508 ' CE1' HD12 ' A' ' 296' ' ' LEU . 46.7 m-85 -116.79 174.21 6.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 4.2 t -75.58 -42.41 52.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.829 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 49.2 m -132.3 143.32 48.37 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.635 0.731 . . . . 0.0 110.917 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.16 -58.24 1.85 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.737 2.291 . . . . 0.0 112.344 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -40.6 -56.17 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -53.81 -42.51 68.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.913 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.82 -43.95 91.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.078 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 47.0 m -48.59 -65.21 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.147 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.443 ' O ' ' C ' ' A' ' 349' ' ' ALA . 42.7 tttt -38.6 -64.97 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.888 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -34.52 -55.25 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . 0.469 ' CG2' HD21 ' A' ' 296' ' ' LEU . 58.7 t -38.02 -52.84 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 56.0 m -80.6 -53.72 6.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.144 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -49.94 -19.19 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' MET . . . . . 0.421 ' O ' ' C ' ' A' ' 354' ' ' ASN . 71.8 mmm -107.08 -59.85 1.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 353' ' ' MET . 9.1 t30 -36.3 111.01 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.895 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 99.01 9.62 51.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -95.86 118.84 33.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 110.89 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 11.0 mm -89.27 138.35 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 71.8 t -127.34 -43.64 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -116.43 -73.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.98 -47.62 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.14 156.9 37.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.63 0.728 . . . . 0.0 110.875 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.82 139.34 17.55 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.723 2.282 . . . . 0.0 112.341 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 65.1 mt -69.47 101.08 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.933 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -68.43 96.82 0.71 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 21.8 t -103.57 131.62 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.105 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -157.44 145.33 18.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.084 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 32.2 mt -63.0 138.87 58.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -95.53 86.83 4.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.059 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -38.49 -57.69 1.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -113.9 151.22 32.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.55 127.37 54.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.937 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -102.2 109.34 21.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.859 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -118.48 84.81 2.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -121.21 85.64 2.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -68.55 100.0 1.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 7.4 t -164.0 173.8 12.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -175.39 156.18 21.62 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.51 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.04 104.03 1.84 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.665 2.243 . . . . 0.0 112.391 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 77.3 p -60.95 91.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 2.5 m -161.93 163.39 29.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.833 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.485 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.5 m -101.56 110.16 22.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 110.883 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 30.6 t -112.04 140.56 46.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -178.45 -52.36 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.454 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 12.4 m -78.0 91.37 4.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.904 0.383 . . . . 0.0 110.864 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 73.0 m -125.48 83.73 2.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.826 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -56.75 130.16 50.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.484 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -117.41 -50.16 2.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.68 84.0 4.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.903 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 2.5 pp -86.67 143.84 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.144 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 72.2 p -82.25 140.35 33.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.103 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -107.59 -54.88 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.838 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -102.41 129.18 48.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -46.8 124.36 6.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.64 92.81 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.158 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 343' ' ' PRO . 15.1 m -93.07 -34.99 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -59.01 140.76 55.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.514 HD12 ' CE1' ' A' ' 340' ' ' PHE . 35.6 mt -130.4 135.58 48.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -96.13 106.14 18.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 49.0 t -89.77 131.13 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.118 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.457 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 20.5 tttt -135.22 161.82 34.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . 0.457 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 11.1 t-20 74.5 37.87 0.53 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 46.8 mt -79.98 91.32 5.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -46.26 148.62 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.42 -36.49 9.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.96 -40.62 98.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 41.6 mt -65.99 140.81 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.855 0.359 . . . . 0.0 111.113 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -134.15 177.71 7.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -52.45 -41.66 63.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -65.96 -61.8 1.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 64.8 mtt-85 -49.3 -34.14 14.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.423 ' CD1' ' CE1' ' A' ' 314' ' ' PHE . 61.5 tp -67.61 -71.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 45.3 ttt-85 -50.44 -25.45 3.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -73.89 -30.26 62.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -94.16 20.28 8.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.128 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.445 ' CB ' ' CD1' ' A' ' 320' ' ' ILE . 7.0 m-85 -126.17 -30.77 2.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.1 t -56.12 -45.32 99.92 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.688 0.756 . . . . 0.0 110.878 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 315' ' ' SER . 66.1 Cg_exo -48.02 -17.04 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.718 2.279 . . . . 0.0 112.324 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . 0.511 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 60.0 m-85 -99.93 -52.39 3.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.62 165.91 35.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.418 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.5 m -62.85 138.23 58.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.761 0.315 . . . . 0.0 111.145 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.445 ' CD1' ' CB ' ' A' ' 314' ' ' PHE . 82.0 mt -118.32 132.1 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 67.2 p -105.77 -40.48 5.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -126.51 111.14 14.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.81 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -142.6 119.83 11.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.1 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -153.56 162.36 41.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 78.4 t -121.72 142.98 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.136 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 34.1 mmt -68.39 95.58 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 71.3 mmm -109.2 121.2 44.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -145.95 119.42 9.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 83.86 57.21 2.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.476 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 38.45 40.33 0.93 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.443 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.51 169.36 24.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 110.857 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.8 t -106.6 118.83 37.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.825 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.2 -47.65 65.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 123.62 29.93 1.12 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 12.7 p90 -171.32 158.07 5.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.372 . . . . 0.0 110.868 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -161.45 -166.88 21.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.501 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -139.04 143.89 38.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 22.7 t -138.96 140.04 39.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 23.7 m -117.54 149.33 40.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.514 ' CE1' HD12 ' A' ' 296' ' ' LEU . 10.4 m-85 -122.84 176.92 5.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.835 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 32.6 t -78.45 -39.2 39.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.885 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 27.2 m -136.87 143.19 41.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.683 0.754 . . . . 0.0 110.843 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.455 ' N ' HG13 ' A' ' 294' ' ' VAL . 73.2 Cg_exo -47.35 -59.15 1.35 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 2.243 . . . . 0.0 112.347 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 343' ' ' PRO . 30.9 tt0 -37.63 -59.76 0.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -49.33 -41.39 38.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.08 -42.72 93.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.109 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.4 m -50.72 -67.81 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.167 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -40.55 -56.53 2.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 350' ' ' VAL . . . -44.4 -55.51 4.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.097 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . 0.445 ' HA ' ' CG1' ' A' ' 365' ' ' VAL . 84.3 t -36.6 -58.48 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.136 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 353' ' ' MET . 35.2 m -75.94 -60.35 2.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . 0.511 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 3.7 mm-40 -39.99 -27.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' MET . . . . . 0.491 ' HG2' ' CE2' ' A' ' 317' ' ' PHE . 77.6 mmm -101.29 -42.33 6.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 26.1 t30 -60.15 106.28 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.859 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 113.92 -3.66 24.23 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.469 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -98.88 144.24 28.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.894 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . 0.449 HG21 ' N ' ' A' ' 358' ' ' VAL . 8.3 mm -95.23 152.01 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.129 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.449 ' N ' HG21 ' A' ' 357' ' ' ILE . 45.1 t -131.95 -40.9 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.081 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -130.21 -66.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.0 -54.52 0.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.15 154.92 36.89 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.564 0.697 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.43 134.07 15.13 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 35.7 mt -66.16 123.92 21.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -95.96 89.44 5.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.445 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 2.9 t -90.78 134.53 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.061 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -153.87 142.87 21.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.068 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 27.9 mt -60.79 144.88 51.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -105.26 80.02 1.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -46.38 -52.74 12.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -100.81 153.44 19.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -161.86 116.7 1.95 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -103.11 137.56 41.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.859 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -88.33 133.57 34.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.907 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -100.01 121.78 41.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.901 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -135.63 152.95 51.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 74.6 m -55.84 155.59 5.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -179.81 74.18 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.511 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.6 150.37 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.642 2.228 . . . . 0.0 112.363 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 72.0 m -150.71 154.68 37.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 1.1 t -153.71 164.01 39.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.474 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 42.5 t -107.6 99.76 9.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.869 0.366 . . . . 0.0 110.876 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 4.0 m -154.54 152.83 30.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -175.97 113.96 0.46 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.478 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 8.0 m -113.18 131.65 55.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 0.0 110.841 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 41.8 t -100.45 -47.26 4.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.824 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.33 124.4 3.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.533 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -84.24 87.97 7.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 110.847 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -127.8 85.46 2.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 66.3 mt -140.78 130.94 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 82.5 p -98.61 167.41 10.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.141 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -123.56 -48.24 1.94 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -77.85 122.62 25.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -69.68 110.76 5.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 84.0 t -119.13 93.39 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.8 m -93.25 -30.65 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -67.99 133.11 48.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.46 HD22 ' CG2' ' A' ' 350' ' ' VAL . 65.6 mt -121.94 135.84 54.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -94.27 119.93 33.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.938 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 59.3 t -104.14 137.71 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.163 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 10.8 tttp -137.22 161.78 35.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.938 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . 0.471 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.1 m120 63.79 53.84 1.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.464 HD23 ' CD2' ' A' ' 363' ' ' LEU . 32.0 mt -86.67 94.47 9.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -44.41 149.15 0.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.81 -36.3 62.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.91 -38.36 95.97 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.468 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 81.6 mt -73.58 121.9 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.351 . . . . 0.0 111.103 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.43 177.91 4.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -39.28 -46.25 1.52 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 309' ' ' ARG . 0.2 OUTLIER -65.35 -69.57 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 308' ' ' GLU . 10.4 mmt180 -35.19 -36.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.541 HD11 ' CE1' ' A' ' 314' ' ' PHE . 47.8 tp -68.05 -75.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -48.85 -25.06 1.69 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -79.33 -32.64 43.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.99 21.03 2.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.094 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.541 ' CE1' HD11 ' A' ' 310' ' ' LEU . 8.8 m-85 -130.22 -30.41 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.597 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.1 t -53.1 -44.92 98.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.7 0.762 . . . . 0.0 110.872 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.4 Cg_exo -47.95 -17.59 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.685 2.257 . . . . 0.0 112.351 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -100.22 -54.9 2.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -159.28 163.67 33.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.462 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 44.5 m -61.31 143.27 55.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.727 0.298 . . . . 0.0 111.139 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 59.6 mt -117.69 149.37 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.122 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 61.9 p -117.27 -43.83 2.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.157 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 70.8 m -132.69 112.53 12.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -141.01 119.55 12.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.174 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -153.45 147.78 25.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 49.0 t -89.87 118.58 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.121 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' MET . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 335' ' ' PHE . 26.3 mmm -75.29 94.8 3.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.852 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' MET . . . . . 0.457 ' CB ' ' HA ' ' A' ' 332' ' ' SER . 5.1 ptp -119.84 179.71 4.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -126.14 91.3 3.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 73.09 -110.31 3.1 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.518 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . 0.411 ' C ' ' HG3' ' A' ' 331' ' ' ARG . . . -108.89 35.36 4.99 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.411 ' HG3' ' C ' ' A' ' 330' ' ' GLY . 18.4 mtm-85 -147.46 115.21 6.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 0.0 110.875 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.457 ' HA ' ' CB ' ' A' ' 327' ' ' MET . 47.1 t -71.25 99.0 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -38.62 -45.8 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 121.01 43.05 0.46 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.493 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 326' ' ' MET . 2.0 p90 -175.53 160.57 2.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 110.881 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -156.97 177.0 34.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -127.74 132.74 49.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.871 0.367 . . . . 0.0 110.837 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 37.2 t -133.24 135.3 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 9.6 t -117.23 135.96 53.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.459 ' CE1' HD11 ' A' ' 296' ' ' LEU . 10.9 m-85 -107.98 162.19 14.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 12.5 t -58.82 -46.92 86.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.85 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.14 146.1 58.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.654 0.74 . . . . 0.0 110.861 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 344' ' ' GLU . 71.9 Cg_exo -46.16 -57.78 2.02 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.694 2.263 . . . . 0.0 112.356 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 343' ' ' PRO . 17.4 mm-40 -37.09 -64.7 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.413 ' N ' ' CD ' ' A' ' 345' ' ' GLU . 0.2 OUTLIER -49.09 -43.25 41.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.89 -48.05 83.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.102 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 75.1 m -46.08 -63.02 1.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.178 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 349' ' ' ALA . 1.3 ttmp? -40.65 -65.56 0.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.58 -54.93 0.87 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.114 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . 0.498 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 59.3 t -41.43 -51.0 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.163 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 66.1 m -79.37 -58.0 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.118 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -45.78 -25.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.933 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 356' ' ' ARG . 65.3 mmm -102.16 -52.37 3.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 4.7 t-20 -34.25 111.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.916 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.04 20.98 58.28 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.497 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 353' ' ' MET . 17.5 tpp180 -98.05 123.33 42.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.883 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 10.9 mm -93.14 125.35 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.108 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 74.8 t -110.52 -51.63 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.133 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -113.22 -69.48 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.09 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 1.4 p -131.6 -53.23 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.65 153.37 37.95 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.589 0.709 . . . . 0.0 110.861 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.67 145.3 22.97 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.69 2.26 . . . . 0.0 112.344 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.464 ' CD2' HD23 ' A' ' 301' ' ' LEU . 48.4 mt -82.74 92.08 7.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -66.82 100.52 0.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.6 t -106.43 136.35 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -158.32 149.18 20.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 34.4 mt -59.31 137.28 58.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -114.41 122.48 46.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -74.49 131.78 41.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -133.71 162.69 31.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -170.25 105.04 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 44.18 41.66 4.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -73.96 -45.86 47.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.865 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . 0.416 ' C ' ' HD2' ' A' ' 374' ' ' ARG . 6.4 tmm_? -110.48 109.32 19.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -127.3 127.08 43.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.903 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 5.9 t -141.61 128.65 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -178.29 75.78 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.498 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.02 168.03 24.07 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.671 2.248 . . . . 0.0 112.322 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 50.3 p -116.35 147.67 41.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 33.3 t -108.7 153.56 23.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.502 -179.967 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 69.6 m -76.77 145.78 38.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.936 0.398 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 43.2 t -81.89 148.12 28.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.831 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 173.49 138.63 2.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.503 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 29.8 t -159.09 148.81 18.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 110.885 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 7.7 t -127.2 83.88 2.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.846 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -169.23 120.71 0.89 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -148.08 122.75 9.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.804 0.335 . . . . 0.0 110.879 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -97.37 144.65 26.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 65.9 mt -125.72 104.95 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 24.9 m -90.39 91.34 8.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -57.8 -44.04 86.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -66.55 155.98 36.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -81.76 105.88 13.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 86.8 t -126.58 96.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.097 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 29.0 m -95.88 -32.24 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.178 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -69.26 126.12 28.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.401 HD13 ' CE1' ' A' ' 340' ' ' PHE . 39.3 mt -114.6 140.17 49.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -95.59 121.16 36.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 67.0 t -103.01 133.53 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.127 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 26.8 tttm -133.82 162.49 31.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . 0.481 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.4 m120 63.77 48.27 3.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.907 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.462 HD13 ' CA ' ' A' ' 335' ' ' PHE . 28.9 mt -86.81 99.61 11.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -44.79 157.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -59.14 -42.18 90.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.53 -38.96 94.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.511 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 77.9 mt -65.92 132.33 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.896 0.379 . . . . 0.0 111.123 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.68 -174.93 3.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -46.96 -60.86 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 309' ' ' ARG . 12.5 tt0 -49.65 -65.13 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 308' ' ' GLU . 9.8 mmt85 -34.4 -49.08 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.863 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.565 HD12 ' CE1' ' A' ' 314' ' ' PHE . 67.7 tp -55.42 -74.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -49.07 -25.05 1.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -74.47 -40.47 61.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.34 19.01 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.109 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.565 ' CE1' HD12 ' A' ' 310' ' ' LEU . 7.3 m-85 -127.36 -30.16 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.598 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.2 t -54.02 -45.0 99.16 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.688 0.756 . . . . 0.0 110.872 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.8 Cg_exo -48.03 -17.88 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.703 2.268 . . . . 0.0 112.351 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . 0.558 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 57.4 m-85 -100.45 -61.09 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.863 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -148.69 159.32 27.99 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.458 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.432 HG23 ' N ' ' A' ' 320' ' ' ILE . 26.2 m -65.36 141.92 58.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.769 0.318 . . . . 0.0 111.157 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.458 HD11 ' CG1' ' A' ' 338' ' ' VAL . 79.8 mt -120.26 135.41 60.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 66.4 p -99.45 -36.55 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.6 t -137.81 122.62 18.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -137.16 124.18 21.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.062 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -150.67 149.81 30.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 79.5 t -115.38 138.87 44.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.099 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 39.3 mmt -61.45 122.68 15.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' MET . . . . . 0.404 ' HE1' ' C ' ' A' ' 331' ' ' ARG . 35.0 mtp -140.8 135.46 31.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -131.87 87.84 2.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.64 56.73 1.02 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.493 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 40.71 45.49 3.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.445 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.404 ' C ' ' HE1' ' A' ' 327' ' ' MET . 50.6 ptt85 -152.49 129.57 11.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 82.2 p -65.3 114.73 4.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.4 ' HE2' ' CZ ' ' A' ' 335' ' ' PHE . 22.7 mtpt -65.24 -47.07 78.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.39 27.45 0.62 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.488 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.462 ' CA ' HD13 ' A' ' 301' ' ' LEU . 7.8 p90 -174.98 165.72 3.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.883 0.373 . . . . 0.0 110.893 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -167.41 -163.31 21.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -144.16 138.98 28.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.377 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.458 ' CG1' HD11 ' A' ' 320' ' ' ILE . 53.7 t -130.73 142.46 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . 0.444 ' N ' HG13 ' A' ' 338' ' ' VAL . 74.0 m -114.29 145.7 41.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.401 ' CE1' HD13 ' A' ' 296' ' ' LEU . 18.1 m-85 -120.83 174.55 6.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.5 t -73.58 -42.0 62.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.85 145.88 38.49 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.645 0.736 . . . . 0.0 110.837 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.402 ' O ' ' C ' ' A' ' 344' ' ' GLU . 71.5 Cg_exo -46.41 -56.18 3.15 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.699 2.266 . . . . 0.0 112.332 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 343' ' ' PRO . 3.6 mm-40 -37.56 -63.52 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -47.75 -45.89 29.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.92 -44.06 97.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 92.8 m -45.9 -61.67 1.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.167 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 349' ' ' ALA . 15.4 ttmt -46.94 -61.95 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -37.52 -50.35 1.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . 0.499 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 57.7 t -41.16 -57.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.113 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 94.2 m -77.48 -55.33 5.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.154 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . 0.558 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 25.6 mm-40 -43.24 -30.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' MET . . . . . 0.448 ' O ' ' C ' ' A' ' 354' ' ' ASN . 72.8 mmm -100.82 -53.66 3.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 2.9 t30 -34.02 115.95 0.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 81.03 27.18 50.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.478 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -99.98 118.24 35.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.868 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . 0.444 HD13 ' CA ' ' A' ' 362' ' ' PRO . 27.0 mm -91.51 117.49 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 97.0 t -106.83 -45.01 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -118.55 -72.83 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.093 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.0 p -132.14 -51.74 0.96 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -100.32 148.84 35.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.549 0.69 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.444 ' CA ' HD13 ' A' ' 357' ' ' ILE . 62.9 Cg_endo -77.97 137.34 15.58 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.702 2.268 . . . . 0.0 112.374 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 62.5 mt -74.5 91.93 2.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -64.19 105.15 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.433 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 47.0 t -108.79 133.11 54.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.094 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -152.48 151.23 30.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.115 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 73.7 mt -58.79 136.49 57.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -98.68 172.73 7.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? -101.06 78.72 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.986 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 19.4 mmm-85 -145.83 158.51 43.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 31.5 mttp -106.73 -70.84 0.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -147.1 156.91 43.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -113.23 159.59 19.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -129.37 157.09 42.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -116.94 127.25 54.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 8.7 t -169.8 170.61 7.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -140.12 70.77 0.44 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.503 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.08 -179.08 5.08 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.715 2.277 . . . . 0.0 112.322 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 61.0 m -121.96 143.94 49.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.82 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 30.3 m -126.78 140.61 52.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.819 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.48 179.985 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 280' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 279' ' ' GLY . 92.8 p 35.61 44.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 0.0 110.888 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 66.1 m -140.07 162.13 35.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.85 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -174.57 160.33 29.61 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.525 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 2.6 m -148.57 170.81 17.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.855 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 78.2 p -133.38 172.31 12.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.884 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 136.32 109.39 0.97 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.484 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -173.0 169.26 4.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -109.32 166.99 10.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.849 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . 0.417 ' C ' HD12 ' A' ' 288' ' ' ILE . 2.7 pp -114.17 151.6 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.16 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 68.6 p -118.34 95.42 4.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 23.3 mmm-85 -63.7 -45.71 88.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -75.14 107.33 7.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -53.58 123.55 12.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.8 p -141.66 119.47 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 343' ' ' PRO . 19.2 m -118.45 -25.12 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -77.21 143.85 38.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.417 HD11 ' CE1' ' A' ' 340' ' ' PHE . 35.4 mt -131.3 135.87 47.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -94.93 123.83 38.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.2 t -105.07 130.82 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.139 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 34.4 tttp -129.54 162.24 28.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.872 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . 0.479 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.8 m-20 63.86 52.25 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 27.7 mt -93.51 91.16 6.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -40.52 135.34 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -41.08 -41.62 1.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -57.3 -38.72 88.04 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.506 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 57.8 mt -65.89 127.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.831 0.348 . . . . 0.0 111.168 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.4 178.51 4.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.828 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -54.8 -41.49 70.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.847 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -63.43 -57.61 9.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -42.36 -51.76 4.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 49.5 tp -57.28 -70.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -47.91 -27.63 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 10.7 mtpp -74.3 -32.06 62.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -91.66 18.4 7.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -127.11 -29.56 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.594 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -54.51 -45.35 99.44 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.673 0.749 . . . . 0.0 110.858 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.1 Cg_exo -47.92 -17.1 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.666 2.244 . . . . 0.0 112.38 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . 0.559 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 61.7 m-85 -99.87 -57.6 2.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -155.94 167.66 33.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.479 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 8.1 m -65.82 143.88 57.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.0 111.102 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 80.2 mt -123.81 139.43 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.7 p -110.74 -38.86 5.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.136 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 14.8 m -127.32 111.12 13.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -145.4 126.01 14.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.161 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.449 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 12.5 tptm -165.05 149.73 9.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.449 ' N ' ' HG3' ' A' ' 324' ' ' LYS . 93.7 t -98.13 139.47 20.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' MET . . . . . 0.41 ' N ' HG12 ' A' ' 325' ' ' VAL . 37.7 mmt -72.97 96.14 2.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 88.6 mmm -92.64 169.95 10.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.27 107.59 2.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 58.6 -111.88 3.59 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.516 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -113.14 41.18 2.29 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.5 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -160.84 171.23 19.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 110.89 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 333' ' ' LYS . 37.6 t -115.45 108.66 16.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.54 ' HD3' ' CZ ' ' A' ' 335' ' ' PHE . 22.1 mtpp -35.14 -48.01 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 117.38 36.59 0.99 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.46 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.54 ' CZ ' ' HD3' ' A' ' 333' ' ' LYS . 13.3 p90 -174.47 164.45 3.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.896 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -160.99 -166.78 20.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.404 ' C ' HG22 ' A' ' 338' ' ' VAL . 36.9 m-85 -134.4 144.37 48.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.868 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.404 HG22 ' C ' ' A' ' 337' ' ' PHE . 49.0 t -137.08 132.13 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 7.2 t -115.92 134.76 54.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.417 ' CE1' HD11 ' A' ' 296' ' ' LEU . 16.5 m-85 -110.86 170.19 8.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.916 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 47.9 t -79.97 -43.32 22.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.895 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 3.0 m -125.29 138.48 31.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.666 0.746 . . . . 0.0 110.84 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.467 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.1 Cg_exo -47.43 -60.02 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.643 2.229 . . . . 0.0 112.37 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 343' ' ' PRO . 42.6 mt-10 -37.44 -58.7 0.83 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -47.35 -45.06 24.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.41 -43.18 99.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.071 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.7 m -51.07 -67.64 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.216 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 349' ' ' ALA . 26.3 tttt -41.32 -63.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.96 -52.93 0.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 60.9 t -40.06 -54.25 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 81.0 m -79.76 -54.49 5.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.149 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . 0.559 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 17.5 mm-40 -46.42 -25.64 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' MET . . . . . 0.435 ' O ' ' C ' ' A' ' 354' ' ' ASN . 73.4 mmm -104.26 -52.23 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 4.2 t-20 -34.89 110.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 91.88 25.88 21.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -99.76 119.99 39.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 8.8 mm -90.66 127.49 43.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.173 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 67.1 t -116.68 -40.98 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.142 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.11 -70.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.128 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.3 p -132.03 -52.91 0.98 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.151 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -99.99 149.44 35.98 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.606 0.717 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.57 136.81 17.69 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.721 2.281 . . . . 0.0 112.295 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 37.0 mt -66.85 100.35 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -73.75 95.4 2.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 52.7 t -96.95 144.05 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.077 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -157.96 171.7 19.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 28.4 mt -81.14 140.77 34.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.868 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -105.18 -61.41 1.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.102 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -67.87 137.18 55.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -97.05 -35.85 10.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.825 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -155.81 134.58 11.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -116.09 139.15 50.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -44.99 153.59 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -73.38 -66.05 0.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.39 178.39 9.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 64.5 p -161.82 129.79 4.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.829 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 137.6 146.19 5.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.458 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.17 156.48 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.702 2.268 . . . . 0.0 112.337 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 41.1 p -118.9 165.95 13.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.89 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 1.3 t -60.19 137.71 58.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.863 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.443 -180.0 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 4.0 m -99.01 160.68 14.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 110.86 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 47.1 m -102.17 -55.93 2.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 70.98 -142.79 35.18 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.494 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 4.6 t -173.06 147.26 1.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 110.809 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 41.9 m -96.61 160.44 14.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.881 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -175.77 115.97 0.55 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.507 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -161.56 160.33 28.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.806 0.336 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -143.28 149.48 37.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.826 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 17.7 pt -129.23 135.34 62.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 14.8 t -174.94 152.41 1.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.182 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 43.9 mtt-85 -140.75 175.44 9.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -143.42 152.76 41.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.943 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -59.95 113.14 2.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 81.4 t -140.99 111.03 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.72 -25.22 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -75.38 128.25 34.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.404 HD23 ' CG2' ' A' ' 350' ' ' VAL . 46.1 mt -118.62 147.84 43.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -106.76 115.51 30.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 31.8 t -100.46 127.95 52.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.155 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.445 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 42.9 tttp -129.16 160.88 31.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . 0.445 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.5 m120 63.78 50.48 2.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 24.1 mt -84.28 105.32 15.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 -45.19 137.42 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -44.97 -40.58 6.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -65.53 -37.97 94.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.479 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.61 107.6 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.822 0.344 . . . . 0.0 111.12 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -95.78 -176.46 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -51.22 -45.91 62.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -66.11 -54.14 29.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -45.27 -42.99 10.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.837 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.541 HD11 ' CE1' ' A' ' 314' ' ' PHE . 54.0 tp -60.22 -70.29 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.925 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.41 ' NH1' ' HB3' ' A' ' 311' ' ' ARG . 19.3 ttp-105 -53.37 -23.82 10.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -67.96 -35.99 79.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -95.01 20.25 9.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.087 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.541 ' CE1' HD11 ' A' ' 310' ' ' LEU . 7.2 m-85 -126.48 -30.38 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.596 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.0 OUTLIER -57.29 -44.79 99.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.62 0.724 . . . . 0.0 110.829 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.7 Cg_exo -48.07 -17.02 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.683 2.255 . . . . 0.0 112.335 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 53.6 m-85 -100.24 -51.48 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.97 163.9 34.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.4 m -63.99 140.7 58.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.124 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 90.9 mt -121.5 143.15 34.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.129 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 69.2 p -117.74 -42.19 2.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.156 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 65.4 m -115.47 105.89 13.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.845 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -137.52 112.71 9.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.059 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.436 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 33.5 tptt -143.54 145.01 32.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.436 ' N ' ' HG3' ' A' ' 324' ' ' LYS . 49.0 t -110.16 117.48 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 35.8 mmt -55.49 141.72 35.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' MET . . . . . 0.437 ' N ' ' HD2' ' A' ' 333' ' ' LYS . 50.4 mtp -146.21 165.56 28.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.452 ' HG3' ' CG ' ' A' ' 333' ' ' LYS . 56.4 mt-10 -113.37 64.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 79.63 -41.35 2.32 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.509 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -152.37 -35.4 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.436 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -85.66 154.23 21.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 110.853 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 67.9 p -89.04 110.53 21.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.819 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.552 ' HB3' ' CE2' ' A' ' 335' ' ' PHE . 23.7 mttm -48.59 -52.3 23.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 122.33 33.47 0.89 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.508 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 333' ' ' LYS . 20.1 p90 -173.03 159.67 4.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.924 0.392 . . . . 0.0 110.864 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -162.08 -170.46 26.88 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.401 ' C ' HG22 ' A' ' 338' ' ' VAL . 37.7 m-85 -131.56 141.02 49.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.882 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.401 HG22 ' C ' ' A' ' 337' ' ' PHE . 18.5 t -136.51 125.95 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 10.1 t -110.4 134.88 51.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -107.59 165.6 11.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 5.0 t -73.36 -39.75 64.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 68.4 m -127.01 139.5 35.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.663 0.744 . . . . 0.0 110.878 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.62 -60.5 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.715 2.276 . . . . 0.0 112.341 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -40.31 -57.67 1.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -46.87 -46.77 21.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.65 99.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.081 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 56.5 m -53.2 -63.56 1.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 349' ' ' ALA . 37.8 tttt -43.64 -62.77 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -37.37 -51.65 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . 0.502 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 58.0 t -40.53 -55.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.151 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 73.4 m -78.74 -55.44 5.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . 0.501 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 2.5 mm-40 -45.01 -27.86 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' MET . . . . . 0.484 ' O ' ' CB ' ' A' ' 356' ' ' ARG . 82.3 mmm -102.49 -52.24 3.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.838 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 2.5 t30 -33.96 118.66 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 79.5 18.8 72.76 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.453 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 353' ' ' MET . 22.4 tpp180 -100.12 125.79 46.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.752 0.31 . . . . 0.0 110.872 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . 0.441 HD12 ' CA ' ' A' ' 362' ' ' PRO . 29.2 mm -88.59 139.88 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 90.7 t -128.35 -34.74 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.153 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -131.27 -69.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.68 -51.2 0.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.177 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.32 155.84 37.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.603 0.716 . . . . 0.0 110.886 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.441 ' CA ' HD12 ' A' ' 357' ' ' ILE . 63.1 Cg_endo -77.77 142.67 20.4 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.369 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 34.4 mt -79.19 92.97 5.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -65.23 97.69 0.28 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 7.6 t -101.17 145.11 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.104 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -158.95 154.64 26.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.093 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.63 140.66 58.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -119.2 100.64 7.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -114.21 41.59 2.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -88.59 -53.77 4.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 28.0 tttp -139.54 153.43 47.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -125.75 122.31 35.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.872 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.84 145.29 47.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -146.83 162.83 37.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -90.2 95.17 10.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.904 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 87.9 p -164.12 144.32 8.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.89 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 120.44 98.64 1.68 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.459 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.9 149.2 32.85 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.69 2.26 . . . . 0.0 112.393 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 18.3 m -100.48 133.7 44.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.858 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 34.8 t -164.64 164.63 21.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.868 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.449 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 93.1 p -94.88 123.28 38.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.812 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 3.2 m -67.62 -54.03 23.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.844 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 112.18 135.53 6.56 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.504 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 53.1 p -114.18 161.16 18.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 0.0 110.831 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 28.0 t -123.33 101.66 7.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.845 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 169.0 149.33 6.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.531 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.52 95.03 9.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.805 0.336 . . . . 0.0 110.87 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -67.88 -32.72 73.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 61.4 mt -49.47 100.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.121 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 57.8 m -148.7 127.15 12.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.101 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . 0.421 ' O ' ' CG ' ' A' ' 291' ' ' TYR . 59.9 mtp180 -128.1 96.54 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.859 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.421 ' CG ' ' O ' ' A' ' 290' ' ' ARG . 45.4 m-85 -161.6 129.9 4.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -89.16 115.76 26.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 88.1 t -130.63 111.69 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.409 HG21 ' N ' ' A' ' 295' ' ' ASN . 24.2 m -108.85 -34.72 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.409 ' N ' HG21 ' A' ' 294' ' ' VAL . 2.0 p-10 -59.64 143.74 49.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 20.2 mt -134.7 153.38 52.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -115.3 118.81 34.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.7 t -100.19 137.06 28.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.076 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -138.92 155.71 47.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 74.78 39.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 33.9 mt -73.43 90.66 1.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.911 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -40.76 139.92 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.4 -41.58 9.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.862 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.85 -38.97 94.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.44 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 66.7 mt -66.52 143.69 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.856 0.36 . . . . 0.0 111.157 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -132.21 -175.03 3.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -57.79 -42.73 84.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -64.65 -63.81 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 74.5 mtt-85 -46.23 -44.56 16.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.51 HD11 ' CE1' ' A' ' 314' ' ' PHE . 47.5 tp -55.37 -75.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.415 ' HG3' ' CD1' ' A' ' 320' ' ' ILE . 58.7 ttp180 -48.95 -29.53 4.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -72.14 -33.68 67.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -85.98 20.35 2.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.51 ' CE1' HD11 ' A' ' 310' ' ' LEU . 8.4 m-85 -128.99 -30.73 2.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.83 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.81 -45.34 97.25 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.716 0.769 . . . . 0.0 110.882 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.6 Cg_exo -48.03 -16.73 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.664 2.243 . . . . 0.0 112.351 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . 0.551 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 57.9 m-85 -99.84 -46.62 5.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -169.0 165.97 39.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.542 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.436 HG23 ' N ' ' A' ' 320' ' ' ILE . 42.0 m -62.59 140.19 58.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.116 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.436 ' N ' HG23 ' A' ' 319' ' ' THR . 74.5 mt -109.92 145.56 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.112 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 82.4 p -109.98 -45.39 3.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 82.7 p -136.3 116.53 13.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.842 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -135.2 123.46 23.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -150.61 152.4 33.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 55.2 t -112.34 130.17 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 37.5 mmt -75.48 113.63 13.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' MET . . . . . 0.421 ' CB ' ' HA ' ' A' ' 332' ' ' SER . 4.4 ptp -151.37 169.56 21.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.3 112.17 10.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.934 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 64.06 -113.75 6.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -110.44 39.74 2.79 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.452 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -150.17 125.75 10.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.853 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.421 ' HA ' ' CB ' ' A' ' 327' ' ' MET . 1.4 t -87.62 121.61 30.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.879 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.532 ' HB3' ' CE2' ' A' ' 335' ' ' PHE . 58.2 mttt -52.49 -61.47 2.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 136.9 37.58 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.466 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.532 ' CE2' ' HB3' ' A' ' 333' ' ' LYS . 23.2 p90 -174.82 162.06 3.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 0.0 110.907 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -159.27 -169.16 22.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.477 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -138.8 137.02 36.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.866 0.365 . . . . 0.0 110.912 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 48.8 t -138.04 136.48 44.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.149 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 10.1 t -121.39 133.49 55.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -104.13 158.91 16.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.851 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.4 m -64.04 -43.07 96.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 71.0 m -125.38 136.97 28.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.67 0.748 . . . . 0.0 110.859 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.4 -56.87 2.69 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.648 2.232 . . . . 0.0 112.361 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -43.82 -61.33 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -47.66 -46.05 28.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.75 -41.18 97.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.062 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 31.4 m -51.49 -60.9 2.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.108 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -40.96 -58.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -46.48 -53.14 11.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.101 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . 0.469 ' HA ' ' CG1' ' A' ' 365' ' ' VAL . 98.6 t -38.48 -58.69 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.162 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 72.4 m -75.36 -59.08 2.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . 0.551 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 39.4 mm-40 -41.54 -28.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.9 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' MET . . . . . 0.455 ' HG2' ' CE2' ' A' ' 317' ' ' PHE . 64.1 mmm -100.06 -40.63 7.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -46.1 109.07 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.44 21.93 55.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . 0.42 ' C ' ' HD3' ' A' ' 356' ' ' ARG . 0.0 OUTLIER -98.1 125.19 42.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.762 0.315 . . . . 0.0 110.862 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . 0.455 HD13 ' CA ' ' A' ' 362' ' ' PRO . 27.6 mm -89.42 127.26 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 66.3 t -113.38 -42.89 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -123.0 -74.36 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.089 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 5.2 p -128.9 -49.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.184 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -105.14 150.15 38.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.574 0.702 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.455 ' CA ' HD13 ' A' ' 357' ' ' ILE . 61.5 Cg_endo -76.76 140.98 21.3 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.688 2.259 . . . . 0.0 112.331 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 32.4 mt -80.39 115.87 20.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -83.21 99.66 10.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.469 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 39.0 t -103.37 140.83 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -166.41 152.8 8.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.073 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 26.9 mt -65.93 132.48 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -79.37 173.84 12.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.072 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 370' ' ' ARG . 49.6 mt-30 -113.29 -42.21 3.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 369' ' ' GLN . 24.0 mmt-85 -34.51 -45.56 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.44 48.53 16.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.38 153.54 38.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -135.11 150.18 50.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -135.7 109.35 8.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.833 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -42.54 147.62 0.27 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.962 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 98.0 p -150.63 125.72 9.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.892 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -138.91 145.93 17.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.46 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.67 161.05 31.09 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.72 2.28 . . . . 0.0 112.303 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 4.1 m -165.58 176.54 8.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 32.6 p -111.82 99.51 8.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.51 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 4.3 m -115.89 166.67 11.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.389 . . . . 0.0 110.825 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 25.6 p -141.82 124.13 15.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 128.0 54.11 0.12 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.451 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 77.3 p -128.27 99.52 5.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.879 0.371 . . . . 0.0 110.843 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 43.4 p -143.02 160.72 39.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.78 87.75 0.31 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.508 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -149.43 141.96 24.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.84 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -112.29 145.81 39.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 20.3 pt -136.84 164.78 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.56 ' HB ' ' CE2' ' A' ' 291' ' ' TYR . 36.9 p -150.99 109.09 3.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.157 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . 0.419 ' HB3' ' NH1' ' A' ' 290' ' ' ARG . 21.5 ttp-105 -87.56 89.67 8.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.85 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.56 ' CE2' ' HB ' ' A' ' 289' ' ' THR . 36.0 m-85 -141.65 163.12 33.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -77.37 82.24 3.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.953 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 1.8 p -120.03 112.87 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.13 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.42 HG11 ' N ' ' A' ' 343' ' ' PRO . 23.1 m -117.88 -26.8 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -74.12 114.94 13.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 38.4 mt -105.45 132.97 50.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.955 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -90.28 120.09 31.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 299' ' ' LYS . 98.6 t -101.05 137.43 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.116 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.466 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 35.8 tttt -137.03 161.46 36.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . 0.466 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.0 m120 63.53 47.69 3.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.439 HD22 ' CD2' ' A' ' 363' ' ' LEU . 28.4 mt -80.23 102.46 9.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -45.9 143.9 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -52.39 -39.45 60.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -61.95 -37.11 93.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.79 148.22 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.852 0.358 . . . . 0.0 111.136 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -137.36 179.78 6.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -52.52 -38.67 60.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 309' ' ' ARG . 16.4 mm-40 -68.63 -72.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.888 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 308' ' ' GLU . 61.0 mtt-85 -36.99 -38.89 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.562 HD12 ' CE1' ' A' ' 314' ' ' PHE . 44.0 tp -63.32 -70.72 0.2 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.437 ' HG3' ' CD1' ' A' ' 320' ' ' ILE . 46.3 ttt180 -50.85 -24.98 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -79.4 -32.96 43.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.47 18.88 3.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.081 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.562 ' CE1' HD12 ' A' ' 310' ' ' LEU . 8.4 m-85 -129.36 -30.92 2.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.874 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.584 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.7 OUTLIER -50.79 -45.65 86.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.634 0.73 . . . . 0.0 110.84 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.7 Cg_exo -47.94 -17.05 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.662 2.241 . . . . 0.0 112.353 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . 0.432 ' CE2' ' HG2' ' A' ' 353' ' ' MET . 54.4 m-85 -99.84 -47.45 5.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -166.14 158.61 31.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.484 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.42 HG23 ' N ' ' A' ' 320' ' ' ILE . 40.8 m -60.7 139.13 57.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.738 0.304 . . . . 0.0 111.163 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 321' ' ' THR . 46.7 mt -110.99 141.69 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.463 ' N ' HG22 ' A' ' 320' ' ' ILE . 67.9 p -110.34 -40.39 4.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.068 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 3.5 m -132.12 121.24 23.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.883 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -132.98 125.18 29.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.102 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 22.2 mtpt -142.48 154.99 45.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 31.5 t -129.96 117.57 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.16 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' MET . . . . . 0.473 ' HE1' ' N ' ' A' ' 326' ' ' MET . 30.0 mmt -66.35 107.14 1.91 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 80.5 mtp -110.87 150.34 29.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.891 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -96.18 38.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 68.2 57.88 7.97 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.484 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 121.97 -40.46 2.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.478 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -115.44 102.93 10.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 9.2 t -44.55 116.32 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.46 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 21.2 mtpp -46.96 -53.31 12.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 300' ' ' ASN . . . 132.59 33.36 0.39 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.46 ' CE1' ' HB3' ' A' ' 333' ' ' LYS . 29.4 p90 -175.15 157.29 2.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -156.89 -161.38 10.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -142.46 131.65 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.386 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.43 HG12 ' CE1' ' A' ' 340' ' ' PHE . 61.7 t -127.36 134.25 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 7.3 m -110.26 138.78 46.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.43 ' CE1' HG12 ' A' ' 338' ' ' VAL . 28.8 m-85 -114.14 164.41 13.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.904 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.9 t -67.76 -46.51 71.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 3.5 m -130.69 142.67 46.37 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.638 0.733 . . . . 0.0 110.876 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 344' ' ' GLU . 72.8 Cg_exo -47.05 -59.34 1.28 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.652 2.234 . . . . 0.0 112.36 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 343' ' ' PRO . 39.8 mt-10 -36.09 -61.83 0.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -46.87 -47.28 21.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.89 -41.02 95.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 90.1 m -50.13 -62.8 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 349' ' ' ALA . 27.0 tttm -46.52 -63.94 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.21 -48.96 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.071 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . 0.474 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 47.0 t -41.66 -56.42 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.187 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 92.9 m -79.58 -51.99 8.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . 0.425 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 20.5 mm-40 -46.3 -29.44 1.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' MET . . . . . 0.439 ' O ' ' C ' ' A' ' 354' ' ' ASN . 53.4 mmm -101.51 -52.71 3.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 1.8 t30 -34.22 116.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.921 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 82.7 25.57 49.58 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.523 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -100.05 118.27 36.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.723 0.297 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . 0.446 HD11 ' CA ' ' A' ' 362' ' ' PRO . 29.6 mm -86.73 126.43 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 94.9 t -112.18 -48.49 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.172 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -120.75 -68.24 0.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.067 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 6.0 p -130.88 -54.44 1.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.139 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.43 151.17 37.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.561 0.696 . . . . 0.0 110.882 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.446 ' CA ' HD11 ' A' ' 357' ' ' ILE . 63.0 Cg_endo -77.13 143.78 22.96 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.641 2.227 . . . . 0.0 112.353 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.439 ' CD2' HD22 ' A' ' 301' ' ' LEU . 33.2 mt -78.68 91.97 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -64.32 101.82 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 50.8 t -105.66 134.49 47.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.122 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -154.54 153.65 31.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.26 136.75 58.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -124.31 109.21 13.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.169 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -92.47 128.32 38.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.926 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 10.8 ttm105 -159.7 158.68 31.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.853 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -115.48 169.96 8.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 43.89 43.55 5.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' A' ' 374' ' ' ARG . 7.5 pt-20 -45.15 -38.18 5.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . 0.402 ' N ' ' HG3' ' A' ' 373' ' ' GLU . 15.9 tpp85 -174.93 127.82 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.1 108.79 2.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.5 m -151.15 166.99 29.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -136.04 95.61 0.25 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.457 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -77.99 38.81 0.71 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.718 2.279 . . . . 0.0 112.355 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 5.9 p -45.56 -28.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.824 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 12.3 t -113.46 105.55 13.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.536 -179.943 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 7.9 t -111.77 -52.31 2.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.917 0.389 . . . . 0.0 110.869 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 22.9 t -45.43 -45.41 12.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.891 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 46.97 56.02 7.99 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.443 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 3.5 m -72.8 90.16 1.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.929 0.395 . . . . 0.0 110.817 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.8 t -56.67 -60.37 3.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.864 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -132.73 141.05 12.37 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.476 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -43.96 -51.56 7.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.859 0.361 . . . . 0.0 110.85 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 16.2 mtp85 50.51 42.3 26.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.879 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 62.5 mt -91.96 -45.1 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 14.9 t -159.45 152.76 22.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.144 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -125.05 40.69 3.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -146.76 148.34 31.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.879 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . 0.438 ' CD ' ' O ' ' A' ' 292' ' ' GLN . 5.1 pp0? -78.64 118.17 20.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 99.6 t -126.49 93.53 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.406 HG11 ' N ' ' A' ' 343' ' ' PRO . 4.6 m -93.85 -32.54 4.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -64.93 135.84 56.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.459 ' CD2' HD21 ' A' ' 367' ' ' LEU . 48.4 mt -122.33 137.73 54.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -98.75 106.56 18.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.2 t -90.3 135.75 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.164 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.492 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 17.3 ttmm -133.25 164.76 26.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . 0.492 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.7 m-20 63.77 45.34 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.462 HD21 ' CD2' ' A' ' 363' ' ' LEU . 28.4 mt -90.61 98.09 11.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -46.35 163.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.32 -36.62 84.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.26 -43.58 97.13 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.533 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 39.6 mt -60.91 147.49 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.336 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -137.31 -176.82 4.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.823 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -60.14 -34.08 73.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -72.13 -62.25 1.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.878 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -46.82 -42.78 17.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.416 ' CD1' ' CE1' ' A' ' 314' ' ' PHE . 61.2 tp -62.38 -71.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.447 ' CG ' HD11 ' A' ' 320' ' ' ILE . 37.2 ttt180 -48.43 -26.58 2.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -70.48 -33.69 71.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -92.35 18.94 7.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.108 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.416 ' CE1' ' CD1' ' A' ' 310' ' ' LEU . 6.3 m-85 -123.76 -31.16 3.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.8 OUTLIER -56.85 -45.48 99.95 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.643 0.735 . . . . 0.0 110.846 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.9 Cg_exo -47.95 -17.06 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 0.0 112.385 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . 0.568 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 62.0 m-85 -99.92 -48.91 4.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.26 168.08 37.11 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.455 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.3 m -64.37 139.39 58.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.787 0.327 . . . . 0.0 111.124 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.447 HD11 ' CG ' ' A' ' 311' ' ' ARG . 42.1 mt -115.85 133.93 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 75.2 p -108.15 -40.62 5.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.127 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.9 m -130.09 112.61 13.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.815 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -138.65 124.31 19.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.122 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 19.2 tptm -163.63 146.55 9.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.458 HG13 ' N ' ' A' ' 326' ' ' MET . 98.9 t -101.05 136.23 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.113 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' MET . . . . . 0.458 ' N ' HG13 ' A' ' 325' ' ' VAL . 37.5 mmt -74.8 95.2 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 49.5 mtp -110.04 164.45 12.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.842 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -152.17 132.29 13.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.948 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 49.43 65.1 2.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.451 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 42.3 39.15 3.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.461 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 -155.57 122.36 5.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.862 0.363 . . . . 0.0 110.881 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 5.6 t -75.85 121.53 22.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -58.11 -53.62 56.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.899 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 138.78 36.86 0.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.5 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -171.93 152.76 3.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.857 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -154.08 -174.11 23.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.519 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -133.62 143.74 48.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 110.895 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 48.7 t -138.7 147.59 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 62.6 m -124.52 149.03 47.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -125.2 175.96 7.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 90.2 p -75.11 -29.79 60.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 43.4 t -156.75 145.05 14.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.717 0.77 . . . . 0.0 110.789 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 346' ' ' ALA . 71.3 Cg_exo -45.06 -54.01 4.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.693 2.262 . . . . 0.0 112.359 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -39.01 -37.92 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -76.2 -38.64 56.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 343' ' ' PRO . . . -65.79 -45.39 82.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 87.5 m -49.3 -67.82 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.172 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.442 ' HG2' ' CG ' ' A' ' 352' ' ' GLU . 19.7 tttm -41.14 -60.71 1.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -40.8 -52.45 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 66.2 t -39.47 -59.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 353' ' ' MET . 51.9 m -77.51 -59.6 2.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.159 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . 0.568 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 30.9 mm-40 -37.44 -29.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' MET . . . . . 0.468 ' N ' ' O ' ' A' ' 351' ' ' THR . 79.6 mmm -100.24 -61.3 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 353' ' ' MET . 8.0 t30 -36.8 101.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 125.68 -9.26 7.68 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.511 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.42 126.54 35.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 110.878 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . 0.467 HD11 ' CA ' ' A' ' 362' ' ' PRO . 23.4 mm -87.94 135.27 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 65.6 t -113.63 -54.54 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -116.08 -65.39 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.064 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.76 -52.65 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.81 153.67 38.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.548 0.69 . . . . 0.0 110.893 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.467 ' CA ' HD11 ' A' ' 357' ' ' ILE . 60.0 Cg_endo -73.5 148.24 42.31 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.324 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.462 ' CD2' HD21 ' A' ' 301' ' ' LEU . 58.7 mt -70.8 93.61 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -68.08 88.28 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 14.3 t -92.66 140.09 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.09 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -155.96 138.32 14.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . 0.459 HD21 ' CD2' ' A' ' 296' ' ' LEU . 60.2 mt -57.76 141.45 48.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -101.71 94.01 5.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.121 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 370' ' ' ARG . 34.2 mt-30 -100.07 -32.45 10.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 369' ' ' GLN . 13.4 mtt85 -38.13 -51.91 1.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -170.49 131.77 0.94 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.841 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -91.07 159.91 15.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -91.35 100.81 13.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -160.35 131.86 5.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -80.88 134.0 35.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 31.5 m -130.92 -56.79 1.04 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 64.3 95.6 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.488 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -43.96 -51.52 6.41 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.709 2.272 . . . . 0.0 112.33 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 3.4 m -163.64 159.73 22.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 90.7 p -72.85 117.55 14.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.816 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.488 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.451 -0.259 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.4 t -127.4 140.93 51.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.935 0.397 . . . . 0.0 110.864 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 75.5 m -150.2 177.79 9.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.847 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 133.82 64.24 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.474 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 67.7 m -128.74 165.71 20.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.841 0.353 . . . . 0.0 110.905 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.6 t -103.3 -54.86 2.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 109.35 170.47 20.52 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.489 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -87.01 116.63 25.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -147.83 141.47 25.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 3.2 pt -128.07 133.56 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.123 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 57.5 m -142.05 107.64 5.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.179 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . 0.405 ' O ' ' CG ' ' A' ' 291' ' ' TYR . 7.8 mmt85 -122.96 79.41 1.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.405 ' CG ' ' O ' ' A' ' 290' ' ' ARG . 70.2 m-85 -157.14 159.62 37.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.935 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -93.25 95.43 9.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 98.6 t -132.89 95.02 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 343' ' ' PRO . 23.9 m -94.55 -23.82 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.175 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -78.35 137.92 38.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.458 ' CD1' ' CE1' ' A' ' 340' ' ' PHE . 36.2 mt -128.08 142.85 51.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.958 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -99.65 121.87 41.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.57 130.1 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.098 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 16.0 tttm -128.44 157.56 40.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . . . . . . . . . 3.4 m120 63.83 54.94 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.456 HD21 ' CD2' ' A' ' 363' ' ' LEU . 28.3 mt -92.56 98.07 11.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.939 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 303' ' ' ASP . 14.8 t70 -50.24 131.42 23.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 302' ' ' ASP . 12.9 t70 -35.61 -49.86 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -48.35 -44.98 28.45 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.73 143.15 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.826 0.346 . . . . 0.0 111.125 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.8 -175.76 4.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.828 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.74 -42.94 65.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -62.25 -70.25 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 66.7 mtt-85 -41.66 -40.73 2.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.535 HD13 ' CE1' ' A' ' 314' ' ' PHE . 43.2 tp -60.72 -70.92 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.438 ' HG3' ' CD1' ' A' ' 320' ' ' ILE . 54.6 ttt180 -53.2 -23.71 9.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -68.7 -37.97 79.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -91.82 20.09 5.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.098 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.535 ' CE1' HD13 ' A' ' 310' ' ' LEU . 7.1 m-85 -126.19 -30.34 2.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.864 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.589 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.0 OUTLIER -56.9 -45.52 99.95 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.664 0.745 . . . . 0.0 110.822 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 315' ' ' SER . 66.1 Cg_exo -48.0 -17.16 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 0.0 112.354 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . 0.532 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 48.6 m-85 -100.8 -52.84 3.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -145.72 170.62 26.94 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.464 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.4 m -85.93 95.19 9.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 0.0 111.143 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.438 ' CD1' ' HG3' ' A' ' 311' ' ' ARG . 93.4 mt -62.07 143.59 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.181 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 39.1 p -112.13 -28.54 7.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 2.6 t -155.37 109.23 2.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -123.19 135.77 54.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -156.57 152.7 27.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 86.7 t -115.96 139.18 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.101 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 35.9 mmt -70.72 136.99 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' MET . . . . . 0.403 ' HE1' ' C ' ' A' ' 331' ' ' ARG . 18.4 mtp -133.91 178.17 7.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -116.15 -30.19 6.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.861 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 147.72 41.59 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.459 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 155.41 -42.61 0.57 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.479 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . 0.403 ' C ' ' HE1' ' A' ' 327' ' ' MET . 10.0 ptp180 -127.7 159.97 33.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.823 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 59.2 p -81.76 140.35 34.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.416 ' HD3' ' CZ ' ' A' ' 335' ' ' PHE . 19.0 mtpt -75.57 -60.77 2.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 149.14 37.72 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.525 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.416 ' CZ ' ' HD3' ' A' ' 333' ' ' LYS . 34.9 p90 -174.02 150.09 1.56 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.899 0.38 . . . . 0.0 110.891 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -158.12 -169.0 21.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.479 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -136.34 143.22 43.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 0.0 110.882 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.432 HG11 ' CE1' ' A' ' 340' ' ' PHE . 41.2 t -134.05 126.84 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.15 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 74.3 m -101.41 127.56 48.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.458 ' CE1' ' CD1' ' A' ' 296' ' ' LEU . 15.5 m-85 -101.76 168.14 9.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 25.1 t -78.36 -42.24 31.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.9 m -131.24 139.75 36.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.664 0.745 . . . . 0.0 110.875 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.468 ' N ' HG12 ' A' ' 294' ' ' VAL . 72.8 Cg_exo -47.43 -59.01 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.718 2.279 . . . . 0.0 112.332 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 343' ' ' PRO . 27.9 tt0 -36.39 -59.06 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.921 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.43 -48.11 56.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -55.88 -42.92 76.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.088 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 99.2 m -52.93 -67.15 0.27 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.19 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 349' ' ' ALA . 15.2 ttmt -40.85 -65.06 0.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.6 -48.24 0.51 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.112 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . 0.492 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 43.4 t -44.38 -52.66 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 53.1 m -81.79 -50.41 9.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . 0.532 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 23.4 mm-40 -49.62 -28.13 5.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 356' ' ' ARG . 83.7 mmm -101.84 -49.0 4.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 3.5 t30 -36.1 110.53 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 87.75 19.83 52.74 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.507 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 353' ' ' MET . 21.8 tpp85 -99.11 120.97 40.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.897 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 9.0 mm -87.11 130.92 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.145 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 85.2 t -116.43 -42.29 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.073 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -126.1 -69.23 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.11 -55.25 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.98 155.68 36.17 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.558 0.694 . . . . 0.0 110.942 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.18 135.55 15.34 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.68 2.253 . . . . 0.0 112.301 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.456 ' CD2' HD21 ' A' ' 301' ' ' LEU . 28.0 mt -71.72 88.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -64.48 100.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.94 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 28.8 t -100.09 135.25 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -153.94 143.16 21.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 71.7 mt -54.14 145.18 17.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -133.79 176.19 8.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -84.51 128.57 34.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.865 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -94.67 156.33 16.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -107.83 160.56 15.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -78.76 -47.76 16.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 374' ' ' ARG . 29.9 tt0 -167.61 155.67 9.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.843 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . 0.462 ' N ' ' HG2' ' A' ' 373' ' ' GLU . 0.3 OUTLIER -153.34 132.37 12.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.869 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -122.75 140.09 53.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 82.5 p -59.96 -46.92 87.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 40.12 75.26 0.12 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.13 -20.22 13.02 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.655 2.237 . . . . 0.0 112.39 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 380' ' ' SER . 3.1 m -148.88 131.76 16.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.825 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 379' ' ' SER . 46.6 t -36.93 -53.79 0.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.896 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 72.3 m -68.09 -54.78 15.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 3.5 t -110.88 159.21 17.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 150.4 50.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.444 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 8.9 t -85.68 153.31 22.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.868 0.366 . . . . 0.0 110.858 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.0 p -107.43 156.29 19.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 79.56 67.86 1.54 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.451 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -132.19 94.3 3.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.812 0.339 . . . . 0.0 110.829 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -85.04 112.85 21.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 21.0 mm -96.44 -55.64 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 14.6 t -147.7 145.3 28.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.85 -13.67 15.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -73.85 133.46 43.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.909 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -62.29 95.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 74.7 t -120.32 88.15 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.46 HG13 ' N ' ' A' ' 343' ' ' PRO . 16.6 m -87.13 -30.39 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -69.63 123.21 20.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.552 HD13 ' CE1' ' A' ' 340' ' ' PHE . 69.1 mt -112.45 136.84 51.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.966 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -90.21 119.52 30.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.98 129.73 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.119 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.488 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 11.0 tttp -129.61 162.71 27.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . 0.488 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.4 m120 63.8 51.21 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.441 ' CD1' HG11 ' A' ' 325' ' ' VAL . 39.8 mt -85.85 99.41 11.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -46.91 144.26 2.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -47.45 -40.27 17.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -61.28 -36.82 93.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.503 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 66.9 mt -69.11 135.97 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.826 0.346 . . . . 0.0 111.14 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -136.18 -176.36 4.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -43.04 -63.3 0.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -47.06 -63.83 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -39.59 -52.5 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.564 HD12 ' CE1' ' A' ' 314' ' ' PHE . 53.1 tp -50.22 -74.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.96 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.461 ' CG ' HD12 ' A' ' 320' ' ' ILE . 19.3 ttt180 -54.2 -21.45 8.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -78.41 -29.51 47.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -99.91 17.96 19.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.564 ' CE1' HD12 ' A' ' 310' ' ' LEU . 8.0 m-85 -128.59 -30.39 2.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.73 -45.4 96.81 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.644 0.735 . . . . 0.0 110.82 -179.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 315' ' ' SER . 66.0 Cg_exo -48.0 -17.13 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.67 2.247 . . . . 0.0 112.341 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 52.0 m-85 -99.95 -50.11 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -145.91 169.19 27.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 90.4 m -81.86 88.19 6.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.725 0.298 . . . . 0.0 111.136 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.461 HD12 ' CG ' ' A' ' 311' ' ' ARG . 64.8 mt -65.56 131.57 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.151 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 3.1 t -108.75 -29.65 8.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.1 t -139.98 126.17 19.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -140.24 140.93 35.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.093 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -156.43 150.65 25.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 326' ' ' MET . 95.5 t -125.12 135.68 63.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' MET . . . . . 0.45 ' N ' HG13 ' A' ' 325' ' ' VAL . 35.7 mmt -70.11 106.15 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 42.1 mtp -111.65 153.47 26.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.442 ' OE1' ' C ' ' A' ' 328' ' ' GLU . 0.0 OUTLIER -124.03 103.05 8.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 65.88 -103.29 0.82 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.499 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -121.38 39.77 2.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.496 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -167.55 140.45 3.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 0.0 110.889 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.9 t -73.98 126.62 30.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.404 ' CG ' ' HB2' ' A' ' 328' ' ' GLU . 94.5 mttt -58.22 -56.31 23.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 141.14 36.9 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.471 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -174.2 161.37 3.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.92 0.391 . . . . 0.0 110.846 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -164.85 -167.83 26.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.492 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -144.2 136.13 26.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.902 0.382 . . . . 0.0 110.887 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.415 HG13 ' CE1' ' A' ' 340' ' ' PHE . 60.1 t -123.05 134.82 65.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 64.5 m -107.34 128.58 54.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.552 ' CE1' HD13 ' A' ' 296' ' ' LEU . 21.9 m-85 -105.03 160.86 14.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 95.7 p -67.42 -31.36 71.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.905 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' SER . . . . . 0.419 ' C ' HG13 ' A' ' 294' ' ' VAL . 4.8 t -148.48 143.41 17.33 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.681 0.753 . . . . 0.0 110.842 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.46 ' N ' HG13 ' A' ' 294' ' ' VAL . 72.9 Cg_exo -47.28 -58.97 1.42 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.636 2.224 . . . . 0.0 112.368 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 343' ' ' PRO . 22.4 mp0 -36.09 -64.94 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -44.8 -45.47 10.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.1 -42.51 96.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.137 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 97.2 m -45.8 -62.37 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.095 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 349' ' ' ALA . 44.4 tttp -48.41 -63.74 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.65 -48.06 0.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 48.3 t -43.19 -54.93 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.106 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 85.8 m -80.65 -48.99 11.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . 0.407 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 17.1 mm-40 -50.7 -26.65 5.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' MET . . . . . 0.458 ' O ' ' N ' ' A' ' 356' ' ' ARG . 75.2 mmm -103.31 -50.36 3.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 3.5 t-20 -40.72 105.92 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 95.71 16.78 38.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 353' ' ' MET . 0.0 OUTLIER -98.04 122.0 40.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.762 0.315 . . . . 0.0 110.893 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . 0.441 HD11 ' CA ' ' A' ' 362' ' ' PRO . 23.4 mm -88.76 134.26 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.113 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.86 -59.83 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.13 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -105.72 -70.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.099 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 16.9 p -133.64 -47.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.163 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -104.32 154.85 38.01 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.567 0.698 . . . . 0.0 110.886 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.441 ' CA ' HD11 ' A' ' 357' ' ' ILE . 62.6 Cg_endo -77.7 144.07 21.8 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.674 2.249 . . . . 0.0 112.363 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 37.8 mt -81.02 92.6 6.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -61.45 102.65 0.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 47.4 t -108.84 137.67 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.091 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -163.38 149.05 11.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.087 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 18.0 mt -60.5 148.38 37.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -113.84 174.8 5.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.105 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . 0.404 ' C ' ' HD3' ' A' ' 370' ' ' ARG . 24.9 mt-30 -150.85 151.4 32.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . 0.404 ' HD3' ' C ' ' A' ' 369' ' ' GLN . 1.6 mpp_? -140.26 174.51 10.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -125.15 110.63 14.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -87.29 -64.12 1.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -146.81 159.58 43.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.947 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -98.02 -58.05 2.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -62.37 147.19 49.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 5.6 t -99.9 -44.15 6.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 145.81 -162.93 28.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.514 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.6 101.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.716 2.277 . . . . 0.0 112.358 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 20.2 p -42.49 -42.27 3.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 43.6 m 49.69 43.29 24.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.489 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.5 t -110.56 -56.23 2.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.83 0.348 . . . . 0.0 110.828 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 20.1 m -60.53 114.29 2.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.854 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -131.49 46.78 1.05 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.443 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 33.8 m -131.22 156.32 45.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.916 0.389 . . . . 0.0 110.814 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 16.1 m -94.45 152.86 18.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.843 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.35 117.96 4.34 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.522 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -97.96 -56.93 2.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.844 0.354 . . . . 0.0 110.892 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -84.96 140.74 30.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 5.1 mp -88.08 -48.13 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 68.9 p -110.12 44.75 1.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 29.1 ttt85 -55.4 -53.4 56.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.824 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -105.67 126.12 51.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.903 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -93.36 102.36 14.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 1.3 p -125.25 111.57 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.171 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.42 HG13 ' C ' ' A' ' 342' ' ' SER . 10.1 m -112.12 -22.28 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -75.16 125.9 29.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.439 HD13 ' CE1' ' A' ' 340' ' ' PHE . 49.9 mt -111.37 145.03 39.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -110.99 105.53 14.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 39.1 t -89.5 137.14 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.168 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.559 ' HE2' ' CD1' ' A' ' 364' ' ' TYR . 17.7 ttpt -132.85 162.04 32.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . 0.47 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.8 m-20 64.02 51.72 2.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 30.9 mt -90.39 106.63 18.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -52.31 150.29 4.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.842 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -56.64 -34.3 67.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -64.82 -39.73 96.8 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.497 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 60.7 mt -62.82 139.14 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.829 0.347 . . . . 0.0 111.123 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -128.32 174.74 9.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.83 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -49.12 -43.1 41.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -62.86 -64.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 58.5 mtt-85 -42.81 -34.33 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 59.5 tp -67.74 -75.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -48.28 -25.79 1.7 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -70.51 -36.1 73.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -93.82 20.54 7.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.088 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.401 ' C ' ' HD2' ' A' ' 316' ' ' PRO . 7.3 m-85 -127.06 -29.69 2.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.636 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 2.7 t -58.05 -42.74 96.7 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.665 0.745 . . . . 0.0 110.887 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 315' ' ' SER . 63.4 Cg_exo -47.89 -17.21 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.67 2.247 . . . . 0.0 112.395 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -100.23 -51.94 3.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -158.31 175.65 35.42 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.447 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 92.0 m -77.39 134.25 38.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.728 0.299 . . . . 0.0 111.171 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 321' ' ' THR . 84.3 mt -110.32 138.36 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.13 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.435 ' N ' HG22 ' A' ' 320' ' ' ILE . 82.8 p -108.24 -39.06 5.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 72.7 m -127.56 106.74 9.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.807 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -131.32 114.37 14.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.084 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.441 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 2.9 tppp? -146.82 145.01 29.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.441 ' N ' ' HG3' ' A' ' 324' ' ' LYS . 44.1 t -106.13 140.4 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 33.8 mmt -86.49 90.64 8.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 2.9 ptp -123.15 176.65 5.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.55 -62.01 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 177.78 36.86 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.485 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 166.29 -31.73 0.21 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.484 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 -133.77 116.74 16.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.789 0.328 . . . . 0.0 110.848 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 333' ' ' LYS . 5.4 t -58.66 112.8 1.74 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.843 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 332' ' ' SER . 2.9 mtpm? -34.54 -49.67 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 136.79 33.17 0.23 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -173.35 154.69 2.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -158.95 179.1 34.82 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.452 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -128.34 129.26 46.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 12.7 t -130.56 130.27 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 33.2 t -109.16 154.14 22.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.439 ' CE1' HD13 ' A' ' 296' ' ' LEU . 19.6 m-85 -125.61 177.54 6.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 93.1 p -77.32 -38.08 51.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' SER . . . . . 0.42 ' C ' HG13 ' A' ' 294' ' ' VAL . 27.0 t -142.98 146.5 37.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.689 0.756 . . . . 0.0 110.888 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 344' ' ' GLU . 71.6 Cg_exo -46.56 -60.39 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.717 2.278 . . . . 0.0 112.316 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 343' ' ' PRO . 20.8 mt-10 -35.75 -70.04 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -44.03 -43.86 7.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.827 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -60.92 -43.63 98.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.086 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.8 m -52.41 -60.31 3.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.149 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -46.27 -52.4 12.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -53.83 -53.08 57.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . 0.476 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 76.0 t -39.02 -49.58 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 353' ' ' MET . 50.9 m -82.58 -62.18 1.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -41.04 -24.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 351' ' ' THR . 94.4 mmm -102.06 -43.41 5.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 17.2 t-20 -59.22 109.54 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 108.5 -11.99 36.04 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -87.39 147.45 25.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.772 0.32 . . . . 0.0 110.888 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 6.2 mm -97.47 148.98 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.97 -54.01 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.162 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -113.01 -72.72 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.089 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 2.4 t -131.86 -49.08 0.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -101.08 154.0 37.42 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.618 0.723 . . . . 0.0 110.916 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.38 129.14 10.9 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.697 2.265 . . . . 0.0 112.329 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 52.3 mt -67.08 122.55 18.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.914 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.559 ' CD1' ' HE2' ' A' ' 299' ' ' LYS . 25.1 t80 -101.83 93.48 5.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.6 144.22 10.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.126 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -162.43 145.94 11.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.085 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 35.9 mt -53.14 145.9 12.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.943 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -130.2 176.31 8.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -123.43 118.3 27.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.959 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 35.5 ttt-85 -147.09 144.52 29.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.897 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -172.74 144.4 1.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -166.16 109.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -131.8 123.88 28.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.897 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -174.55 144.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -94.96 169.45 10.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.965 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.2 t -106.24 153.11 22.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.826 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -130.54 95.24 0.33 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.456 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.31 14.31 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.711 2.274 . . . . 0.0 112.336 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 13.4 t -76.18 95.92 3.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.814 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 1.6 t -56.63 162.11 2.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.479 179.983 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.0 p -116.39 104.64 11.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.896 0.379 . . . . 0.0 110.827 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 56.0 m -159.13 162.97 36.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.828 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 160.34 60.68 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.452 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 41.5 t -122.71 142.27 50.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.898 0.38 . . . . 0.0 110.84 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 72.3 p -150.14 157.97 43.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 158.96 111.36 0.3 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.471 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.29 97.58 11.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.867 0.365 . . . . 0.0 110.89 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.4 42.83 3.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . 0.427 HG22 ' N ' ' A' ' 289' ' ' THR . 5.2 mp -105.36 134.78 45.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.139 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.427 ' N ' HG22 ' A' ' 288' ' ' ILE . 14.8 t -130.0 147.38 51.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.158 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . 0.46 ' O ' ' CG ' ' A' ' 291' ' ' TYR . 1.0 OUTLIER -134.01 90.88 2.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.846 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.46 ' CG ' ' O ' ' A' ' 290' ' ' ARG . 97.9 m-85 -159.68 126.69 4.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -48.26 96.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 97.0 t -122.55 94.82 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.111 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.1 m -92.1 -32.5 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.158 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -65.59 136.1 55.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.499 HD12 ' CE1' ' A' ' 340' ' ' PHE . 30.7 mt -123.58 137.2 54.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.967 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -101.62 103.05 13.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 32.2 t -88.45 136.21 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.572 ' HE3' ' CD1' ' A' ' 364' ' ' TYR . 13.2 ttpp -135.41 162.8 31.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . 0.455 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.6 m120 63.97 47.84 3.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 35.7 mt -86.22 98.44 10.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -41.47 134.98 2.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -45.83 -36.4 5.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.15 -42.72 97.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.5 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 63.0 mt -60.44 147.65 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.834 0.349 . . . . 0.0 111.173 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -130.34 -174.61 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.23 -28.47 69.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.48 -55.07 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -51.89 -41.89 62.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.42 HD21 ' CG2' ' A' ' 325' ' ' VAL . 62.9 tp -61.89 -72.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 13.7 ttt-85 -50.38 -24.89 3.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -80.0 -29.02 39.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -93.34 17.65 10.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.096 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.445 ' CB ' HD11 ' A' ' 320' ' ' ILE . 6.9 m-85 -126.01 -31.49 2.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.49 -45.27 95.67 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.648 0.737 . . . . 0.0 110.799 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.5 Cg_exo -48.03 -16.67 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.716 2.277 . . . . 0.0 112.325 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -99.67 -52.17 3.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.835 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.27 166.56 36.51 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.475 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 23.9 m -64.08 144.48 57.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.743 0.306 . . . . 0.0 111.18 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.467 HG21 ' N ' ' A' ' 321' ' ' THR . 49.6 mt -119.75 137.73 52.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.467 ' N ' HG21 ' A' ' 320' ' ' ILE . 68.4 p -100.94 -41.43 6.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.145 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.1 t -142.28 124.53 15.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.825 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -145.57 124.76 12.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.08 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -149.25 159.0 44.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.42 ' CG2' HD21 ' A' ' 310' ' ' LEU . 89.9 t -120.32 123.87 71.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.097 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' MET . . . . . 0.492 ' HG3' ' CZ ' ' A' ' 335' ' ' PHE . 33.5 mmt -59.03 148.0 32.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 25.8 mtp -137.21 164.25 28.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -110.95 38.51 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 104.43 -66.55 0.3 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.502 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -113.64 -39.79 1.07 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.503 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -107.63 171.2 7.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.795 0.331 . . . . 0.0 110.876 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.7 m -83.58 139.8 32.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -69.68 -44.76 69.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 125.39 34.74 0.65 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.439 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.492 ' CZ ' ' HG3' ' A' ' 326' ' ' MET . 2.5 p90 -174.75 161.13 3.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.913 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -164.7 -172.05 31.69 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.519 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -131.21 146.46 52.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.868 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 50.5 t -142.43 131.9 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.091 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 6.5 t -112.94 144.27 42.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.499 ' CE1' HD12 ' A' ' 296' ' ' LEU . 9.0 m-85 -118.52 178.63 4.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.1 t -78.49 -39.88 36.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.3 t -137.53 142.36 36.83 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.671 0.748 . . . . 0.0 110.855 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.99 -54.51 4.9 Favored 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.686 2.258 . . . . 0.0 112.369 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -41.83 -52.05 4.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.93 -46.06 82.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.03 -38.86 80.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.152 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 348' ' ' LYS . 60.9 m -52.04 -74.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 347' ' ' THR . 10.1 ttmm -35.25 -64.8 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.953 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.41 -54.5 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.117 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 33.5 t -47.52 -46.25 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.163 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 27.3 m -77.57 -59.48 2.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.133 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -50.49 -22.08 1.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 90.1 mmm -100.22 -43.34 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 9.2 t-20 -58.98 97.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 123.58 -11.49 8.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.492 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -85.15 122.44 29.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 11.5 mm -84.99 149.63 4.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.24 -49.37 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -120.28 -68.97 0.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.32 -51.25 0.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.185 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.58 151.81 37.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.545 0.688 . . . . 0.0 110.899 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.15 151.98 44.73 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.728 2.285 . . . . 0.0 112.345 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 63.1 mt -77.09 96.51 4.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . 0.572 ' CD1' ' HE3' ' A' ' 299' ' ' LYS . 10.1 t80 -74.48 85.8 2.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.67 144.41 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.131 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -152.09 168.07 26.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.148 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 29.5 mt -72.35 145.95 47.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -123.31 125.81 45.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.099 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 11.1 tp60 -116.81 48.5 1.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.872 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -124.7 82.67 2.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -122.85 115.79 22.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -124.38 40.59 3.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -130.91 125.25 33.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -110.17 141.99 42.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -133.18 120.24 20.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 51.3 p -146.75 159.58 43.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 168.85 145.12 4.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.51 164.77 25.86 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.752 2.301 . . . . 0.0 112.321 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 58.9 m -136.87 134.48 36.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 13.4 m -164.73 124.34 1.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.83 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.476 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 65.9 p -109.03 174.08 6.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.835 0.35 . . . . 0.0 110.845 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 4.5 m -64.13 -60.03 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.875 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 100.96 126.17 5.76 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.481 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 71.8 p -89.24 126.87 35.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.869 0.366 . . . . 0.0 110.85 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 72.4 p -125.09 151.7 45.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.819 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 162.2 78.3 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.474 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -131.92 151.33 51.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -106.11 145.4 31.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 54.7 mt -58.62 -58.29 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 14.3 t -168.67 151.44 5.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.186 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . 0.417 ' HB3' ' CE2' ' A' ' 291' ' ' TYR . 56.7 mtt180 -123.28 -46.58 2.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 290' ' ' ARG . 12.2 m-85 -150.25 167.18 27.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -63.86 114.93 4.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 93.7 t -132.69 94.85 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.171 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.414 HG23 ' N ' ' A' ' 295' ' ' ASN . 24.3 m -87.27 -30.32 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.414 ' N ' HG23 ' A' ' 294' ' ' VAL . 14.4 t-20 -72.69 135.83 45.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.829 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 28.9 mt -129.76 132.99 46.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.916 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -90.81 121.06 32.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.958 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.3 t -104.5 132.49 51.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.112 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.49 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 22.3 tttm -132.86 164.05 27.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.898 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . 0.49 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.8 m120 64.14 45.7 3.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 32.7 mt -84.31 95.26 8.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -41.24 136.76 1.55 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -45.16 -40.54 7.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -58.97 -35.77 85.03 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.525 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 65.7 mt -68.36 126.98 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.785 0.326 . . . . 0.0 111.153 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -115.7 175.67 5.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -42.45 -63.82 0.7 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.802 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -47.48 -55.67 8.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.877 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? -45.05 -51.61 9.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.527 HD11 ' CE1' ' A' ' 314' ' ' PHE . 54.7 tp -53.91 -74.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.927 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.458 ' HG3' ' CD1' ' A' ' 320' ' ' ILE . 31.3 ttt180 -45.84 -27.95 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -68.66 -42.78 77.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -83.93 25.1 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.103 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.527 ' CE1' HD11 ' A' ' 310' ' ' LEU . 10.7 m-85 -133.72 -32.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.599 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -51.82 -45.27 92.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.662 0.744 . . . . 0.0 110.867 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.3 Cg_exo -47.95 -17.17 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.642 2.228 . . . . 0.0 112.367 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . 0.468 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 46.9 m-85 -100.07 -45.83 5.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -167.8 167.01 39.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.466 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.445 HG21 ' N ' ' A' ' 320' ' ' ILE . 35.9 m -68.72 141.16 55.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.785 0.326 . . . . 0.0 111.154 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.458 ' CD1' ' HG3' ' A' ' 311' ' ' ARG . 53.3 mt -113.95 144.09 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.457 ' N ' HG22 ' A' ' 320' ' ' ILE . 61.6 p -114.12 -38.55 4.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.145 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -133.36 111.05 10.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.825 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -135.45 122.98 22.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -147.28 152.99 39.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.459 ' CG2' HD23 ' A' ' 310' ' ' LEU . 81.9 t -119.41 135.85 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.148 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 38.0 mmt -68.4 114.37 6.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 48.1 mtp -123.87 151.89 42.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.421 ' CG ' ' HE3' ' A' ' 333' ' ' LYS . 73.1 mt-10 -107.24 43.41 1.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 67.67 85.51 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.496 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 105.36 -44.36 1.49 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.496 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -116.89 159.14 22.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 5.0 t -102.13 126.22 49.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.826 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.478 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 55.1 mttp -51.76 -51.25 57.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.936 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 133.02 35.24 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.445 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 333' ' ' LYS . 5.3 p90 -173.04 165.89 5.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.885 0.374 . . . . 0.0 110.906 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -166.71 -171.43 32.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.541 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -136.82 140.03 42.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.883 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.435 HG13 ' CE1' ' A' ' 340' ' ' PHE . 43.9 t -131.28 133.55 62.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.134 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 8.7 m -111.77 133.2 54.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.435 ' CE1' HG13 ' A' ' 338' ' ' VAL . 25.3 m-85 -109.51 173.3 6.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 13.2 t -87.15 -40.68 14.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.833 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 49.7 m -123.66 130.19 24.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.648 0.737 . . . . 0.0 110.846 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -45.88 -58.57 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.678 2.252 . . . . 0.0 112.345 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -38.62 -52.66 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -54.12 -46.78 72.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.54 -42.38 98.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.115 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.4 m -49.95 -60.35 3.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.125 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 349' ' ' ALA . 46.3 tttt -48.13 -62.94 1.22 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.855 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.62 -48.96 0.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . 0.44 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 57.6 t -42.49 -56.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.163 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 61.2 m -78.33 -54.65 5.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.147 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . 0.468 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 2.2 mm-40 -44.22 -29.54 0.66 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' MET . . . . . 0.451 ' O ' ' N ' ' A' ' 356' ' ' ARG . 76.9 mmm -100.06 -51.55 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 1.6 t30 -39.49 103.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 97.66 18.24 28.43 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.501 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 353' ' ' MET . 0.0 OUTLIER -99.04 118.11 35.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.324 . . . . 0.0 110.883 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . 0.42 HD13 ' N ' ' A' ' 362' ' ' PRO . 20.7 mm -85.89 133.75 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.178 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 84.4 t -118.05 -41.99 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -126.26 -65.18 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.065 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.7 p -134.52 -53.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.11 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -101.58 154.22 37.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.569 0.7 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.42 ' N ' HD13 ' A' ' 357' ' ' ILE . 63.1 Cg_endo -78.17 143.46 20.09 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.448 HD11 ' CE ' ' A' ' 353' ' ' MET . 61.8 mt -75.11 90.92 2.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -61.38 99.73 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.427 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 40.8 t -106.8 141.58 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -161.37 157.8 25.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.059 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 30.8 mt -63.58 141.79 58.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.93 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -129.13 74.7 1.6 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.089 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -151.63 176.08 11.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -146.42 162.52 38.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -38.46 141.28 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -95.9 168.89 10.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -119.67 -58.75 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -169.32 142.11 2.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.831 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -117.28 135.41 53.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 13.6 t -133.34 143.07 48.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.862 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 167.27 84.08 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.449 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.08 98.55 1.23 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.72 2.28 . . . . 0.0 112.361 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 60.3 p -101.19 149.88 23.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 9.3 t -118.93 160.92 21.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.879 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.483 179.999 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.7 t -144.43 158.03 43.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.909 0.385 . . . . 0.0 110.879 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.9 t -106.48 168.78 8.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.882 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -147.81 58.48 0.48 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.446 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 27.0 t -69.32 130.79 43.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.822 0.344 . . . . 0.0 110.857 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 51.4 p -169.37 173.49 6.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -126.39 153.7 18.76 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.476 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -122.29 136.5 54.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.329 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 30.2 mmt-85 -119.59 92.4 3.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 13.4 tt -63.99 123.77 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.119 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.5 t -112.14 -34.47 5.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.166 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 61.06 48.51 6.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -161.71 160.89 29.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.921 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -101.75 114.84 29.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.922 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 95.9 t -134.96 91.79 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.463 HG13 ' N ' ' A' ' 343' ' ' PRO . 22.9 m -87.75 -35.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.148 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.423 ' N ' HG23 ' A' ' 294' ' ' VAL . 0.2 OUTLIER -62.42 129.96 43.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.489 HD12 ' CE1' ' A' ' 340' ' ' PHE . 60.1 mt -118.44 136.3 53.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -94.11 125.96 39.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . 0.425 HG11 ' N ' ' A' ' 299' ' ' LYS . 57.7 t -110.29 143.55 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.154 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.519 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 14.1 ttmm -144.49 164.57 30.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . 0.519 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.5 m120 64.14 44.72 4.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.469 HD23 ' CD2' ' A' ' 363' ' ' LEU . 25.5 mt -84.67 99.87 11.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 301' ' ' LEU . 30.0 m-20 -37.52 155.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -31.91 73.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -67.87 -38.32 89.06 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.498 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.434 ' CG2' ' N ' ' A' ' 306' ' ' ASP . 62.8 mt -56.94 162.94 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.851 0.358 . . . . 0.0 111.104 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.434 ' N ' ' CG2' ' A' ' 305' ' ' ILE . 8.7 t0 -149.28 -176.75 5.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -59.68 -41.82 91.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -64.86 -57.46 8.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.88 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 29.5 mtt-85 -47.06 -45.17 21.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.57 HD11 ' CE1' ' A' ' 314' ' ' PHE . 50.4 tp -57.36 -71.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -49.73 -32.19 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -72.14 -33.73 67.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -85.74 19.31 2.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.059 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.57 ' CE1' HD11 ' A' ' 310' ' ' LEU . 8.2 m-85 -129.73 -30.19 2.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.899 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.18 -45.24 94.1 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.645 0.735 . . . . 0.0 110.866 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.1 Cg_exo -47.94 -16.69 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.71 2.273 . . . . 0.0 112.329 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -99.6 -54.35 2.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.871 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -158.37 170.75 35.11 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.446 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 49.4 m -65.2 144.24 57.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 111.113 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.417 HG21 ' N ' ' A' ' 321' ' ' THR . 48.5 mt -124.41 140.91 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.417 ' N ' HG21 ' A' ' 320' ' ' ILE . 82.6 p -114.16 -46.73 2.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -121.55 111.0 16.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -138.92 121.33 16.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -155.4 156.27 35.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 48.0 t -110.56 143.33 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' MET . . . . . 0.55 ' HG3' ' CE2' ' A' ' 335' ' ' PHE . 38.7 mmt -72.4 135.87 45.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 27.3 mtp -138.6 171.69 13.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -114.66 -45.8 2.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.877 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 161.84 39.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.447 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 160.19 -37.34 0.45 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.469 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -124.31 166.45 15.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.342 . . . . 0.0 110.86 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.1 t -85.13 122.22 29.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.565 ' HD3' ' CZ ' ' A' ' 335' ' ' PHE . 28.9 mttm -50.89 -42.27 58.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 128.76 -31.23 3.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.537 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.565 ' CZ ' ' HD3' ' A' ' 333' ' ' LYS . 5.4 p90 -111.64 161.8 15.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.9 0.381 . . . . 0.0 110.881 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -155.37 -174.24 25.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.522 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -136.51 140.63 43.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.928 0.394 . . . . 0.0 110.841 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 51.5 t -136.93 131.52 46.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.164 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 4.7 m -111.33 141.33 45.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.489 ' CE1' HD12 ' A' ' 296' ' ' LEU . 14.5 m-85 -115.75 171.85 7.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 62.7 p -71.73 -37.01 70.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.854 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 6.2 t -144.44 143.07 20.57 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.668 0.747 . . . . 0.0 110.828 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.463 ' N ' HG13 ' A' ' 294' ' ' VAL . 71.9 Cg_exo -46.49 -56.07 3.25 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.74 2.294 . . . . 0.0 112.317 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 343' ' ' PRO . 1.2 mp0 -37.21 -61.29 0.59 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -50.3 -43.38 53.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.59 -41.01 98.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 86.2 m -49.29 -60.83 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -47.37 -60.46 2.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -42.51 -48.87 5.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . 0.445 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 47.1 t -41.49 -55.73 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.111 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 82.7 m -78.74 -55.75 4.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -44.18 -28.96 0.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.886 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' MET . . . . . 0.468 ' CE ' HD11 ' A' ' 363' ' ' LEU . 79.3 mmm -100.2 -49.81 4.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 9.4 t30 -40.14 110.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 85.29 20.7 56.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.481 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 353' ' ' MET . 19.7 tpp180 -99.94 112.46 24.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.815 0.341 . . . . 0.0 110.885 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 17.6 mm -77.67 150.49 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 95.3 t -132.52 -48.01 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.8 -68.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 19.0 p -130.79 -53.14 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.106 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -100.05 151.42 37.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.576 0.703 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.58 155.95 35.9 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.706 2.271 . . . . 0.0 112.374 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.469 ' CD2' HD23 ' A' ' 301' ' ' LEU . 32.9 mt -94.49 87.44 5.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.944 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -61.48 106.66 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.964 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.423 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 47.8 t -113.91 134.63 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.104 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -155.27 145.32 21.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.137 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 77.9 mt -54.66 134.18 47.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -107.55 136.83 46.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -80.44 -48.93 12.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -49.24 132.27 19.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.906 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -132.76 107.13 8.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -61.83 133.72 55.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -146.88 118.6 8.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -101.16 127.95 47.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -157.04 142.32 17.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.4 m -136.68 167.1 22.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.828 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 165.17 81.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.504 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.0 125.91 8.31 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.67 2.246 . . . . 0.0 112.332 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 61.2 m -133.22 158.52 42.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.861 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 1.9 t -166.05 124.46 1.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.466 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 8.9 t -131.26 177.26 7.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 0.0 110.891 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 7.1 m -123.17 87.44 2.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 45.89 -124.23 7.07 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.539 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 24.1 p -167.02 166.28 15.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.874 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 33.0 p -99.78 144.82 28.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -136.18 177.88 19.21 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.466 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.12 135.93 45.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -102.55 98.65 8.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 13.9 pt -134.7 147.05 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.09 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 14.7 t -118.0 37.71 3.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -104.32 176.61 5.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 56.11 50.86 12.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.932 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -46.29 125.08 6.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 73.8 t -127.14 92.04 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 343' ' ' PRO . 6.4 m -86.61 -37.11 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -52.27 142.17 17.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.558 HD11 ' CE1' ' A' ' 340' ' ' PHE . 32.5 mt -135.48 132.64 37.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -102.08 113.02 25.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 45.7 t -100.83 145.5 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.132 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 0.0 OUTLIER -132.4 165.84 23.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . 0.537 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 4.0 m-20 63.48 46.57 4.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.92 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' A' ' 302' ' ' ASP . 32.8 mt -82.43 91.97 6.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 301' ' ' LEU . 86.5 m-20 -36.05 132.09 0.54 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.86 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.58 -41.68 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -60.13 -36.19 89.83 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.468 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . 0.462 HG22 ' CB ' ' A' ' 309' ' ' ARG . 75.5 mt -64.92 118.49 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.143 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -103.55 -175.74 2.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.37 -45.96 76.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -62.76 -48.96 76.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . 0.462 ' CB ' HG22 ' A' ' 305' ' ' ILE . 4.3 mmm180 -46.68 -49.66 18.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.561 HD12 ' CE1' ' A' ' 314' ' ' PHE . 43.2 tp -56.65 -73.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 15.8 ttp180 -46.89 -26.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -70.01 -41.72 73.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -88.9 21.35 3.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.058 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.561 ' CE1' HD12 ' A' ' 310' ' ' LEU . 8.2 m-85 -129.41 -29.96 2.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -55.38 -44.95 99.9 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.662 0.744 . . . . 0.0 110.883 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.7 Cg_exo -47.97 -16.57 0.59 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.747 2.298 . . . . 0.0 112.288 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . 0.496 ' CD2' ' HB1' ' A' ' 349' ' ' ALA . 51.5 m-85 -99.64 -51.87 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -163.68 166.07 37.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 64.4 m -67.2 137.91 56.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.785 0.326 . . . . 0.0 111.144 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 321' ' ' THR . 93.3 mt -109.65 142.15 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.165 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.434 ' N ' HG22 ' A' ' 320' ' ' ILE . 70.3 p -111.74 -35.8 5.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.172 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -133.58 104.51 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -134.58 122.48 22.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.084 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.401 ' HG2' ' N ' ' A' ' 325' ' ' VAL . 44.0 tttp -156.72 152.52 27.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.441 HG11 ' N ' ' A' ' 326' ' ' MET . 59.4 t -107.44 140.33 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' MET . . . . . 0.537 ' HG3' ' CE2' ' A' ' 335' ' ' PHE . 34.4 mmt -85.73 100.61 12.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 77.9 mtp -97.99 176.5 5.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.467 ' HB3' ' CE ' ' A' ' 333' ' ' LYS . 0.4 OUTLIER -161.07 133.37 5.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 49.33 32.54 14.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.452 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 88.55 -30.24 5.39 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.506 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -94.54 136.51 34.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.787 0.327 . . . . 0.0 110.877 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 89.8 p -63.14 140.04 58.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.467 ' CE ' ' HB3' ' A' ' 328' ' ' GLU . 89.9 mttt -71.24 -58.13 3.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 139.95 35.76 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.516 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.537 ' CE2' ' HG3' ' A' ' 326' ' ' MET . 25.7 p90 -174.95 163.65 3.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 0.0 110.857 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -162.09 -179.77 36.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -123.88 139.24 54.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 110.897 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.463 ' CG2' HD21 ' A' ' 310' ' ' LEU . 29.9 t -134.59 127.72 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.169 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 68.8 m -111.93 134.38 53.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.902 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.558 ' CE1' HD11 ' A' ' 296' ' ' LEU . 43.4 m-85 -111.39 177.18 4.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 6.4 t -78.21 -35.52 48.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.9 t -141.61 141.71 23.56 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.62 0.724 . . . . 0.0 110.885 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.405 ' N ' HG13 ' A' ' 294' ' ' VAL . 72.4 Cg_exo -46.65 -53.65 5.85 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.692 2.261 . . . . 0.0 112.327 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -40.82 -63.74 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -46.09 -44.22 15.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.863 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.15 -59.58 5.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.076 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 28.7 m -41.58 -56.05 2.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.408 ' NZ ' ' HG3' ' A' ' 352' ' ' GLU . 2.3 tmtm? -45.84 -56.31 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.496 ' HB1' ' CD2' ' A' ' 317' ' ' PHE . . . -54.51 -51.12 66.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.068 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . 0.467 ' CG2' HD21 ' A' ' 296' ' ' LEU . 91.9 t -39.38 -53.21 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.143 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 86.7 m -75.29 -59.28 2.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . 0.408 ' HG3' ' NZ ' ' A' ' 348' ' ' LYS . 3.9 mm-40 -49.08 -18.84 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 90.0 mmm -107.28 -35.14 6.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.459 ' OD1' ' C ' ' A' ' 354' ' ' ASN . 5.4 t-20 -59.1 96.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 112.47 -15.86 24.53 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 17.6 tpp85 -73.27 110.19 7.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 20.5 mm -68.12 151.2 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.422 HG11 ' NH2' ' A' ' 309' ' ' ARG . 58.4 t -132.26 -39.46 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.115 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -133.22 -71.36 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.095 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 4.9 p -128.96 -55.05 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.95 153.45 37.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.558 0.694 . . . . 0.0 110.873 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.1 153.49 46.61 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.719 2.279 . . . . 0.0 112.332 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.401 ' CD2' HD21 ' A' ' 301' ' ' LEU . 30.5 mt -87.77 99.44 12.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -79.24 91.39 4.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.96 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 4.2 t -95.33 141.33 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.127 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -159.84 142.98 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.078 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 24.4 mt -52.99 153.43 3.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -112.75 132.02 55.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.094 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -100.3 86.75 3.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.92 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -115.4 -36.98 4.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -80.62 -42.84 21.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -38.49 -65.71 0.33 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.414 ' C ' ' OE1' ' A' ' 373' ' ' GLU . 0.6 OUTLIER -41.86 -40.47 2.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -80.82 155.37 26.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.856 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 41.58 41.13 1.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 1.5 t -59.14 -52.45 65.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -56.42 -90.24 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.479 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.65 114.3 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.652 2.235 . . . . 0.0 112.337 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 90.9 p -79.73 133.13 36.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 74.6 m -60.04 153.51 21.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.471 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.3 t -82.7 159.98 22.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 0.0 110.846 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 8.1 t -138.54 167.35 22.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 100.66 118.15 4.23 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.499 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 27.5 p -103.94 157.24 17.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.89 0.376 . . . . 0.0 110.843 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 10.2 m -91.66 -58.89 2.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 89.65 57.35 1.75 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.503 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.13 110.87 13.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.836 0.35 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . 0.443 ' HD3' ' N ' ' A' ' 287' ' ' ARG . 1.9 mpp_? -122.78 96.0 4.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 25.2 mm -122.45 139.41 49.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 22.9 m -110.68 -60.33 1.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -173.22 151.84 2.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.499 ' CE2' HG13 ' A' ' 293' ' ' VAL . 0.7 OUTLIER -174.85 140.55 0.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -104.17 110.31 22.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.929 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.499 HG13 ' CE2' ' A' ' 291' ' ' TYR . 6.5 p -132.15 107.47 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.02 -21.51 5.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.095 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.1 152.05 38.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.529 HD13 ' CE1' ' A' ' 340' ' ' PHE . 14.7 mt -143.87 134.21 24.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -101.85 120.47 40.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.25 145.5 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.113 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.484 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 13.4 ttmm -136.58 162.68 32.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . 0.484 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 6.8 m-20 62.59 51.11 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.467 HD23 ' CD2' ' A' ' 363' ' ' LEU . 28.0 mt -88.86 104.52 17.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -45.92 162.05 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.872 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -64.2 -38.87 92.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.26 -40.59 99.2 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.494 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 59.9 mt -57.41 132.64 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 111.176 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.23 -174.82 3.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -49.86 -46.38 51.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -60.69 -61.13 2.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -41.8 -46.05 3.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.565 HD13 ' CE1' ' A' ' 314' ' ' PHE . 20.4 tp -52.23 -75.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.948 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . 0.492 ' HG3' ' CB ' ' A' ' 323' ' ' ALA . 19.4 mtp180 -53.22 -24.72 11.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -67.58 -39.96 84.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -97.79 19.74 13.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.063 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.565 ' CE1' HD13 ' A' ' 310' ' ' LEU . 7.1 m-85 -127.29 -29.72 2.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.584 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.8 OUTLIER -57.7 -45.61 99.81 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.704 0.764 . . . . 0.0 110.905 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.2 Cg_exo -47.98 -16.63 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.634 2.222 . . . . 0.0 112.377 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . 0.479 ' CE2' ' HG2' ' A' ' 353' ' ' MET . 50.0 m-85 -99.61 -46.92 5.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -165.05 166.31 38.14 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 33.9 m -67.33 133.6 49.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 111.141 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 321' ' ' THR . 37.7 mt -110.37 139.58 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.46 ' N ' HG22 ' A' ' 320' ' ' ILE . 41.6 p -109.85 -36.24 5.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 71.0 m -137.42 126.81 24.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . 0.492 ' CB ' ' HG3' ' A' ' 311' ' ' ARG . . . -156.46 119.25 4.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.068 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -150.24 132.25 15.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 49.9 t -82.22 125.2 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.153 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 20.8 mmm -68.86 86.4 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' MET . . . . . 0.463 ' CB ' ' HA ' ' A' ' 332' ' ' SER . 21.5 ptm -126.15 159.27 33.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.945 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -116.17 139.26 50.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 46.67 -105.22 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.502 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -127.51 50.71 0.88 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.512 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.68 124.5 3.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 110.904 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.463 ' HA ' ' CB ' ' A' ' 327' ' ' MET . 29.9 t -77.87 117.7 19.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -53.72 -52.04 61.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 137.63 34.16 0.2 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.425 ' C ' HD12 ' A' ' 301' ' ' LEU . 4.0 p90 -175.39 156.38 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -154.47 172.45 32.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.508 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -117.22 139.41 50.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.411 ' CG2' HD11 ' A' ' 310' ' ' LEU . 24.1 t -133.85 149.29 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.172 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 20.9 t -132.76 134.23 44.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.838 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.529 ' CE1' HD13 ' A' ' 296' ' ' LEU . 6.5 m-85 -113.24 172.46 6.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.882 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.4 p -78.98 -47.94 15.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 54.8 m -121.37 136.12 25.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.691 0.757 . . . . 0.0 110.83 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 346' ' ' ALA . 71.5 Cg_exo -45.87 -63.01 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.72 2.28 . . . . 0.0 112.357 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 343' ' ' PRO . 49.0 tt0 -36.2 -53.62 0.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -52.36 -44.4 65.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 343' ' ' PRO . . . -64.29 -41.91 96.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.08 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 98.1 m -50.77 -64.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 349' ' ' ALA . 31.8 tttm -43.09 -62.91 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.902 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.27 -53.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.108 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . . . . . . . . . 93.6 t -38.2 -60.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 62.5 m -75.14 -55.27 5.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . 0.431 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 23.5 mm-40 -44.8 -26.26 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' MET . . . . . 0.479 ' HG2' ' CE2' ' A' ' 317' ' ' PHE . 83.3 mmm -102.19 -62.03 1.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -40.66 107.22 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 116.15 -5.88 19.65 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -95.74 125.78 40.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 0.0 110.871 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . 0.408 HG23 ' N ' ' A' ' 358' ' ' VAL . 7.8 mm -85.7 150.31 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.131 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . 0.408 ' N ' HG23 ' A' ' 357' ' ' ILE . 95.6 t -132.23 -41.06 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -126.64 -71.91 0.67 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.093 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 16.5 p -131.63 -50.16 0.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.18 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.86 152.14 39.51 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.555 0.693 . . . . 0.0 110.909 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.48 146.77 35.43 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.699 2.266 . . . . 0.0 112.324 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.467 ' CD2' HD23 ' A' ' 301' ' ' LEU . 37.3 mt -77.22 88.95 3.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -66.34 94.56 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 17.2 t -97.12 150.95 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -164.3 166.24 21.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 58.7 mt -71.32 143.61 50.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -110.97 -68.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -80.1 112.3 17.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 15.7 ttt85 -65.91 -46.19 79.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -174.07 140.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -80.27 159.62 25.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -146.39 134.9 22.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -65.13 102.6 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -121.0 142.59 49.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 58.6 p -168.14 124.96 1.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -166.35 146.04 10.57 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.468 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.37 -34.68 1.43 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.737 2.291 . . . . 0.0 112.329 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 4.2 m -88.17 126.15 34.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.848 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 12.3 m -85.46 -49.15 8.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.859 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.467 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 6.1 t -158.92 134.05 8.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.94 0.4 . . . . 0.0 110.818 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 23.4 t -149.85 122.92 8.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.819 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -107.04 76.35 0.23 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.511 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 4.8 m -73.09 104.11 4.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 110.87 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 2.9 m -54.6 -56.0 23.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 79.82 153.94 8.76 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.482 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -136.72 107.85 6.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.792 0.33 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -84.57 97.05 9.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 3.2 tt -74.72 80.9 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.157 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.3 m -92.45 44.49 1.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.166 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 34.1 mtt180 -58.27 -56.11 26.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.3 143.85 26.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -78.55 114.2 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.14 114.89 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 25.2 m -115.79 -23.98 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -67.13 104.13 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.554 HD13 ' CE1' ' A' ' 340' ' ' PHE . 45.6 mt -94.85 133.79 38.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -96.45 114.06 25.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.6 t -98.62 139.44 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.114 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.51 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 24.5 tttt -137.33 163.94 29.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . 0.51 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 6.4 m-20 63.19 49.38 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 25.0 mt -87.8 114.88 24.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.36 140.47 27.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -50.5 -42.31 54.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.812 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.26 -30.08 66.96 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.463 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 95.8 mt -72.62 130.78 35.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.34 . . . . 0.0 111.126 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -114.33 -179.11 3.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.96 -45.71 67.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.4 -54.12 47.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -47.03 -47.59 22.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.553 HD12 ' CE1' ' A' ' 314' ' ' PHE . 16.6 tp -53.96 -75.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -49.2 -25.4 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -78.81 -32.82 46.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.9 15.72 10.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.083 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.6 ' CZ ' ' SD ' ' A' ' 353' ' ' MET . 10.7 m-85 -128.79 -28.49 2.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -50.25 -46.07 83.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.679 0.752 . . . . 0.0 110.859 -179.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 315' ' ' SER . 63.8 Cg_exo -47.92 -16.89 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.688 2.259 . . . . 0.0 112.367 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -99.66 -41.49 7.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.52 169.0 36.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.492 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 97.0 m -83.21 96.48 8.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.81 0.338 . . . . 0.0 111.17 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 321' ' ' THR . 93.5 mt -65.55 145.9 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.423 ' N ' HG23 ' A' ' 320' ' ' ILE . 73.5 p -117.34 -28.52 6.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.125 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 3.0 p -152.83 109.38 3.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -131.72 142.56 49.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.093 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -154.08 170.24 21.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.13 121.55 54.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.145 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' MET . . . . . 0.541 ' HB2' ' CE2' ' A' ' 335' ' ' PHE . 10.2 mmm -75.46 117.01 16.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' MET . . . . . 0.456 ' CA ' ' HD2' ' A' ' 333' ' ' LYS . 37.9 mtp -127.8 169.19 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.417 ' CG ' ' HE2' ' A' ' 333' ' ' LYS . 15.0 mt-10 -93.14 -66.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.925 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -159.88 -52.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.469 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -132.39 30.19 3.19 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.483 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -168.34 115.0 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.819 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 333' ' ' LYS . 20.2 t -54.95 104.87 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.472 ' HD3' ' CE1' ' A' ' 335' ' ' PHE . 18.3 mttm -34.57 -55.22 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 128.62 29.95 0.73 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.471 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.541 ' CE2' ' HB2' ' A' ' 326' ' ' MET . 43.7 p90 -164.74 157.15 16.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 0.0 110.907 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -159.63 -167.05 19.73 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.458 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -135.13 122.19 21.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.928 0.394 . . . . 0.0 110.872 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.423 ' CG2' HD13 ' A' ' 310' ' ' LEU . 46.5 t -116.18 98.1 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.122 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 1.7 m -86.9 135.84 33.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.554 ' CE1' HD13 ' A' ' 296' ' ' LEU . 23.1 m-85 -107.88 178.0 4.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 7.2 t -82.69 -36.48 25.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.813 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.9 m -133.57 133.92 23.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.681 0.753 . . . . 0.0 110.85 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.26 -59.58 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.725 2.283 . . . . 0.0 112.337 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -38.75 -57.32 1.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -54.29 -45.93 72.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.89 87.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.066 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 348' ' ' LYS . 14.5 m -45.65 -63.86 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.152 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 347' ' ' THR . 3.9 ttpm? -37.51 -65.93 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -41.13 -53.7 3.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 46.2 t -39.75 -52.24 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.129 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 82.7 m -78.85 -56.91 4.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -46.69 -24.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' MET . . . . . 0.6 ' SD ' ' CZ ' ' A' ' 314' ' ' PHE . 15.7 mtp -104.05 -43.99 5.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 6.8 t-20 -47.91 115.51 1.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 80.76 17.42 72.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.481 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -98.26 121.39 40.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.765 0.317 . . . . 0.0 110.853 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 9.2 mm -87.77 125.7 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.117 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.26 -59.53 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.164 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -109.01 -67.85 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.104 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 2.3 t -134.87 -49.06 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -99.79 151.24 37.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.568 0.699 . . . . 0.0 110.88 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.37 151.59 29.66 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.704 2.269 . . . . 0.0 112.355 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 32.9 mt -89.65 92.97 9.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -70.77 94.74 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.9 t -106.8 141.73 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.086 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -164.69 145.67 7.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 81.3 mt -56.68 137.83 53.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -110.9 178.37 4.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -136.61 105.47 5.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . 0.429 ' HD3' ' N ' ' A' ' 371' ' ' LYS . 0.0 OUTLIER -172.0 132.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . 0.429 ' N ' ' HD3' ' A' ' 370' ' ' ARG . 0.3 OUTLIER -106.7 135.7 47.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.42 155.66 24.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -153.59 124.49 7.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -109.44 173.37 6.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -133.36 123.62 25.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.956 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 52.4 p -85.57 137.06 33.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 174.3 81.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.96 111.36 3.22 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.681 2.254 . . . . 0.0 112.362 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 34.5 t -77.55 104.95 8.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 3.3 m -166.87 137.23 3.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.464 -179.99 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 87.8 p -164.27 162.4 22.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.888 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.2 t -86.84 -46.76 9.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 88.07 -164.17 33.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.5 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 3.1 m -114.57 170.43 8.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.922 0.391 . . . . 0.0 110.857 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 8.6 t -105.35 -54.4 2.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.855 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.91 -171.41 16.92 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -147.7 126.53 12.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 0.0 110.884 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -102.58 130.08 49.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 288' ' ' ILE . 0.1 OUTLIER -138.86 142.82 33.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.107 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 10.0 t -115.93 153.17 32.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.168 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -104.96 -59.4 1.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -63.65 147.26 52.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.915 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -62.24 108.94 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 97.8 t -129.06 95.47 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.174 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 343' ' ' PRO . 25.9 m -86.04 -36.9 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -54.72 136.59 45.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.42 HD23 ' CG2' ' A' ' 350' ' ' VAL . 40.6 mt -127.87 144.34 51.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -106.36 110.41 22.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.936 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.1 t -94.4 129.81 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.149 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.484 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 37.0 tttt -130.49 163.25 27.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . 0.484 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.5 m120 63.83 49.45 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.901 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.462 HD21 ' CD2' ' A' ' 363' ' ' LEU . 19.8 mt -87.12 105.98 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.427 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 21.2 t70 -46.12 158.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.877 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -62.15 -37.52 85.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -67.02 -38.75 92.88 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.459 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 83.1 mt -61.65 112.69 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 111.138 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.19 -176.8 3.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.822 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.24 -62.6 1.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -52.46 -47.53 66.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -47.28 -34.13 6.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.458 HD12 ' CE1' ' A' ' 314' ' ' PHE . 54.0 tp -77.68 -56.22 4.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -58.33 -24.65 60.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -84.78 -22.82 29.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -95.18 16.21 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.125 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.458 ' CE1' HD12 ' A' ' 310' ' ' LEU . 7.9 m-85 -129.16 -29.12 2.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.593 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.8 OUTLIER -50.36 -45.54 83.75 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.65 0.738 . . . . 0.0 110.873 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.1 Cg_exo -48.04 -15.51 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.661 2.24 . . . . 0.0 112.342 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 352' ' ' GLU . 55.0 m-85 -99.13 -53.84 3.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.69 -179.1 37.06 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.437 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 320' ' ' ILE . 28.9 m -74.52 143.39 44.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 111.129 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . 0.467 ' N ' HG22 ' A' ' 319' ' ' THR . 55.3 mt -115.45 152.53 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.149 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 40.9 p -121.11 -41.2 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.5 t -137.38 119.42 15.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -146.35 126.62 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.081 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.466 ' HG2' ' N ' ' A' ' 325' ' ' VAL . 15.7 ttmm -159.99 151.1 19.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.466 ' N ' ' HG2' ' A' ' 324' ' ' LYS . 99.2 t -110.12 132.99 56.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 38.1 mmt -65.41 125.19 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 21.2 mtp -122.62 162.43 21.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -119.77 38.9 3.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 70.35 87.49 0.11 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.515 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 99.61 -43.27 1.84 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.511 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -112.82 162.27 15.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.857 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.2 t -104.74 127.4 52.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . 0.501 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 12.1 mmmt -53.55 -60.95 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.869 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 136.25 34.69 0.22 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.469 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' A' ' 333' ' ' LYS . 12.9 p90 -173.39 159.37 3.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -158.91 -171.95 25.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.498 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . 0.408 ' C ' HG23 ' A' ' 338' ' ' VAL . 87.2 m-85 -135.14 141.1 45.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.36 . . . . 0.0 110.837 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.437 HG13 ' N ' ' A' ' 339' ' ' CYS . 36.5 t -136.56 140.94 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.112 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . 0.437 ' N ' HG13 ' A' ' 338' ' ' VAL . 65.4 m -117.56 156.57 27.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -130.27 173.89 10.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 51.6 p -80.29 -40.99 25.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' SER . . . . . 0.423 ' C ' HG12 ' A' ' 294' ' ' VAL . 22.9 m -130.62 139.23 34.97 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.649 0.738 . . . . 0.0 110.882 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.451 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.3 Cg_exo -47.44 -54.88 4.49 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.688 2.259 . . . . 0.0 112.316 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -41.28 -55.61 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -51.71 -43.75 62.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.862 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.414 ' CB ' HD21 ' A' ' 296' ' ' LEU . . . -64.15 -41.5 97.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.09 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 94.6 m -49.71 -63.6 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -47.07 -61.92 1.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -37.71 -50.25 1.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . 0.488 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 57.8 t -41.69 -55.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 90.2 m -78.7 -55.84 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 317' ' ' PHE . 18.8 mm-40 -44.08 -27.79 0.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' MET . . . . . 0.431 ' HE1' ' CD1' ' A' ' 363' ' ' LEU . 86.4 mmm -101.83 -42.59 6.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 12.9 t-20 -58.14 96.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 121.92 -13.97 9.1 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.469 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -77.12 112.93 14.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.898 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . 0.432 HD12 ' CA ' ' A' ' 362' ' ' PRO . 13.3 mm -78.25 138.29 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.096 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.99 -65.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.112 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -100.79 -75.24 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' A' ' 361' ' ' LYS . 1.0 OUTLIER -123.5 -47.34 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.555 ' N ' ' CG2' ' A' ' 360' ' ' THR . 12.1 pttm -109.39 159.0 33.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.553 0.692 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.432 ' CA ' HD12 ' A' ' 357' ' ' ILE . 60.2 Cg_endo -80.24 154.04 21.7 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.671 2.247 . . . . 0.0 112.369 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.462 ' CD2' HD21 ' A' ' 301' ' ' LEU . 31.4 mt -78.13 98.31 5.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -67.8 81.61 0.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.46 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 32.2 t -91.14 141.11 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.134 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -160.39 143.33 13.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.096 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 18.8 mt -59.87 141.48 55.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.906 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -105.93 86.51 2.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 370' ' ' ARG . 7.5 pt20 -64.82 -46.0 83.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.903 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 369' ' ' GLN . 6.8 tpt180 -34.61 102.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.73 132.94 47.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -119.71 138.88 53.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -155.49 139.5 16.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.838 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -146.97 151.93 37.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -145.9 171.02 15.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 48.2 m -122.49 -60.55 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 69.63 95.57 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.532 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.05 125.51 9.34 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.693 2.262 . . . . 0.0 112.347 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 38.3 t -167.0 117.37 0.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 34.8 t -167.63 131.48 1.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.904 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.503 -179.975 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 22.2 m -150.39 144.91 25.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 0.0 110.862 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 82.9 p -152.58 142.43 22.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.866 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 149.2 -140.78 8.39 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 4.4 t -170.86 154.07 4.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.907 0.384 . . . . 0.0 110.795 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 19.2 m -128.73 131.89 47.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.876 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 286' ' ' ASP . . . -165.93 83.1 0.1 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.516 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 285' ' ' GLY . 1.1 p-10 -35.3 150.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 0.0 110.829 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' ARG . . . . . 0.415 ' HB2' ' NH1' ' A' ' 287' ' ' ARG . 11.0 ttm105 -132.31 160.61 35.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.902 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -131.09 158.0 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 10.1 t -105.08 142.28 35.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' ARG . . . . . 0.432 ' O ' ' C ' ' A' ' 291' ' ' TYR . 35.6 mmt180 -153.71 178.15 10.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 290' ' ' ARG . 4.7 t80 35.43 35.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.97 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 290' ' ' ARG . 31.6 mt-30 36.31 46.17 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.904 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 70.9 t -66.61 93.06 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.144 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . 0.433 HG12 ' N ' ' A' ' 343' ' ' PRO . 25.8 m -104.02 -35.16 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.54 143.31 57.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.55 HD12 ' CE1' ' A' ' 340' ' ' PHE . 58.2 mt -131.29 144.99 51.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -99.62 123.47 43.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 17.6 t -107.22 134.75 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.163 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.545 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 21.9 ttmt -134.3 165.99 23.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' ASN . . . . . 0.545 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.9 m-20 61.16 51.36 4.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.463 HD21 ' CD2' ' A' ' 363' ' ' LEU . 30.9 mt -91.85 107.54 19.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.39 141.36 24.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -48.4 -34.51 10.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.86 -37.06 94.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.538 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 49.5 mt -70.33 136.91 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 111.164 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -126.49 -178.75 4.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 307' ' ' ASP . 21.5 t0 -51.27 -47.29 62.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -58.44 -66.32 0.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -43.58 -42.1 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.471 HD11 ' CE1' ' A' ' 314' ' ' PHE . 63.2 tp -60.59 -69.35 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -52.32 -27.82 16.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -72.7 -27.52 62.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -95.28 19.23 11.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' PHE . . . . . 0.471 ' CE1' HD11 ' A' ' 310' ' ' LEU . 8.6 m-85 -129.69 -31.31 2.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.854 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' SER . . . . . 0.587 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.2 m -50.89 -45.78 87.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.711 0.767 . . . . 0.0 110.874 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.8 Cg_exo -47.99 -17.25 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.683 2.255 . . . . 0.0 112.314 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' PHE . . . . . 0.561 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 55.5 m-85 -100.05 -49.64 4.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -163.04 160.63 33.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.5 m -60.63 138.28 58.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.311 . . . . 0.0 111.18 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' ILE . . . . . . . . . . . . . 80.3 mt -114.89 130.73 68.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.9 p -103.62 -28.36 11.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 4.7 t -143.19 125.07 15.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -154.64 122.52 5.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.42 ' HD3' ' N ' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -151.93 158.21 42.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.0 134.42 53.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' MET . . . . . 0.54 ' HG3' ' CE2' ' A' ' 335' ' ' PHE . 35.5 mmt -61.16 145.02 52.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 13.1 mtp -146.23 171.13 15.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.854 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -124.33 -51.47 1.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -159.61 -51.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.55 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -149.08 38.6 0.96 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.512 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -168.36 144.29 3.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.863 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.5 t -69.3 116.58 9.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -46.93 -46.81 21.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.68 -28.46 3.39 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.507 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.54 ' CE2' ' HG3' ' A' ' 326' ' ' MET . 3.2 p90 -118.53 160.79 21.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.928 0.394 . . . . 0.0 110.875 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -153.44 -172.45 21.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.531 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -138.44 138.29 38.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.863 0.363 . . . . 0.0 110.884 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.421 HG11 ' N ' ' A' ' 339' ' ' CYS . 30.9 t -130.27 143.79 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.121 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' CYS . . . . . 0.421 ' N ' HG11 ' A' ' 338' ' ' VAL . 84.3 m -121.6 143.09 49.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' PHE . . . . . 0.55 ' CE1' HD12 ' A' ' 296' ' ' LEU . 21.7 m-85 -118.19 175.59 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 23.2 t -83.85 -40.79 18.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' SER . . . . . 0.416 ' C ' HG12 ' A' ' 294' ' ' VAL . 70.7 m -130.37 139.33 35.3 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.898 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' PRO . . . . . 0.433 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.2 Cg_exo -47.43 -56.15 3.32 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.694 2.262 . . . . 0.0 112.332 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -41.49 -54.68 3.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -50.55 -45.35 56.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.56 95.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.086 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 61.0 m -51.25 -65.7 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.166 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 349' ' ' ALA . 28.6 tttt -44.38 -64.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.06 -48.83 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.114 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' VAL . . . . . 0.493 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 49.1 t -42.79 -56.3 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 52.8 m -79.69 -50.71 10.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' GLU . . . . . 0.561 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 24.3 mm-40 -47.66 -29.39 2.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' MET . . . . . 0.453 ' O ' ' N ' ' A' ' 356' ' ' ARG . 75.9 mmm -101.66 -51.75 3.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 7.0 t-20 -35.77 112.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.833 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 87.98 18.87 55.23 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.499 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 353' ' ' MET . 16.5 tpp180 -96.94 126.95 42.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.867 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 11.3 mm -93.27 142.62 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 64.6 t -131.84 -38.81 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.65 -72.68 0.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 2.5 p -131.71 -52.22 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.167 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -101.85 153.91 37.66 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.564 0.697 . . . . 0.0 110.931 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.84 146.38 29.71 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.671 2.248 . . . . 0.0 112.333 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . 0.463 ' CD2' HD21 ' A' ' 301' ' ' LEU . 43.1 mt -81.68 96.3 7.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -64.52 97.38 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' VAL . . . . . 0.465 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 37.0 t -103.19 125.35 57.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.153 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -150.6 150.81 31.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 49.5 mt -60.67 139.37 57.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 369' ' ' GLN . . . -84.4 -44.09 14.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.051 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 368' ' ' ALA . 59.6 mt-30 32.43 47.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.94 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -114.57 -43.15 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -157.35 160.13 38.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.97 159.08 16.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.56 169.09 8.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -127.51 -59.11 1.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.826 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -42.22 130.07 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.0 t -113.67 -59.81 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -141.9 -167.17 11.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.08 162.31 31.87 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.652 2.235 . . . . 0.0 112.376 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 32.3 t -108.21 -43.95 4.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.858 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 37.8 t -98.04 139.44 33.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.84 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.506 179.953 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 83.9 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.886 0.374 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 343' ' ' PRO . 15.4 m -108.72 -26.25 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.135 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -65.59 128.57 36.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.623 ' CD2' HD23 ' A' ' 367' ' ' LEU . 38.5 mt -118.93 145.97 45.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -106.12 115.6 30.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.408 HG21 HD11 ' A' ' 310' ' ' LEU . 58.8 t -103.04 133.13 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.554 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 22.1 tttm -130.81 166.39 20.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ASN . . . . . 0.554 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 6.7 m-20 63.58 54.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 40.9 mt -91.45 105.44 17.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.949 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -51.4 145.05 9.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.859 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -52.08 -34.01 41.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -67.55 -35.16 85.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.443 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.79 123.92 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.836 0.35 . . . . 0.0 111.121 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -116.0 171.32 7.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.827 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -38.02 -68.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -40.88 -56.5 2.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -45.91 -58.51 3.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.408 HD11 HG21 ' A' ' 298' ' ' VAL . 64.1 tp -52.7 -62.74 1.45 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.405 ' HG3' ' HB3' ' A' ' 323' ' ' ALA . 2.1 tmm_? -55.86 -24.56 37.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -81.67 -22.2 37.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -96.21 15.12 21.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.1 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.613 ' CD2' HG11 ' A' ' 338' ' ' VAL . 6.2 m-85 -123.73 -32.38 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.7 OUTLIER -50.36 -45.87 83.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.627 0.727 . . . . 0.0 110.887 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.4 Cg_exo -47.97 -17.34 0.78 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.724 2.282 . . . . 0.0 112.342 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -100.07 -52.32 3.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.07 168.26 37.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.486 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 61.6 m -61.88 147.9 45.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 0.0 111.105 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 339' ' ' CYS . 30.9 mt -125.1 134.05 67.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 71.8 p -110.72 -33.2 6.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -134.37 109.74 8.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -145.03 122.49 11.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.075 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -160.46 153.33 21.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 93.7 t -111.65 136.86 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 33.4 mmt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 179.875 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 333' ' ' LYS . 68.0 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.92 0.39 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' LYS . . . . . 0.496 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 11.8 mmtp -35.7 -58.75 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.8 27.79 0.58 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.508 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.496 ' CE1' ' HB3' ' A' ' 333' ' ' LYS . 42.0 p90 -171.32 147.54 2.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.915 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -146.33 -170.37 14.86 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.458 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -134.22 142.09 47.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.899 0.38 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.613 HG11 ' CD2' ' A' ' 314' ' ' PHE . 33.6 t -135.83 132.54 50.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' CYS . . . . . 0.561 ' O ' HG23 ' A' ' 320' ' ' ILE . 65.5 m -117.61 145.48 44.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.892 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.592 ' HE1' HD12 ' A' ' 296' ' ' LEU . 46.7 m-85 -116.79 174.21 6.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 4.2 t -75.58 -42.41 52.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.829 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 49.2 m -132.3 143.32 48.37 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.635 0.731 . . . . 0.0 110.917 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.429 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.0 Cg_exo -47.16 -58.24 1.85 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.737 2.291 . . . . 0.0 112.344 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -40.6 -56.17 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -53.81 -42.51 68.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.913 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.82 -43.95 91.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.078 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 47.0 m -48.59 -65.21 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.147 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.443 ' O ' ' C ' ' A' ' 349' ' ' ALA . 42.7 tttt -38.6 -64.97 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.888 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -34.52 -55.25 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.47 HG22 HD22 ' A' ' 296' ' ' LEU . 58.7 t -38.02 -52.84 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 56.0 m -80.6 -53.72 6.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.144 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -49.94 -19.19 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' MET . . . . . 0.446 ' HB3' HG21 ' A' ' 365' ' ' VAL . 71.8 mmm -107.08 -59.85 1.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 353' ' ' MET . 9.1 t30 -36.3 111.01 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.895 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 99.01 9.62 51.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -95.86 118.84 33.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 110.89 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' ILE . . . . . 0.474 HD13 ' N ' ' A' ' 362' ' ' PRO . 11.0 mm -89.27 138.35 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 71.8 t -127.34 -43.64 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -116.43 -73.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.579 HG23 ' CD ' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -132.98 -47.62 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.579 ' CD ' HG23 ' A' ' 360' ' ' THR . 0.0 OUTLIER -108.14 156.9 37.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.63 0.728 . . . . 0.0 110.875 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.474 ' N ' HD13 ' A' ' 357' ' ' ILE . 62.6 Cg_endo -77.82 139.34 17.55 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.723 2.282 . . . . 0.0 112.341 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 365' ' ' VAL . 65.1 mt -69.47 101.08 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.933 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -68.43 96.82 0.71 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' A' ' 353' ' ' MET . 21.8 t -103.57 131.62 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.105 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -157.44 145.33 18.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.084 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.623 HD23 ' CD2' ' A' ' 296' ' ' LEU . 32.2 mt -63.0 138.87 58.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.059 179.837 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.849 0.357 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 343' ' ' PRO . 15.1 m -93.07 -34.99 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -59.01 140.76 55.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.76 HD21 ' HB1' ' A' ' 346' ' ' ALA . 35.6 mt -130.4 135.58 48.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -96.13 106.14 18.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 49.0 t -89.77 131.13 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.118 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 300' ' ' ASN . 20.5 tttt -135.22 161.82 34.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ASN . . . . . 0.462 ' N ' ' HG2' ' A' ' 299' ' ' LYS . 11.1 t-20 74.5 37.87 0.53 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.415 HD12 ' CA ' ' A' ' 335' ' ' PHE . 46.8 mt -79.98 91.32 5.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.485 ' H ' HD12 ' A' ' 305' ' ' ILE . 3.5 t70 -46.26 148.62 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.42 -36.49 9.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.96 -40.62 98.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.485 HD12 ' H ' ' A' ' 302' ' ' ASP . 41.6 mt -65.99 140.81 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.855 0.359 . . . . 0.0 111.113 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -134.15 177.71 7.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -52.45 -41.66 63.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -65.96 -61.8 1.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 64.8 mtt-85 -49.3 -34.14 14.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.508 HD12 ' CE1' ' A' ' 314' ' ' PHE . 61.5 tp -67.61 -71.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 45.3 ttt-85 -50.44 -25.45 3.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -73.89 -30.26 62.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -94.16 20.28 8.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.128 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.898 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.0 m-85 -126.17 -30.77 2.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.1 t -56.12 -45.32 99.92 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.688 0.756 . . . . 0.0 110.878 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 315' ' ' SER . 66.1 Cg_exo -48.02 -17.04 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.718 2.279 . . . . 0.0 112.324 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 60.0 m-85 -99.93 -52.39 3.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.62 165.91 35.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.418 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.5 m -62.85 138.23 58.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.761 0.315 . . . . 0.0 111.145 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.898 HD11 ' HB3' ' A' ' 314' ' ' PHE . 82.0 mt -118.32 132.1 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 67.2 p -105.77 -40.48 5.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -126.51 111.14 14.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.81 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ALA . . . . . 0.582 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -142.6 119.83 11.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.1 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.455 ' HD2' ' N ' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -153.56 162.36 41.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 78.4 t -121.72 142.98 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.136 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 34.1 mmt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.942 0.401 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.2 -47.65 65.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 123.62 29.93 1.12 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.415 ' CA ' HD12 ' A' ' 301' ' ' LEU . 12.7 p90 -171.32 158.07 5.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.372 . . . . 0.0 110.868 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -161.45 -166.88 21.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.501 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -139.04 143.89 38.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 22.7 t -138.96 140.04 39.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 23.7 m -117.54 149.33 40.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -122.84 176.92 5.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.835 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 32.6 t -78.45 -39.2 39.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.885 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 27.2 m -136.87 143.19 41.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.683 0.754 . . . . 0.0 110.843 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.432 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.2 Cg_exo -47.35 -59.15 1.35 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 2.243 . . . . 0.0 112.347 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 343' ' ' PRO . 30.9 tt0 -37.63 -59.76 0.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -49.33 -41.39 38.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.76 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -65.08 -42.72 93.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.109 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.4 m -50.72 -67.81 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.167 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -40.55 -56.53 2.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 350' ' ' VAL . . . -44.4 -55.51 4.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.097 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.548 HG22 HD22 ' A' ' 296' ' ' LEU . 84.3 t -36.6 -58.48 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.136 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 353' ' ' MET . 35.2 m -75.94 -60.35 2.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.525 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 3.7 mm-40 -39.99 -27.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' MET . . . . . 0.505 ' CB ' HG21 ' A' ' 365' ' ' VAL . 77.6 mmm -101.29 -42.33 6.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 26.1 t30 -60.15 106.28 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.859 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 113.92 -3.66 24.23 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.469 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -98.88 144.24 28.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.894 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' ILE . . . . . 0.402 HD13 ' CA ' ' A' ' 362' ' ' PRO . 8.3 mm -95.23 152.01 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.129 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.4 ' N ' HG22 ' A' ' 357' ' ' ILE . 45.1 t -131.95 -40.9 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.081 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -130.21 -66.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.0 -54.52 0.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.15 154.92 36.89 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.564 0.697 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.402 ' CA ' HD13 ' A' ' 357' ' ' ILE . 61.4 Cg_endo -76.43 134.07 15.13 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 35.7 mt -66.16 123.92 21.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -95.96 89.44 5.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.505 HG21 ' CB ' ' A' ' 353' ' ' MET . 2.9 t -90.78 134.53 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.061 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -153.87 142.87 21.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.068 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 27.9 mt -60.79 144.88 51.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 179.742 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 367' ' ' LEU . 84.0 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.882 0.372 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.8 m -93.25 -30.65 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -67.99 133.11 48.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.624 HD22 ' CG2' ' A' ' 350' ' ' VAL . 65.6 mt -121.94 135.84 54.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.668 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 39.5 t80 -94.27 119.93 33.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.938 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.411 HG21 HD11 ' A' ' 310' ' ' LEU . 59.3 t -104.14 137.71 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.163 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 10.8 tttp -137.22 161.78 35.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.938 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ASN . . . . . 0.471 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.1 m120 63.79 53.84 1.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.487 HD13 HG22 ' A' ' 325' ' ' VAL . 32.0 mt -86.67 94.47 9.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -44.41 149.15 0.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.81 -36.3 62.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.91 -38.36 95.97 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.468 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 81.6 mt -73.58 121.9 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.351 . . . . 0.0 111.103 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.43 177.91 4.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -39.28 -46.25 1.52 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 309' ' ' ARG . 0.2 OUTLIER -65.35 -69.57 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 309' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 308' ' ' GLU . 10.4 mmt180 -35.19 -36.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.492 HD12 ' CE1' ' A' ' 314' ' ' PHE . 47.8 tp -68.05 -75.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.447 ' HG3' ' HB3' ' A' ' 323' ' ' ALA . 2.6 tmm_? -48.85 -25.06 1.69 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -79.33 -32.64 43.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.99 21.03 2.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.094 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.624 ' CB ' HD11 ' A' ' 320' ' ' ILE . 8.8 m-85 -130.22 -30.41 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.597 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.1 t -53.1 -44.92 98.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.7 0.762 . . . . 0.0 110.872 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.4 Cg_exo -47.95 -17.59 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.685 2.257 . . . . 0.0 112.351 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -100.22 -54.9 2.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -159.28 163.67 33.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.462 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 44.5 m -61.31 143.27 55.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.727 0.298 . . . . 0.0 111.139 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.624 HD11 ' CB ' ' A' ' 314' ' ' PHE . 59.6 mt -117.69 149.37 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 61.9 p -117.27 -43.83 2.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.157 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 70.8 m -132.69 112.53 12.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ALA . . . . . 0.447 ' HB3' ' HG3' ' A' ' 311' ' ' ARG . . . -141.01 119.55 12.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.174 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -153.45 147.78 25.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.487 HG22 HD13 ' A' ' 301' ' ' LEU . 49.0 t -89.87 118.58 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.121 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' MET . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 335' ' ' PHE . 26.3 mmm . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.852 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.971 0.415 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -38.62 -45.8 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 121.01 43.05 0.46 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.493 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 326' ' ' MET . 2.0 p90 -175.53 160.57 2.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 110.881 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -156.97 177.0 34.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -127.74 132.74 49.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.871 0.367 . . . . 0.0 110.837 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 37.2 t -133.24 135.3 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 9.6 t -117.23 135.96 53.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . 10.9 m-85 -107.98 162.19 14.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 12.5 t -58.82 -46.92 86.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.85 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.14 146.1 58.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.654 0.74 . . . . 0.0 110.861 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 344' ' ' GLU . 71.9 Cg_exo -46.16 -57.78 2.02 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.694 2.263 . . . . 0.0 112.356 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 343' ' ' PRO . 17.4 mm-40 -37.09 -64.7 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' GLU . . . . . 0.413 ' N ' ' CD ' ' A' ' 345' ' ' GLU . 0.2 OUTLIER -49.09 -43.25 41.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.589 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -60.89 -48.05 83.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.102 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 75.1 m -46.08 -63.02 1.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.178 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 349' ' ' ALA . 1.3 ttmp? -40.65 -65.56 0.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.58 -54.93 0.87 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.114 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.624 ' CG2' HD22 ' A' ' 296' ' ' LEU . 59.3 t -41.43 -51.0 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.163 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 66.1 m -79.37 -58.0 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.118 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -45.78 -25.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.933 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 356' ' ' ARG . 65.3 mmm -102.16 -52.37 3.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 4.7 t-20 -34.25 111.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.916 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.04 20.98 58.28 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.497 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 353' ' ' MET . 17.5 tpp180 -98.05 123.33 42.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.883 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 357' ' ' ILE . . . . . 0.489 HD13 ' N ' ' A' ' 362' ' ' PRO . 10.9 mm -93.14 125.35 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.108 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 74.8 t -110.52 -51.63 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.133 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -113.22 -69.48 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.09 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 1.4 p -131.6 -53.23 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.65 153.37 37.95 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.589 0.709 . . . . 0.0 110.861 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.489 ' N ' HD13 ' A' ' 357' ' ' ILE . 62.6 Cg_endo -77.67 145.3 22.97 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.69 2.26 . . . . 0.0 112.344 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.518 ' O ' HG23 ' A' ' 365' ' ' VAL . 48.4 mt -82.74 92.08 7.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -66.82 100.52 0.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 363' ' ' LEU . 7.6 t -106.43 136.35 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -158.32 149.18 20.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.442 ' HB3' HG11 ' A' ' 293' ' ' VAL . 34.4 mt -59.31 137.28 58.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' ALA . . . . . 0.668 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 86.8 t . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.85 0.357 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 343' ' ' PRO . 29.0 m -95.88 -32.24 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.178 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -69.26 126.12 28.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.762 HD21 ' HB1' ' A' ' 346' ' ' ALA . 39.3 mt -114.6 140.17 49.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -95.59 121.16 36.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.725 HG21 HD11 ' A' ' 310' ' ' LEU . 67.0 t -103.01 133.53 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.127 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 26.8 tttm -133.82 162.49 31.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ASN . . . . . 0.481 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.4 m120 63.77 48.27 3.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.907 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.501 HD21 HG11 ' A' ' 298' ' ' VAL . 28.9 mt -86.81 99.61 11.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -44.79 157.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -59.14 -42.18 90.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.53 -38.96 94.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.511 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.511 HD13 HD21 ' A' ' 363' ' ' LEU . 77.9 mt -65.92 132.33 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.896 0.379 . . . . 0.0 111.123 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.68 -174.93 3.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -46.96 -60.86 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 309' ' ' ARG . 12.5 tt0 -49.65 -65.13 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 308' ' ' GLU . 9.8 mmt85 -34.4 -49.08 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.863 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.725 HD11 HG21 ' A' ' 298' ' ' VAL . 67.7 tp -55.42 -74.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -49.07 -25.05 1.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -74.47 -40.47 61.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.34 19.01 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.109 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.629 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.3 m-85 -127.36 -30.16 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.598 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.2 t -54.02 -45.0 99.16 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.688 0.756 . . . . 0.0 110.872 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.8 Cg_exo -48.03 -17.88 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.703 2.268 . . . . 0.0 112.351 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' PHE . . . . . 0.572 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 57.4 m-85 -100.45 -61.09 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.863 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -148.69 159.32 27.99 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.458 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.2 m -65.36 141.92 58.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.769 0.318 . . . . 0.0 111.157 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.831 HG23 ' O ' ' A' ' 339' ' ' CYS . 79.8 mt -120.26 135.41 60.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 66.4 p -99.45 -36.55 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.6 t -137.81 122.62 18.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ALA . . . . . 0.456 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -137.16 124.18 21.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -150.67 149.81 30.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 335' ' ' PHE . 79.5 t -115.38 138.87 44.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.099 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 39.3 mmt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.895 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 82.2 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.9 0.381 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 333' ' ' LYS . . . . . 0.411 ' HE2' ' CZ ' ' A' ' 335' ' ' PHE . 22.7 mtpt -65.24 -47.07 78.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.39 27.45 0.62 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.488 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.463 ' O ' HG13 ' A' ' 325' ' ' VAL . 7.8 p90 -174.98 165.72 3.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.883 0.373 . . . . 0.0 110.893 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -167.41 -163.31 21.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -144.16 138.98 28.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.377 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.666 ' CG2' HD21 ' A' ' 310' ' ' LEU . 53.7 t -130.73 142.46 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' CYS . . . . . 0.831 ' O ' HG23 ' A' ' 320' ' ' ILE . 74.0 m -114.29 145.7 41.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -120.83 174.55 6.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.5 t -73.58 -42.0 62.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.85 145.88 38.49 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.645 0.736 . . . . 0.0 110.837 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.568 ' N ' HG12 ' A' ' 294' ' ' VAL . 71.5 Cg_exo -46.41 -56.18 3.15 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.699 2.266 . . . . 0.0 112.332 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 343' ' ' PRO . 3.6 mm-40 -37.56 -63.52 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -47.75 -45.89 29.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.762 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -60.92 -44.06 97.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 92.8 m -45.9 -61.67 1.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.167 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 349' ' ' ALA . 15.4 ttmt -46.94 -61.95 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -37.52 -50.35 1.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.499 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 57.7 t -41.16 -57.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.113 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 94.2 m -77.48 -55.33 5.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.154 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.572 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 25.6 mm-40 -43.24 -30.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' MET . . . . . 0.448 ' O ' ' C ' ' A' ' 354' ' ' ASN . 72.8 mmm -100.82 -53.66 3.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 2.9 t30 -34.02 115.95 0.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 81.03 27.18 50.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.478 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -99.98 118.24 35.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.868 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' ILE . . . . . 0.504 HD13 ' CA ' ' A' ' 362' ' ' PRO . 27.0 mm -91.51 117.49 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 97.0 t -106.83 -45.01 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -118.55 -72.83 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.093 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.0 p -132.14 -51.74 0.96 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -100.32 148.84 35.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.549 0.69 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.504 ' CA ' HD13 ' A' ' 357' ' ' ILE . 62.9 Cg_endo -77.97 137.34 15.58 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.702 2.268 . . . . 0.0 112.374 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.511 HD21 HD13 ' A' ' 305' ' ' ILE . 62.5 mt -74.5 91.93 2.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -64.19 105.15 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 363' ' ' LEU . 47.0 t -108.79 133.11 54.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.094 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -152.48 151.23 30.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.115 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 73.7 mt -58.79 136.49 57.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 179.825 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.909 0.385 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 343' ' ' PRO . 19.2 m -118.45 -25.12 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -77.21 143.85 38.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.651 HD12 ' CE1' ' A' ' 340' ' ' PHE . 35.4 mt -131.3 135.87 47.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -94.93 123.83 38.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.2 t -105.07 130.82 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.139 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 34.4 tttp -129.54 162.24 28.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.872 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ASN . . . . . 0.479 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.8 m-20 63.86 52.25 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.582 HD12 ' C ' ' A' ' 335' ' ' PHE . 27.7 mt -93.51 91.16 6.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -40.52 135.34 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -41.08 -41.62 1.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -57.3 -38.72 88.04 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.506 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 57.8 mt -65.89 127.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.831 0.348 . . . . 0.0 111.168 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.4 178.51 4.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.828 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -54.8 -41.49 70.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.847 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -63.43 -57.61 9.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -42.36 -51.76 4.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.474 HD13 HD21 ' A' ' 301' ' ' LEU . 49.5 tp -57.28 -70.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -47.91 -27.63 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 10.7 mtpp -74.3 -32.06 62.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -91.66 18.4 7.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.746 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.3 m-85 -127.11 -29.56 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.594 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -54.51 -45.35 99.44 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.673 0.749 . . . . 0.0 110.858 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.1 Cg_exo -47.92 -17.1 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.666 2.244 . . . . 0.0 112.38 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 61.7 m-85 -99.87 -57.6 2.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -155.94 167.66 33.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.479 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 8.1 m -65.82 143.88 57.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.0 111.102 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.746 HD11 ' HB3' ' A' ' 314' ' ' PHE . 80.2 mt -123.81 139.43 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.7 p -110.74 -38.86 5.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.136 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 14.8 m -127.32 111.12 13.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ALA . . . . . 0.557 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -145.4 126.01 14.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.161 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 12.5 tptm -165.05 149.73 9.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.534 HG22 HD13 ' A' ' 301' ' ' LEU . 93.7 t -98.13 139.47 20.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 37.7 mmt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 179.95 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 333' ' ' LYS . 37.6 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.904 0.383 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' LYS . . . . . 0.532 ' HD3' ' CZ ' ' A' ' 335' ' ' PHE . 22.1 mtpp -35.14 -48.01 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 117.38 36.59 0.99 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.46 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.582 ' C ' HD12 ' A' ' 301' ' ' LEU . 13.3 p90 -174.47 164.45 3.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.896 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -160.99 -166.78 20.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -134.4 144.37 48.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.868 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 49.0 t -137.08 132.13 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' CYS . . . . . 0.427 ' O ' HG23 ' A' ' 320' ' ' ILE . 7.2 t -115.92 134.76 54.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.651 ' CE1' HD12 ' A' ' 296' ' ' LEU . 16.5 m-85 -110.86 170.19 8.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.916 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 47.9 t -79.97 -43.32 22.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.895 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 3.0 m -125.29 138.48 31.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.666 0.746 . . . . 0.0 110.84 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.485 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.1 Cg_exo -47.43 -60.02 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.643 2.229 . . . . 0.0 112.37 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 343' ' ' PRO . 42.6 mt-10 -37.44 -58.7 0.83 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -47.35 -45.06 24.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.626 ' O ' HG23 ' A' ' 350' ' ' VAL . . . -61.41 -43.18 99.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.071 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.7 m -51.07 -67.64 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.216 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 349' ' ' ALA . 26.3 tttt -41.32 -63.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.96 -52.93 0.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.641 HG22 HD22 ' A' ' 296' ' ' LEU . 60.9 t -40.06 -54.25 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 81.0 m -79.76 -54.49 5.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.149 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.573 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 17.5 mm-40 -46.42 -25.64 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 353' ' ' MET . . . . . 0.435 ' O ' ' C ' ' A' ' 354' ' ' ASN . 73.4 mmm -104.26 -52.23 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 4.2 t-20 -34.89 110.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 91.88 25.88 21.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -99.76 119.99 39.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 8.8 mm -90.66 127.49 43.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.173 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 67.1 t -116.68 -40.98 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.142 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.11 -70.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.128 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.3 p -132.03 -52.91 0.98 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.151 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -99.99 149.44 35.98 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.606 0.717 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.57 136.81 17.69 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.721 2.281 . . . . 0.0 112.295 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 37.0 mt -66.85 100.35 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -73.75 95.4 2.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.403 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 52.7 t -96.95 144.05 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.077 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -157.96 171.7 19.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 28.4 mt -81.14 140.77 34.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.868 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.102 179.788 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 81.4 t . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.866 0.365 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.72 -25.22 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -75.38 128.25 34.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.657 HD21 ' HB1' ' A' ' 346' ' ' ALA . 46.1 mt -118.62 147.84 43.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 299' ' ' LYS . 31.8 t80 -106.76 115.51 30.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 31.8 t -100.46 127.95 52.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.155 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.445 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 42.9 tttp -129.16 160.88 31.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ASN . . . . . 0.445 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.5 m120 63.78 50.48 2.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.679 HD21 HD13 ' A' ' 310' ' ' LEU . 24.1 mt -84.28 105.32 15.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.558 ' OD2' ' HB3' ' A' ' 359' ' ' ALA . 62.2 m-20 -45.19 137.42 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -44.97 -40.58 6.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -65.53 -37.97 94.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.479 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.61 107.6 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.822 0.344 . . . . 0.0 111.12 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -95.78 -176.46 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -51.22 -45.91 62.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -66.11 -54.14 29.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -45.27 -42.99 10.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.837 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.679 HD13 HD21 ' A' ' 301' ' ' LEU . 54.0 tp -60.22 -70.29 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.925 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.421 ' NH1' ' HB3' ' A' ' 311' ' ' ARG . 19.3 ttp-105 -53.37 -23.82 10.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -67.96 -35.99 79.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -95.01 20.25 9.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.087 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.878 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.2 m-85 -126.48 -30.38 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.596 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.0 OUTLIER -57.29 -44.79 99.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.62 0.724 . . . . 0.0 110.829 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.7 Cg_exo -48.07 -17.02 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.683 2.255 . . . . 0.0 112.335 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 53.6 m-85 -100.24 -51.48 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.97 163.9 34.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.4 m -63.99 140.7 58.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.124 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.878 HD11 ' HB3' ' A' ' 314' ' ' PHE . 90.9 mt -121.5 143.15 34.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.129 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 69.2 p -117.74 -42.19 2.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.156 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 65.4 m -115.47 105.89 13.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.845 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ALA . . . . . 0.445 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -137.52 112.71 9.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.059 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 33.5 tptt -143.54 145.01 32.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.428 ' N ' ' HG3' ' A' ' 324' ' ' LYS . 49.0 t -110.16 117.48 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' MET . . . . . 0.411 ' HB3' ' CD ' ' A' ' 333' ' ' LYS . 35.8 mmt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 67.9 p . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.886 0.374 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 333' ' ' LYS . . . . . 0.569 ' HB3' ' CE2' ' A' ' 335' ' ' PHE . 23.7 mttm -48.59 -52.3 23.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 122.33 33.47 0.89 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.508 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 333' ' ' LYS . 20.1 p90 -173.03 159.67 4.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.924 0.392 . . . . 0.0 110.864 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -162.08 -170.46 26.88 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -131.56 141.02 49.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.882 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 18.5 t -136.51 125.95 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 10.1 t -110.4 134.88 51.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.416 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . 9.4 m-85 -107.59 165.6 11.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 5.0 t -73.36 -39.75 64.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 68.4 m -127.01 139.5 35.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.663 0.744 . . . . 0.0 110.878 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.62 -60.5 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.715 2.276 . . . . 0.0 112.341 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -40.31 -57.67 1.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -46.87 -46.77 21.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.657 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -62.82 -42.65 99.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.081 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 56.5 m -53.2 -63.56 1.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 349' ' ' ALA . 37.8 tttt -43.64 -62.77 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -37.37 -51.65 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 346' ' ' ALA . 58.0 t -40.53 -55.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.151 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 73.4 m -78.74 -55.44 5.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.514 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 2.5 mm-40 -45.01 -27.86 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 353' ' ' MET . . . . . 0.484 ' O ' ' CB ' ' A' ' 356' ' ' ARG . 82.3 mmm -102.49 -52.24 3.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.838 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 2.5 t30 -33.96 118.66 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 79.5 18.8 72.76 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.453 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 353' ' ' MET . 22.4 tpp180 -100.12 125.79 46.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.752 0.31 . . . . 0.0 110.872 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 29.2 mm -88.59 139.88 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 90.7 t -128.35 -34.74 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.153 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.558 ' HB3' ' OD2' ' A' ' 302' ' ' ASP . . . -131.27 -69.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.68 -51.2 0.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.177 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.32 155.84 37.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.603 0.716 . . . . 0.0 110.886 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.77 142.67 20.4 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.369 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.587 HD21 HD23 ' A' ' 301' ' ' LEU . 34.4 mt -79.19 92.97 5.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.883 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -65.23 97.69 0.28 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 363' ' ' LEU . 7.6 t -101.17 145.11 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.104 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -158.95 154.64 26.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.093 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.63 140.66 58.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 179.761 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 88.1 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.843 0.354 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.461 HG23 ' SG ' ' A' ' 339' ' ' CYS . 24.2 m -108.85 -34.72 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -59.64 143.74 49.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.573 HD22 HG22 ' A' ' 350' ' ' VAL . 20.2 mt -134.7 153.38 52.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -115.3 118.81 34.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.7 t -100.19 137.06 28.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.076 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -138.92 155.71 47.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 74.78 39.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.477 HD21 HD13 ' A' ' 310' ' ' LEU . 33.9 mt -73.43 90.66 1.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -40.76 139.92 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.4 -41.58 9.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.862 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.85 -38.97 94.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.44 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 66.7 mt -66.52 143.69 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.856 0.36 . . . . 0.0 111.157 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -132.21 -175.03 3.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -57.79 -42.73 84.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -64.65 -63.81 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 74.5 mtt-85 -46.23 -44.56 16.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.477 HD13 HD21 ' A' ' 301' ' ' LEU . 47.5 tp -55.37 -75.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.617 ' HG3' HD13 ' A' ' 320' ' ' ILE . 58.7 ttp180 -48.95 -29.53 4.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -72.14 -33.68 67.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -85.98 20.35 2.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.446 ' HB2' HD11 ' A' ' 320' ' ' ILE . 8.4 m-85 -128.99 -30.73 2.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.83 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.81 -45.34 97.25 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.716 0.769 . . . . 0.0 110.882 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.6 Cg_exo -48.03 -16.73 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.664 2.243 . . . . 0.0 112.351 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 57.9 m-85 -99.84 -46.62 5.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -169.0 165.97 39.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.542 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 42.0 m -62.59 140.19 58.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.116 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.617 HD13 ' HG3' ' A' ' 311' ' ' ARG . 74.5 mt -109.92 145.56 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.112 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 82.4 p -109.98 -45.39 3.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 82.7 p -136.3 116.53 13.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.842 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ALA . . . . . 0.576 ' HB3' ' HD3' ' A' ' 311' ' ' ARG . . . -135.2 123.46 23.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -150.61 152.4 33.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.475 HG22 HD22 ' A' ' 310' ' ' LEU . 55.2 t -112.34 130.17 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 37.5 mmt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 179.965 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.895 0.379 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 333' ' ' LYS . . . . . 0.552 ' HB3' ' CE2' ' A' ' 335' ' ' PHE . 58.2 mttt -52.49 -61.47 2.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 136.9 37.58 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.466 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 333' ' ' LYS . 23.2 p90 -174.82 162.06 3.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 0.0 110.907 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -159.27 -169.16 22.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.477 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -138.8 137.02 36.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.866 0.365 . . . . 0.0 110.912 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 48.8 t -138.04 136.48 44.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.149 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' CYS . . . . . 0.461 ' SG ' HG23 ' A' ' 294' ' ' VAL . 10.1 t -121.39 133.49 55.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.881 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . 11.4 m-85 -104.13 158.91 16.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.851 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.4 m -64.04 -43.07 96.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 71.0 m -125.38 136.97 28.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.67 0.748 . . . . 0.0 110.859 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.4 -56.87 2.69 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.648 2.232 . . . . 0.0 112.361 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -43.82 -61.33 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -47.66 -46.05 28.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.881 ' HB2' ' HB2' ' A' ' 340' ' ' PHE . . . -61.75 -41.18 97.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.062 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 31.4 m -51.49 -60.9 2.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.108 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -40.96 -58.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -46.48 -53.14 11.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.101 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.573 HG22 HD22 ' A' ' 296' ' ' LEU . 98.6 t -38.48 -58.69 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.162 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 72.4 m -75.36 -59.08 2.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.564 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 39.4 mm-40 -41.54 -28.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.9 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 353' ' ' MET . . . . . 0.468 ' HG2' ' CE2' ' A' ' 317' ' ' PHE . 64.1 mmm -100.06 -40.63 7.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 354' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -46.1 109.07 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.44 21.93 55.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' ARG . . . . . 0.419 ' HD3' ' C ' ' A' ' 356' ' ' ARG . 0.0 OUTLIER -98.1 125.19 42.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.762 0.315 . . . . 0.0 110.862 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 357' ' ' ILE . . . . . 0.458 HD13 ' CA ' ' A' ' 362' ' ' PRO . 27.6 mm -89.42 127.26 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 66.3 t -113.38 -42.89 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -123.0 -74.36 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.089 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 5.2 p -128.9 -49.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.184 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -105.14 150.15 38.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.574 0.702 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.458 ' CA ' HD13 ' A' ' 357' ' ' ILE . 61.5 Cg_endo -76.76 140.98 21.3 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.688 2.259 . . . . 0.0 112.331 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 32.4 mt -80.39 115.87 20.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -83.21 99.66 10.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.476 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 39.0 t -103.37 140.83 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -166.41 152.8 8.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.073 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 26.9 mt -65.93 132.48 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.072 179.802 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.493 HG21 HD22 ' A' ' 367' ' ' LEU . 1.8 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.857 0.361 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 343' ' ' PRO . 23.1 m -117.88 -26.8 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -74.12 114.94 13.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.816 HD21 ' HB1' ' A' ' 346' ' ' ALA . 38.4 mt -105.45 132.97 50.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.955 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.735 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 5.9 t80 -90.28 120.09 31.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.407 HG11 HD21 ' A' ' 301' ' ' LEU . 98.6 t -101.05 137.43 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.116 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.466 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 35.8 tttt -137.03 161.46 36.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ASN . . . . . 0.466 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.0 m120 63.53 47.69 3.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.407 HD21 HG11 ' A' ' 298' ' ' VAL . 28.4 mt -80.23 102.46 9.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -45.9 143.9 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -52.39 -39.45 60.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -61.95 -37.11 93.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.79 148.22 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.852 0.358 . . . . 0.0 111.136 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -137.36 179.78 6.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -52.52 -38.67 60.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 309' ' ' ARG . 16.4 mm-40 -68.63 -72.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.888 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 308' ' ' GLU . 61.0 mtt-85 -36.99 -38.89 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.528 HD12 ' CE1' ' A' ' 314' ' ' PHE . 44.0 tp -63.32 -70.72 0.2 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.45 ' HG3' ' CD1' ' A' ' 320' ' ' ILE . 46.3 ttt180 -50.85 -24.98 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -79.4 -32.96 43.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.47 18.88 3.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.081 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.528 ' CE1' HD12 ' A' ' 310' ' ' LEU . 8.4 m-85 -129.36 -30.92 2.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.874 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.584 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.7 OUTLIER -50.79 -45.65 86.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.634 0.73 . . . . 0.0 110.84 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.7 Cg_exo -47.94 -17.05 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.662 2.241 . . . . 0.0 112.353 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' PHE . . . . . 0.443 ' CE2' ' HG2' ' A' ' 353' ' ' MET . 54.4 m-85 -99.84 -47.45 5.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -166.14 158.61 31.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.484 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 40.8 m -60.7 139.13 57.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.738 0.304 . . . . 0.0 111.163 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 339' ' ' CYS . 46.7 mt -110.99 141.69 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 67.9 p -110.34 -40.39 4.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.068 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 3.5 m -132.12 121.24 23.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.883 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -132.98 125.18 29.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.102 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 22.2 mtpt -142.48 154.99 45.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 31.5 t -129.96 117.57 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.16 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 30.0 mmt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.913 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.904 0.383 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 333' ' ' LYS . . . . . 0.479 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 21.2 mtpp -46.96 -53.31 12.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 300' ' ' ASN . . . 132.59 33.36 0.39 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 333' ' ' LYS . 29.4 p90 -175.15 157.29 2.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -156.89 -161.38 10.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -142.46 131.65 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.386 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 61.7 t -127.36 134.25 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' CYS . . . . . 0.632 ' O ' HG23 ' A' ' 320' ' ' ILE . 7.3 m -110.26 138.78 46.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.486 ' CE1' HD12 ' A' ' 296' ' ' LEU . 28.8 m-85 -114.14 164.41 13.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.904 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.9 t -67.76 -46.51 71.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 3.5 m -130.69 142.67 46.37 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.638 0.733 . . . . 0.0 110.876 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 344' ' ' GLU . 72.8 Cg_exo -47.05 -59.34 1.28 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.652 2.234 . . . . 0.0 112.36 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 343' ' ' PRO . 39.8 mt-10 -36.09 -61.83 0.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -46.87 -47.28 21.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.816 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -60.89 -41.02 95.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 90.1 m -50.13 -62.8 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 349' ' ' ALA . 27.0 tttm -46.52 -63.94 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.21 -48.96 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.071 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 346' ' ' ALA . 47.0 t -41.66 -56.42 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.187 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 92.9 m -79.58 -51.99 8.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.437 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 20.5 mm-40 -46.3 -29.44 1.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 353' ' ' MET . . . . . 0.443 ' HG2' ' CE2' ' A' ' 317' ' ' PHE . 53.4 mmm -101.51 -52.71 3.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 1.8 t30 -34.22 116.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.921 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 82.7 25.57 49.58 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.523 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -100.05 118.27 36.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.723 0.297 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' ILE . . . . . 0.516 HD13 ' CA ' ' A' ' 362' ' ' PRO . 29.6 mm -86.73 126.43 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 94.9 t -112.18 -48.49 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.172 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -120.75 -68.24 0.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.067 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 6.0 p -130.88 -54.44 1.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.139 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.43 151.17 37.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.561 0.696 . . . . 0.0 110.882 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.516 ' CA ' HD13 ' A' ' 357' ' ' ILE . 63.0 Cg_endo -77.13 143.78 22.96 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.641 2.227 . . . . 0.0 112.353 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 365' ' ' VAL . 33.2 mt -78.68 91.97 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -64.32 101.82 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.47 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 50.8 t -105.66 134.49 47.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.122 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -154.54 153.65 31.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.493 HD22 HG21 ' A' ' 293' ' ' VAL . 79.4 mt -62.26 136.75 58.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 368' ' ' ALA . . . . . 0.735 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.169 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 99.6 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.857 0.361 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 4.6 m -93.85 -32.54 4.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -64.93 135.84 56.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.928 HD21 ' HB1' ' A' ' 346' ' ' ALA . 48.4 mt -122.33 137.73 54.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -98.75 106.56 18.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.2 t -90.3 135.75 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.164 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.492 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 17.3 ttmm -133.25 164.76 26.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ASN . . . . . 0.492 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.7 m-20 63.77 45.34 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 28.4 mt -90.61 98.09 11.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -46.35 163.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.32 -36.62 84.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.26 -43.58 97.13 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.533 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 39.6 mt -60.91 147.49 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.336 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -137.31 -176.82 4.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.823 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -60.14 -34.08 73.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -72.13 -62.25 1.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.878 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -46.82 -42.78 17.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.455 HD12 ' CE1' ' A' ' 314' ' ' PHE . 61.2 tp -62.38 -71.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -48.43 -26.58 2.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -70.48 -33.69 71.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -92.35 18.94 7.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.108 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.472 ' CB ' HD11 ' A' ' 320' ' ' ILE . 6.3 m-85 -123.76 -31.16 3.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.8 OUTLIER -56.85 -45.48 99.95 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.643 0.735 . . . . 0.0 110.846 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.9 Cg_exo -47.95 -17.06 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 0.0 112.385 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' PHE . . . . . 0.58 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 62.0 m-85 -99.92 -48.91 4.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.26 168.08 37.11 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.455 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.3 m -64.37 139.39 58.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.787 0.327 . . . . 0.0 111.124 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.477 HG21 ' HB2' ' A' ' 323' ' ' ALA . 42.1 mt -115.85 133.93 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 75.2 p -108.15 -40.62 5.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.127 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.9 m -130.09 112.61 13.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.815 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -138.65 124.31 19.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.122 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.447 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 19.2 tptm -163.63 146.55 9.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.447 ' N ' ' HG3' ' A' ' 324' ' ' LYS . 98.9 t -101.05 136.23 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.113 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 37.5 mmt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 179.887 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.963 0.411 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -58.11 -53.62 56.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.899 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 138.78 36.86 0.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.5 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -171.93 152.76 3.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.857 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -154.08 -174.11 23.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.519 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -133.62 143.74 48.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 110.895 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 48.7 t -138.7 147.59 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' CYS . . . . . 0.424 ' O ' HG23 ' A' ' 320' ' ' ILE . 62.6 m -124.52 149.03 47.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -125.2 175.96 7.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 90.2 p -75.11 -29.79 60.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 43.4 t -156.75 145.05 14.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.717 0.77 . . . . 0.0 110.789 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 346' ' ' ALA . 71.3 Cg_exo -45.06 -54.01 4.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.693 2.262 . . . . 0.0 112.359 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -39.01 -37.92 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -76.2 -38.64 56.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.928 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -65.79 -45.39 82.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 87.5 m -49.3 -67.82 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.172 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.453 ' HG2' ' CG ' ' A' ' 352' ' ' GLU . 19.7 tttm -41.14 -60.71 1.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -40.8 -52.45 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 346' ' ' ALA . 66.2 t -39.47 -59.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 353' ' ' MET . 51.9 m -77.51 -59.6 2.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.159 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.58 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 30.9 mm-40 -37.44 -29.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 353' ' ' MET . . . . . 0.468 ' N ' ' O ' ' A' ' 351' ' ' THR . 79.6 mmm -100.24 -61.3 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 353' ' ' MET . 8.0 t30 -36.8 101.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 125.68 -9.26 7.68 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.511 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.42 126.54 35.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 110.878 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 357' ' ' ILE . . . . . 0.437 HD13 ' CA ' ' A' ' 362' ' ' PRO . 23.4 mm -87.94 135.27 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 65.6 t -113.63 -54.54 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -116.08 -65.39 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.064 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.501 HG23 ' HD3' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -133.76 -52.65 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.501 ' HD3' HG23 ' A' ' 360' ' ' THR . 0.0 OUTLIER -102.81 153.67 38.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.548 0.69 . . . . 0.0 110.893 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.437 ' CA ' HD13 ' A' ' 357' ' ' ILE . 60.0 Cg_endo -73.5 148.24 42.31 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.324 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.477 ' O ' HG23 ' A' ' 365' ' ' VAL . 58.7 mt -70.8 93.61 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -68.08 88.28 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 363' ' ' LEU . 14.3 t -92.66 140.09 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.09 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -155.96 138.32 14.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.478 HD23 ' CD2' ' A' ' 296' ' ' LEU . 60.2 mt -57.76 141.45 48.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.121 179.763 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 98.6 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.864 0.364 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 343' ' ' PRO . 23.9 m -94.55 -23.82 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.175 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -78.35 137.92 38.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.831 HD21 ' HB1' ' A' ' 346' ' ' ALA . 36.2 mt -128.08 142.85 51.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.958 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.64 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 32.9 t80 -99.65 121.87 41.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.54 HG21 HD11 ' A' ' 310' ' ' LEU . 39.3 t -99.57 130.1 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.098 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 16.0 tttm -128.44 157.56 40.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ASN . . . . . . . . . . . . . 3.4 m120 63.83 54.94 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.511 HD21 HG11 ' A' ' 298' ' ' VAL . 28.3 mt -92.56 98.07 11.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.939 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 303' ' ' ASP . 14.8 t70 -50.24 131.42 23.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 302' ' ' ASP . 12.9 t70 -35.61 -49.86 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -48.35 -44.98 28.45 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.73 143.15 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.826 0.346 . . . . 0.0 111.125 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.8 -175.76 4.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.828 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.74 -42.94 65.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -62.25 -70.25 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 66.7 mtt-85 -41.66 -40.73 2.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.54 HD11 HG21 ' A' ' 298' ' ' VAL . 43.2 tp -60.72 -70.92 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.653 ' HG3' HD12 ' A' ' 320' ' ' ILE . 54.6 ttt180 -53.2 -23.71 9.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -68.7 -37.97 79.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -91.82 20.09 5.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.098 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.626 ' CB ' HD11 ' A' ' 320' ' ' ILE . 7.1 m-85 -126.19 -30.34 2.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.864 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.589 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.0 OUTLIER -56.9 -45.52 99.95 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.664 0.745 . . . . 0.0 110.822 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 315' ' ' SER . 66.1 Cg_exo -48.0 -17.16 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 0.0 112.354 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 48.6 m-85 -100.8 -52.84 3.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -145.72 170.62 26.94 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.464 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.4 m -85.93 95.19 9.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 0.0 111.143 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.653 HD12 ' HG3' ' A' ' 311' ' ' ARG . 93.4 mt -62.07 143.59 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.181 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 39.1 p -112.13 -28.54 7.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 2.6 t -155.37 109.23 2.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ALA . . . . . 0.481 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -123.19 135.77 54.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.135 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -156.57 152.7 27.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 86.7 t -115.96 139.18 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.101 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 35.9 mmt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 59.2 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.907 0.384 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 333' ' ' LYS . . . . . 0.423 ' HD3' ' CZ ' ' A' ' 335' ' ' PHE . 19.0 mtpt -75.57 -60.77 2.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 149.14 37.72 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.525 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.488 ' CA ' HD12 ' A' ' 301' ' ' LEU . 34.9 p90 -174.02 150.09 1.56 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.899 0.38 . . . . 0.0 110.891 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -158.12 -169.0 21.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.479 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -136.34 143.22 43.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 0.0 110.882 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 41.2 t -134.05 126.84 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.15 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 74.3 m -101.41 127.56 48.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.727 ' CE1' HD12 ' A' ' 296' ' ' LEU . 15.5 m-85 -101.76 168.14 9.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 25.1 t -78.36 -42.24 31.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.9 m -131.24 139.75 36.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.664 0.745 . . . . 0.0 110.875 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 344' ' ' GLU . 72.8 Cg_exo -47.43 -59.01 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.718 2.279 . . . . 0.0 112.332 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 343' ' ' PRO . 27.9 tt0 -36.39 -59.06 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.921 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.43 -48.11 56.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.831 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -55.88 -42.92 76.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.088 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 99.2 m -52.93 -67.15 0.27 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.19 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 349' ' ' ALA . 15.2 ttmt -40.85 -65.06 0.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.6 -48.24 0.51 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.112 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 346' ' ' ALA . 43.4 t -44.38 -52.66 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 53.1 m -81.79 -50.41 9.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.542 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 23.4 mm-40 -49.62 -28.13 5.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 353' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 356' ' ' ARG . 83.7 mmm -101.84 -49.0 4.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 3.5 t30 -36.1 110.53 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 87.75 19.83 52.74 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.507 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 356' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 353' ' ' MET . 21.8 tpp85 -99.11 120.97 40.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.897 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 9.0 mm -87.11 130.92 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.145 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 85.2 t -116.43 -42.29 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.073 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -126.1 -69.23 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.11 -55.25 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.98 155.68 36.17 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.558 0.694 . . . . 0.0 110.942 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.18 135.55 15.34 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.68 2.253 . . . . 0.0 112.301 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 365' ' ' VAL . 28.0 mt -71.72 88.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -64.48 100.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.94 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 363' ' ' LEU . 28.8 t -100.09 135.25 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -153.94 143.16 21.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 71.7 mt -54.14 145.18 17.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' ALA . . . . . 0.64 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 74.7 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.882 0.372 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.457 HG12 ' C ' ' A' ' 342' ' ' SER . 16.6 m -87.13 -30.39 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -69.63 123.21 20.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.668 HD21 ' HB1' ' A' ' 346' ' ' ALA . 69.1 mt -112.45 136.84 51.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.966 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -90.21 119.52 30.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.485 HG21 HD11 ' A' ' 310' ' ' LEU . 21.2 t -106.98 129.73 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.119 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.488 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 11.0 tttp -129.61 162.71 27.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' ASN . . . . . 0.488 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.4 m120 63.8 51.21 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 39.8 mt -85.85 99.41 11.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -46.91 144.26 2.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -47.45 -40.27 17.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -61.28 -36.82 93.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.503 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.591 HD13 HD21 ' A' ' 363' ' ' LEU . 66.9 mt -69.11 135.97 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.826 0.346 . . . . 0.0 111.14 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -136.18 -176.36 4.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -43.04 -63.3 0.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -47.06 -63.83 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -39.59 -52.5 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.515 HD21 ' CG2' ' A' ' 338' ' ' VAL . 53.1 tp -50.22 -74.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.96 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.723 ' HG3' HG21 ' A' ' 320' ' ' ILE . 19.3 ttt180 -54.2 -21.45 8.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -78.41 -29.51 47.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -99.91 17.96 19.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.806 ' CB ' HD11 ' A' ' 320' ' ' ILE . 8.0 m-85 -128.59 -30.39 2.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.73 -45.4 96.81 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.644 0.735 . . . . 0.0 110.82 -179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 315' ' ' SER . 66.0 Cg_exo -48.0 -17.13 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.67 2.247 . . . . 0.0 112.341 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' PHE . . . . . 0.419 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 52.0 m-85 -99.95 -50.11 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -145.91 169.19 27.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 90.4 m -81.86 88.19 6.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.725 0.298 . . . . 0.0 111.136 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.806 HD11 ' CB ' ' A' ' 314' ' ' PHE . 64.8 mt -65.56 131.57 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.151 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 3.1 t -108.75 -29.65 8.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.1 t -139.98 126.17 19.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -140.24 140.93 35.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.093 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -156.43 150.65 25.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 95.5 t -125.12 135.68 63.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 35.7 mmt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.908 0.385 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -58.22 -56.31 23.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 141.14 36.9 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.471 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -174.2 161.37 3.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.92 0.391 . . . . 0.0 110.846 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -164.85 -167.83 26.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.492 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -144.2 136.13 26.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.902 0.382 . . . . 0.0 110.887 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.515 ' CG2' HD21 ' A' ' 310' ' ' LEU . 60.1 t -123.05 134.82 65.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 64.5 m -107.34 128.58 54.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.517 ' CE1' HD12 ' A' ' 296' ' ' LEU . 21.9 m-85 -105.03 160.86 14.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 95.7 p -67.42 -31.36 71.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.905 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' SER . . . . . 0.457 ' C ' HG12 ' A' ' 294' ' ' VAL . 4.8 t -148.48 143.41 17.33 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.681 0.753 . . . . 0.0 110.842 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 344' ' ' GLU . 72.9 Cg_exo -47.28 -58.97 1.42 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.636 2.224 . . . . 0.0 112.368 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 343' ' ' PRO . 22.4 mp0 -36.09 -64.94 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -44.8 -45.47 10.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.668 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -64.1 -42.51 96.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.137 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 97.2 m -45.8 -62.37 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.095 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 349' ' ' ALA . 44.4 tttp -48.41 -63.74 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.65 -48.06 0.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 346' ' ' ALA . 48.3 t -43.19 -54.93 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.106 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 85.8 m -80.65 -48.99 11.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.419 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 17.1 mm-40 -50.7 -26.65 5.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 353' ' ' MET . . . . . 0.458 ' O ' ' N ' ' A' ' 356' ' ' ARG . 75.2 mmm -103.31 -50.36 3.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 0.4 OUTLIER -40.72 105.92 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 95.71 16.78 38.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 356' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 353' ' ' MET . 0.0 OUTLIER -98.04 122.0 40.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.762 0.315 . . . . 0.0 110.893 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 357' ' ' ILE . . . . . 0.42 HD13 ' CA ' ' A' ' 362' ' ' PRO . 23.4 mm -88.76 134.26 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.113 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.86 -59.83 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.13 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -105.72 -70.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.099 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 16.9 p -133.64 -47.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.163 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -104.32 154.85 38.01 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.567 0.698 . . . . 0.0 110.886 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.42 ' CA ' HD13 ' A' ' 357' ' ' ILE . 62.6 Cg_endo -77.7 144.07 21.8 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.674 2.249 . . . . 0.0 112.363 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.591 HD21 HD13 ' A' ' 305' ' ' ILE . 37.8 mt -81.02 92.6 6.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.935 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -61.45 102.65 0.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 363' ' ' LEU . 47.4 t -108.84 137.67 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.091 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -163.38 149.05 11.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.087 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 18.0 mt -60.5 148.38 37.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.105 179.792 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.47 HG21 HD22 ' A' ' 367' ' ' LEU . 1.3 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.872 0.368 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 343' ' ' PRO . 10.1 m -112.12 -22.28 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -75.16 125.9 29.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.784 HD22 ' CG2' ' A' ' 350' ' ' VAL . 49.9 mt -111.37 145.03 39.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.612 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 24.5 t80 -110.99 105.53 14.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 39.1 t -89.5 137.14 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.168 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.564 ' HE2' ' CD1' ' A' ' 364' ' ' TYR . 17.7 ttpt -132.85 162.04 32.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 300' ' ' ASN . . . . . 0.47 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.8 m-20 64.02 51.72 2.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.524 HD12 ' C ' ' A' ' 335' ' ' PHE . 30.9 mt -90.39 106.63 18.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -52.31 150.29 4.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.842 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -56.64 -34.3 67.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -64.82 -39.73 96.8 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.497 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 60.7 mt -62.82 139.14 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.829 0.347 . . . . 0.0 111.123 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -128.32 174.74 9.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.83 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -49.12 -43.1 41.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -62.86 -64.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 58.5 mtt-85 -42.81 -34.33 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.541 HD12 ' CE1' ' A' ' 314' ' ' PHE . 59.5 tp -67.74 -75.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -48.28 -25.79 1.7 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -70.51 -36.1 73.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -93.82 20.54 7.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.088 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.714 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.3 m-85 -127.06 -29.69 2.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.636 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 2.7 t -58.05 -42.74 96.7 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.665 0.745 . . . . 0.0 110.887 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 315' ' ' SER . 63.4 Cg_exo -47.89 -17.21 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.67 2.247 . . . . 0.0 112.395 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -100.23 -51.94 3.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -158.31 175.65 35.42 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.447 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 92.0 m -77.39 134.25 38.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.728 0.299 . . . . 0.0 111.171 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.714 HD11 ' HB3' ' A' ' 314' ' ' PHE . 84.3 mt -110.32 138.36 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.13 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 82.8 p -108.24 -39.06 5.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 72.7 m -127.56 106.74 9.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.807 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' ALA . . . . . 0.677 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -131.32 114.37 14.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.084 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.432 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 2.9 tppp? -146.82 145.01 29.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.432 ' N ' ' HG3' ' A' ' 324' ' ' LYS . 44.1 t -106.13 140.4 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 33.8 mmt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 333' ' ' LYS . 5.4 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.925 0.393 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 333' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 332' ' ' SER . 2.9 mtpm? -34.54 -49.67 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 136.79 33.17 0.23 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.524 ' C ' HD12 ' A' ' 301' ' ' LEU . 12.1 p90 -173.35 154.69 2.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 0.0 110.862 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -158.95 179.1 34.82 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.452 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -128.34 129.26 46.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.453 ' CG1' HD13 ' A' ' 320' ' ' ILE . 12.7 t -130.56 130.27 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 339' ' ' CYS . . . . . 0.545 ' O ' HG23 ' A' ' 320' ' ' ILE . 33.2 t -109.16 154.14 22.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.449 ' CE1' HD12 ' A' ' 296' ' ' LEU . 19.6 m-85 -125.61 177.54 6.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 93.1 p -77.32 -38.08 51.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' SER . . . . . 0.42 ' C ' HG12 ' A' ' 294' ' ' VAL . 27.0 t -142.98 146.5 37.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.689 0.756 . . . . 0.0 110.888 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 344' ' ' GLU . 71.6 Cg_exo -46.56 -60.39 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.717 2.278 . . . . 0.0 112.316 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 343' ' ' PRO . 20.8 mt-10 -35.75 -70.04 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 345' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 345' ' ' GLU . 0.3 OUTLIER -44.03 -43.86 7.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.827 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.755 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -60.92 -43.63 98.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.086 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.8 m -52.41 -60.31 3.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.149 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -46.27 -52.4 12.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -53.83 -53.08 57.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.784 ' CG2' HD22 ' A' ' 296' ' ' LEU . 76.0 t -39.02 -49.58 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 351' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 353' ' ' MET . 50.9 m -82.58 -62.18 1.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -41.04 -24.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 351' ' ' THR . 94.4 mmm -102.06 -43.41 5.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 17.2 t-20 -59.22 109.54 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 108.5 -11.99 36.04 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -87.39 147.45 25.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.772 0.32 . . . . 0.0 110.888 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 6.2 mm -97.47 148.98 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 358' ' ' VAL . . . . . 0.418 HG21 HD11 ' A' ' 363' ' ' LEU . 61.8 t -131.97 -54.01 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.162 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -113.01 -72.72 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.089 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.447 HG23 ' N ' ' A' ' 361' ' ' LYS . 2.4 t -131.86 -49.08 0.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.447 ' N ' HG23 ' A' ' 360' ' ' THR . 17.2 mttm -101.08 154.0 37.42 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.618 0.723 . . . . 0.0 110.916 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.38 129.14 10.9 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.697 2.265 . . . . 0.0 112.329 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.451 ' CD2' HD23 ' A' ' 301' ' ' LEU . 52.3 mt -67.08 122.55 18.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.914 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.564 ' CD1' ' HE2' ' A' ' 299' ' ' LYS . 25.1 t80 -101.83 93.48 5.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.6 144.22 10.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.126 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -162.43 145.94 11.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.085 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 293' ' ' VAL . 35.9 mt -53.14 145.9 12.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.943 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 368' ' ' ALA . . . . . 0.612 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 368' ' ' ALA . 97.0 t . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.837 0.351 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.1 m -92.1 -32.5 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.158 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -65.59 136.1 55.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.896 HD21 ' HB1' ' A' ' 346' ' ' ALA . 30.7 mt -123.58 137.2 54.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.967 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -101.62 103.05 13.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 32.2 t -88.45 136.21 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.581 ' HE3' ' CD1' ' A' ' 364' ' ' TYR . 13.2 ttpp -135.41 162.8 31.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 300' ' ' ASN . . . . . 0.455 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.6 m120 63.97 47.84 3.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 35.7 mt -86.22 98.44 10.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.724 ' OD2' ' HB3' ' A' ' 359' ' ' ALA . 91.6 m-20 -41.47 134.98 2.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -45.83 -36.4 5.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.15 -42.72 97.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.5 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 63.0 mt -60.44 147.65 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.834 0.349 . . . . 0.0 111.173 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -130.34 -174.61 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.23 -28.47 69.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.48 -55.07 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -51.89 -41.89 62.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.533 HD12 ' CE1' ' A' ' 314' ' ' PHE . 62.9 tp -61.89 -72.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.449 ' HD2' ' HB3' ' A' ' 323' ' ' ALA . 13.7 ttt-85 -50.38 -24.89 3.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -80.0 -29.02 39.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -93.34 17.65 10.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.096 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.533 ' CE1' HD12 ' A' ' 310' ' ' LEU . 6.9 m-85 -126.01 -31.49 2.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.49 -45.27 95.67 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.648 0.737 . . . . 0.0 110.799 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.5 Cg_exo -48.03 -16.67 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.716 2.277 . . . . 0.0 112.325 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -99.67 -52.17 3.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.835 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.27 166.56 36.51 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.475 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 23.9 m -64.08 144.48 57.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.743 0.306 . . . . 0.0 111.18 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 339' ' ' CYS . 49.6 mt -119.75 137.73 52.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 68.4 p -100.94 -41.43 6.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.145 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.1 t -142.28 124.53 15.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.825 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' ALA . . . . . 0.449 ' HB3' ' HD2' ' A' ' 311' ' ' ARG . . . -145.57 124.76 12.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.08 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -149.25 159.0 44.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.32 123.87 71.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.097 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' MET . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 335' ' ' PHE . 33.5 mmt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.972 0.415 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -69.68 -44.76 69.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 125.39 34.74 0.65 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.439 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.485 ' CZ ' ' HG3' ' A' ' 326' ' ' MET . 2.5 p90 -174.75 161.13 3.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.913 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -164.7 -172.05 31.69 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.519 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -131.21 146.46 52.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.868 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 50.5 t -142.43 131.9 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.091 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 339' ' ' CYS . . . . . 0.547 ' O ' HG23 ' A' ' 320' ' ' ILE . 6.5 t -112.94 144.27 42.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -118.52 178.63 4.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.1 t -78.49 -39.88 36.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.3 t -137.53 142.36 36.83 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.671 0.748 . . . . 0.0 110.855 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.99 -54.51 4.9 Favored 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.686 2.258 . . . . 0.0 112.369 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -41.83 -52.05 4.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.93 -46.06 82.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.896 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -59.03 -38.86 80.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.152 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 348' ' ' LYS . 60.9 m -52.04 -74.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 347' ' ' THR . 10.1 ttmm -35.25 -64.8 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.953 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.41 -54.5 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.117 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 346' ' ' ALA . 33.5 t -47.52 -46.25 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.163 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 27.3 m -77.57 -59.48 2.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.133 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -50.49 -22.08 1.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 90.1 mmm -100.22 -43.34 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 9.2 t-20 -58.98 97.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 123.58 -11.49 8.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.492 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -85.15 122.44 29.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' ILE . . . . . 0.401 HD13 ' CA ' ' A' ' 362' ' ' PRO . 11.5 mm -84.99 149.63 4.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.24 -49.37 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.724 ' HB3' ' OD2' ' A' ' 302' ' ' ASP . . . -120.28 -68.97 0.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.32 -51.25 0.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.185 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.58 151.81 37.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.545 0.688 . . . . 0.0 110.899 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.401 ' CA ' HD13 ' A' ' 357' ' ' ILE . 60.4 Cg_endo -74.15 151.98 44.73 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.728 2.285 . . . . 0.0 112.345 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 63.1 mt -77.09 96.51 4.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' TYR . . . . . 0.581 ' CD1' ' HE3' ' A' ' 299' ' ' LYS . 10.1 t80 -74.48 85.8 2.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.67 144.41 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.131 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -152.09 168.07 26.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.148 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 29.5 mt -72.35 145.95 47.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 293' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.099 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 93.7 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.883 0.373 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 24.3 m -87.27 -30.32 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -72.69 135.83 45.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.829 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.695 HD21 ' HB1' ' A' ' 346' ' ' ALA . 28.9 mt -129.76 132.99 46.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.916 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.672 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 26.7 t80 -90.81 121.06 32.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.496 HG21 HD11 ' A' ' 310' ' ' LEU . 56.3 t -104.5 132.49 51.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.112 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.49 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 22.3 tttm -132.86 164.05 27.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.898 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' ASN . . . . . 0.49 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.8 m120 64.14 45.7 3.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.599 HD12 ' C ' ' A' ' 335' ' ' PHE . 32.7 mt -84.31 95.26 8.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -41.24 136.76 1.55 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -45.16 -40.54 7.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -58.97 -35.77 85.03 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.525 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.515 HD13 HD21 ' A' ' 363' ' ' LEU . 65.7 mt -68.36 126.98 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.785 0.326 . . . . 0.0 111.153 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -115.7 175.67 5.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -42.45 -63.82 0.7 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.802 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -47.48 -55.67 8.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.877 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? -45.05 -51.61 9.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.497 HD12 ' CE1' ' A' ' 314' ' ' PHE . 54.7 tp -53.91 -74.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.927 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.481 ' HG3' ' CD1' ' A' ' 320' ' ' ILE . 31.3 ttt180 -45.84 -27.95 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -68.66 -42.78 77.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -83.93 25.1 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.103 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.497 ' CE1' HD12 ' A' ' 310' ' ' LEU . 10.7 m-85 -133.72 -32.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.599 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -51.82 -45.27 92.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.662 0.744 . . . . 0.0 110.867 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.3 Cg_exo -47.95 -17.17 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.642 2.228 . . . . 0.0 112.367 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 317' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 46.9 m-85 -100.07 -45.83 5.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -167.8 167.01 39.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.466 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 35.9 m -68.72 141.16 55.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.785 0.326 . . . . 0.0 111.154 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.524 HG21 ' HB2' ' A' ' 323' ' ' ALA . 53.3 mt -113.95 144.09 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 61.6 p -114.12 -38.55 4.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.145 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -133.36 111.05 10.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.825 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' ALA . . . . . 0.524 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -135.45 122.98 22.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -147.28 152.99 39.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.442 HG22 HD22 ' A' ' 310' ' ' LEU . 81.9 t -119.41 135.85 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.148 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 38.0 mmt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.921 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.956 0.408 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 333' ' ' LYS . . . . . 0.499 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 55.1 mttp -51.76 -51.25 57.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.936 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 133.02 35.24 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.445 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.599 ' C ' HD12 ' A' ' 301' ' ' LEU . 5.3 p90 -173.04 165.89 5.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.885 0.374 . . . . 0.0 110.906 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -166.71 -171.43 32.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.541 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -136.82 140.03 42.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.883 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.28 133.55 62.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.134 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 8.7 m -111.77 133.2 54.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -109.51 173.3 6.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 13.2 t -87.15 -40.68 14.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.833 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 49.7 m -123.66 130.19 24.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.648 0.737 . . . . 0.0 110.846 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -45.88 -58.57 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.678 2.252 . . . . 0.0 112.345 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -38.62 -52.66 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -54.12 -46.78 72.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.695 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -61.54 -42.38 98.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.115 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.4 m -49.95 -60.35 3.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.125 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 349' ' ' ALA . 46.3 tttt -48.13 -62.94 1.22 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.855 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.62 -48.96 0.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.633 HG22 HD22 ' A' ' 296' ' ' LEU . 57.6 t -42.49 -56.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.163 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 61.2 m -78.33 -54.65 5.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.147 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.481 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 2.2 mm-40 -44.22 -29.54 0.66 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 353' ' ' MET . . . . . 0.451 ' O ' ' N ' ' A' ' 356' ' ' ARG . 76.9 mmm -100.06 -51.55 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 2.9 t-20 -39.49 103.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 97.66 18.24 28.43 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.501 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 356' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 353' ' ' MET . 0.0 OUTLIER -99.04 118.11 35.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.324 . . . . 0.0 110.883 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 357' ' ' ILE . . . . . 0.503 HD13 ' N ' ' A' ' 362' ' ' PRO . 20.7 mm -85.89 133.75 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.178 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 84.4 t -118.05 -41.99 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -126.26 -65.18 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.065 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.7 p -134.52 -53.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.11 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -101.58 154.22 37.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.569 0.7 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.503 ' N ' HD13 ' A' ' 357' ' ' ILE . 63.1 Cg_endo -78.17 143.46 20.09 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.585 ' O ' HG23 ' A' ' 365' ' ' VAL . 61.8 mt -75.11 90.92 2.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -61.38 99.73 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 363' ' ' LEU . 40.8 t -106.8 141.58 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -161.37 157.8 25.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.059 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 30.8 mt -63.58 141.79 58.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.93 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.089 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.401 HG11 ' HB3' ' A' ' 367' ' ' LEU . 95.9 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.819 0.342 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 343' ' ' PRO . 22.9 m -87.75 -35.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.148 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -62.42 129.96 43.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.69 HD22 HG22 ' A' ' 350' ' ' VAL . 60.1 mt -118.44 136.3 53.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -94.11 125.96 39.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 310' ' ' LEU . 57.7 t -110.29 143.55 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.154 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.519 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 14.1 ttmm -144.49 164.57 30.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' ASN . . . . . 0.519 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.5 m120 64.14 44.72 4.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 302' ' ' ASP . 25.5 mt -84.67 99.87 11.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 301' ' ' LEU . 30.0 m-20 -37.52 155.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -31.91 73.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -67.87 -38.32 89.06 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.498 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.583 HG22 ' N ' ' A' ' 306' ' ' ASP . 62.8 mt -56.94 162.94 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.851 0.358 . . . . 0.0 111.104 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.583 ' N ' HG22 ' A' ' 305' ' ' ILE . 8.7 t0 -149.28 -176.75 5.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -59.68 -41.82 91.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -64.86 -57.46 8.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.88 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 29.5 mtt-85 -47.06 -45.17 21.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 298' ' ' VAL . 50.4 tp -57.36 -71.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -49.73 -32.19 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -72.14 -33.73 67.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -85.74 19.31 2.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.059 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.496 ' CB ' HD11 ' A' ' 320' ' ' ILE . 8.2 m-85 -129.73 -30.19 2.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.899 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.18 -45.24 94.1 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.645 0.735 . . . . 0.0 110.866 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.1 Cg_exo -47.94 -16.69 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.71 2.273 . . . . 0.0 112.329 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -99.6 -54.35 2.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.871 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -158.37 170.75 35.11 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.446 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 49.4 m -65.2 144.24 57.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 111.113 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.496 HD11 ' CB ' ' A' ' 314' ' ' PHE . 48.5 mt -124.41 140.91 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 82.6 p -114.16 -46.73 2.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -121.55 111.0 16.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' ALA . . . . . 0.412 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -138.92 121.33 16.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -155.4 156.27 35.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 48.0 t -110.56 143.33 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' MET . . . . . 0.551 ' HG3' ' CE2' ' A' ' 335' ' ' PHE . 38.7 mmt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.9 0.381 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 333' ' ' LYS . . . . . 0.578 ' HD3' ' CZ ' ' A' ' 335' ' ' PHE . 28.9 mttm -50.89 -42.27 58.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 128.76 -31.23 3.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.537 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.578 ' CZ ' ' HD3' ' A' ' 333' ' ' LYS . 5.4 p90 -111.64 161.8 15.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.9 0.381 . . . . 0.0 110.881 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -155.37 -174.24 25.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.522 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -136.51 140.63 43.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.928 0.394 . . . . 0.0 110.841 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 51.5 t -136.93 131.52 46.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.164 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' CYS . . . . . 0.439 ' O ' HG23 ' A' ' 320' ' ' ILE . 4.7 m -111.33 141.33 45.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -115.75 171.85 7.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 62.7 p -71.73 -37.01 70.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.854 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 6.2 t -144.44 143.07 20.57 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.668 0.747 . . . . 0.0 110.828 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.496 ' N ' HG12 ' A' ' 294' ' ' VAL . 71.9 Cg_exo -46.49 -56.07 3.25 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.74 2.294 . . . . 0.0 112.317 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 344' ' ' GLU . 1.2 mp0 -37.21 -61.29 0.59 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -50.3 -43.38 53.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.736 ' O ' HG23 ' A' ' 350' ' ' VAL . . . -63.59 -41.01 98.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 86.2 m -49.29 -60.83 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -47.37 -60.46 2.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -42.51 -48.87 5.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 346' ' ' ALA . 47.1 t -41.49 -55.73 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.111 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 82.7 m -78.74 -55.75 4.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -44.18 -28.96 0.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.886 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 353' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 356' ' ' ARG . 79.3 mmm -100.2 -49.81 4.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 9.4 t30 -40.14 110.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 85.29 20.7 56.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.481 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 356' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 353' ' ' MET . 19.7 tpp180 -99.94 112.46 24.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.815 0.341 . . . . 0.0 110.885 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 357' ' ' ILE . . . . . 0.431 HD13 ' CA ' ' A' ' 362' ' ' PRO . 17.6 mm -77.67 150.49 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 95.3 t -132.52 -48.01 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.8 -68.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 19.0 p -130.79 -53.14 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.106 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -100.05 151.42 37.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.576 0.703 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.431 ' CA ' HD13 ' A' ' 357' ' ' ILE . 61.6 Cg_endo -76.58 155.95 35.9 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.706 2.271 . . . . 0.0 112.374 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 365' ' ' VAL . 32.9 mt -94.49 87.44 5.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.944 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -61.48 106.66 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.964 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 363' ' ' LEU . 47.8 t -113.91 134.63 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.104 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -155.27 145.32 21.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.137 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.401 ' HB3' HG11 ' A' ' 293' ' ' VAL . 77.9 mt -54.66 134.18 47.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.757 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 73.8 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.86 0.362 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.4 m -86.61 -37.11 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.623 ' O ' HD23 ' A' ' 296' ' ' LEU . 49.7 t30 -52.27 142.17 17.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.973 HD21 ' HB1' ' A' ' 346' ' ' ALA . 32.5 mt -135.48 132.64 37.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -102.08 113.02 25.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' VAL . . . . . 0.438 HG22 HG13 ' A' ' 365' ' ' VAL . 45.7 t -100.83 145.5 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.132 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 0.0 OUTLIER -132.4 165.84 23.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 300' ' ' ASN . . . . . 0.537 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 4.0 m-20 63.48 46.57 4.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.92 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.448 HD12 ' C ' ' A' ' 335' ' ' PHE . 32.8 mt -82.43 91.97 6.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.842 ' OD2' ' HB3' ' A' ' 359' ' ' ALA . 86.5 m-20 -36.05 132.09 0.54 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.86 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.58 -41.68 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -60.13 -36.19 89.83 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.468 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' A' ' 309' ' ' ARG . 75.5 mt -64.92 118.49 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.143 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -103.55 -175.74 2.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.37 -45.96 76.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -62.76 -48.96 76.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' ARG . . . . . 0.415 ' HB3' HG23 ' A' ' 305' ' ' ILE . 4.3 mmm180 -46.68 -49.66 18.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.534 HD12 ' CE1' ' A' ' 314' ' ' PHE . 43.2 tp -56.65 -73.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.416 ' HG3' HD12 ' A' ' 320' ' ' ILE . 15.8 ttp180 -46.89 -26.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -70.01 -41.72 73.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -88.9 21.35 3.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.058 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.565 ' HB3' HD11 ' A' ' 320' ' ' ILE . 8.2 m-85 -129.41 -29.96 2.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -55.38 -44.95 99.9 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.662 0.744 . . . . 0.0 110.883 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.7 Cg_exo -47.97 -16.57 0.59 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.747 2.298 . . . . 0.0 112.288 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -99.64 -51.87 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -163.68 166.07 37.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 64.4 m -67.2 137.91 56.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.785 0.326 . . . . 0.0 111.144 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.734 HG21 ' HB2' ' A' ' 323' ' ' ALA . 93.3 mt -109.65 142.15 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.165 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 70.3 p -111.74 -35.8 5.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.172 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -133.58 104.51 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' ALA . . . . . 0.734 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -134.58 122.48 22.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.084 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' A' ' 325' ' ' VAL . 44.0 tttp -156.72 152.52 27.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.413 ' N ' ' HG2' ' A' ' 324' ' ' LYS . 59.4 t -107.44 140.33 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 326' ' ' MET . . . . . 0.545 ' HG3' ' CE2' ' A' ' 335' ' ' PHE . 34.4 mmt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.918 0.389 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -71.24 -58.13 3.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 139.95 35.76 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.516 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.545 ' CE2' ' HG3' ' A' ' 326' ' ' MET . 25.7 p90 -174.95 163.65 3.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 0.0 110.857 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -162.09 -179.77 36.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -123.88 139.24 54.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 110.897 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.418 HG11 ' CD2' ' A' ' 314' ' ' PHE . 29.9 t -134.59 127.72 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.169 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 339' ' ' CYS . . . . . 0.548 ' O ' HG23 ' A' ' 320' ' ' ILE . 68.8 m -111.93 134.38 53.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.902 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.534 ' HE1' HD12 ' A' ' 296' ' ' LEU . 43.4 m-85 -111.39 177.18 4.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 6.4 t -78.21 -35.52 48.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.9 t -141.61 141.71 23.56 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.62 0.724 . . . . 0.0 110.885 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.65 -53.65 5.85 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.692 2.261 . . . . 0.0 112.327 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -40.82 -63.74 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -46.09 -44.22 15.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.863 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.973 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -59.15 -59.58 5.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.076 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 28.7 m -41.58 -56.05 2.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.424 ' NZ ' ' HG3' ' A' ' 352' ' ' GLU . 2.3 tmtm? -45.84 -56.31 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -54.51 -51.12 66.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.068 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.419 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 91.9 t -39.38 -53.21 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.143 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 86.7 m -75.29 -59.28 2.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.424 ' HG3' ' NZ ' ' A' ' 348' ' ' LYS . 3.9 mm-40 -49.08 -18.84 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 90.0 mmm -107.28 -35.14 6.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.459 ' OD1' ' C ' ' A' ' 354' ' ' ASN . 5.4 t-20 -59.1 96.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 112.47 -15.86 24.53 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 17.6 tpp85 -73.27 110.19 7.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 20.5 mm -68.12 151.2 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.26 -39.46 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.115 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 359' ' ' ALA . . . . . 0.842 ' HB3' ' OD2' ' A' ' 302' ' ' ASP . . . -133.22 -71.36 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.095 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 4.9 p -128.96 -55.05 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.95 153.45 37.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.558 0.694 . . . . 0.0 110.873 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.1 153.49 46.61 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.719 2.279 . . . . 0.0 112.332 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 30.5 mt -87.77 99.44 12.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -79.24 91.39 4.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.96 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.438 HG13 HG22 ' A' ' 298' ' ' VAL . 4.2 t -95.33 141.33 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.127 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -159.84 142.98 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.078 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 24.4 mt -52.99 153.43 3.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.094 179.793 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 293' ' ' VAL . 6.5 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.855 0.359 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.02 -21.51 5.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.095 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.1 152.05 38.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.69 HD21 ' HB1' ' A' ' 346' ' ' ALA . 14.7 mt -143.87 134.21 24.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -101.85 120.47 40.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.25 145.5 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.113 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.484 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 13.4 ttmm -136.58 162.68 32.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 300' ' ' ASN . . . . . 0.484 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 6.8 m-20 62.59 51.11 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.543 HD12 ' C ' ' A' ' 335' ' ' PHE . 28.0 mt -88.86 104.52 17.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.452 ' H ' HD12 ' A' ' 305' ' ' ILE . 12.6 t70 -45.92 162.05 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.872 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -64.2 -38.87 92.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.26 -40.59 99.2 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.494 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' ILE . . . . . 0.452 HD12 ' H ' ' A' ' 302' ' ' ASP . 59.9 mt -57.41 132.64 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 111.176 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.23 -174.82 3.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -49.86 -46.38 51.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -60.69 -61.13 2.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -41.8 -46.05 3.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.895 HD21 HG22 ' A' ' 338' ' ' VAL . 20.4 tp -52.23 -75.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.948 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.721 ' HD2' ' HB3' ' A' ' 323' ' ' ALA . 19.4 mtp180 -53.22 -24.72 11.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -67.58 -39.96 84.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -97.79 19.74 13.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.063 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.554 ' CB ' HD11 ' A' ' 320' ' ' ILE . 7.1 m-85 -127.29 -29.72 2.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.584 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.8 OUTLIER -57.7 -45.61 99.81 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.704 0.764 . . . . 0.0 110.905 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.2 Cg_exo -47.98 -16.63 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.634 2.222 . . . . 0.0 112.377 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' PHE . . . . . 0.49 ' CE2' ' HG2' ' A' ' 353' ' ' MET . 50.0 m-85 -99.61 -46.92 5.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -165.05 166.31 38.14 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 33.9 m -67.33 133.6 49.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 111.141 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 339' ' ' CYS . 37.7 mt -110.37 139.58 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 41.6 p -109.85 -36.24 5.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 71.0 m -137.42 126.81 24.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' ALA . . . . . 0.721 ' HB3' ' HD2' ' A' ' 311' ' ' ARG . . . -156.46 119.25 4.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.068 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -150.24 132.25 15.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 49.9 t -82.22 125.2 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.153 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 20.8 mmm . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.878 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 29.9 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.934 0.397 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -53.72 -52.04 61.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 137.63 34.16 0.2 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.543 ' C ' HD12 ' A' ' 301' ' ' LEU . 4.0 p90 -175.39 156.38 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -154.47 172.45 32.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.508 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -117.22 139.41 50.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.895 HG22 HD21 ' A' ' 310' ' ' LEU . 24.1 t -133.85 149.29 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.172 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 339' ' ' CYS . . . . . 0.584 ' O ' HG23 ' A' ' 320' ' ' ILE . 20.9 t -132.76 134.23 44.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.838 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.501 ' CE1' HD12 ' A' ' 296' ' ' LEU . 6.5 m-85 -113.24 172.46 6.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.882 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.4 p -78.98 -47.94 15.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 54.8 m -121.37 136.12 25.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.691 0.757 . . . . 0.0 110.83 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 346' ' ' ALA . 71.5 Cg_exo -45.87 -63.01 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.72 2.28 . . . . 0.0 112.357 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 344' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 343' ' ' PRO . 49.0 tt0 -36.2 -53.62 0.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -52.36 -44.4 65.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.69 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -64.29 -41.91 96.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.08 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 98.1 m -50.77 -64.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 349' ' ' ALA . 31.8 tttm -43.09 -62.91 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.902 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.27 -53.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.108 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.562 HG22 HD22 ' A' ' 296' ' ' LEU . 93.6 t -38.2 -60.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 62.5 m -75.14 -55.27 5.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.444 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 23.5 mm-40 -44.8 -26.26 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 353' ' ' MET . . . . . 0.49 ' HG2' ' CE2' ' A' ' 317' ' ' PHE . 83.3 mmm -102.19 -62.03 1.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 354' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -40.66 107.22 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 116.15 -5.88 19.65 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -95.74 125.78 40.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 0.0 110.871 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 357' ' ' ILE . . . . . 0.405 HD13 ' CA ' ' A' ' 362' ' ' PRO . 7.8 mm -85.7 150.31 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.131 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 95.6 t -132.23 -41.06 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -126.64 -71.91 0.67 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.093 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 16.5 p -131.63 -50.16 0.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.18 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.86 152.14 39.51 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.555 0.693 . . . . 0.0 110.909 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.405 ' CA ' HD13 ' A' ' 357' ' ' ILE . 60.5 Cg_endo -74.48 146.77 35.43 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.699 2.266 . . . . 0.0 112.324 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.497 ' O ' HG23 ' A' ' 365' ' ' VAL . 37.3 mt -77.22 88.95 3.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -66.34 94.56 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 363' ' ' LEU . 17.2 t -97.12 150.95 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -164.3 166.24 21.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 58.7 mt -71.32 143.61 50.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.803 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.539 HG11 HD13 ' A' ' 367' ' ' LEU . 6.1 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.874 0.368 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 25.2 m -115.79 -23.98 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -67.13 104.13 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.697 HD22 HG22 ' A' ' 350' ' ' VAL . 45.6 mt -94.85 133.79 38.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.617 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 25.7 t80 -96.45 114.06 25.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.6 t -98.62 139.44 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.114 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.51 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 24.5 tttt -137.33 163.94 29.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' ASN . . . . . 0.51 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 6.4 m-20 63.19 49.38 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 25.0 mt -87.8 114.88 24.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.36 140.47 27.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -50.5 -42.31 54.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.812 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.26 -30.08 66.96 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.463 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 95.8 mt -72.62 130.78 35.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.34 . . . . 0.0 111.126 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -114.33 -179.11 3.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.96 -45.71 67.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.4 -54.12 47.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -47.03 -47.59 22.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.737 HD11 HG21 ' A' ' 338' ' ' VAL . 16.6 tp -53.96 -75.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' ARG . . . . . 0.438 ' HG3' HD12 ' A' ' 320' ' ' ILE . 33.5 ttt180 -49.2 -25.4 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -78.81 -32.82 46.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.9 15.72 10.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.083 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.6 ' CZ ' ' SD ' ' A' ' 353' ' ' MET . 10.7 m-85 -128.79 -28.49 2.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -50.25 -46.07 83.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.679 0.752 . . . . 0.0 110.859 -179.823 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 315' ' ' SER . 63.8 Cg_exo -47.92 -16.89 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.688 2.259 . . . . 0.0 112.367 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -99.66 -41.49 7.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.52 169.0 36.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.492 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 97.0 m -83.21 96.48 8.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.81 0.338 . . . . 0.0 111.17 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.458 HD11 ' CB ' ' A' ' 314' ' ' PHE . 93.5 mt -65.55 145.9 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 73.5 p -117.34 -28.52 6.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.125 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 3.0 p -152.83 109.38 3.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -131.72 142.56 49.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.093 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -154.08 170.24 21.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.13 121.55 54.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.145 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 326' ' ' MET . . . . . 0.544 ' HB2' ' CE2' ' A' ' 335' ' ' PHE . 10.2 mmm . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 333' ' ' LYS . 20.2 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.929 0.395 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 333' ' ' LYS . . . . . 0.473 ' HD3' ' CE1' ' A' ' 335' ' ' PHE . 18.3 mttm -34.57 -55.22 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 128.62 29.95 0.73 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.471 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.544 ' CE2' ' HB2' ' A' ' 326' ' ' MET . 43.7 p90 -164.74 157.15 16.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 0.0 110.907 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -159.63 -167.05 19.73 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.458 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -135.13 122.19 21.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.928 0.394 . . . . 0.0 110.872 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 338' ' ' VAL . . . . . 0.737 HG21 HD11 ' A' ' 310' ' ' LEU . 46.5 t -116.18 98.1 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.122 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 339' ' ' CYS . . . . . 0.422 ' O ' HG23 ' A' ' 320' ' ' ILE . 1.7 m -86.9 135.84 33.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 340' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . 23.1 m-85 -107.88 178.0 4.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 7.2 t -82.69 -36.48 25.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.813 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.9 m -133.57 133.92 23.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.681 0.753 . . . . 0.0 110.85 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.26 -59.58 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.725 2.283 . . . . 0.0 112.337 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -38.75 -57.32 1.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -54.29 -45.93 72.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.623 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -59.33 -46.89 87.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.066 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 347' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 348' ' ' LYS . 14.5 m -45.65 -63.86 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.152 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 347' ' ' THR . 3.9 ttpm? -37.51 -65.93 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -41.13 -53.7 3.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.697 HG22 HD22 ' A' ' 296' ' ' LEU . 46.2 t -39.75 -52.24 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.129 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 82.7 m -78.85 -56.91 4.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -46.69 -24.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' MET . . . . . 0.6 ' SD ' ' CZ ' ' A' ' 314' ' ' PHE . 15.7 mtp -104.05 -43.99 5.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 6.8 t-20 -47.91 115.51 1.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 80.76 17.42 72.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.481 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -98.26 121.39 40.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.765 0.317 . . . . 0.0 110.853 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 9.2 mm -87.77 125.7 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.117 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.26 -59.53 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.164 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -109.01 -67.85 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.104 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 361' ' ' LYS . 2.3 t -134.87 -49.06 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.438 ' N ' HG23 ' A' ' 360' ' ' THR . 13.1 mtpp -99.79 151.24 37.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.568 0.699 . . . . 0.0 110.88 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.37 151.59 29.66 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.704 2.269 . . . . 0.0 112.355 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 32.9 mt -89.65 92.97 9.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -70.77 94.74 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.9 t -106.8 141.73 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.086 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -164.69 145.67 7.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.549 HD23 ' CD2' ' A' ' 296' ' ' LEU . 81.3 mt -56.68 137.83 53.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 368' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 97.8 t . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.864 0.364 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 343' ' ' PRO . 25.9 m -86.04 -36.9 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -54.72 136.59 45.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.89 HD21 ' HB1' ' A' ' 346' ' ' ALA . 40.6 mt -127.87 144.34 51.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -106.36 110.41 22.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.936 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.1 t -94.4 129.81 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.149 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.484 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 37.0 tttt -130.49 163.25 27.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' ASN . . . . . 0.484 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.5 m120 63.83 49.45 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.901 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.528 HD12 ' CA ' ' A' ' 335' ' ' PHE . 19.8 mt -87.12 105.98 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 302' ' ' ASP . . . . . 0.429 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 21.2 t70 -46.12 158.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.877 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -62.15 -37.52 85.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -67.02 -38.75 92.88 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.459 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 83.1 mt -61.65 112.69 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 111.138 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.19 -176.8 3.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.822 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.24 -62.6 1.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.4 ' O ' ' HD3' ' A' ' 312' ' ' LYS . 7.4 pt-20 -52.46 -47.53 66.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -47.28 -34.13 6.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.463 HD12 ' CE1' ' A' ' 314' ' ' PHE . 54.0 tp -77.68 -56.22 4.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -58.33 -24.65 60.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 308' ' ' GLU . 9.2 mptt -84.78 -22.82 29.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -95.18 16.21 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.125 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.463 ' CE1' HD12 ' A' ' 310' ' ' LEU . 7.9 m-85 -129.16 -29.12 2.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.593 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.8 OUTLIER -50.36 -45.54 83.75 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.65 0.738 . . . . 0.0 110.873 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.1 Cg_exo -48.04 -15.51 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.661 2.24 . . . . 0.0 112.342 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 352' ' ' GLU . 55.0 m-85 -99.13 -53.84 3.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.69 -179.1 37.06 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.437 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 28.9 m -74.52 143.39 44.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 111.129 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 339' ' ' CYS . 55.3 mt -115.45 152.53 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.149 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.411 ' N ' HG22 ' A' ' 320' ' ' ILE . 40.9 p -121.11 -41.2 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.5 t -137.38 119.42 15.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -146.35 126.62 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.081 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.474 ' HG2' ' N ' ' A' ' 325' ' ' VAL . 15.7 ttmm -159.99 151.1 19.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.474 ' N ' ' HG2' ' A' ' 324' ' ' LYS . 99.2 t -110.12 132.99 56.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 38.1 mmt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.934 0.397 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 333' ' ' LYS . . . . . 0.522 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 12.1 mmmt -53.55 -60.95 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.869 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 136.25 34.69 0.22 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.469 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.528 ' CA ' HD12 ' A' ' 301' ' ' LEU . 12.9 p90 -173.39 159.37 3.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -158.91 -171.95 25.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.498 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -135.14 141.1 45.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.36 . . . . 0.0 110.837 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 36.5 t -136.56 140.94 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.112 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 339' ' ' CYS . . . . . 0.42 ' O ' HG23 ' A' ' 320' ' ' ILE . 65.4 m -117.56 156.57 27.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -130.27 173.89 10.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 51.6 p -80.29 -40.99 25.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' SER . . . . . 0.414 ' C ' HG12 ' A' ' 294' ' ' VAL . 22.9 m -130.62 139.23 34.97 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.649 0.738 . . . . 0.0 110.882 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.494 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.3 Cg_exo -47.44 -54.88 4.49 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.688 2.259 . . . . 0.0 112.316 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -41.28 -55.61 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -51.71 -43.75 62.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.862 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.89 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -64.15 -41.5 97.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.09 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 94.6 m -49.71 -63.6 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -47.07 -61.92 1.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -37.71 -50.25 1.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 346' ' ' ALA . 57.8 t -41.69 -55.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 90.2 m -78.7 -55.84 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 317' ' ' PHE . 18.8 mm-40 -44.08 -27.79 0.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 353' ' ' MET . . . . . 0.412 ' CB ' HG21 ' A' ' 365' ' ' VAL . 86.4 mmm -101.83 -42.59 6.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 12.9 t-20 -58.14 96.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 121.92 -13.97 9.1 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.469 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -77.12 112.93 14.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.898 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' ILE . . . . . 0.543 HD13 ' CA ' ' A' ' 362' ' ' PRO . 13.3 mm -78.25 138.29 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.096 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.99 -65.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.112 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -100.79 -75.24 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 360' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' A' ' 361' ' ' LYS . 1.0 OUTLIER -123.5 -47.34 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.555 ' N ' ' CG2' ' A' ' 360' ' ' THR . 12.1 pttm -109.39 159.0 33.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.553 0.692 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.543 ' CA ' HD13 ' A' ' 357' ' ' ILE . 60.2 Cg_endo -80.24 154.04 21.7 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.671 2.247 . . . . 0.0 112.369 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 365' ' ' VAL . 31.4 mt -78.13 98.31 5.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -67.8 81.61 0.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 32.2 t -91.14 141.11 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.134 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -160.39 143.33 13.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.096 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.657 ' CD2' HG21 ' A' ' 350' ' ' VAL . 18.8 mt -59.87 141.48 55.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.906 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.801 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 70.9 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.882 0.372 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 294' ' ' VAL . . . . . 0.631 HG12 ' N ' ' A' ' 343' ' ' PRO . 25.8 m -104.02 -35.16 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.54 143.31 57.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.562 HD22 HG22 ' A' ' 350' ' ' VAL . 58.2 mt -131.29 144.99 51.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -99.62 123.47 43.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 17.6 t -107.22 134.75 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.163 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' LYS . . . . . 0.545 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 21.9 ttmt -134.3 165.99 23.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 300' ' ' ASN . . . . . 0.545 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.9 m-20 61.16 51.36 4.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 30.9 mt -91.85 107.54 19.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.39 141.36 24.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -48.4 -34.51 10.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.86 -37.06 94.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.538 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 49.5 mt -70.33 136.91 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 111.164 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -126.49 -178.75 4.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 307' ' ' ASP . 21.5 t0 -51.27 -47.29 62.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -58.44 -66.32 0.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -43.58 -42.1 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 63.2 tp -60.59 -69.35 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -52.32 -27.82 16.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -72.7 -27.52 62.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -95.28 19.23 11.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' PHE . . . . . 0.673 ' CB ' HD11 ' A' ' 320' ' ' ILE . 8.6 m-85 -129.69 -31.31 2.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.854 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' SER . . . . . 0.587 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.2 m -50.89 -45.78 87.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.711 0.767 . . . . 0.0 110.874 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.8 Cg_exo -47.99 -17.25 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.683 2.255 . . . . 0.0 112.314 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' PHE . . . . . 0.574 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 55.5 m-85 -100.05 -49.64 4.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -163.04 160.63 33.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.5 m -60.63 138.28 58.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.311 . . . . 0.0 111.18 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' ILE . . . . . 0.673 HD11 ' CB ' ' A' ' 314' ' ' PHE . 80.3 mt -114.89 130.73 68.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.9 p -103.62 -28.36 11.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 4.7 t -143.19 125.07 15.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -154.64 122.52 5.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -151.93 158.21 42.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.0 134.42 53.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 326' ' ' MET . . . . . 0.548 ' HG3' ' CE2' ' A' ' 335' ' ' PHE . 35.5 mmt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.008 0.433 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -46.93 -46.81 21.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.68 -28.46 3.39 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.507 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.548 ' CE2' ' HG3' ' A' ' 326' ' ' MET . 3.2 p90 -118.53 160.79 21.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.928 0.394 . . . . 0.0 110.875 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -153.44 -172.45 21.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.531 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -138.44 138.29 38.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.863 0.363 . . . . 0.0 110.884 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 30.9 t -130.27 143.79 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.121 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 339' ' ' CYS . . . . . 0.574 ' O ' HG23 ' A' ' 320' ' ' ILE . 84.3 m -121.6 143.09 49.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -118.19 175.59 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 23.2 t -83.85 -40.79 18.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 70.7 m -130.37 139.33 35.3 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.898 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' PRO . . . . . 0.631 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.2 Cg_exo -47.43 -56.15 3.32 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.694 2.262 . . . . 0.0 112.332 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -41.49 -54.68 3.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -50.55 -45.35 56.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 350' ' ' VAL . . . -61.93 -40.56 95.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.086 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 61.0 m -51.25 -65.7 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.166 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 348' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 349' ' ' ALA . 28.6 tttt -44.38 -64.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 349' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.06 -48.83 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.114 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 350' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 346' ' ' ALA . 49.1 t -42.79 -56.3 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 52.8 m -79.69 -50.71 10.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 352' ' ' GLU . . . . . 0.574 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 24.3 mm-40 -47.66 -29.39 2.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 353' ' ' MET . . . . . 0.601 ' HB3' HG21 ' A' ' 365' ' ' VAL . 75.9 mmm -101.66 -51.75 3.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 354' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 7.0 t-20 -35.77 112.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.833 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 87.98 18.87 55.23 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.499 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 356' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 353' ' ' MET . 16.5 tpp180 -96.94 126.95 42.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.867 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 357' ' ' ILE . . . . . 0.405 HD13 ' CA ' ' A' ' 362' ' ' PRO . 11.3 mm -93.27 142.62 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 64.6 t -131.84 -38.81 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.65 -72.68 0.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 2.5 p -131.71 -52.22 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.167 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -101.85 153.91 37.66 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.564 0.697 . . . . 0.0 110.931 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.405 ' CA ' HD13 ' A' ' 357' ' ' ILE . 61.1 Cg_endo -75.84 146.38 29.71 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.671 2.248 . . . . 0.0 112.333 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 363' ' ' LEU . . . . . 0.509 ' O ' HG23 ' A' ' 365' ' ' VAL . 43.1 mt -81.68 96.3 7.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -64.52 97.38 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 365' ' ' VAL . . . . . 0.601 HG21 ' HB3' ' A' ' 353' ' ' MET . 37.0 t -103.19 125.35 57.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.153 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -150.6 150.81 31.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 367' ' ' LEU . . . . . 0.529 HD21 HG21 ' A' ' 350' ' ' VAL . 49.5 mt -60.67 139.37 57.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.051 179.824 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.6 m -151.42 123.65 8.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 110.831 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 57.8 m -143.64 174.46 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 174.94 148.77 6.85 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.505 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 2.5 t -104.81 126.23 51.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 110.857 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 58.5 m -132.63 175.26 9.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.73 69.66 0.45 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.5 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 287' ' ' ARG . 1.2 m-20 -64.53 -51.35 63.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.342 . . . . 0.0 110.85 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 286' ' ' ASP . 16.8 ptp180 35.49 38.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.507 HD12 ' C ' ' A' ' 288' ' ' ILE . 2.3 pp -83.92 -2.22 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.3 t -64.21 139.17 58.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.16 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -171.46 150.47 2.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -50.19 168.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.962 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -59.83 95.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.94 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 83.9 t -128.63 103.13 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 343' ' ' PRO . 15.4 m -108.72 -26.25 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.135 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -65.59 128.57 36.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.623 ' CD2' HD23 ' A' ' 367' ' ' LEU . 38.5 mt -118.93 145.97 45.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -106.12 115.6 30.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.408 HG21 HD11 ' A' ' 310' ' ' LEU . 58.8 t -103.04 133.13 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.554 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 22.1 tttm -130.81 166.39 20.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ASN . . . . . 0.554 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 6.7 m-20 63.58 54.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 40.9 mt -91.45 105.44 17.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.949 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -51.4 145.05 9.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.859 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -52.08 -34.01 41.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -67.55 -35.16 85.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.443 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.79 123.92 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.836 0.35 . . . . 0.0 111.121 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -116.0 171.32 7.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.827 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -38.02 -68.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -40.88 -56.5 2.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -45.91 -58.51 3.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.408 HD11 HG21 ' A' ' 298' ' ' VAL . 64.1 tp -52.7 -62.74 1.45 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.405 ' HG3' ' HB3' ' A' ' 323' ' ' ALA . 2.1 tmm_? -55.86 -24.56 37.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -81.67 -22.2 37.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -96.21 15.12 21.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.1 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.613 ' CD2' HG11 ' A' ' 338' ' ' VAL . 6.2 m-85 -123.73 -32.38 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.7 OUTLIER -50.36 -45.87 83.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.627 0.727 . . . . 0.0 110.887 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.4 Cg_exo -47.97 -17.34 0.78 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.724 2.282 . . . . 0.0 112.342 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -100.07 -52.32 3.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.07 168.26 37.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.486 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 61.6 m -61.88 147.9 45.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 0.0 111.105 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 339' ' ' CYS . 30.9 mt -125.1 134.05 67.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 71.8 p -110.72 -33.2 6.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -134.37 109.74 8.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -145.03 122.49 11.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.075 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -160.46 153.33 21.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 93.7 t -111.65 136.86 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 33.4 mmt -70.04 127.04 31.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 35.1 mmm -125.19 140.8 52.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.67 34.31 1.35 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 68.94 85.63 0.11 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.466 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 111.07 -41.2 2.3 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.474 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 -121.58 167.16 13.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.339 . . . . 0.0 110.845 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 333' ' ' LYS . 68.0 p -101.02 109.11 20.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.496 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 11.8 mmtp -35.7 -58.75 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.8 27.79 0.58 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.508 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.496 ' CE1' ' HB3' ' A' ' 333' ' ' LYS . 42.0 p90 -171.32 147.54 2.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.915 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -146.33 -170.37 14.86 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.458 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -134.22 142.09 47.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.899 0.38 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.613 HG11 ' CD2' ' A' ' 314' ' ' PHE . 33.6 t -135.83 132.54 50.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' CYS . . . . . 0.561 ' O ' HG23 ' A' ' 320' ' ' ILE . 65.5 m -117.61 145.48 44.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.892 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.592 ' HE1' HD12 ' A' ' 296' ' ' LEU . 46.7 m-85 -116.79 174.21 6.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 4.2 t -75.58 -42.41 52.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.829 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 49.2 m -132.3 143.32 48.37 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.635 0.731 . . . . 0.0 110.917 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.429 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.0 Cg_exo -47.16 -58.24 1.85 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.737 2.291 . . . . 0.0 112.344 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -40.6 -56.17 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -53.81 -42.51 68.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.913 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.82 -43.95 91.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.078 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 47.0 m -48.59 -65.21 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.147 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.443 ' O ' ' C ' ' A' ' 349' ' ' ALA . 42.7 tttt -38.6 -64.97 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.888 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -34.52 -55.25 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.47 HG22 HD22 ' A' ' 296' ' ' LEU . 58.7 t -38.02 -52.84 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 56.0 m -80.6 -53.72 6.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.144 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -49.94 -19.19 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' MET . . . . . 0.446 ' HB3' HG21 ' A' ' 365' ' ' VAL . 71.8 mmm -107.08 -59.85 1.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 353' ' ' MET . 9.1 t30 -36.3 111.01 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.895 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 99.01 9.62 51.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -95.86 118.84 33.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 110.89 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' ILE . . . . . 0.474 HD13 ' N ' ' A' ' 362' ' ' PRO . 11.0 mm -89.27 138.35 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 71.8 t -127.34 -43.64 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -116.43 -73.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.579 HG23 ' CD ' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -132.98 -47.62 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.579 ' CD ' HG23 ' A' ' 360' ' ' THR . 0.0 OUTLIER -108.14 156.9 37.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.63 0.728 . . . . 0.0 110.875 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.474 ' N ' HD13 ' A' ' 357' ' ' ILE . 62.6 Cg_endo -77.82 139.34 17.55 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.723 2.282 . . . . 0.0 112.341 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 365' ' ' VAL . 65.1 mt -69.47 101.08 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.933 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -68.43 96.82 0.71 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' A' ' 353' ' ' MET . 21.8 t -103.57 131.62 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.105 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -157.44 145.33 18.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.084 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.623 HD23 ' CD2' ' A' ' 296' ' ' LEU . 32.2 mt -63.0 138.87 58.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -95.53 86.83 4.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.059 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -38.49 -57.69 1.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -113.9 151.22 32.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.55 127.37 54.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.937 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -102.2 109.34 21.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.859 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -118.48 84.81 2.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -121.21 85.64 2.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -68.55 100.0 1.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 7.4 t -164.0 173.8 12.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -175.39 156.18 21.62 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.51 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.04 104.03 1.84 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.665 2.243 . . . . 0.0 112.391 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 77.3 p -60.95 91.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 2.5 m -161.93 163.39 29.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.833 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.485 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.5 m -101.56 110.16 22.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 110.883 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 30.6 t -112.04 140.56 46.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -178.45 -52.36 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.454 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 12.4 m -78.0 91.37 4.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.904 0.383 . . . . 0.0 110.864 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 73.0 m -125.48 83.73 2.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.826 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -56.75 130.16 50.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.484 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' ASP . . . . . 0.431 ' CB ' ' HE ' ' A' ' 287' ' ' ARG . 82.5 m-20 -117.41 -50.16 2.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ARG . . . . . 0.431 ' HE ' ' CB ' ' A' ' 286' ' ' ASP . 0.0 OUTLIER -77.68 84.0 4.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.903 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.631 ' O ' HD12 ' A' ' 288' ' ' ILE . 2.5 pp -86.67 143.84 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.144 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 72.2 p -82.25 140.35 33.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.103 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -107.59 -54.88 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.838 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.742 ' O ' HG23 ' A' ' 293' ' ' VAL . 62.7 m-85 -102.41 129.18 48.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -46.8 124.36 6.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 291' ' ' TYR . 58.6 t -129.64 92.81 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.158 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 343' ' ' PRO . 15.1 m -93.07 -34.99 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -59.01 140.76 55.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.76 HD21 ' HB1' ' A' ' 346' ' ' ALA . 35.6 mt -130.4 135.58 48.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -96.13 106.14 18.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 49.0 t -89.77 131.13 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.118 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 300' ' ' ASN . 20.5 tttt -135.22 161.82 34.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ASN . . . . . 0.462 ' N ' ' HG2' ' A' ' 299' ' ' LYS . 11.1 t-20 74.5 37.87 0.53 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.415 HD12 ' CA ' ' A' ' 335' ' ' PHE . 46.8 mt -79.98 91.32 5.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.485 ' H ' HD12 ' A' ' 305' ' ' ILE . 3.5 t70 -46.26 148.62 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.42 -36.49 9.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.96 -40.62 98.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.485 HD12 ' H ' ' A' ' 302' ' ' ASP . 41.6 mt -65.99 140.81 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.855 0.359 . . . . 0.0 111.113 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -134.15 177.71 7.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -52.45 -41.66 63.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -65.96 -61.8 1.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 64.8 mtt-85 -49.3 -34.14 14.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.508 HD12 ' CE1' ' A' ' 314' ' ' PHE . 61.5 tp -67.61 -71.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 45.3 ttt-85 -50.44 -25.45 3.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -73.89 -30.26 62.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -94.16 20.28 8.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.128 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.898 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.0 m-85 -126.17 -30.77 2.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.1 t -56.12 -45.32 99.92 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.688 0.756 . . . . 0.0 110.878 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 315' ' ' SER . 66.1 Cg_exo -48.02 -17.04 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.718 2.279 . . . . 0.0 112.324 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 60.0 m-85 -99.93 -52.39 3.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.62 165.91 35.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.418 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.5 m -62.85 138.23 58.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.761 0.315 . . . . 0.0 111.145 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.898 HD11 ' HB3' ' A' ' 314' ' ' PHE . 82.0 mt -118.32 132.1 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 67.2 p -105.77 -40.48 5.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -126.51 111.14 14.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.81 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ALA . . . . . 0.582 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -142.6 119.83 11.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.1 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.455 ' HD2' ' N ' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -153.56 162.36 41.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 78.4 t -121.72 142.98 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.136 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 34.1 mmt -68.39 95.58 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 71.3 mmm -109.2 121.2 44.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -145.95 119.42 9.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 83.86 57.21 2.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.476 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 38.45 40.33 0.93 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.443 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.51 169.36 24.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 110.857 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.8 t -106.6 118.83 37.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.825 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.2 -47.65 65.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 123.62 29.93 1.12 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.415 ' CA ' HD12 ' A' ' 301' ' ' LEU . 12.7 p90 -171.32 158.07 5.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.372 . . . . 0.0 110.868 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -161.45 -166.88 21.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.501 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -139.04 143.89 38.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 22.7 t -138.96 140.04 39.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 23.7 m -117.54 149.33 40.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -122.84 176.92 5.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.835 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 32.6 t -78.45 -39.2 39.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.885 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 27.2 m -136.87 143.19 41.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.683 0.754 . . . . 0.0 110.843 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.432 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.2 Cg_exo -47.35 -59.15 1.35 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 2.243 . . . . 0.0 112.347 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 343' ' ' PRO . 30.9 tt0 -37.63 -59.76 0.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -49.33 -41.39 38.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.76 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -65.08 -42.72 93.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.109 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.4 m -50.72 -67.81 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.167 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -40.55 -56.53 2.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 350' ' ' VAL . . . -44.4 -55.51 4.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.097 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.548 HG22 HD22 ' A' ' 296' ' ' LEU . 84.3 t -36.6 -58.48 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.136 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 353' ' ' MET . 35.2 m -75.94 -60.35 2.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.525 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 3.7 mm-40 -39.99 -27.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' MET . . . . . 0.505 ' CB ' HG21 ' A' ' 365' ' ' VAL . 77.6 mmm -101.29 -42.33 6.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 26.1 t30 -60.15 106.28 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.859 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 113.92 -3.66 24.23 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.469 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -98.88 144.24 28.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.894 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' ILE . . . . . 0.402 HD13 ' CA ' ' A' ' 362' ' ' PRO . 8.3 mm -95.23 152.01 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.129 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.4 ' N ' HG22 ' A' ' 357' ' ' ILE . 45.1 t -131.95 -40.9 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.081 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -130.21 -66.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.0 -54.52 0.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.15 154.92 36.89 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.564 0.697 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.402 ' CA ' HD13 ' A' ' 357' ' ' ILE . 61.4 Cg_endo -76.43 134.07 15.13 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 35.7 mt -66.16 123.92 21.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -95.96 89.44 5.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.505 HG21 ' CB ' ' A' ' 353' ' ' MET . 2.9 t -90.78 134.53 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.061 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -153.87 142.87 21.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.068 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 27.9 mt -60.79 144.88 51.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -105.26 80.02 1.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -46.38 -52.74 12.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -100.81 153.44 19.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -161.86 116.7 1.95 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -103.11 137.56 41.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.859 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -88.33 133.57 34.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.907 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -100.01 121.78 41.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.901 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -135.63 152.95 51.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 74.6 m -55.84 155.59 5.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -179.81 74.18 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.511 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.6 150.37 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.642 2.228 . . . . 0.0 112.363 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 72.0 m -150.71 154.68 37.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 1.1 t -153.71 164.01 39.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.474 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 42.5 t -107.6 99.76 9.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.869 0.366 . . . . 0.0 110.876 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 4.0 m -154.54 152.83 30.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -175.97 113.96 0.46 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.478 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 8.0 m -113.18 131.65 55.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 0.0 110.841 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 41.8 t -100.45 -47.26 4.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.824 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.33 124.4 3.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.533 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -84.24 87.97 7.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 110.847 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -127.8 85.46 2.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 66.3 mt -140.78 130.94 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 82.5 p -98.61 167.41 10.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.141 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -123.56 -48.24 1.94 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -77.85 122.62 25.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -69.68 110.76 5.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 367' ' ' LEU . 84.0 t -119.13 93.39 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.8 m -93.25 -30.65 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -67.99 133.11 48.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.624 HD22 ' CG2' ' A' ' 350' ' ' VAL . 65.6 mt -121.94 135.84 54.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.668 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 39.5 t80 -94.27 119.93 33.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.938 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.411 HG21 HD11 ' A' ' 310' ' ' LEU . 59.3 t -104.14 137.71 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.163 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 10.8 tttp -137.22 161.78 35.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.938 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ASN . . . . . 0.471 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.1 m120 63.79 53.84 1.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.487 HD13 HG22 ' A' ' 325' ' ' VAL . 32.0 mt -86.67 94.47 9.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -44.41 149.15 0.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.81 -36.3 62.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.91 -38.36 95.97 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.468 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 81.6 mt -73.58 121.9 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.351 . . . . 0.0 111.103 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.43 177.91 4.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -39.28 -46.25 1.52 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 309' ' ' ARG . 0.2 OUTLIER -65.35 -69.57 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 309' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 308' ' ' GLU . 10.4 mmt180 -35.19 -36.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.492 HD12 ' CE1' ' A' ' 314' ' ' PHE . 47.8 tp -68.05 -75.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.447 ' HG3' ' HB3' ' A' ' 323' ' ' ALA . 2.6 tmm_? -48.85 -25.06 1.69 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -79.33 -32.64 43.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.99 21.03 2.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.094 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.624 ' CB ' HD11 ' A' ' 320' ' ' ILE . 8.8 m-85 -130.22 -30.41 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.597 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.1 t -53.1 -44.92 98.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.7 0.762 . . . . 0.0 110.872 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.4 Cg_exo -47.95 -17.59 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.685 2.257 . . . . 0.0 112.351 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -100.22 -54.9 2.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -159.28 163.67 33.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.462 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 44.5 m -61.31 143.27 55.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.727 0.298 . . . . 0.0 111.139 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.624 HD11 ' CB ' ' A' ' 314' ' ' PHE . 59.6 mt -117.69 149.37 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 61.9 p -117.27 -43.83 2.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.157 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 70.8 m -132.69 112.53 12.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ALA . . . . . 0.447 ' HB3' ' HG3' ' A' ' 311' ' ' ARG . . . -141.01 119.55 12.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.174 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -153.45 147.78 25.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.487 HG22 HD13 ' A' ' 301' ' ' LEU . 49.0 t -89.87 118.58 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.121 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' MET . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 335' ' ' PHE . 26.3 mmm -75.29 94.8 3.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.852 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' MET . . . . . 0.466 ' CB ' ' HA ' ' A' ' 332' ' ' SER . 5.1 ptp -119.84 179.71 4.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -126.14 91.3 3.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 73.09 -110.31 3.1 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.518 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' GLY . . . . . 0.418 ' C ' ' HG3' ' A' ' 331' ' ' ARG . . . -108.89 35.36 4.99 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.418 ' HG3' ' C ' ' A' ' 330' ' ' GLY . 18.4 mtm-85 -147.46 115.21 6.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 0.0 110.875 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.466 ' HA ' ' CB ' ' A' ' 327' ' ' MET . 47.1 t -71.25 99.0 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -38.62 -45.8 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 121.01 43.05 0.46 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.493 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 326' ' ' MET . 2.0 p90 -175.53 160.57 2.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 110.881 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -156.97 177.0 34.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -127.74 132.74 49.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.871 0.367 . . . . 0.0 110.837 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 37.2 t -133.24 135.3 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 9.6 t -117.23 135.96 53.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . 10.9 m-85 -107.98 162.19 14.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 12.5 t -58.82 -46.92 86.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.85 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.14 146.1 58.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.654 0.74 . . . . 0.0 110.861 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 344' ' ' GLU . 71.9 Cg_exo -46.16 -57.78 2.02 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.694 2.263 . . . . 0.0 112.356 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 343' ' ' PRO . 17.4 mm-40 -37.09 -64.7 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.413 ' N ' ' CD ' ' A' ' 345' ' ' GLU . 0.2 OUTLIER -49.09 -43.25 41.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.589 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -60.89 -48.05 83.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.102 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 75.1 m -46.08 -63.02 1.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.178 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 349' ' ' ALA . 1.3 ttmp? -40.65 -65.56 0.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.58 -54.93 0.87 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.114 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.624 ' CG2' HD22 ' A' ' 296' ' ' LEU . 59.3 t -41.43 -51.0 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.163 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 66.1 m -79.37 -58.0 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.118 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -45.78 -25.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.933 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 356' ' ' ARG . 65.3 mmm -102.16 -52.37 3.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 4.7 t-20 -34.25 111.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.916 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.04 20.98 58.28 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.497 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 353' ' ' MET . 17.5 tpp180 -98.05 123.33 42.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.883 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 357' ' ' ILE . . . . . 0.489 HD13 ' N ' ' A' ' 362' ' ' PRO . 10.9 mm -93.14 125.35 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.108 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 74.8 t -110.52 -51.63 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.133 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -113.22 -69.48 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.09 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 1.4 p -131.6 -53.23 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.65 153.37 37.95 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.589 0.709 . . . . 0.0 110.861 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.489 ' N ' HD13 ' A' ' 357' ' ' ILE . 62.6 Cg_endo -77.67 145.3 22.97 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.69 2.26 . . . . 0.0 112.344 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.518 ' O ' HG23 ' A' ' 365' ' ' VAL . 48.4 mt -82.74 92.08 7.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -66.82 100.52 0.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 363' ' ' LEU . 7.6 t -106.43 136.35 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -158.32 149.18 20.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.442 ' HB3' HG11 ' A' ' 293' ' ' VAL . 34.4 mt -59.31 137.28 58.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ALA . . . . . 0.668 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . -114.41 122.48 46.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -74.49 131.78 41.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -133.71 162.69 31.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -170.25 105.04 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 44.18 41.66 4.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -73.96 -45.86 47.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.865 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.411 ' C ' ' HD2' ' A' ' 374' ' ' ARG . 6.4 tmm_? -110.48 109.32 19.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -127.3 127.08 43.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.903 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 5.9 t -141.61 128.65 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -178.29 75.78 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.498 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.02 168.03 24.07 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.671 2.248 . . . . 0.0 112.322 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 50.3 p -116.35 147.67 41.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 33.3 t -108.7 153.56 23.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.502 -179.967 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 69.6 m -76.77 145.78 38.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.936 0.398 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 43.2 t -81.89 148.12 28.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.831 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 173.49 138.63 2.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.503 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 29.8 t -159.09 148.81 18.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 110.885 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 7.7 t -127.2 83.88 2.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.846 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -169.23 120.71 0.89 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -148.08 122.75 9.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.804 0.335 . . . . 0.0 110.879 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -97.37 144.65 26.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 65.9 mt -125.72 104.95 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 24.9 m -90.39 91.34 8.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -57.8 -44.04 86.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -66.55 155.98 36.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -81.76 105.88 13.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 86.8 t -126.58 96.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.097 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 343' ' ' PRO . 29.0 m -95.88 -32.24 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.178 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -69.26 126.12 28.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.762 HD21 ' HB1' ' A' ' 346' ' ' ALA . 39.3 mt -114.6 140.17 49.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -95.59 121.16 36.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.725 HG21 HD11 ' A' ' 310' ' ' LEU . 67.0 t -103.01 133.53 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.127 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 26.8 tttm -133.82 162.49 31.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ASN . . . . . 0.481 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.4 m120 63.77 48.27 3.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.907 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.501 HD21 HG11 ' A' ' 298' ' ' VAL . 28.9 mt -86.81 99.61 11.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -44.79 157.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -59.14 -42.18 90.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.53 -38.96 94.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.511 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.511 HD13 HD21 ' A' ' 363' ' ' LEU . 77.9 mt -65.92 132.33 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.896 0.379 . . . . 0.0 111.123 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.68 -174.93 3.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -46.96 -60.86 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 309' ' ' ARG . 12.5 tt0 -49.65 -65.13 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 308' ' ' GLU . 9.8 mmt85 -34.4 -49.08 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.863 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.725 HD11 HG21 ' A' ' 298' ' ' VAL . 67.7 tp -55.42 -74.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -49.07 -25.05 1.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -74.47 -40.47 61.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.34 19.01 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.109 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.629 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.3 m-85 -127.36 -30.16 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.598 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.2 t -54.02 -45.0 99.16 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.688 0.756 . . . . 0.0 110.872 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.8 Cg_exo -48.03 -17.88 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.703 2.268 . . . . 0.0 112.351 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' PHE . . . . . 0.572 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 57.4 m-85 -100.45 -61.09 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.863 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -148.69 159.32 27.99 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.458 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.2 m -65.36 141.92 58.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.769 0.318 . . . . 0.0 111.157 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.831 HG23 ' O ' ' A' ' 339' ' ' CYS . 79.8 mt -120.26 135.41 60.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 66.4 p -99.45 -36.55 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.6 t -137.81 122.62 18.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ALA . . . . . 0.456 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -137.16 124.18 21.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -150.67 149.81 30.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 335' ' ' PHE . 79.5 t -115.38 138.87 44.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.099 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 39.3 mmt -61.45 122.68 15.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' MET . . . . . 0.58 ' HE2' ' C ' ' A' ' 331' ' ' ARG . 35.0 mtp -140.8 135.46 31.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -131.87 87.84 2.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.64 56.73 1.02 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.493 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 40.71 45.49 3.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.445 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ARG . . . . . 0.58 ' C ' ' HE2' ' A' ' 327' ' ' MET . 50.6 ptt85 -152.49 129.57 11.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 82.2 p -65.3 114.73 4.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.411 ' HE2' ' CZ ' ' A' ' 335' ' ' PHE . 22.7 mtpt -65.24 -47.07 78.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.39 27.45 0.62 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.488 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.463 ' O ' HG13 ' A' ' 325' ' ' VAL . 7.8 p90 -174.98 165.72 3.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.883 0.373 . . . . 0.0 110.893 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -167.41 -163.31 21.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -144.16 138.98 28.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.377 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.666 ' CG2' HD21 ' A' ' 310' ' ' LEU . 53.7 t -130.73 142.46 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' CYS . . . . . 0.831 ' O ' HG23 ' A' ' 320' ' ' ILE . 74.0 m -114.29 145.7 41.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -120.83 174.55 6.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.5 t -73.58 -42.0 62.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.85 145.88 38.49 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.645 0.736 . . . . 0.0 110.837 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.568 ' N ' HG12 ' A' ' 294' ' ' VAL . 71.5 Cg_exo -46.41 -56.18 3.15 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.699 2.266 . . . . 0.0 112.332 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 343' ' ' PRO . 3.6 mm-40 -37.56 -63.52 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -47.75 -45.89 29.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.762 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -60.92 -44.06 97.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 92.8 m -45.9 -61.67 1.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.167 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 349' ' ' ALA . 15.4 ttmt -46.94 -61.95 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -37.52 -50.35 1.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.499 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 57.7 t -41.16 -57.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.113 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 94.2 m -77.48 -55.33 5.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.154 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.572 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 25.6 mm-40 -43.24 -30.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' MET . . . . . 0.448 ' O ' ' C ' ' A' ' 354' ' ' ASN . 72.8 mmm -100.82 -53.66 3.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 2.9 t30 -34.02 115.95 0.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 81.03 27.18 50.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.478 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -99.98 118.24 35.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.868 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' ILE . . . . . 0.504 HD13 ' CA ' ' A' ' 362' ' ' PRO . 27.0 mm -91.51 117.49 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 97.0 t -106.83 -45.01 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -118.55 -72.83 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.093 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.0 p -132.14 -51.74 0.96 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -100.32 148.84 35.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.549 0.69 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.504 ' CA ' HD13 ' A' ' 357' ' ' ILE . 62.9 Cg_endo -77.97 137.34 15.58 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.702 2.268 . . . . 0.0 112.374 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.511 HD21 HD13 ' A' ' 305' ' ' ILE . 62.5 mt -74.5 91.93 2.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -64.19 105.15 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 363' ' ' LEU . 47.0 t -108.79 133.11 54.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.094 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -152.48 151.23 30.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.115 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 73.7 mt -58.79 136.49 57.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -98.68 172.73 7.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? -101.06 78.72 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.986 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 19.4 mmm-85 -145.83 158.51 43.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 31.5 mttp -106.73 -70.84 0.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -147.1 156.91 43.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -113.23 159.59 19.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -129.37 157.09 42.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -116.94 127.25 54.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 8.7 t -169.8 170.61 7.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -140.12 70.77 0.44 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.503 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.08 -179.08 5.08 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.715 2.277 . . . . 0.0 112.322 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 61.0 m -121.96 143.94 49.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.82 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 30.3 m -126.78 140.61 52.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.819 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.48 179.985 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 280' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 279' ' ' GLY . 92.8 p 35.61 44.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 0.0 110.888 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 66.1 m -140.07 162.13 35.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.85 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -174.57 160.33 29.61 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.525 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 2.6 m -148.57 170.81 17.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.855 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 78.2 p -133.38 172.31 12.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.884 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 136.32 109.39 0.97 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.484 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -173.0 169.26 4.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -109.32 166.99 10.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.849 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.478 HD12 ' C ' ' A' ' 288' ' ' ILE . 2.7 pp -114.17 151.6 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.16 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 68.6 p -118.34 95.42 4.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 23.3 mmm-85 -63.7 -45.71 88.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -75.14 107.33 7.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -53.58 123.55 12.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.8 p -141.66 119.47 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 343' ' ' PRO . 19.2 m -118.45 -25.12 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -77.21 143.85 38.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.651 HD12 ' CE1' ' A' ' 340' ' ' PHE . 35.4 mt -131.3 135.87 47.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -94.93 123.83 38.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.2 t -105.07 130.82 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.139 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 34.4 tttp -129.54 162.24 28.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.872 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ASN . . . . . 0.479 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.8 m-20 63.86 52.25 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.582 HD12 ' C ' ' A' ' 335' ' ' PHE . 27.7 mt -93.51 91.16 6.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -40.52 135.34 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -41.08 -41.62 1.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -57.3 -38.72 88.04 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.506 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 57.8 mt -65.89 127.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.831 0.348 . . . . 0.0 111.168 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.4 178.51 4.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.828 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -54.8 -41.49 70.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.847 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -63.43 -57.61 9.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -42.36 -51.76 4.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.474 HD13 HD21 ' A' ' 301' ' ' LEU . 49.5 tp -57.28 -70.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -47.91 -27.63 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 10.7 mtpp -74.3 -32.06 62.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -91.66 18.4 7.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.746 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.3 m-85 -127.11 -29.56 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.594 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -54.51 -45.35 99.44 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.673 0.749 . . . . 0.0 110.858 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.1 Cg_exo -47.92 -17.1 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.666 2.244 . . . . 0.0 112.38 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 61.7 m-85 -99.87 -57.6 2.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -155.94 167.66 33.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.479 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 8.1 m -65.82 143.88 57.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.0 111.102 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.746 HD11 ' HB3' ' A' ' 314' ' ' PHE . 80.2 mt -123.81 139.43 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.7 p -110.74 -38.86 5.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.136 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 14.8 m -127.32 111.12 13.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ALA . . . . . 0.557 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -145.4 126.01 14.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.161 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 12.5 tptm -165.05 149.73 9.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.534 HG22 HD13 ' A' ' 301' ' ' LEU . 93.7 t -98.13 139.47 20.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 37.7 mmt -72.97 96.14 2.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 88.6 mmm -92.64 169.95 10.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.27 107.59 2.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 58.6 -111.88 3.59 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.516 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -113.14 41.18 2.29 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.5 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -160.84 171.23 19.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 110.89 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 333' ' ' LYS . 37.6 t -115.45 108.66 16.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.532 ' HD3' ' CZ ' ' A' ' 335' ' ' PHE . 22.1 mtpp -35.14 -48.01 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 117.38 36.59 0.99 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.46 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.582 ' C ' HD12 ' A' ' 301' ' ' LEU . 13.3 p90 -174.47 164.45 3.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.896 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -160.99 -166.78 20.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -134.4 144.37 48.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.868 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 49.0 t -137.08 132.13 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' CYS . . . . . 0.427 ' O ' HG23 ' A' ' 320' ' ' ILE . 7.2 t -115.92 134.76 54.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.651 ' CE1' HD12 ' A' ' 296' ' ' LEU . 16.5 m-85 -110.86 170.19 8.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.916 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 47.9 t -79.97 -43.32 22.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.895 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 3.0 m -125.29 138.48 31.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.666 0.746 . . . . 0.0 110.84 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.485 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.1 Cg_exo -47.43 -60.02 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.643 2.229 . . . . 0.0 112.37 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 343' ' ' PRO . 42.6 mt-10 -37.44 -58.7 0.83 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -47.35 -45.06 24.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.626 ' O ' HG23 ' A' ' 350' ' ' VAL . . . -61.41 -43.18 99.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.071 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.7 m -51.07 -67.64 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.216 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 349' ' ' ALA . 26.3 tttt -41.32 -63.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.96 -52.93 0.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.641 HG22 HD22 ' A' ' 296' ' ' LEU . 60.9 t -40.06 -54.25 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 81.0 m -79.76 -54.49 5.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.149 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.573 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 17.5 mm-40 -46.42 -25.64 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' MET . . . . . 0.435 ' O ' ' C ' ' A' ' 354' ' ' ASN . 73.4 mmm -104.26 -52.23 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 4.2 t-20 -34.89 110.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 91.88 25.88 21.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -99.76 119.99 39.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 8.8 mm -90.66 127.49 43.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.173 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 67.1 t -116.68 -40.98 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.142 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.11 -70.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.128 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.3 p -132.03 -52.91 0.98 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.151 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -99.99 149.44 35.98 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.606 0.717 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.57 136.81 17.69 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.721 2.281 . . . . 0.0 112.295 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 37.0 mt -66.85 100.35 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -73.75 95.4 2.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.403 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 52.7 t -96.95 144.05 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.077 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -157.96 171.7 19.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 28.4 mt -81.14 140.77 34.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.868 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -105.18 -61.41 1.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.102 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -67.87 137.18 55.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -97.05 -35.85 10.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.825 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -155.81 134.58 11.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -116.09 139.15 50.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -44.99 153.59 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -73.38 -66.05 0.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.39 178.39 9.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 64.5 p -161.82 129.79 4.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.829 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 137.6 146.19 5.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.458 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.17 156.48 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.702 2.268 . . . . 0.0 112.337 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 41.1 p -118.9 165.95 13.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.89 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 1.3 t -60.19 137.71 58.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.863 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.443 -180.0 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 4.0 m -99.01 160.68 14.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 110.86 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 47.1 m -102.17 -55.93 2.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 70.98 -142.79 35.18 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.494 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 4.6 t -173.06 147.26 1.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 110.809 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 41.9 m -96.61 160.44 14.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.881 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -175.77 115.97 0.55 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.507 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -161.56 160.33 28.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.806 0.336 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -143.28 149.48 37.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.826 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 17.7 pt -129.23 135.34 62.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 14.8 t -174.94 152.41 1.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.182 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 43.9 mtt-85 -140.75 175.44 9.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -143.42 152.76 41.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.943 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -59.95 113.14 2.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 81.4 t -140.99 111.03 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.72 -25.22 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -75.38 128.25 34.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.657 HD21 ' HB1' ' A' ' 346' ' ' ALA . 46.1 mt -118.62 147.84 43.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 299' ' ' LYS . 31.8 t80 -106.76 115.51 30.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 31.8 t -100.46 127.95 52.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.155 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.445 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 42.9 tttp -129.16 160.88 31.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ASN . . . . . 0.445 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.5 m120 63.78 50.48 2.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.679 HD21 HD13 ' A' ' 310' ' ' LEU . 24.1 mt -84.28 105.32 15.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.558 ' OD2' ' HB3' ' A' ' 359' ' ' ALA . 62.2 m-20 -45.19 137.42 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -44.97 -40.58 6.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -65.53 -37.97 94.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.479 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.61 107.6 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.822 0.344 . . . . 0.0 111.12 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -95.78 -176.46 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -51.22 -45.91 62.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -66.11 -54.14 29.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -45.27 -42.99 10.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.837 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.679 HD13 HD21 ' A' ' 301' ' ' LEU . 54.0 tp -60.22 -70.29 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.925 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.421 ' NH1' ' HB3' ' A' ' 311' ' ' ARG . 19.3 ttp-105 -53.37 -23.82 10.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -67.96 -35.99 79.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -95.01 20.25 9.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.087 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.878 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.2 m-85 -126.48 -30.38 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.596 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.0 OUTLIER -57.29 -44.79 99.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.62 0.724 . . . . 0.0 110.829 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.7 Cg_exo -48.07 -17.02 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.683 2.255 . . . . 0.0 112.335 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 53.6 m-85 -100.24 -51.48 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.97 163.9 34.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.4 m -63.99 140.7 58.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.124 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.878 HD11 ' HB3' ' A' ' 314' ' ' PHE . 90.9 mt -121.5 143.15 34.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.129 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 69.2 p -117.74 -42.19 2.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.156 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 65.4 m -115.47 105.89 13.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.845 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ALA . . . . . 0.445 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -137.52 112.71 9.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.059 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 33.5 tptt -143.54 145.01 32.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.428 ' N ' ' HG3' ' A' ' 324' ' ' LYS . 49.0 t -110.16 117.48 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' MET . . . . . 0.411 ' HB3' ' CD ' ' A' ' 333' ' ' LYS . 35.8 mmt -55.49 141.72 35.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' MET . . . . . 0.441 ' N ' ' HD2' ' A' ' 333' ' ' LYS . 50.4 mtp -146.21 165.56 28.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.466 ' HG3' ' CG ' ' A' ' 333' ' ' LYS . 56.4 mt-10 -113.37 64.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 79.63 -41.35 2.32 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.509 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -152.37 -35.4 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.436 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -85.66 154.23 21.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 110.853 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 67.9 p -89.04 110.53 21.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.819 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.569 ' HB3' ' CE2' ' A' ' 335' ' ' PHE . 23.7 mttm -48.59 -52.3 23.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 122.33 33.47 0.89 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.508 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 333' ' ' LYS . 20.1 p90 -173.03 159.67 4.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.924 0.392 . . . . 0.0 110.864 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -162.08 -170.46 26.88 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -131.56 141.02 49.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.882 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 18.5 t -136.51 125.95 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 10.1 t -110.4 134.88 51.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.416 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . 9.4 m-85 -107.59 165.6 11.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 5.0 t -73.36 -39.75 64.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 68.4 m -127.01 139.5 35.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.663 0.744 . . . . 0.0 110.878 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.62 -60.5 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.715 2.276 . . . . 0.0 112.341 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -40.31 -57.67 1.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -46.87 -46.77 21.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.657 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -62.82 -42.65 99.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.081 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 56.5 m -53.2 -63.56 1.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 349' ' ' ALA . 37.8 tttt -43.64 -62.77 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -37.37 -51.65 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 346' ' ' ALA . 58.0 t -40.53 -55.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.151 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 73.4 m -78.74 -55.44 5.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.514 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 2.5 mm-40 -45.01 -27.86 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 353' ' ' MET . . . . . 0.484 ' O ' ' CB ' ' A' ' 356' ' ' ARG . 82.3 mmm -102.49 -52.24 3.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.838 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 2.5 t30 -33.96 118.66 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 79.5 18.8 72.76 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.453 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 353' ' ' MET . 22.4 tpp180 -100.12 125.79 46.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.752 0.31 . . . . 0.0 110.872 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 29.2 mm -88.59 139.88 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 90.7 t -128.35 -34.74 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.153 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.558 ' HB3' ' OD2' ' A' ' 302' ' ' ASP . . . -131.27 -69.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.68 -51.2 0.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.177 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.32 155.84 37.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.603 0.716 . . . . 0.0 110.886 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.77 142.67 20.4 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.369 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.587 HD21 HD23 ' A' ' 301' ' ' LEU . 34.4 mt -79.19 92.97 5.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.883 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -65.23 97.69 0.28 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 363' ' ' LEU . 7.6 t -101.17 145.11 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.104 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -158.95 154.64 26.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.093 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.63 140.66 58.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -119.2 100.64 7.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -114.21 41.59 2.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -88.59 -53.77 4.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 28.0 tttp -139.54 153.43 47.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -125.75 122.31 35.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.872 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.84 145.29 47.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -146.83 162.83 37.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -90.2 95.17 10.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.904 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 87.9 p -164.12 144.32 8.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.89 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 120.44 98.64 1.68 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.459 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.9 149.2 32.85 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.69 2.26 . . . . 0.0 112.393 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 18.3 m -100.48 133.7 44.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.858 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 34.8 t -164.64 164.63 21.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.868 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.449 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 93.1 p -94.88 123.28 38.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.812 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 3.2 m -67.62 -54.03 23.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.844 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 112.18 135.53 6.56 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.504 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 53.1 p -114.18 161.16 18.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 0.0 110.831 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 28.0 t -123.33 101.66 7.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.845 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 169.0 149.33 6.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.531 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.52 95.03 9.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.805 0.336 . . . . 0.0 110.87 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -67.88 -32.72 73.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 61.4 mt -49.47 100.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.121 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 57.8 m -148.7 127.15 12.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.101 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ARG . . . . . 0.421 ' O ' ' CG ' ' A' ' 291' ' ' TYR . 59.9 mtp180 -128.1 96.54 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.859 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.421 ' CG ' ' O ' ' A' ' 290' ' ' ARG . 45.4 m-85 -161.6 129.9 4.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -89.16 115.76 26.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 88.1 t -130.63 111.69 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.461 HG23 ' SG ' ' A' ' 339' ' ' CYS . 24.2 m -108.85 -34.72 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -59.64 143.74 49.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.573 HD22 HG22 ' A' ' 350' ' ' VAL . 20.2 mt -134.7 153.38 52.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -115.3 118.81 34.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.7 t -100.19 137.06 28.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.076 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -138.92 155.71 47.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 74.78 39.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.477 HD21 HD13 ' A' ' 310' ' ' LEU . 33.9 mt -73.43 90.66 1.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -40.76 139.92 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.4 -41.58 9.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.862 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.85 -38.97 94.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.44 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 66.7 mt -66.52 143.69 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.856 0.36 . . . . 0.0 111.157 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -132.21 -175.03 3.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -57.79 -42.73 84.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -64.65 -63.81 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 74.5 mtt-85 -46.23 -44.56 16.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.477 HD13 HD21 ' A' ' 301' ' ' LEU . 47.5 tp -55.37 -75.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.617 ' HG3' HD13 ' A' ' 320' ' ' ILE . 58.7 ttp180 -48.95 -29.53 4.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -72.14 -33.68 67.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -85.98 20.35 2.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.446 ' HB2' HD11 ' A' ' 320' ' ' ILE . 8.4 m-85 -128.99 -30.73 2.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.83 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.81 -45.34 97.25 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.716 0.769 . . . . 0.0 110.882 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.6 Cg_exo -48.03 -16.73 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.664 2.243 . . . . 0.0 112.351 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 57.9 m-85 -99.84 -46.62 5.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -169.0 165.97 39.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.542 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 42.0 m -62.59 140.19 58.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.116 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.617 HD13 ' HG3' ' A' ' 311' ' ' ARG . 74.5 mt -109.92 145.56 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.112 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 82.4 p -109.98 -45.39 3.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 82.7 p -136.3 116.53 13.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.842 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ALA . . . . . 0.576 ' HB3' ' HD3' ' A' ' 311' ' ' ARG . . . -135.2 123.46 23.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -150.61 152.4 33.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.475 HG22 HD22 ' A' ' 310' ' ' LEU . 55.2 t -112.34 130.17 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 37.5 mmt -75.48 113.63 13.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' MET . . . . . 0.429 ' CB ' ' HA ' ' A' ' 332' ' ' SER . 4.4 ptp -151.37 169.56 21.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.3 112.17 10.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.934 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 64.06 -113.75 6.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -110.44 39.74 2.79 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.452 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -150.17 125.75 10.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.853 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.429 ' HA ' ' CB ' ' A' ' 327' ' ' MET . 1.4 t -87.62 121.61 30.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.879 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.552 ' HB3' ' CE2' ' A' ' 335' ' ' PHE . 58.2 mttt -52.49 -61.47 2.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 136.9 37.58 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.466 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 333' ' ' LYS . 23.2 p90 -174.82 162.06 3.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 0.0 110.907 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -159.27 -169.16 22.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.477 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -138.8 137.02 36.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.866 0.365 . . . . 0.0 110.912 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 48.8 t -138.04 136.48 44.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.149 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' CYS . . . . . 0.461 ' SG ' HG23 ' A' ' 294' ' ' VAL . 10.1 t -121.39 133.49 55.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.881 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . 11.4 m-85 -104.13 158.91 16.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.851 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.4 m -64.04 -43.07 96.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 71.0 m -125.38 136.97 28.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.67 0.748 . . . . 0.0 110.859 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.4 -56.87 2.69 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.648 2.232 . . . . 0.0 112.361 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -43.82 -61.33 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -47.66 -46.05 28.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.881 ' HB2' ' HB2' ' A' ' 340' ' ' PHE . . . -61.75 -41.18 97.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.062 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 31.4 m -51.49 -60.9 2.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.108 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -40.96 -58.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -46.48 -53.14 11.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.101 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.573 HG22 HD22 ' A' ' 296' ' ' LEU . 98.6 t -38.48 -58.69 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.162 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 72.4 m -75.36 -59.08 2.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.564 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 39.4 mm-40 -41.54 -28.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.9 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 353' ' ' MET . . . . . 0.468 ' HG2' ' CE2' ' A' ' 317' ' ' PHE . 64.1 mmm -100.06 -40.63 7.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -46.1 109.07 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.44 21.93 55.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ARG . . . . . 0.419 ' HD3' ' C ' ' A' ' 356' ' ' ARG . 0.0 OUTLIER -98.1 125.19 42.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.762 0.315 . . . . 0.0 110.862 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 357' ' ' ILE . . . . . 0.458 HD13 ' CA ' ' A' ' 362' ' ' PRO . 27.6 mm -89.42 127.26 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 66.3 t -113.38 -42.89 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -123.0 -74.36 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.089 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 5.2 p -128.9 -49.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.184 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -105.14 150.15 38.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.574 0.702 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.458 ' CA ' HD13 ' A' ' 357' ' ' ILE . 61.5 Cg_endo -76.76 140.98 21.3 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.688 2.259 . . . . 0.0 112.331 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 32.4 mt -80.39 115.87 20.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -83.21 99.66 10.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.476 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 39.0 t -103.37 140.83 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -166.41 152.8 8.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.073 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 26.9 mt -65.93 132.48 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -79.37 173.84 12.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.072 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 370' ' ' ARG . 49.6 mt-30 -113.29 -42.21 3.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 369' ' ' GLN . 24.0 mmt-85 -34.51 -45.56 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.44 48.53 16.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.38 153.54 38.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -135.11 150.18 50.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -135.7 109.35 8.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.833 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -42.54 147.62 0.27 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.962 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 98.0 p -150.63 125.72 9.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.892 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -138.91 145.93 17.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.46 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.67 161.05 31.09 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.72 2.28 . . . . 0.0 112.303 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 4.1 m -165.58 176.54 8.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 32.6 p -111.82 99.51 8.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.51 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 4.3 m -115.89 166.67 11.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.389 . . . . 0.0 110.825 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 25.6 p -141.82 124.13 15.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 128.0 54.11 0.12 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.451 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 77.3 p -128.27 99.52 5.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.879 0.371 . . . . 0.0 110.843 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 43.4 p -143.02 160.72 39.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.78 87.75 0.31 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.508 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -149.43 141.96 24.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.84 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -112.29 145.81 39.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 20.3 pt -136.84 164.78 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.572 ' HB ' ' CE2' ' A' ' 291' ' ' TYR . 36.9 p -150.99 109.09 3.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.157 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ARG . . . . . 0.434 ' HB3' ' NH1' ' A' ' 290' ' ' ARG . 21.5 ttp-105 -87.56 89.67 8.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.85 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.572 ' CE2' ' HB ' ' A' ' 289' ' ' THR . 36.0 m-85 -141.65 163.12 33.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -77.37 82.24 3.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.953 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.493 HG21 HD22 ' A' ' 367' ' ' LEU . 1.8 p -120.03 112.87 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.13 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 343' ' ' PRO . 23.1 m -117.88 -26.8 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -74.12 114.94 13.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.816 HD21 ' HB1' ' A' ' 346' ' ' ALA . 38.4 mt -105.45 132.97 50.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.955 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.735 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 5.9 t80 -90.28 120.09 31.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.407 HG11 HD21 ' A' ' 301' ' ' LEU . 98.6 t -101.05 137.43 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.116 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.466 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 35.8 tttt -137.03 161.46 36.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ASN . . . . . 0.466 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.0 m120 63.53 47.69 3.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.407 HD21 HG11 ' A' ' 298' ' ' VAL . 28.4 mt -80.23 102.46 9.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -45.9 143.9 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -52.39 -39.45 60.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -61.95 -37.11 93.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.79 148.22 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.852 0.358 . . . . 0.0 111.136 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -137.36 179.78 6.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -52.52 -38.67 60.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 309' ' ' ARG . 16.4 mm-40 -68.63 -72.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.888 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 308' ' ' GLU . 61.0 mtt-85 -36.99 -38.89 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.528 HD12 ' CE1' ' A' ' 314' ' ' PHE . 44.0 tp -63.32 -70.72 0.2 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.45 ' HG3' ' CD1' ' A' ' 320' ' ' ILE . 46.3 ttt180 -50.85 -24.98 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -79.4 -32.96 43.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.47 18.88 3.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.081 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.528 ' CE1' HD12 ' A' ' 310' ' ' LEU . 8.4 m-85 -129.36 -30.92 2.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.874 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.584 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.7 OUTLIER -50.79 -45.65 86.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.634 0.73 . . . . 0.0 110.84 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.7 Cg_exo -47.94 -17.05 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.662 2.241 . . . . 0.0 112.353 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' PHE . . . . . 0.443 ' CE2' ' HG2' ' A' ' 353' ' ' MET . 54.4 m-85 -99.84 -47.45 5.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -166.14 158.61 31.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.484 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 40.8 m -60.7 139.13 57.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.738 0.304 . . . . 0.0 111.163 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 339' ' ' CYS . 46.7 mt -110.99 141.69 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 67.9 p -110.34 -40.39 4.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.068 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 3.5 m -132.12 121.24 23.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.883 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -132.98 125.18 29.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.102 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 22.2 mtpt -142.48 154.99 45.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 31.5 t -129.96 117.57 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.16 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 30.0 mmt -66.35 107.14 1.91 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 80.5 mtp -110.87 150.34 29.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.891 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -96.18 38.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 68.2 57.88 7.97 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.484 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 121.97 -40.46 2.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.478 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -115.44 102.93 10.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 9.2 t -44.55 116.32 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.479 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 21.2 mtpp -46.96 -53.31 12.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 300' ' ' ASN . . . 132.59 33.36 0.39 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 333' ' ' LYS . 29.4 p90 -175.15 157.29 2.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -156.89 -161.38 10.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -142.46 131.65 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.386 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 61.7 t -127.36 134.25 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' CYS . . . . . 0.632 ' O ' HG23 ' A' ' 320' ' ' ILE . 7.3 m -110.26 138.78 46.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.486 ' CE1' HD12 ' A' ' 296' ' ' LEU . 28.8 m-85 -114.14 164.41 13.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.904 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.9 t -67.76 -46.51 71.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 3.5 m -130.69 142.67 46.37 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.638 0.733 . . . . 0.0 110.876 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 344' ' ' GLU . 72.8 Cg_exo -47.05 -59.34 1.28 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.652 2.234 . . . . 0.0 112.36 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 343' ' ' PRO . 39.8 mt-10 -36.09 -61.83 0.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -46.87 -47.28 21.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.816 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -60.89 -41.02 95.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 90.1 m -50.13 -62.8 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 349' ' ' ALA . 27.0 tttm -46.52 -63.94 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.21 -48.96 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.071 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 346' ' ' ALA . 47.0 t -41.66 -56.42 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.187 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 92.9 m -79.58 -51.99 8.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.437 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 20.5 mm-40 -46.3 -29.44 1.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' MET . . . . . 0.443 ' HG2' ' CE2' ' A' ' 317' ' ' PHE . 53.4 mmm -101.51 -52.71 3.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 1.8 t30 -34.22 116.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.921 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 82.7 25.57 49.58 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.523 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -100.05 118.27 36.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.723 0.297 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' ILE . . . . . 0.516 HD13 ' CA ' ' A' ' 362' ' ' PRO . 29.6 mm -86.73 126.43 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 94.9 t -112.18 -48.49 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.172 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -120.75 -68.24 0.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.067 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 6.0 p -130.88 -54.44 1.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.139 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.43 151.17 37.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.561 0.696 . . . . 0.0 110.882 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.516 ' CA ' HD13 ' A' ' 357' ' ' ILE . 63.0 Cg_endo -77.13 143.78 22.96 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.641 2.227 . . . . 0.0 112.353 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 365' ' ' VAL . 33.2 mt -78.68 91.97 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -64.32 101.82 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.47 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 50.8 t -105.66 134.49 47.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.122 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -154.54 153.65 31.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.493 HD22 HG21 ' A' ' 293' ' ' VAL . 79.4 mt -62.26 136.75 58.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ALA . . . . . 0.735 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . -124.31 109.21 13.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.169 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -92.47 128.32 38.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.926 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 10.8 ttm105 -159.7 158.68 31.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.853 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -115.48 169.96 8.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 43.89 43.55 5.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 374' ' ' ARG . 7.5 pt-20 -45.15 -38.18 5.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.411 ' N ' ' HG3' ' A' ' 373' ' ' GLU . 15.9 tpp85 -174.93 127.82 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.1 108.79 2.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.5 m -151.15 166.99 29.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -136.04 95.61 0.25 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.457 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -77.99 38.81 0.71 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.718 2.279 . . . . 0.0 112.355 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 5.9 p -45.56 -28.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.824 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 12.3 t -113.46 105.55 13.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.536 -179.943 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 7.9 t -111.77 -52.31 2.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.917 0.389 . . . . 0.0 110.869 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 22.9 t -45.43 -45.41 12.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.891 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 46.97 56.02 7.99 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.443 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 3.5 m -72.8 90.16 1.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.929 0.395 . . . . 0.0 110.817 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.8 t -56.67 -60.37 3.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.864 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -132.73 141.05 12.37 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.476 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -43.96 -51.56 7.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.859 0.361 . . . . 0.0 110.85 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 16.2 mtp85 50.51 42.3 26.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.879 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 62.5 mt -91.96 -45.1 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 14.9 t -159.45 152.76 22.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.144 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -125.05 40.69 3.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -146.76 148.34 31.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.879 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLN . . . . . 0.438 ' CD ' ' O ' ' A' ' 292' ' ' GLN . 5.1 pp0? -78.64 118.17 20.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 99.6 t -126.49 93.53 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 4.6 m -93.85 -32.54 4.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -64.93 135.84 56.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.928 HD21 ' HB1' ' A' ' 346' ' ' ALA . 48.4 mt -122.33 137.73 54.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -98.75 106.56 18.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.2 t -90.3 135.75 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.164 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.492 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 17.3 ttmm -133.25 164.76 26.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ASN . . . . . 0.492 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.7 m-20 63.77 45.34 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 28.4 mt -90.61 98.09 11.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -46.35 163.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.32 -36.62 84.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.26 -43.58 97.13 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.533 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 39.6 mt -60.91 147.49 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.336 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -137.31 -176.82 4.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.823 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -60.14 -34.08 73.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -72.13 -62.25 1.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.878 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -46.82 -42.78 17.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.455 HD12 ' CE1' ' A' ' 314' ' ' PHE . 61.2 tp -62.38 -71.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -48.43 -26.58 2.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -70.48 -33.69 71.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -92.35 18.94 7.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.108 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.472 ' CB ' HD11 ' A' ' 320' ' ' ILE . 6.3 m-85 -123.76 -31.16 3.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.8 OUTLIER -56.85 -45.48 99.95 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.643 0.735 . . . . 0.0 110.846 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.9 Cg_exo -47.95 -17.06 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 0.0 112.385 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' PHE . . . . . 0.58 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 62.0 m-85 -99.92 -48.91 4.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.26 168.08 37.11 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.455 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.3 m -64.37 139.39 58.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.787 0.327 . . . . 0.0 111.124 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.477 HG21 ' HB2' ' A' ' 323' ' ' ALA . 42.1 mt -115.85 133.93 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 75.2 p -108.15 -40.62 5.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.127 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.9 m -130.09 112.61 13.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.815 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -138.65 124.31 19.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.122 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.447 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 19.2 tptm -163.63 146.55 9.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.447 ' N ' ' HG3' ' A' ' 324' ' ' LYS . 98.9 t -101.05 136.23 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.113 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 37.5 mmt -74.8 95.2 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 49.5 mtp -110.04 164.45 12.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.842 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -152.17 132.29 13.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.948 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 49.43 65.1 2.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.451 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 42.3 39.15 3.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.461 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 -155.57 122.36 5.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.862 0.363 . . . . 0.0 110.881 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 5.6 t -75.85 121.53 22.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -58.11 -53.62 56.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.899 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 138.78 36.86 0.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.5 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -171.93 152.76 3.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.857 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -154.08 -174.11 23.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.519 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -133.62 143.74 48.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 110.895 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 48.7 t -138.7 147.59 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' CYS . . . . . 0.424 ' O ' HG23 ' A' ' 320' ' ' ILE . 62.6 m -124.52 149.03 47.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -125.2 175.96 7.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 90.2 p -75.11 -29.79 60.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 43.4 t -156.75 145.05 14.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.717 0.77 . . . . 0.0 110.789 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 346' ' ' ALA . 71.3 Cg_exo -45.06 -54.01 4.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.693 2.262 . . . . 0.0 112.359 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -39.01 -37.92 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -76.2 -38.64 56.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.928 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -65.79 -45.39 82.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 87.5 m -49.3 -67.82 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.172 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.453 ' HG2' ' CG ' ' A' ' 352' ' ' GLU . 19.7 tttm -41.14 -60.71 1.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -40.8 -52.45 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 346' ' ' ALA . 66.2 t -39.47 -59.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 353' ' ' MET . 51.9 m -77.51 -59.6 2.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.159 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.58 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 30.9 mm-40 -37.44 -29.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' MET . . . . . 0.468 ' N ' ' O ' ' A' ' 351' ' ' THR . 79.6 mmm -100.24 -61.3 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 353' ' ' MET . 8.0 t30 -36.8 101.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 125.68 -9.26 7.68 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.511 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.42 126.54 35.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 110.878 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 357' ' ' ILE . . . . . 0.437 HD13 ' CA ' ' A' ' 362' ' ' PRO . 23.4 mm -87.94 135.27 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 65.6 t -113.63 -54.54 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -116.08 -65.39 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.064 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.501 HG23 ' HD3' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -133.76 -52.65 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.501 ' HD3' HG23 ' A' ' 360' ' ' THR . 0.0 OUTLIER -102.81 153.67 38.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.548 0.69 . . . . 0.0 110.893 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.437 ' CA ' HD13 ' A' ' 357' ' ' ILE . 60.0 Cg_endo -73.5 148.24 42.31 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.324 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.477 ' O ' HG23 ' A' ' 365' ' ' VAL . 58.7 mt -70.8 93.61 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -68.08 88.28 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 363' ' ' LEU . 14.3 t -92.66 140.09 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.09 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -155.96 138.32 14.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.478 HD23 ' CD2' ' A' ' 296' ' ' LEU . 60.2 mt -57.76 141.45 48.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -101.71 94.01 5.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.121 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 370' ' ' ARG . 34.2 mt-30 -100.07 -32.45 10.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 369' ' ' GLN . 13.4 mtt85 -38.13 -51.91 1.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -170.49 131.77 0.94 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.841 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -91.07 159.91 15.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -91.35 100.81 13.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -160.35 131.86 5.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -80.88 134.0 35.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 31.5 m -130.92 -56.79 1.04 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 64.3 95.6 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.488 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -43.96 -51.52 6.41 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.709 2.272 . . . . 0.0 112.33 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 3.4 m -163.64 159.73 22.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 90.7 p -72.85 117.55 14.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.816 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.488 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.451 -0.259 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.4 t -127.4 140.93 51.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.935 0.397 . . . . 0.0 110.864 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 75.5 m -150.2 177.79 9.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.847 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 133.82 64.24 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.474 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 67.7 m -128.74 165.71 20.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.841 0.353 . . . . 0.0 110.905 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.6 t -103.3 -54.86 2.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 109.35 170.47 20.52 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.489 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -87.01 116.63 25.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -147.83 141.47 25.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 3.2 pt -128.07 133.56 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.123 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 57.5 m -142.05 107.64 5.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.179 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ARG . . . . . 0.405 ' O ' ' CG ' ' A' ' 291' ' ' TYR . 7.8 mmt85 -122.96 79.41 1.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.405 ' CG ' ' O ' ' A' ' 290' ' ' ARG . 70.2 m-85 -157.14 159.62 37.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.935 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -93.25 95.43 9.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 98.6 t -132.89 95.02 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 343' ' ' PRO . 23.9 m -94.55 -23.82 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.175 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -78.35 137.92 38.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.831 HD21 ' HB1' ' A' ' 346' ' ' ALA . 36.2 mt -128.08 142.85 51.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.958 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.64 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 32.9 t80 -99.65 121.87 41.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.54 HG21 HD11 ' A' ' 310' ' ' LEU . 39.3 t -99.57 130.1 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.098 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 16.0 tttm -128.44 157.56 40.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ASN . . . . . . . . . . . . . 3.4 m120 63.83 54.94 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.511 HD21 HG11 ' A' ' 298' ' ' VAL . 28.3 mt -92.56 98.07 11.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.939 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 303' ' ' ASP . 14.8 t70 -50.24 131.42 23.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 302' ' ' ASP . 12.9 t70 -35.61 -49.86 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -48.35 -44.98 28.45 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.73 143.15 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.826 0.346 . . . . 0.0 111.125 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.8 -175.76 4.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.828 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.74 -42.94 65.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -62.25 -70.25 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 66.7 mtt-85 -41.66 -40.73 2.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.54 HD11 HG21 ' A' ' 298' ' ' VAL . 43.2 tp -60.72 -70.92 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.653 ' HG3' HD12 ' A' ' 320' ' ' ILE . 54.6 ttt180 -53.2 -23.71 9.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -68.7 -37.97 79.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -91.82 20.09 5.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.098 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.626 ' CB ' HD11 ' A' ' 320' ' ' ILE . 7.1 m-85 -126.19 -30.34 2.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.864 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.589 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.0 OUTLIER -56.9 -45.52 99.95 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.664 0.745 . . . . 0.0 110.822 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 315' ' ' SER . 66.1 Cg_exo -48.0 -17.16 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 0.0 112.354 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 48.6 m-85 -100.8 -52.84 3.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -145.72 170.62 26.94 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.464 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.4 m -85.93 95.19 9.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 0.0 111.143 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.653 HD12 ' HG3' ' A' ' 311' ' ' ARG . 93.4 mt -62.07 143.59 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.181 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 39.1 p -112.13 -28.54 7.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 2.6 t -155.37 109.23 2.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ALA . . . . . 0.481 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -123.19 135.77 54.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.135 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -156.57 152.7 27.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 86.7 t -115.96 139.18 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.101 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 35.9 mmt -70.72 136.99 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 18.4 mtp -133.91 178.17 7.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -116.15 -30.19 6.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.861 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 147.72 41.59 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.459 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 155.41 -42.61 0.57 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.479 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -127.7 159.97 33.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.823 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 59.2 p -81.76 140.35 34.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.423 ' HD3' ' CZ ' ' A' ' 335' ' ' PHE . 19.0 mtpt -75.57 -60.77 2.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 149.14 37.72 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.525 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.488 ' CA ' HD12 ' A' ' 301' ' ' LEU . 34.9 p90 -174.02 150.09 1.56 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.899 0.38 . . . . 0.0 110.891 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -158.12 -169.0 21.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.479 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -136.34 143.22 43.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 0.0 110.882 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 41.2 t -134.05 126.84 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.15 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 74.3 m -101.41 127.56 48.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.727 ' CE1' HD12 ' A' ' 296' ' ' LEU . 15.5 m-85 -101.76 168.14 9.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 25.1 t -78.36 -42.24 31.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.9 m -131.24 139.75 36.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.664 0.745 . . . . 0.0 110.875 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 344' ' ' GLU . 72.8 Cg_exo -47.43 -59.01 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.718 2.279 . . . . 0.0 112.332 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 343' ' ' PRO . 27.9 tt0 -36.39 -59.06 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.921 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.43 -48.11 56.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.831 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -55.88 -42.92 76.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.088 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 99.2 m -52.93 -67.15 0.27 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.19 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 349' ' ' ALA . 15.2 ttmt -40.85 -65.06 0.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.6 -48.24 0.51 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.112 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 346' ' ' ALA . 43.4 t -44.38 -52.66 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 53.1 m -81.79 -50.41 9.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.542 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 23.4 mm-40 -49.62 -28.13 5.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 353' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 356' ' ' ARG . 83.7 mmm -101.84 -49.0 4.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 3.5 t30 -36.1 110.53 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 87.75 19.83 52.74 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.507 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 353' ' ' MET . 21.8 tpp85 -99.11 120.97 40.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.897 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 9.0 mm -87.11 130.92 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.145 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 85.2 t -116.43 -42.29 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.073 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -126.1 -69.23 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.11 -55.25 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.98 155.68 36.17 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.558 0.694 . . . . 0.0 110.942 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.18 135.55 15.34 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.68 2.253 . . . . 0.0 112.301 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 365' ' ' VAL . 28.0 mt -71.72 88.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -64.48 100.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.94 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 363' ' ' LEU . 28.8 t -100.09 135.25 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -153.94 143.16 21.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 71.7 mt -54.14 145.18 17.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ALA . . . . . 0.64 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . -133.79 176.19 8.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -84.51 128.57 34.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.865 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -94.67 156.33 16.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -107.83 160.56 15.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -78.76 -47.76 16.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.477 ' HG2' ' N ' ' A' ' 374' ' ' ARG . 29.9 tt0 -167.61 155.67 9.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.843 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' ARG . . . . . 0.477 ' N ' ' HG2' ' A' ' 373' ' ' GLU . 0.3 OUTLIER -153.34 132.37 12.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.869 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -122.75 140.09 53.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 82.5 p -59.96 -46.92 87.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 40.12 75.26 0.12 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.13 -20.22 13.02 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.655 2.237 . . . . 0.0 112.39 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 380' ' ' SER . 3.1 m -148.88 131.76 16.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.825 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 380' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 379' ' ' SER . 46.6 t -36.93 -53.79 0.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.896 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 72.3 m -68.09 -54.78 15.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 3.5 t -110.88 159.21 17.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 150.4 50.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.444 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 8.9 t -85.68 153.31 22.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.868 0.366 . . . . 0.0 110.858 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.0 p -107.43 156.29 19.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 79.56 67.86 1.54 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.451 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -132.19 94.3 3.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.812 0.339 . . . . 0.0 110.829 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -85.04 112.85 21.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 21.0 mm -96.44 -55.64 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 14.6 t -147.7 145.3 28.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.85 -13.67 15.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -73.85 133.46 43.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.909 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -62.29 95.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 74.7 t -120.32 88.15 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.457 HG12 ' C ' ' A' ' 342' ' ' SER . 16.6 m -87.13 -30.39 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -69.63 123.21 20.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.668 HD21 ' HB1' ' A' ' 346' ' ' ALA . 69.1 mt -112.45 136.84 51.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.966 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -90.21 119.52 30.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.485 HG21 HD11 ' A' ' 310' ' ' LEU . 21.2 t -106.98 129.73 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.119 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.488 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 11.0 tttp -129.61 162.71 27.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ASN . . . . . 0.488 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.4 m120 63.8 51.21 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 39.8 mt -85.85 99.41 11.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -46.91 144.26 2.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -47.45 -40.27 17.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -61.28 -36.82 93.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.503 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.591 HD13 HD21 ' A' ' 363' ' ' LEU . 66.9 mt -69.11 135.97 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.826 0.346 . . . . 0.0 111.14 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -136.18 -176.36 4.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -43.04 -63.3 0.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -47.06 -63.83 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -39.59 -52.5 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.515 HD21 ' CG2' ' A' ' 338' ' ' VAL . 53.1 tp -50.22 -74.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.96 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.723 ' HG3' HG21 ' A' ' 320' ' ' ILE . 19.3 ttt180 -54.2 -21.45 8.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -78.41 -29.51 47.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -99.91 17.96 19.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.806 ' CB ' HD11 ' A' ' 320' ' ' ILE . 8.0 m-85 -128.59 -30.39 2.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.73 -45.4 96.81 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.644 0.735 . . . . 0.0 110.82 -179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 315' ' ' SER . 66.0 Cg_exo -48.0 -17.13 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.67 2.247 . . . . 0.0 112.341 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' PHE . . . . . 0.419 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 52.0 m-85 -99.95 -50.11 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -145.91 169.19 27.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 90.4 m -81.86 88.19 6.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.725 0.298 . . . . 0.0 111.136 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.806 HD11 ' CB ' ' A' ' 314' ' ' PHE . 64.8 mt -65.56 131.57 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.151 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 3.1 t -108.75 -29.65 8.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.1 t -139.98 126.17 19.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -140.24 140.93 35.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.093 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -156.43 150.65 25.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 95.5 t -125.12 135.68 63.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 35.7 mmt -70.11 106.15 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 42.1 mtp -111.65 153.47 26.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.442 ' OE1' ' C ' ' A' ' 328' ' ' GLU . 0.0 OUTLIER -124.03 103.05 8.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 65.88 -103.29 0.82 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.499 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -121.38 39.77 2.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.496 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -167.55 140.45 3.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 0.0 110.889 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.9 t -73.98 126.62 30.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.417 ' CG ' ' HB2' ' A' ' 328' ' ' GLU . 94.5 mttt -58.22 -56.31 23.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 141.14 36.9 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.471 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -174.2 161.37 3.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.92 0.391 . . . . 0.0 110.846 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -164.85 -167.83 26.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.492 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -144.2 136.13 26.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.902 0.382 . . . . 0.0 110.887 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.515 ' CG2' HD21 ' A' ' 310' ' ' LEU . 60.1 t -123.05 134.82 65.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 64.5 m -107.34 128.58 54.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.517 ' CE1' HD12 ' A' ' 296' ' ' LEU . 21.9 m-85 -105.03 160.86 14.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 95.7 p -67.42 -31.36 71.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.905 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.457 ' C ' HG12 ' A' ' 294' ' ' VAL . 4.8 t -148.48 143.41 17.33 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.681 0.753 . . . . 0.0 110.842 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 344' ' ' GLU . 72.9 Cg_exo -47.28 -58.97 1.42 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.636 2.224 . . . . 0.0 112.368 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 343' ' ' PRO . 22.4 mp0 -36.09 -64.94 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -44.8 -45.47 10.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.668 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -64.1 -42.51 96.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.137 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 97.2 m -45.8 -62.37 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.095 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 349' ' ' ALA . 44.4 tttp -48.41 -63.74 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.65 -48.06 0.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 346' ' ' ALA . 48.3 t -43.19 -54.93 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.106 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 85.8 m -80.65 -48.99 11.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.419 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 17.1 mm-40 -50.7 -26.65 5.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 353' ' ' MET . . . . . 0.458 ' O ' ' N ' ' A' ' 356' ' ' ARG . 75.2 mmm -103.31 -50.36 3.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 0.4 OUTLIER -40.72 105.92 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 95.71 16.78 38.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 353' ' ' MET . 0.0 OUTLIER -98.04 122.0 40.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.762 0.315 . . . . 0.0 110.893 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 357' ' ' ILE . . . . . 0.42 HD13 ' CA ' ' A' ' 362' ' ' PRO . 23.4 mm -88.76 134.26 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.113 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.86 -59.83 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.13 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -105.72 -70.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.099 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 16.9 p -133.64 -47.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.163 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -104.32 154.85 38.01 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.567 0.698 . . . . 0.0 110.886 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.42 ' CA ' HD13 ' A' ' 357' ' ' ILE . 62.6 Cg_endo -77.7 144.07 21.8 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.674 2.249 . . . . 0.0 112.363 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.591 HD21 HD13 ' A' ' 305' ' ' ILE . 37.8 mt -81.02 92.6 6.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.935 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -61.45 102.65 0.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 363' ' ' LEU . 47.4 t -108.84 137.67 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.091 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -163.38 149.05 11.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.087 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 18.0 mt -60.5 148.38 37.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -113.84 174.8 5.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.105 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 369' ' ' GLN . . . . . 0.406 ' C ' ' HD3' ' A' ' 370' ' ' ARG . 24.9 mt-30 -150.85 151.4 32.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 370' ' ' ARG . . . . . 0.406 ' HD3' ' C ' ' A' ' 369' ' ' GLN . 1.6 mpp_? -140.26 174.51 10.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -125.15 110.63 14.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -87.29 -64.12 1.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -146.81 159.58 43.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.947 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -98.02 -58.05 2.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -62.37 147.19 49.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 5.6 t -99.9 -44.15 6.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 145.81 -162.93 28.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.514 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.6 101.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.716 2.277 . . . . 0.0 112.358 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 20.2 p -42.49 -42.27 3.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 43.6 m 49.69 43.29 24.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.489 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.5 t -110.56 -56.23 2.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.83 0.348 . . . . 0.0 110.828 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 20.1 m -60.53 114.29 2.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.854 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -131.49 46.78 1.05 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.443 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 33.8 m -131.22 156.32 45.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.916 0.389 . . . . 0.0 110.814 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 16.1 m -94.45 152.86 18.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.843 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.35 117.96 4.34 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.522 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -97.96 -56.93 2.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.844 0.354 . . . . 0.0 110.892 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -84.96 140.74 30.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 288' ' ' ILE . 5.1 mp -88.08 -48.13 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 68.9 p -110.12 44.75 1.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 29.1 ttt85 -55.4 -53.4 56.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.824 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -105.67 126.12 51.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.903 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -93.36 102.36 14.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.47 HG21 HD22 ' A' ' 367' ' ' LEU . 1.3 p -125.25 111.57 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.171 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 343' ' ' PRO . 10.1 m -112.12 -22.28 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -75.16 125.9 29.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.784 HD22 ' CG2' ' A' ' 350' ' ' VAL . 49.9 mt -111.37 145.03 39.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.612 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 24.5 t80 -110.99 105.53 14.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 39.1 t -89.5 137.14 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.168 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.564 ' HE2' ' CD1' ' A' ' 364' ' ' TYR . 17.7 ttpt -132.85 162.04 32.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ASN . . . . . 0.47 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.8 m-20 64.02 51.72 2.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.524 HD12 ' C ' ' A' ' 335' ' ' PHE . 30.9 mt -90.39 106.63 18.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -52.31 150.29 4.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.842 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -56.64 -34.3 67.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -64.82 -39.73 96.8 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.497 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 60.7 mt -62.82 139.14 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.829 0.347 . . . . 0.0 111.123 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -128.32 174.74 9.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.83 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -49.12 -43.1 41.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -62.86 -64.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 58.5 mtt-85 -42.81 -34.33 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.541 HD12 ' CE1' ' A' ' 314' ' ' PHE . 59.5 tp -67.74 -75.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -48.28 -25.79 1.7 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -70.51 -36.1 73.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -93.82 20.54 7.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.088 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.714 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.3 m-85 -127.06 -29.69 2.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.636 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 2.7 t -58.05 -42.74 96.7 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.665 0.745 . . . . 0.0 110.887 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 315' ' ' SER . 63.4 Cg_exo -47.89 -17.21 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.67 2.247 . . . . 0.0 112.395 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -100.23 -51.94 3.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -158.31 175.65 35.42 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.447 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 92.0 m -77.39 134.25 38.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.728 0.299 . . . . 0.0 111.171 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.714 HD11 ' HB3' ' A' ' 314' ' ' PHE . 84.3 mt -110.32 138.36 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.13 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 82.8 p -108.24 -39.06 5.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 72.7 m -127.56 106.74 9.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.807 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ALA . . . . . 0.677 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -131.32 114.37 14.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.084 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.432 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 2.9 tppp? -146.82 145.01 29.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.432 ' N ' ' HG3' ' A' ' 324' ' ' LYS . 44.1 t -106.13 140.4 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 33.8 mmt -86.49 90.64 8.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 2.9 ptp -123.15 176.65 5.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.55 -62.01 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 177.78 36.86 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.485 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 166.29 -31.73 0.21 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.484 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 -133.77 116.74 16.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.789 0.328 . . . . 0.0 110.848 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 333' ' ' LYS . 5.4 t -58.66 112.8 1.74 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.843 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 332' ' ' SER . 2.9 mtpm? -34.54 -49.67 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 136.79 33.17 0.23 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.524 ' C ' HD12 ' A' ' 301' ' ' LEU . 12.1 p90 -173.35 154.69 2.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 0.0 110.862 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -158.95 179.1 34.82 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.452 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -128.34 129.26 46.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.453 ' CG1' HD13 ' A' ' 320' ' ' ILE . 12.7 t -130.56 130.27 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 339' ' ' CYS . . . . . 0.545 ' O ' HG23 ' A' ' 320' ' ' ILE . 33.2 t -109.16 154.14 22.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.449 ' CE1' HD12 ' A' ' 296' ' ' LEU . 19.6 m-85 -125.61 177.54 6.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 93.1 p -77.32 -38.08 51.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.42 ' C ' HG12 ' A' ' 294' ' ' VAL . 27.0 t -142.98 146.5 37.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.689 0.756 . . . . 0.0 110.888 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 344' ' ' GLU . 71.6 Cg_exo -46.56 -60.39 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.717 2.278 . . . . 0.0 112.316 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 343' ' ' PRO . 20.8 mt-10 -35.75 -70.04 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 345' ' ' GLU . 0.3 OUTLIER -44.03 -43.86 7.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.827 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.755 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -60.92 -43.63 98.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.086 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.8 m -52.41 -60.31 3.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.149 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -46.27 -52.4 12.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -53.83 -53.08 57.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.784 ' CG2' HD22 ' A' ' 296' ' ' LEU . 76.0 t -39.02 -49.58 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 351' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 353' ' ' MET . 50.9 m -82.58 -62.18 1.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -41.04 -24.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 351' ' ' THR . 94.4 mmm -102.06 -43.41 5.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 17.2 t-20 -59.22 109.54 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 108.5 -11.99 36.04 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -87.39 147.45 25.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.772 0.32 . . . . 0.0 110.888 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 6.2 mm -97.47 148.98 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' VAL . . . . . 0.418 HG21 HD11 ' A' ' 363' ' ' LEU . 61.8 t -131.97 -54.01 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.162 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -113.01 -72.72 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.089 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.447 HG23 ' N ' ' A' ' 361' ' ' LYS . 2.4 t -131.86 -49.08 0.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.447 ' N ' HG23 ' A' ' 360' ' ' THR . 17.2 mttm -101.08 154.0 37.42 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.618 0.723 . . . . 0.0 110.916 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.38 129.14 10.9 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.697 2.265 . . . . 0.0 112.329 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.451 ' CD2' HD23 ' A' ' 301' ' ' LEU . 52.3 mt -67.08 122.55 18.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.914 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.564 ' CD1' ' HE2' ' A' ' 299' ' ' LYS . 25.1 t80 -101.83 93.48 5.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.6 144.22 10.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.126 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -162.43 145.94 11.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.085 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 293' ' ' VAL . 35.9 mt -53.14 145.9 12.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.943 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' ALA . . . . . 0.612 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . -130.2 176.31 8.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -123.43 118.3 27.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.959 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 35.5 ttt-85 -147.09 144.52 29.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.897 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -172.74 144.4 1.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -166.16 109.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -131.8 123.88 28.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.897 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -174.55 144.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -94.96 169.45 10.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.965 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.2 t -106.24 153.11 22.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.826 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -130.54 95.24 0.33 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.456 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.31 14.31 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.711 2.274 . . . . 0.0 112.336 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 13.4 t -76.18 95.92 3.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.814 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 1.6 t -56.63 162.11 2.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.479 179.983 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.0 p -116.39 104.64 11.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.896 0.379 . . . . 0.0 110.827 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 56.0 m -159.13 162.97 36.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.828 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 160.34 60.68 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.452 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 41.5 t -122.71 142.27 50.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.898 0.38 . . . . 0.0 110.84 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 72.3 p -150.14 157.97 43.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 158.96 111.36 0.3 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.471 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.29 97.58 11.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.867 0.365 . . . . 0.0 110.89 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.4 42.83 3.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 5.2 mp -105.36 134.78 45.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.139 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 14.8 t -130.0 147.38 51.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.158 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' ARG . . . . . 0.46 ' O ' ' CG ' ' A' ' 291' ' ' TYR . 1.0 OUTLIER -134.01 90.88 2.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.846 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.781 ' O ' HG23 ' A' ' 293' ' ' VAL . 97.9 m-85 -159.68 126.69 4.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -48.26 96.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 291' ' ' TYR . 97.0 t -122.55 94.82 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.111 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.1 m -92.1 -32.5 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.158 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -65.59 136.1 55.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.896 HD21 ' HB1' ' A' ' 346' ' ' ALA . 30.7 mt -123.58 137.2 54.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.967 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -101.62 103.05 13.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 32.2 t -88.45 136.21 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.581 ' HE3' ' CD1' ' A' ' 364' ' ' TYR . 13.2 ttpp -135.41 162.8 31.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ASN . . . . . 0.455 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.6 m120 63.97 47.84 3.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 35.7 mt -86.22 98.44 10.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.724 ' OD2' ' HB3' ' A' ' 359' ' ' ALA . 91.6 m-20 -41.47 134.98 2.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -45.83 -36.4 5.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.15 -42.72 97.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.5 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 63.0 mt -60.44 147.65 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.834 0.349 . . . . 0.0 111.173 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -130.34 -174.61 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.23 -28.47 69.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.48 -55.07 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -51.89 -41.89 62.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.533 HD12 ' CE1' ' A' ' 314' ' ' PHE . 62.9 tp -61.89 -72.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.449 ' HD2' ' HB3' ' A' ' 323' ' ' ALA . 13.7 ttt-85 -50.38 -24.89 3.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -80.0 -29.02 39.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -93.34 17.65 10.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.096 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.533 ' CE1' HD12 ' A' ' 310' ' ' LEU . 6.9 m-85 -126.01 -31.49 2.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.49 -45.27 95.67 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.648 0.737 . . . . 0.0 110.799 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.5 Cg_exo -48.03 -16.67 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.716 2.277 . . . . 0.0 112.325 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -99.67 -52.17 3.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.835 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.27 166.56 36.51 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.475 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 23.9 m -64.08 144.48 57.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.743 0.306 . . . . 0.0 111.18 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 339' ' ' CYS . 49.6 mt -119.75 137.73 52.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 68.4 p -100.94 -41.43 6.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.145 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.1 t -142.28 124.53 15.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.825 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' ALA . . . . . 0.449 ' HB3' ' HD2' ' A' ' 311' ' ' ARG . . . -145.57 124.76 12.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.08 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -149.25 159.0 44.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.32 123.87 71.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.097 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' MET . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 335' ' ' PHE . 33.5 mmt -59.03 148.0 32.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 327' ' ' MET . . . . . 0.401 ' C ' ' HG3' ' A' ' 333' ' ' LYS . 25.8 mtp -137.21 164.25 28.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -110.95 38.51 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 104.43 -66.55 0.3 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.502 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -113.64 -39.79 1.07 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.503 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -107.63 171.2 7.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.795 0.331 . . . . 0.0 110.876 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.7 m -83.58 139.8 32.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.401 ' HG3' ' C ' ' A' ' 327' ' ' MET . 65.5 mttt -69.68 -44.76 69.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.868 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 125.39 34.74 0.65 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.439 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.485 ' CZ ' ' HG3' ' A' ' 326' ' ' MET . 2.5 p90 -174.75 161.13 3.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.913 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -164.7 -172.05 31.69 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.519 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -131.21 146.46 52.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.868 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 50.5 t -142.43 131.9 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.091 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' CYS . . . . . 0.547 ' O ' HG23 ' A' ' 320' ' ' ILE . 6.5 t -112.94 144.27 42.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -118.52 178.63 4.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.1 t -78.49 -39.88 36.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.3 t -137.53 142.36 36.83 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.671 0.748 . . . . 0.0 110.855 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.99 -54.51 4.9 Favored 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.686 2.258 . . . . 0.0 112.369 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -41.83 -52.05 4.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.93 -46.06 82.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.896 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -59.03 -38.86 80.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.152 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 348' ' ' LYS . 60.9 m -52.04 -74.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 347' ' ' THR . 10.1 ttmm -35.25 -64.8 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.953 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.41 -54.5 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.117 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 346' ' ' ALA . 33.5 t -47.52 -46.25 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.163 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 27.3 m -77.57 -59.48 2.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.133 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -50.49 -22.08 1.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 90.1 mmm -100.22 -43.34 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 9.2 t-20 -58.98 97.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 123.58 -11.49 8.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.492 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -85.15 122.44 29.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' ILE . . . . . 0.401 HD13 ' CA ' ' A' ' 362' ' ' PRO . 11.5 mm -84.99 149.63 4.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.24 -49.37 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.724 ' HB3' ' OD2' ' A' ' 302' ' ' ASP . . . -120.28 -68.97 0.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.32 -51.25 0.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.185 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.58 151.81 37.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.545 0.688 . . . . 0.0 110.899 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.401 ' CA ' HD13 ' A' ' 357' ' ' ILE . 60.4 Cg_endo -74.15 151.98 44.73 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.728 2.285 . . . . 0.0 112.345 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 63.1 mt -77.09 96.51 4.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' TYR . . . . . 0.581 ' CD1' ' HE3' ' A' ' 299' ' ' LYS . 10.1 t80 -74.48 85.8 2.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.67 144.41 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.131 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -152.09 168.07 26.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.148 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 29.5 mt -72.35 145.95 47.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 293' ' ' VAL . . . -123.31 125.81 45.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.099 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 -116.81 48.5 1.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.872 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -124.7 82.67 2.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -122.85 115.79 22.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -124.38 40.59 3.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -130.91 125.25 33.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -110.17 141.99 42.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -133.18 120.24 20.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 51.3 p -146.75 159.58 43.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 168.85 145.12 4.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.51 164.77 25.86 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.752 2.301 . . . . 0.0 112.321 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 58.9 m -136.87 134.48 36.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 13.4 m -164.73 124.34 1.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.83 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.476 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 65.9 p -109.03 174.08 6.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.835 0.35 . . . . 0.0 110.845 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 4.5 m -64.13 -60.03 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.875 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 100.96 126.17 5.76 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.481 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 71.8 p -89.24 126.87 35.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.869 0.366 . . . . 0.0 110.85 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 72.4 p -125.09 151.7 45.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.819 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 162.2 78.3 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.474 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -131.92 151.33 51.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -106.11 145.4 31.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 54.7 mt -58.62 -58.29 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 14.3 t -168.67 151.44 5.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.186 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' ARG . . . . . 0.435 ' HB3' ' CE2' ' A' ' 291' ' ' TYR . 56.7 mtt180 -123.28 -46.58 2.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.435 ' CE2' ' HB3' ' A' ' 290' ' ' ARG . 12.2 m-85 -150.25 167.18 27.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -63.86 114.93 4.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.425 HG13 ' HG3' ' A' ' 369' ' ' GLN . 93.7 t -132.69 94.85 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.171 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 24.3 m -87.27 -30.32 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -72.69 135.83 45.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.829 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.695 HD21 ' HB1' ' A' ' 346' ' ' ALA . 28.9 mt -129.76 132.99 46.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.916 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.672 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 26.7 t80 -90.81 121.06 32.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.496 HG21 HD11 ' A' ' 310' ' ' LEU . 56.3 t -104.5 132.49 51.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.112 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.49 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 22.3 tttm -132.86 164.05 27.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.898 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ASN . . . . . 0.49 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.8 m120 64.14 45.7 3.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.599 HD12 ' C ' ' A' ' 335' ' ' PHE . 32.7 mt -84.31 95.26 8.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -41.24 136.76 1.55 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -45.16 -40.54 7.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -58.97 -35.77 85.03 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.525 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.515 HD13 HD21 ' A' ' 363' ' ' LEU . 65.7 mt -68.36 126.98 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.785 0.326 . . . . 0.0 111.153 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -115.7 175.67 5.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -42.45 -63.82 0.7 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.802 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -47.48 -55.67 8.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.877 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? -45.05 -51.61 9.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.497 HD12 ' CE1' ' A' ' 314' ' ' PHE . 54.7 tp -53.91 -74.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.927 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.481 ' HG3' ' CD1' ' A' ' 320' ' ' ILE . 31.3 ttt180 -45.84 -27.95 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -68.66 -42.78 77.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -83.93 25.1 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.103 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.497 ' CE1' HD12 ' A' ' 310' ' ' LEU . 10.7 m-85 -133.72 -32.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.599 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -51.82 -45.27 92.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.662 0.744 . . . . 0.0 110.867 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.3 Cg_exo -47.95 -17.17 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.642 2.228 . . . . 0.0 112.367 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 46.9 m-85 -100.07 -45.83 5.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -167.8 167.01 39.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.466 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 35.9 m -68.72 141.16 55.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.785 0.326 . . . . 0.0 111.154 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.524 HG21 ' HB2' ' A' ' 323' ' ' ALA . 53.3 mt -113.95 144.09 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 61.6 p -114.12 -38.55 4.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.145 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -133.36 111.05 10.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.825 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' ALA . . . . . 0.524 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -135.45 122.98 22.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -147.28 152.99 39.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.442 HG22 HD22 ' A' ' 310' ' ' LEU . 81.9 t -119.41 135.85 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.148 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 38.0 mmt -68.4 114.37 6.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 48.1 mtp -123.87 151.89 42.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.413 ' CG ' ' HE3' ' A' ' 333' ' ' LYS . 73.1 mt-10 -107.24 43.41 1.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 67.67 85.51 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.496 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 105.36 -44.36 1.49 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.496 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -116.89 159.14 22.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 5.0 t -102.13 126.22 49.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.826 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.499 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 55.1 mttp -51.76 -51.25 57.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.936 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 133.02 35.24 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.445 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.599 ' C ' HD12 ' A' ' 301' ' ' LEU . 5.3 p90 -173.04 165.89 5.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.885 0.374 . . . . 0.0 110.906 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -166.71 -171.43 32.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.541 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -136.82 140.03 42.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.883 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.28 133.55 62.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.134 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 8.7 m -111.77 133.2 54.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -109.51 173.3 6.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 13.2 t -87.15 -40.68 14.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.833 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 49.7 m -123.66 130.19 24.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.648 0.737 . . . . 0.0 110.846 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -45.88 -58.57 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.678 2.252 . . . . 0.0 112.345 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -38.62 -52.66 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -54.12 -46.78 72.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.695 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -61.54 -42.38 98.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.115 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.4 m -49.95 -60.35 3.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.125 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 349' ' ' ALA . 46.3 tttt -48.13 -62.94 1.22 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.855 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.62 -48.96 0.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.633 HG22 HD22 ' A' ' 296' ' ' LEU . 57.6 t -42.49 -56.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.163 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 61.2 m -78.33 -54.65 5.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.147 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.481 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 2.2 mm-40 -44.22 -29.54 0.66 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' MET . . . . . 0.451 ' O ' ' N ' ' A' ' 356' ' ' ARG . 76.9 mmm -100.06 -51.55 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 2.9 t-20 -39.49 103.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 97.66 18.24 28.43 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.501 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 353' ' ' MET . 0.0 OUTLIER -99.04 118.11 35.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.324 . . . . 0.0 110.883 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 357' ' ' ILE . . . . . 0.503 HD13 ' N ' ' A' ' 362' ' ' PRO . 20.7 mm -85.89 133.75 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.178 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 84.4 t -118.05 -41.99 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -126.26 -65.18 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.065 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.7 p -134.52 -53.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.11 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -101.58 154.22 37.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.569 0.7 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.503 ' N ' HD13 ' A' ' 357' ' ' ILE . 63.1 Cg_endo -78.17 143.46 20.09 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.585 ' O ' HG23 ' A' ' 365' ' ' VAL . 61.8 mt -75.11 90.92 2.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -61.38 99.73 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 363' ' ' LEU . 40.8 t -106.8 141.58 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -161.37 157.8 25.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.059 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 30.8 mt -63.58 141.79 58.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.93 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . -129.13 74.7 1.6 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.089 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 369' ' ' GLN . . . . . 0.425 ' HG3' HG13 ' A' ' 293' ' ' VAL . 15.0 mm-40 -151.63 176.08 11.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -146.42 162.52 38.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -38.46 141.28 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -95.9 168.89 10.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -119.67 -58.75 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -169.32 142.11 2.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.831 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -117.28 135.41 53.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 13.6 t -133.34 143.07 48.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.862 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 167.27 84.08 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.449 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.08 98.55 1.23 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.72 2.28 . . . . 0.0 112.361 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 60.3 p -101.19 149.88 23.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 9.3 t -118.93 160.92 21.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.879 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.483 179.999 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.7 t -144.43 158.03 43.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.909 0.385 . . . . 0.0 110.879 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.9 t -106.48 168.78 8.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.882 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -147.81 58.48 0.48 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.446 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 27.0 t -69.32 130.79 43.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.822 0.344 . . . . 0.0 110.857 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 51.4 p -169.37 173.49 6.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -126.39 153.7 18.76 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.476 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -122.29 136.5 54.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.329 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 30.2 mmt-85 -119.59 92.4 3.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.542 HD11 ' HE ' ' A' ' 290' ' ' ARG . 13.4 tt -63.99 123.77 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.119 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.5 t -112.14 -34.47 5.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.166 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' ARG . . . . . 0.542 ' HE ' HD11 ' A' ' 288' ' ' ILE . 25.3 mmt180 61.06 48.51 6.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -161.71 160.89 29.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.921 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -101.75 114.84 29.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.922 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.401 HG11 ' HB3' ' A' ' 367' ' ' LEU . 95.9 t -134.96 91.79 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 343' ' ' PRO . 22.9 m -87.75 -35.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.148 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -62.42 129.96 43.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.69 HD22 HG22 ' A' ' 350' ' ' VAL . 60.1 mt -118.44 136.3 53.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -94.11 125.96 39.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 310' ' ' LEU . 57.7 t -110.29 143.55 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.154 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.519 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 14.1 ttmm -144.49 164.57 30.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ASN . . . . . 0.519 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.5 m120 64.14 44.72 4.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 302' ' ' ASP . 25.5 mt -84.67 99.87 11.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 301' ' ' LEU . 30.0 m-20 -37.52 155.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -31.91 73.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -67.87 -38.32 89.06 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.498 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.583 HG22 ' N ' ' A' ' 306' ' ' ASP . 62.8 mt -56.94 162.94 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.851 0.358 . . . . 0.0 111.104 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.583 ' N ' HG22 ' A' ' 305' ' ' ILE . 8.7 t0 -149.28 -176.75 5.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -59.68 -41.82 91.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -64.86 -57.46 8.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.88 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 29.5 mtt-85 -47.06 -45.17 21.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 298' ' ' VAL . 50.4 tp -57.36 -71.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -49.73 -32.19 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -72.14 -33.73 67.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -85.74 19.31 2.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.059 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.496 ' CB ' HD11 ' A' ' 320' ' ' ILE . 8.2 m-85 -129.73 -30.19 2.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.899 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.18 -45.24 94.1 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.645 0.735 . . . . 0.0 110.866 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.1 Cg_exo -47.94 -16.69 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.71 2.273 . . . . 0.0 112.329 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -99.6 -54.35 2.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.871 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -158.37 170.75 35.11 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.446 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 49.4 m -65.2 144.24 57.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 111.113 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.496 HD11 ' CB ' ' A' ' 314' ' ' PHE . 48.5 mt -124.41 140.91 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 82.6 p -114.16 -46.73 2.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -121.55 111.0 16.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' ALA . . . . . 0.412 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -138.92 121.33 16.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -155.4 156.27 35.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 48.0 t -110.56 143.33 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' MET . . . . . 0.551 ' HG3' ' CE2' ' A' ' 335' ' ' PHE . 38.7 mmt -72.4 135.87 45.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 27.3 mtp -138.6 171.69 13.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -114.66 -45.8 2.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.877 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 161.84 39.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.447 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 160.19 -37.34 0.45 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.469 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -124.31 166.45 15.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.342 . . . . 0.0 110.86 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.1 t -85.13 122.22 29.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.578 ' HD3' ' CZ ' ' A' ' 335' ' ' PHE . 28.9 mttm -50.89 -42.27 58.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 128.76 -31.23 3.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.537 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.578 ' CZ ' ' HD3' ' A' ' 333' ' ' LYS . 5.4 p90 -111.64 161.8 15.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.9 0.381 . . . . 0.0 110.881 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -155.37 -174.24 25.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.522 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -136.51 140.63 43.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.928 0.394 . . . . 0.0 110.841 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 51.5 t -136.93 131.52 46.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.164 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' CYS . . . . . 0.439 ' O ' HG23 ' A' ' 320' ' ' ILE . 4.7 m -111.33 141.33 45.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -115.75 171.85 7.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 62.7 p -71.73 -37.01 70.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.854 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 6.2 t -144.44 143.07 20.57 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.668 0.747 . . . . 0.0 110.828 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.496 ' N ' HG12 ' A' ' 294' ' ' VAL . 71.9 Cg_exo -46.49 -56.07 3.25 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.74 2.294 . . . . 0.0 112.317 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 344' ' ' GLU . 1.2 mp0 -37.21 -61.29 0.59 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -50.3 -43.38 53.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.736 ' O ' HG23 ' A' ' 350' ' ' VAL . . . -63.59 -41.01 98.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 86.2 m -49.29 -60.83 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -47.37 -60.46 2.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -42.51 -48.87 5.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 346' ' ' ALA . 47.1 t -41.49 -55.73 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.111 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 82.7 m -78.74 -55.75 4.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -44.18 -28.96 0.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.886 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 356' ' ' ARG . 79.3 mmm -100.2 -49.81 4.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 9.4 t30 -40.14 110.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 85.29 20.7 56.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.481 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 353' ' ' MET . 19.7 tpp180 -99.94 112.46 24.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.815 0.341 . . . . 0.0 110.885 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' ILE . . . . . 0.431 HD13 ' CA ' ' A' ' 362' ' ' PRO . 17.6 mm -77.67 150.49 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 95.3 t -132.52 -48.01 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.8 -68.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 19.0 p -130.79 -53.14 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.106 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -100.05 151.42 37.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.576 0.703 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.431 ' CA ' HD13 ' A' ' 357' ' ' ILE . 61.6 Cg_endo -76.58 155.95 35.9 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.706 2.271 . . . . 0.0 112.374 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 365' ' ' VAL . 32.9 mt -94.49 87.44 5.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.944 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -61.48 106.66 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.964 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 363' ' ' LEU . 47.8 t -113.91 134.63 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.104 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -155.27 145.32 21.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.137 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.401 ' HB3' HG11 ' A' ' 293' ' ' VAL . 77.9 mt -54.66 134.18 47.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -107.55 136.83 46.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -80.44 -48.93 12.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -49.24 132.27 19.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.906 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -132.76 107.13 8.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -61.83 133.72 55.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -146.88 118.6 8.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -101.16 127.95 47.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -157.04 142.32 17.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.4 m -136.68 167.1 22.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.828 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 165.17 81.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.504 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.0 125.91 8.31 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.67 2.246 . . . . 0.0 112.332 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 61.2 m -133.22 158.52 42.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.861 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 1.9 t -166.05 124.46 1.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.466 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 8.9 t -131.26 177.26 7.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 0.0 110.891 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 7.1 m -123.17 87.44 2.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 45.89 -124.23 7.07 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.539 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 24.1 p -167.02 166.28 15.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.874 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 33.0 p -99.78 144.82 28.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -136.18 177.88 19.21 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.466 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.12 135.93 45.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -102.55 98.65 8.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 13.9 pt -134.7 147.05 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.09 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 289' ' ' THR . 14.7 t -118.0 37.71 3.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -104.32 176.61 5.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.621 ' O ' HG23 ' A' ' 293' ' ' VAL . 30.3 m-85 56.11 50.86 12.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.932 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -46.29 125.08 6.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 291' ' ' TYR . 73.8 t -127.14 92.04 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.4 m -86.61 -37.11 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.623 ' O ' HD23 ' A' ' 296' ' ' LEU . 49.7 t30 -52.27 142.17 17.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.973 HD21 ' HB1' ' A' ' 346' ' ' ALA . 32.5 mt -135.48 132.64 37.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -102.08 113.02 25.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' VAL . . . . . 0.438 HG22 HG13 ' A' ' 365' ' ' VAL . 45.7 t -100.83 145.5 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.132 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 0.0 OUTLIER -132.4 165.84 23.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ASN . . . . . 0.537 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 4.0 m-20 63.48 46.57 4.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.92 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.448 HD12 ' C ' ' A' ' 335' ' ' PHE . 32.8 mt -82.43 91.97 6.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.842 ' OD2' ' HB3' ' A' ' 359' ' ' ALA . 86.5 m-20 -36.05 132.09 0.54 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.86 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.58 -41.68 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -60.13 -36.19 89.83 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.468 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' A' ' 309' ' ' ARG . 75.5 mt -64.92 118.49 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.143 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -103.55 -175.74 2.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.37 -45.96 76.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -62.76 -48.96 76.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' ARG . . . . . 0.415 ' HB3' HG23 ' A' ' 305' ' ' ILE . 4.3 mmm180 -46.68 -49.66 18.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.534 HD12 ' CE1' ' A' ' 314' ' ' PHE . 43.2 tp -56.65 -73.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.416 ' HG3' HD12 ' A' ' 320' ' ' ILE . 15.8 ttp180 -46.89 -26.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -70.01 -41.72 73.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -88.9 21.35 3.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.058 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.565 ' HB3' HD11 ' A' ' 320' ' ' ILE . 8.2 m-85 -129.41 -29.96 2.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -55.38 -44.95 99.9 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.662 0.744 . . . . 0.0 110.883 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.7 Cg_exo -47.97 -16.57 0.59 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.747 2.298 . . . . 0.0 112.288 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -99.64 -51.87 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -163.68 166.07 37.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 64.4 m -67.2 137.91 56.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.785 0.326 . . . . 0.0 111.144 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.734 HG21 ' HB2' ' A' ' 323' ' ' ALA . 93.3 mt -109.65 142.15 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.165 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 70.3 p -111.74 -35.8 5.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.172 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -133.58 104.51 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' ALA . . . . . 0.734 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -134.58 122.48 22.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.084 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' A' ' 325' ' ' VAL . 44.0 tttp -156.72 152.52 27.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.413 ' N ' ' HG2' ' A' ' 324' ' ' LYS . 59.4 t -107.44 140.33 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' MET . . . . . 0.545 ' HG3' ' CE2' ' A' ' 335' ' ' PHE . 34.4 mmt -85.73 100.61 12.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 77.9 mtp -97.99 176.5 5.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.48 ' HB3' ' CE ' ' A' ' 333' ' ' LYS . 0.4 OUTLIER -161.07 133.37 5.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 49.33 32.54 14.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.452 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 88.55 -30.24 5.39 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.506 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -94.54 136.51 34.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.787 0.327 . . . . 0.0 110.877 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 89.8 p -63.14 140.04 58.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.48 ' CE ' ' HB3' ' A' ' 328' ' ' GLU . 89.9 mttt -71.24 -58.13 3.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 139.95 35.76 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.516 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.545 ' CE2' ' HG3' ' A' ' 326' ' ' MET . 25.7 p90 -174.95 163.65 3.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 0.0 110.857 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -162.09 -179.77 36.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -123.88 139.24 54.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 110.897 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.418 HG11 ' CD2' ' A' ' 314' ' ' PHE . 29.9 t -134.59 127.72 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.169 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 339' ' ' CYS . . . . . 0.548 ' O ' HG23 ' A' ' 320' ' ' ILE . 68.8 m -111.93 134.38 53.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.902 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.534 ' HE1' HD12 ' A' ' 296' ' ' LEU . 43.4 m-85 -111.39 177.18 4.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 6.4 t -78.21 -35.52 48.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.9 t -141.61 141.71 23.56 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.62 0.724 . . . . 0.0 110.885 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.65 -53.65 5.85 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.692 2.261 . . . . 0.0 112.327 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -40.82 -63.74 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -46.09 -44.22 15.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.863 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.973 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -59.15 -59.58 5.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.076 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 28.7 m -41.58 -56.05 2.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.424 ' NZ ' ' HG3' ' A' ' 352' ' ' GLU . 2.3 tmtm? -45.84 -56.31 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -54.51 -51.12 66.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.068 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.419 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 91.9 t -39.38 -53.21 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.143 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 86.7 m -75.29 -59.28 2.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.424 ' HG3' ' NZ ' ' A' ' 348' ' ' LYS . 3.9 mm-40 -49.08 -18.84 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 90.0 mmm -107.28 -35.14 6.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.459 ' OD1' ' C ' ' A' ' 354' ' ' ASN . 5.4 t-20 -59.1 96.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 112.47 -15.86 24.53 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 17.6 tpp85 -73.27 110.19 7.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 20.5 mm -68.12 151.2 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.26 -39.46 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.115 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ALA . . . . . 0.842 ' HB3' ' OD2' ' A' ' 302' ' ' ASP . . . -133.22 -71.36 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.095 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 4.9 p -128.96 -55.05 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.95 153.45 37.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.558 0.694 . . . . 0.0 110.873 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.1 153.49 46.61 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.719 2.279 . . . . 0.0 112.332 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 30.5 mt -87.77 99.44 12.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -79.24 91.39 4.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.96 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.438 HG13 HG22 ' A' ' 298' ' ' VAL . 4.2 t -95.33 141.33 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.127 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -159.84 142.98 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.078 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 24.4 mt -52.99 153.43 3.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -112.75 132.02 55.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.094 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -100.3 86.75 3.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.92 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -115.4 -36.98 4.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -80.62 -42.84 21.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -38.49 -65.71 0.33 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.414 ' C ' ' OE1' ' A' ' 373' ' ' GLU . 0.6 OUTLIER -41.86 -40.47 2.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -80.82 155.37 26.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.856 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 41.58 41.13 1.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 1.5 t -59.14 -52.45 65.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -56.42 -90.24 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.479 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.65 114.3 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.652 2.235 . . . . 0.0 112.337 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 90.9 p -79.73 133.13 36.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 74.6 m -60.04 153.51 21.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.471 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.3 t -82.7 159.98 22.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 0.0 110.846 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 8.1 t -138.54 167.35 22.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 100.66 118.15 4.23 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.499 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 27.5 p -103.94 157.24 17.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.89 0.376 . . . . 0.0 110.843 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 10.2 m -91.66 -58.89 2.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 89.65 57.35 1.75 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.503 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.13 110.87 13.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.836 0.35 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ARG . . . . . 0.431 ' HD3' ' N ' ' A' ' 287' ' ' ARG . 1.9 mpp_? -122.78 96.0 4.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 25.2 mm -122.45 139.41 49.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 22.9 m -110.68 -60.33 1.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -173.22 151.84 2.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -174.85 140.55 0.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -104.17 110.31 22.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.929 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 293' ' ' VAL . 6.5 p -132.15 107.47 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.02 -21.51 5.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.095 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.1 152.05 38.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.69 HD21 ' HB1' ' A' ' 346' ' ' ALA . 14.7 mt -143.87 134.21 24.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -101.85 120.47 40.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.25 145.5 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.113 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.484 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 13.4 ttmm -136.58 162.68 32.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ASN . . . . . 0.484 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 6.8 m-20 62.59 51.11 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.543 HD12 ' C ' ' A' ' 335' ' ' PHE . 28.0 mt -88.86 104.52 17.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.452 ' H ' HD12 ' A' ' 305' ' ' ILE . 12.6 t70 -45.92 162.05 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.872 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -64.2 -38.87 92.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.26 -40.59 99.2 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.494 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' ILE . . . . . 0.452 HD12 ' H ' ' A' ' 302' ' ' ASP . 59.9 mt -57.41 132.64 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 111.176 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.23 -174.82 3.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -49.86 -46.38 51.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -60.69 -61.13 2.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -41.8 -46.05 3.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.895 HD21 HG22 ' A' ' 338' ' ' VAL . 20.4 tp -52.23 -75.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.948 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.721 ' HD2' ' HB3' ' A' ' 323' ' ' ALA . 19.4 mtp180 -53.22 -24.72 11.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -67.58 -39.96 84.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -97.79 19.74 13.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.063 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.554 ' CB ' HD11 ' A' ' 320' ' ' ILE . 7.1 m-85 -127.29 -29.72 2.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.584 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.8 OUTLIER -57.7 -45.61 99.81 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.704 0.764 . . . . 0.0 110.905 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.2 Cg_exo -47.98 -16.63 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.634 2.222 . . . . 0.0 112.377 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' PHE . . . . . 0.49 ' CE2' ' HG2' ' A' ' 353' ' ' MET . 50.0 m-85 -99.61 -46.92 5.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -165.05 166.31 38.14 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 33.9 m -67.33 133.6 49.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 111.141 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 339' ' ' CYS . 37.7 mt -110.37 139.58 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 41.6 p -109.85 -36.24 5.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 71.0 m -137.42 126.81 24.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' ALA . . . . . 0.721 ' HB3' ' HD2' ' A' ' 311' ' ' ARG . . . -156.46 119.25 4.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.068 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -150.24 132.25 15.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 49.9 t -82.22 125.2 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.153 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 20.8 mmm -68.86 86.4 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' MET . . . . . 0.471 ' CB ' ' HA ' ' A' ' 332' ' ' SER . 21.5 ptm -126.15 159.27 33.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.945 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -116.17 139.26 50.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 46.67 -105.22 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.502 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -127.51 50.71 0.88 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.512 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.68 124.5 3.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 110.904 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.471 ' HA ' ' CB ' ' A' ' 327' ' ' MET . 29.9 t -77.87 117.7 19.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -53.72 -52.04 61.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 137.63 34.16 0.2 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.543 ' C ' HD12 ' A' ' 301' ' ' LEU . 4.0 p90 -175.39 156.38 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -154.47 172.45 32.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.508 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -117.22 139.41 50.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.895 HG22 HD21 ' A' ' 310' ' ' LEU . 24.1 t -133.85 149.29 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.172 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 339' ' ' CYS . . . . . 0.584 ' O ' HG23 ' A' ' 320' ' ' ILE . 20.9 t -132.76 134.23 44.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.838 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.501 ' CE1' HD12 ' A' ' 296' ' ' LEU . 6.5 m-85 -113.24 172.46 6.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.882 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.4 p -78.98 -47.94 15.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 54.8 m -121.37 136.12 25.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.691 0.757 . . . . 0.0 110.83 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 346' ' ' ALA . 71.5 Cg_exo -45.87 -63.01 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.72 2.28 . . . . 0.0 112.357 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 344' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 343' ' ' PRO . 49.0 tt0 -36.2 -53.62 0.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -52.36 -44.4 65.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.69 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -64.29 -41.91 96.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.08 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 98.1 m -50.77 -64.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 349' ' ' ALA . 31.8 tttm -43.09 -62.91 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.902 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.27 -53.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.108 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.562 HG22 HD22 ' A' ' 296' ' ' LEU . 93.6 t -38.2 -60.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 62.5 m -75.14 -55.27 5.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.444 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 23.5 mm-40 -44.8 -26.26 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 353' ' ' MET . . . . . 0.49 ' HG2' ' CE2' ' A' ' 317' ' ' PHE . 83.3 mmm -102.19 -62.03 1.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 354' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -40.66 107.22 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 116.15 -5.88 19.65 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -95.74 125.78 40.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 0.0 110.871 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' ILE . . . . . 0.405 HD13 ' CA ' ' A' ' 362' ' ' PRO . 7.8 mm -85.7 150.31 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.131 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 95.6 t -132.23 -41.06 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -126.64 -71.91 0.67 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.093 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 16.5 p -131.63 -50.16 0.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.18 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.86 152.14 39.51 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.555 0.693 . . . . 0.0 110.909 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.405 ' CA ' HD13 ' A' ' 357' ' ' ILE . 60.5 Cg_endo -74.48 146.77 35.43 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.699 2.266 . . . . 0.0 112.324 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.497 ' O ' HG23 ' A' ' 365' ' ' VAL . 37.3 mt -77.22 88.95 3.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -66.34 94.56 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 363' ' ' LEU . 17.2 t -97.12 150.95 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -164.3 166.24 21.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 58.7 mt -71.32 143.61 50.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -110.97 -68.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 369' ' ' GLN . . . . . 0.532 ' O ' HG23 ' A' ' 293' ' ' VAL . 20.7 tt0 -80.1 112.3 17.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 15.7 ttt85 -65.91 -46.19 79.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -174.07 140.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -80.27 159.62 25.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -146.39 134.9 22.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -65.13 102.6 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -121.0 142.59 49.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 58.6 p -168.14 124.96 1.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -166.35 146.04 10.57 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.468 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.37 -34.68 1.43 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.737 2.291 . . . . 0.0 112.329 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 4.2 m -88.17 126.15 34.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.848 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 12.3 m -85.46 -49.15 8.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.859 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.467 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 6.1 t -158.92 134.05 8.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.94 0.4 . . . . 0.0 110.818 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 23.4 t -149.85 122.92 8.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.819 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -107.04 76.35 0.23 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.511 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 4.8 m -73.09 104.11 4.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 110.87 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 2.9 m -54.6 -56.0 23.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 79.82 153.94 8.76 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.482 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -136.72 107.85 6.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.792 0.33 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -84.57 97.05 9.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.419 ' H ' HG22 ' A' ' 288' ' ' ILE . 3.2 tt -74.72 80.9 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.157 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 289' ' ' THR . 15.3 m -92.45 44.49 1.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.166 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 34.1 mtt180 -58.27 -56.11 26.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.3 143.85 26.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -78.55 114.2 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.539 HG11 HD13 ' A' ' 367' ' ' LEU . 6.1 p -133.14 114.89 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 25.2 m -115.79 -23.98 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -67.13 104.13 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.697 HD22 HG22 ' A' ' 350' ' ' VAL . 45.6 mt -94.85 133.79 38.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.617 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 25.7 t80 -96.45 114.06 25.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.6 t -98.62 139.44 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.114 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.51 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 24.5 tttt -137.33 163.94 29.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ASN . . . . . 0.51 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 6.4 m-20 63.19 49.38 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 25.0 mt -87.8 114.88 24.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.36 140.47 27.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -50.5 -42.31 54.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.812 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.26 -30.08 66.96 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.463 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 95.8 mt -72.62 130.78 35.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.34 . . . . 0.0 111.126 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -114.33 -179.11 3.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.96 -45.71 67.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.4 -54.12 47.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -47.03 -47.59 22.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.737 HD11 HG21 ' A' ' 338' ' ' VAL . 16.6 tp -53.96 -75.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ARG . . . . . 0.438 ' HG3' HD12 ' A' ' 320' ' ' ILE . 33.5 ttt180 -49.2 -25.4 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -78.81 -32.82 46.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.9 15.72 10.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.083 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.6 ' CZ ' ' SD ' ' A' ' 353' ' ' MET . 10.7 m-85 -128.79 -28.49 2.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -50.25 -46.07 83.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.679 0.752 . . . . 0.0 110.859 -179.823 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 315' ' ' SER . 63.8 Cg_exo -47.92 -16.89 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.688 2.259 . . . . 0.0 112.367 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -99.66 -41.49 7.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.52 169.0 36.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.492 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 97.0 m -83.21 96.48 8.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.81 0.338 . . . . 0.0 111.17 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.458 HD11 ' CB ' ' A' ' 314' ' ' PHE . 93.5 mt -65.55 145.9 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 73.5 p -117.34 -28.52 6.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.125 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 3.0 p -152.83 109.38 3.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -131.72 142.56 49.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.093 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -154.08 170.24 21.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.13 121.55 54.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.145 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' MET . . . . . 0.544 ' HB2' ' CE2' ' A' ' 335' ' ' PHE . 10.2 mmm -75.46 117.01 16.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 327' ' ' MET . . . . . 0.462 ' CA ' ' HD2' ' A' ' 333' ' ' LYS . 37.9 mtp -127.8 169.19 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.419 ' CG ' ' HE2' ' A' ' 333' ' ' LYS . 15.0 mt-10 -93.14 -66.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.925 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -159.88 -52.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.469 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -132.39 30.19 3.19 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.483 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -168.34 115.0 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.819 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 333' ' ' LYS . 20.2 t -54.95 104.87 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.473 ' HD3' ' CE1' ' A' ' 335' ' ' PHE . 18.3 mttm -34.57 -55.22 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 128.62 29.95 0.73 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.471 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.544 ' CE2' ' HB2' ' A' ' 326' ' ' MET . 43.7 p90 -164.74 157.15 16.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 0.0 110.907 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -159.63 -167.05 19.73 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.458 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -135.13 122.19 21.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.928 0.394 . . . . 0.0 110.872 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.737 HG21 HD11 ' A' ' 310' ' ' LEU . 46.5 t -116.18 98.1 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.122 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' CYS . . . . . 0.422 ' O ' HG23 ' A' ' 320' ' ' ILE . 1.7 m -86.9 135.84 33.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 340' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . 23.1 m-85 -107.88 178.0 4.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 7.2 t -82.69 -36.48 25.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.813 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.9 m -133.57 133.92 23.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.681 0.753 . . . . 0.0 110.85 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.26 -59.58 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.725 2.283 . . . . 0.0 112.337 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -38.75 -57.32 1.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -54.29 -45.93 72.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.623 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -59.33 -46.89 87.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.066 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 348' ' ' LYS . 14.5 m -45.65 -63.86 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.152 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 347' ' ' THR . 3.9 ttpm? -37.51 -65.93 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -41.13 -53.7 3.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.697 HG22 HD22 ' A' ' 296' ' ' LEU . 46.2 t -39.75 -52.24 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.129 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 82.7 m -78.85 -56.91 4.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -46.69 -24.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' MET . . . . . 0.6 ' SD ' ' CZ ' ' A' ' 314' ' ' PHE . 15.7 mtp -104.05 -43.99 5.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 6.8 t-20 -47.91 115.51 1.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 80.76 17.42 72.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.481 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -98.26 121.39 40.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.765 0.317 . . . . 0.0 110.853 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 9.2 mm -87.77 125.7 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.117 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.26 -59.53 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.164 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -109.01 -67.85 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.104 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 361' ' ' LYS . 2.3 t -134.87 -49.06 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.438 ' N ' HG23 ' A' ' 360' ' ' THR . 13.1 mtpp -99.79 151.24 37.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.568 0.699 . . . . 0.0 110.88 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.37 151.59 29.66 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.704 2.269 . . . . 0.0 112.355 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 32.9 mt -89.65 92.97 9.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -70.77 94.74 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.9 t -106.8 141.73 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.086 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -164.69 145.67 7.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.549 HD23 ' CD2' ' A' ' 296' ' ' LEU . 81.3 mt -56.68 137.83 53.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . -110.9 178.37 4.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -136.61 105.47 5.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' ARG . . . . . 0.436 ' HD3' ' N ' ' A' ' 371' ' ' LYS . 0.0 OUTLIER -172.0 132.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 371' ' ' LYS . . . . . 0.436 ' N ' ' HD3' ' A' ' 370' ' ' ARG . 0.3 OUTLIER -106.7 135.7 47.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.42 155.66 24.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -153.59 124.49 7.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -109.44 173.37 6.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -133.36 123.62 25.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.956 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 52.4 p -85.57 137.06 33.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 174.3 81.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.96 111.36 3.22 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.681 2.254 . . . . 0.0 112.362 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 34.5 t -77.55 104.95 8.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 3.3 m -166.87 137.23 3.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.464 -179.99 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 87.8 p -164.27 162.4 22.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.888 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.2 t -86.84 -46.76 9.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 88.07 -164.17 33.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.5 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 3.1 m -114.57 170.43 8.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.922 0.391 . . . . 0.0 110.857 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 8.6 t -105.35 -54.4 2.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.855 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.91 -171.41 16.92 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -147.7 126.53 12.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 0.0 110.884 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -102.58 130.08 49.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.737 ' H ' HD13 ' A' ' 288' ' ' ILE . 0.1 OUTLIER -138.86 142.82 33.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.107 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 10.0 t -115.93 153.17 32.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.168 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -104.96 -59.4 1.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -63.65 147.26 52.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.915 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -62.24 108.94 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 97.8 t -129.06 95.47 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.174 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 343' ' ' PRO . 25.9 m -86.04 -36.9 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -54.72 136.59 45.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.89 HD21 ' HB1' ' A' ' 346' ' ' ALA . 40.6 mt -127.87 144.34 51.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -106.36 110.41 22.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.936 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.1 t -94.4 129.81 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.149 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.484 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 37.0 tttt -130.49 163.25 27.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' ASN . . . . . 0.484 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.5 m120 63.83 49.45 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.901 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.528 HD12 ' CA ' ' A' ' 335' ' ' PHE . 19.8 mt -87.12 105.98 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.429 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 21.2 t70 -46.12 158.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.877 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -62.15 -37.52 85.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -67.02 -38.75 92.88 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.459 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 83.1 mt -61.65 112.69 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 111.138 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.19 -176.8 3.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.822 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.24 -62.6 1.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.4 ' O ' ' HD3' ' A' ' 312' ' ' LYS . 7.4 pt-20 -52.46 -47.53 66.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -47.28 -34.13 6.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.463 HD12 ' CE1' ' A' ' 314' ' ' PHE . 54.0 tp -77.68 -56.22 4.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -58.33 -24.65 60.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 308' ' ' GLU . 9.2 mptt -84.78 -22.82 29.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -95.18 16.21 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.125 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.463 ' CE1' HD12 ' A' ' 310' ' ' LEU . 7.9 m-85 -129.16 -29.12 2.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.593 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.8 OUTLIER -50.36 -45.54 83.75 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.65 0.738 . . . . 0.0 110.873 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.1 Cg_exo -48.04 -15.51 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.661 2.24 . . . . 0.0 112.342 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 352' ' ' GLU . 55.0 m-85 -99.13 -53.84 3.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.69 -179.1 37.06 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.437 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 28.9 m -74.52 143.39 44.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 111.129 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 339' ' ' CYS . 55.3 mt -115.45 152.53 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.149 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.411 ' N ' HG22 ' A' ' 320' ' ' ILE . 40.9 p -121.11 -41.2 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.5 t -137.38 119.42 15.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -146.35 126.62 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.081 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.474 ' HG2' ' N ' ' A' ' 325' ' ' VAL . 15.7 ttmm -159.99 151.1 19.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.474 ' N ' ' HG2' ' A' ' 324' ' ' LYS . 99.2 t -110.12 132.99 56.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 38.1 mmt -65.41 125.19 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 21.2 mtp -122.62 162.43 21.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -119.77 38.9 3.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 70.35 87.49 0.11 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.515 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 99.61 -43.27 1.84 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.511 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -112.82 162.27 15.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.857 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.2 t -104.74 127.4 52.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' LYS . . . . . 0.522 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 12.1 mmmt -53.55 -60.95 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.869 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 136.25 34.69 0.22 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.469 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.528 ' CA ' HD12 ' A' ' 301' ' ' LEU . 12.9 p90 -173.39 159.37 3.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -158.91 -171.95 25.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.498 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -135.14 141.1 45.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.36 . . . . 0.0 110.837 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 36.5 t -136.56 140.94 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.112 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' CYS . . . . . 0.42 ' O ' HG23 ' A' ' 320' ' ' ILE . 65.4 m -117.56 156.57 27.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -130.27 173.89 10.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 51.6 p -80.29 -40.99 25.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.414 ' C ' HG12 ' A' ' 294' ' ' VAL . 22.9 m -130.62 139.23 34.97 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.649 0.738 . . . . 0.0 110.882 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.494 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.3 Cg_exo -47.44 -54.88 4.49 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.688 2.259 . . . . 0.0 112.316 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -41.28 -55.61 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -51.71 -43.75 62.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.862 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.89 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -64.15 -41.5 97.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.09 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 94.6 m -49.71 -63.6 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -47.07 -61.92 1.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -37.71 -50.25 1.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 346' ' ' ALA . 57.8 t -41.69 -55.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 90.2 m -78.7 -55.84 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 317' ' ' PHE . 18.8 mm-40 -44.08 -27.79 0.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 353' ' ' MET . . . . . 0.412 ' CB ' HG21 ' A' ' 365' ' ' VAL . 86.4 mmm -101.83 -42.59 6.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 12.9 t-20 -58.14 96.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 121.92 -13.97 9.1 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.469 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -77.12 112.93 14.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.898 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' ILE . . . . . 0.543 HD13 ' CA ' ' A' ' 362' ' ' PRO . 13.3 mm -78.25 138.29 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.096 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.99 -65.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.112 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -100.79 -75.24 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' A' ' 361' ' ' LYS . 1.0 OUTLIER -123.5 -47.34 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.555 ' N ' ' CG2' ' A' ' 360' ' ' THR . 12.1 pttm -109.39 159.0 33.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.553 0.692 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.543 ' CA ' HD13 ' A' ' 357' ' ' ILE . 60.2 Cg_endo -80.24 154.04 21.7 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.671 2.247 . . . . 0.0 112.369 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 365' ' ' VAL . 31.4 mt -78.13 98.31 5.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -67.8 81.61 0.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 32.2 t -91.14 141.11 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.134 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -160.39 143.33 13.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.096 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.657 ' CD2' HG21 ' A' ' 350' ' ' VAL . 18.8 mt -59.87 141.48 55.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.906 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -105.93 86.51 2.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 370' ' ' ARG . 7.5 pt20 -64.82 -46.0 83.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.903 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 370' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 369' ' ' GLN . 6.8 tpt180 -34.61 102.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.73 132.94 47.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -119.71 138.88 53.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -155.49 139.5 16.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.838 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -146.97 151.93 37.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -145.9 171.02 15.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 48.2 m -122.49 -60.55 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 69.63 95.57 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.532 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.05 125.51 9.34 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.693 2.262 . . . . 0.0 112.347 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 38.3 t -167.0 117.37 0.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 34.8 t -167.63 131.48 1.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.904 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.503 -179.975 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 22.2 m -150.39 144.91 25.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 0.0 110.862 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 82.9 p -152.58 142.43 22.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.866 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 149.2 -140.78 8.39 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 4.4 t -170.86 154.07 4.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.907 0.384 . . . . 0.0 110.795 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 19.2 m -128.73 131.89 47.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.876 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 286' ' ' ASP . . . -165.93 83.1 0.1 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.516 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 285' ' ' GLY . 1.1 p-10 -35.3 150.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 0.0 110.829 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' ARG . . . . . 0.428 ' HB2' ' NH1' ' A' ' 287' ' ' ARG . 11.0 ttm105 -132.31 160.61 35.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.902 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' ILE . . . . . 0.564 ' H ' HD13 ' A' ' 288' ' ' ILE . 0.3 OUTLIER -131.09 158.0 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 10.1 t -105.08 142.28 35.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' ARG . . . . . 0.432 ' O ' ' C ' ' A' ' 291' ' ' TYR . 35.6 mmt180 -153.71 178.15 10.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 290' ' ' ARG . 4.7 t80 35.43 35.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.97 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 290' ' ' ARG . 31.6 mt-30 36.31 46.17 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.904 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 70.9 t -66.61 93.06 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.144 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' VAL . . . . . 0.631 HG12 ' N ' ' A' ' 343' ' ' PRO . 25.8 m -104.02 -35.16 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.54 143.31 57.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.562 HD22 HG22 ' A' ' 350' ' ' VAL . 58.2 mt -131.29 144.99 51.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -99.62 123.47 43.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 17.6 t -107.22 134.75 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.163 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.545 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 21.9 ttmt -134.3 165.99 23.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 300' ' ' ASN . . . . . 0.545 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.9 m-20 61.16 51.36 4.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 30.9 mt -91.85 107.54 19.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.39 141.36 24.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -48.4 -34.51 10.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.86 -37.06 94.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.538 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 49.5 mt -70.33 136.91 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 111.164 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -126.49 -178.75 4.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 307' ' ' ASP . 21.5 t0 -51.27 -47.29 62.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -58.44 -66.32 0.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -43.58 -42.1 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 63.2 tp -60.59 -69.35 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -52.32 -27.82 16.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -72.7 -27.52 62.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -95.28 19.23 11.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' PHE . . . . . 0.673 ' CB ' HD11 ' A' ' 320' ' ' ILE . 8.6 m-85 -129.69 -31.31 2.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.854 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' SER . . . . . 0.587 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.2 m -50.89 -45.78 87.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.711 0.767 . . . . 0.0 110.874 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.8 Cg_exo -47.99 -17.25 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.683 2.255 . . . . 0.0 112.314 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' PHE . . . . . 0.574 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 55.5 m-85 -100.05 -49.64 4.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -163.04 160.63 33.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.5 m -60.63 138.28 58.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.311 . . . . 0.0 111.18 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' ILE . . . . . 0.673 HD11 ' CB ' ' A' ' 314' ' ' PHE . 80.3 mt -114.89 130.73 68.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.9 p -103.62 -28.36 11.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 4.7 t -143.19 125.07 15.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -154.64 122.52 5.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -151.93 158.21 42.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.0 134.42 53.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' MET . . . . . 0.548 ' HG3' ' CE2' ' A' ' 335' ' ' PHE . 35.5 mmt -61.16 145.02 52.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 13.1 mtp -146.23 171.13 15.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.854 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -124.33 -51.47 1.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -159.61 -51.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.55 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -149.08 38.6 0.96 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.512 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -168.36 144.29 3.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.863 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.5 t -69.3 116.58 9.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -46.93 -46.81 21.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.68 -28.46 3.39 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.507 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.548 ' CE2' ' HG3' ' A' ' 326' ' ' MET . 3.2 p90 -118.53 160.79 21.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.928 0.394 . . . . 0.0 110.875 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -153.44 -172.45 21.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.531 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -138.44 138.29 38.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.863 0.363 . . . . 0.0 110.884 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 30.9 t -130.27 143.79 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.121 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' CYS . . . . . 0.574 ' O ' HG23 ' A' ' 320' ' ' ILE . 84.3 m -121.6 143.09 49.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -118.19 175.59 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 23.2 t -83.85 -40.79 18.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 70.7 m -130.37 139.33 35.3 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.898 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' PRO . . . . . 0.631 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.2 Cg_exo -47.43 -56.15 3.32 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.694 2.262 . . . . 0.0 112.332 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -41.49 -54.68 3.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -50.55 -45.35 56.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 350' ' ' VAL . . . -61.93 -40.56 95.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.086 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 61.0 m -51.25 -65.7 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.166 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 349' ' ' ALA . 28.6 tttt -44.38 -64.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 349' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.06 -48.83 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.114 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 350' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 346' ' ' ALA . 49.1 t -42.79 -56.3 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 52.8 m -79.69 -50.71 10.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' GLU . . . . . 0.574 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 24.3 mm-40 -47.66 -29.39 2.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 353' ' ' MET . . . . . 0.601 ' HB3' HG21 ' A' ' 365' ' ' VAL . 75.9 mmm -101.66 -51.75 3.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 354' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 7.0 t-20 -35.77 112.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.833 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 87.98 18.87 55.23 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.499 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 353' ' ' MET . 16.5 tpp180 -96.94 126.95 42.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.867 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 357' ' ' ILE . . . . . 0.405 HD13 ' CA ' ' A' ' 362' ' ' PRO . 11.3 mm -93.27 142.62 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 64.6 t -131.84 -38.81 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.65 -72.68 0.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 2.5 p -131.71 -52.22 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.167 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -101.85 153.91 37.66 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.564 0.697 . . . . 0.0 110.931 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.405 ' CA ' HD13 ' A' ' 357' ' ' ILE . 61.1 Cg_endo -75.84 146.38 29.71 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.671 2.248 . . . . 0.0 112.333 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' LEU . . . . . 0.509 ' O ' HG23 ' A' ' 365' ' ' VAL . 43.1 mt -81.68 96.3 7.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -64.52 97.38 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' VAL . . . . . 0.601 HG21 ' HB3' ' A' ' 353' ' ' MET . 37.0 t -103.19 125.35 57.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.153 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -150.6 150.81 31.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.529 HD21 HG21 ' A' ' 350' ' ' VAL . 49.5 mt -60.67 139.37 57.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 368' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 369' ' ' GLN . . . -84.4 -44.09 14.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.051 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 368' ' ' ALA . 59.6 mt-30 32.43 47.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.94 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -114.57 -43.15 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -157.35 160.13 38.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.97 159.08 16.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.56 169.09 8.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -127.51 -59.11 1.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.826 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -42.22 130.07 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.0 t -113.67 -59.81 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -141.9 -167.17 11.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.08 162.31 31.87 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.652 2.235 . . . . 0.0 112.376 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 32.3 t -108.21 -43.95 4.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.858 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 37.8 t -98.04 139.44 33.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.84 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.506 179.953 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 83.9 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.886 0.374 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 343' ' ' PRO . 15.4 m -108.72 -26.25 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.135 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -65.59 128.57 36.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.623 ' CD2' HD23 ' A' ' 367' ' ' LEU . 38.5 mt -118.93 145.97 45.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -106.12 115.6 30.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.408 HG21 HD11 ' A' ' 310' ' ' LEU . 58.8 t -103.04 133.13 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.554 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 22.1 tttm -130.81 166.39 20.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . 0.554 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 6.7 m-20 63.58 54.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 40.9 mt -91.45 105.44 17.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.949 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -51.4 145.05 9.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.859 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -52.08 -34.01 41.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -67.55 -35.16 85.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.443 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.79 123.92 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.836 0.35 . . . . 0.0 111.121 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -116.0 171.32 7.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.827 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -38.02 -68.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -40.88 -56.5 2.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -45.91 -58.51 3.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.408 HD11 HG21 ' A' ' 298' ' ' VAL . 64.1 tp -52.7 -62.74 1.45 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.405 ' HG3' ' HB3' ' A' ' 323' ' ' ALA . 2.1 tmm_? -55.86 -24.56 37.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -81.67 -22.2 37.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -96.21 15.12 21.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.1 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.613 ' CD2' HG11 ' A' ' 338' ' ' VAL . 6.2 m-85 -123.73 -32.38 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.7 OUTLIER -50.36 -45.87 83.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.627 0.727 . . . . 0.0 110.887 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.4 Cg_exo -47.97 -17.34 0.78 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.724 2.282 . . . . 0.0 112.342 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -100.07 -52.32 3.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.07 168.26 37.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.486 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 61.6 m -61.88 147.9 45.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 0.0 111.105 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 339' ' ' CYS . 30.9 mt -125.1 134.05 67.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 71.8 p -110.72 -33.2 6.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -134.37 109.74 8.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -145.03 122.49 11.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.075 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -160.46 153.33 21.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 93.7 t -111.65 136.86 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 33.4 mmt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 179.875 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 333' ' ' LYS . 68.0 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.92 0.39 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . 0.496 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 11.8 mmtp -35.7 -58.75 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.8 27.79 0.58 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.508 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.496 ' CE1' ' HB3' ' A' ' 333' ' ' LYS . 42.0 p90 -171.32 147.54 2.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.915 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -146.33 -170.37 14.86 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.458 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -134.22 142.09 47.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.899 0.38 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.613 HG11 ' CD2' ' A' ' 314' ' ' PHE . 33.6 t -135.83 132.54 50.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . 0.561 ' O ' HG23 ' A' ' 320' ' ' ILE . 65.5 m -117.61 145.48 44.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.892 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.592 ' HE1' HD12 ' A' ' 296' ' ' LEU . 46.7 m-85 -116.79 174.21 6.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 4.2 t -75.58 -42.41 52.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.829 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 49.2 m -132.3 143.32 48.37 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.635 0.731 . . . . 0.0 110.917 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.429 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.0 Cg_exo -47.16 -58.24 1.85 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.737 2.291 . . . . 0.0 112.344 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -40.6 -56.17 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -53.81 -42.51 68.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.913 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.82 -43.95 91.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.078 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 47.0 m -48.59 -65.21 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.147 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.443 ' O ' ' C ' ' A' ' 349' ' ' ALA . 42.7 tttt -38.6 -64.97 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.888 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -34.52 -55.25 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.47 HG22 HD22 ' A' ' 296' ' ' LEU . 58.7 t -38.02 -52.84 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 56.0 m -80.6 -53.72 6.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.144 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -49.94 -19.19 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . 0.446 ' HB3' HG21 ' A' ' 365' ' ' VAL . 71.8 mmm -107.08 -59.85 1.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 353' ' ' MET . 9.1 t30 -36.3 111.01 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.895 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 99.01 9.62 51.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -95.86 118.84 33.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 110.89 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . 0.474 HD13 ' N ' ' A' ' 362' ' ' PRO . 11.0 mm -89.27 138.35 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 71.8 t -127.34 -43.64 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -116.43 -73.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.579 HG23 ' CD ' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -132.98 -47.62 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.579 ' CD ' HG23 ' A' ' 360' ' ' THR . 0.0 OUTLIER -108.14 156.9 37.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.63 0.728 . . . . 0.0 110.875 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.474 ' N ' HD13 ' A' ' 357' ' ' ILE . 62.6 Cg_endo -77.82 139.34 17.55 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.723 2.282 . . . . 0.0 112.341 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 365' ' ' VAL . 65.1 mt -69.47 101.08 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.933 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -68.43 96.82 0.71 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' A' ' 353' ' ' MET . 21.8 t -103.57 131.62 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.105 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -157.44 145.33 18.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.084 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.623 HD23 ' CD2' ' A' ' 296' ' ' LEU . 32.2 mt -63.0 138.87 58.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.059 179.837 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.849 0.357 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 343' ' ' PRO . 15.1 m -93.07 -34.99 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -59.01 140.76 55.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.76 HD21 ' HB1' ' A' ' 346' ' ' ALA . 35.6 mt -130.4 135.58 48.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -96.13 106.14 18.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 49.0 t -89.77 131.13 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.118 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 300' ' ' ASN . 20.5 tttt -135.22 161.82 34.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . 0.462 ' N ' ' HG2' ' A' ' 299' ' ' LYS . 11.1 t-20 74.5 37.87 0.53 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.415 HD12 ' CA ' ' A' ' 335' ' ' PHE . 46.8 mt -79.98 91.32 5.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.485 ' H ' HD12 ' A' ' 305' ' ' ILE . 3.5 t70 -46.26 148.62 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.42 -36.49 9.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.96 -40.62 98.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.485 HD12 ' H ' ' A' ' 302' ' ' ASP . 41.6 mt -65.99 140.81 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.855 0.359 . . . . 0.0 111.113 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -134.15 177.71 7.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -52.45 -41.66 63.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -65.96 -61.8 1.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 64.8 mtt-85 -49.3 -34.14 14.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.508 HD12 ' CE1' ' A' ' 314' ' ' PHE . 61.5 tp -67.61 -71.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 45.3 ttt-85 -50.44 -25.45 3.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -73.89 -30.26 62.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -94.16 20.28 8.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.128 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.898 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.0 m-85 -126.17 -30.77 2.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.1 t -56.12 -45.32 99.92 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.688 0.756 . . . . 0.0 110.878 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 315' ' ' SER . 66.1 Cg_exo -48.02 -17.04 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.718 2.279 . . . . 0.0 112.324 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 60.0 m-85 -99.93 -52.39 3.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.62 165.91 35.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.418 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.5 m -62.85 138.23 58.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.761 0.315 . . . . 0.0 111.145 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.898 HD11 ' HB3' ' A' ' 314' ' ' PHE . 82.0 mt -118.32 132.1 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 67.2 p -105.77 -40.48 5.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -126.51 111.14 14.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.81 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . 0.582 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -142.6 119.83 11.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.1 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.455 ' HD2' ' N ' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -153.56 162.36 41.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 78.4 t -121.72 142.98 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.136 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 34.1 mmt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.942 0.401 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.2 -47.65 65.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 123.62 29.93 1.12 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.415 ' CA ' HD12 ' A' ' 301' ' ' LEU . 12.7 p90 -171.32 158.07 5.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.372 . . . . 0.0 110.868 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -161.45 -166.88 21.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.501 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -139.04 143.89 38.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 22.7 t -138.96 140.04 39.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 23.7 m -117.54 149.33 40.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -122.84 176.92 5.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.835 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 32.6 t -78.45 -39.2 39.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.885 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 27.2 m -136.87 143.19 41.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.683 0.754 . . . . 0.0 110.843 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.432 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.2 Cg_exo -47.35 -59.15 1.35 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 2.243 . . . . 0.0 112.347 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 343' ' ' PRO . 30.9 tt0 -37.63 -59.76 0.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -49.33 -41.39 38.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.76 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -65.08 -42.72 93.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.109 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.4 m -50.72 -67.81 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.167 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -40.55 -56.53 2.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 350' ' ' VAL . . . -44.4 -55.51 4.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.097 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.548 HG22 HD22 ' A' ' 296' ' ' LEU . 84.3 t -36.6 -58.48 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.136 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 353' ' ' MET . 35.2 m -75.94 -60.35 2.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.525 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 3.7 mm-40 -39.99 -27.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . 0.505 ' CB ' HG21 ' A' ' 365' ' ' VAL . 77.6 mmm -101.29 -42.33 6.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 26.1 t30 -60.15 106.28 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.859 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 113.92 -3.66 24.23 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.469 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -98.88 144.24 28.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.894 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . 0.402 HD13 ' CA ' ' A' ' 362' ' ' PRO . 8.3 mm -95.23 152.01 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.129 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.4 ' N ' HG22 ' A' ' 357' ' ' ILE . 45.1 t -131.95 -40.9 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.081 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -130.21 -66.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.0 -54.52 0.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.15 154.92 36.89 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.564 0.697 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.402 ' CA ' HD13 ' A' ' 357' ' ' ILE . 61.4 Cg_endo -76.43 134.07 15.13 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 35.7 mt -66.16 123.92 21.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -95.96 89.44 5.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.505 HG21 ' CB ' ' A' ' 353' ' ' MET . 2.9 t -90.78 134.53 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.061 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -153.87 142.87 21.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.068 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 27.9 mt -60.79 144.88 51.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 179.742 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 367' ' ' LEU . 84.0 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.882 0.372 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.8 m -93.25 -30.65 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -67.99 133.11 48.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.624 HD22 ' CG2' ' A' ' 350' ' ' VAL . 65.6 mt -121.94 135.84 54.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.668 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 39.5 t80 -94.27 119.93 33.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.938 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.411 HG21 HD11 ' A' ' 310' ' ' LEU . 59.3 t -104.14 137.71 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.163 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 10.8 tttp -137.22 161.78 35.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.938 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . 0.471 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.1 m120 63.79 53.84 1.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.487 HD13 HG22 ' A' ' 325' ' ' VAL . 32.0 mt -86.67 94.47 9.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -44.41 149.15 0.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.81 -36.3 62.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.91 -38.36 95.97 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.468 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 81.6 mt -73.58 121.9 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.351 . . . . 0.0 111.103 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.43 177.91 4.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -39.28 -46.25 1.52 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 309' ' ' ARG . 0.2 OUTLIER -65.35 -69.57 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 308' ' ' GLU . 10.4 mmt180 -35.19 -36.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.492 HD12 ' CE1' ' A' ' 314' ' ' PHE . 47.8 tp -68.05 -75.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.447 ' HG3' ' HB3' ' A' ' 323' ' ' ALA . 2.6 tmm_? -48.85 -25.06 1.69 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -79.33 -32.64 43.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.99 21.03 2.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.094 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.624 ' CB ' HD11 ' A' ' 320' ' ' ILE . 8.8 m-85 -130.22 -30.41 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.597 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.1 t -53.1 -44.92 98.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.7 0.762 . . . . 0.0 110.872 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.4 Cg_exo -47.95 -17.59 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.685 2.257 . . . . 0.0 112.351 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -100.22 -54.9 2.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -159.28 163.67 33.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.462 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 44.5 m -61.31 143.27 55.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.727 0.298 . . . . 0.0 111.139 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.624 HD11 ' CB ' ' A' ' 314' ' ' PHE . 59.6 mt -117.69 149.37 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 61.9 p -117.27 -43.83 2.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.157 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 70.8 m -132.69 112.53 12.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . 0.447 ' HB3' ' HG3' ' A' ' 311' ' ' ARG . . . -141.01 119.55 12.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.174 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -153.45 147.78 25.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.487 HG22 HD13 ' A' ' 301' ' ' LEU . 49.0 t -89.87 118.58 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.121 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 335' ' ' PHE . 26.3 mmm . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.852 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 47.1 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.971 0.415 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -38.62 -45.8 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 121.01 43.05 0.46 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.493 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 326' ' ' MET . 2.0 p90 -175.53 160.57 2.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 110.881 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -156.97 177.0 34.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -127.74 132.74 49.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.871 0.367 . . . . 0.0 110.837 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 37.2 t -133.24 135.3 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 9.6 t -117.23 135.96 53.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . 10.9 m-85 -107.98 162.19 14.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 12.5 t -58.82 -46.92 86.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.85 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.14 146.1 58.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.654 0.74 . . . . 0.0 110.861 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 344' ' ' GLU . 71.9 Cg_exo -46.16 -57.78 2.02 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.694 2.263 . . . . 0.0 112.356 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 343' ' ' PRO . 17.4 mm-40 -37.09 -64.7 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . 0.413 ' N ' ' CD ' ' A' ' 345' ' ' GLU . 0.2 OUTLIER -49.09 -43.25 41.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.589 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -60.89 -48.05 83.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.102 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 75.1 m -46.08 -63.02 1.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.178 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 349' ' ' ALA . 1.3 ttmp? -40.65 -65.56 0.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.58 -54.93 0.87 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.114 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.624 ' CG2' HD22 ' A' ' 296' ' ' LEU . 59.3 t -41.43 -51.0 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.163 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 66.1 m -79.37 -58.0 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.118 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -45.78 -25.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.933 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 356' ' ' ARG . 65.3 mmm -102.16 -52.37 3.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 4.7 t-20 -34.25 111.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.916 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.04 20.98 58.28 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.497 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 353' ' ' MET . 17.5 tpp180 -98.05 123.33 42.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.883 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . 0.489 HD13 ' N ' ' A' ' 362' ' ' PRO . 10.9 mm -93.14 125.35 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.108 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 74.8 t -110.52 -51.63 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.133 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -113.22 -69.48 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.09 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 1.4 p -131.6 -53.23 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.65 153.37 37.95 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.589 0.709 . . . . 0.0 110.861 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.489 ' N ' HD13 ' A' ' 357' ' ' ILE . 62.6 Cg_endo -77.67 145.3 22.97 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.69 2.26 . . . . 0.0 112.344 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.518 ' O ' HG23 ' A' ' 365' ' ' VAL . 48.4 mt -82.74 92.08 7.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -66.82 100.52 0.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 363' ' ' LEU . 7.6 t -106.43 136.35 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -158.32 149.18 20.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.442 ' HB3' HG11 ' A' ' 293' ' ' VAL . 34.4 mt -59.31 137.28 58.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . 0.668 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 86.8 t . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.85 0.357 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 343' ' ' PRO . 29.0 m -95.88 -32.24 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.178 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -69.26 126.12 28.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.762 HD21 ' HB1' ' A' ' 346' ' ' ALA . 39.3 mt -114.6 140.17 49.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -95.59 121.16 36.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.725 HG21 HD11 ' A' ' 310' ' ' LEU . 67.0 t -103.01 133.53 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.127 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 26.8 tttm -133.82 162.49 31.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . 0.481 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.4 m120 63.77 48.27 3.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.907 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.501 HD21 HG11 ' A' ' 298' ' ' VAL . 28.9 mt -86.81 99.61 11.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -44.79 157.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -59.14 -42.18 90.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.53 -38.96 94.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.511 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.511 HD13 HD21 ' A' ' 363' ' ' LEU . 77.9 mt -65.92 132.33 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.896 0.379 . . . . 0.0 111.123 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.68 -174.93 3.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -46.96 -60.86 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 309' ' ' ARG . 12.5 tt0 -49.65 -65.13 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 308' ' ' GLU . 9.8 mmt85 -34.4 -49.08 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.863 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.725 HD11 HG21 ' A' ' 298' ' ' VAL . 67.7 tp -55.42 -74.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -49.07 -25.05 1.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -74.47 -40.47 61.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.34 19.01 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.109 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.629 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.3 m-85 -127.36 -30.16 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.598 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.2 t -54.02 -45.0 99.16 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.688 0.756 . . . . 0.0 110.872 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.8 Cg_exo -48.03 -17.88 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.703 2.268 . . . . 0.0 112.351 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . 0.572 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 57.4 m-85 -100.45 -61.09 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.863 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -148.69 159.32 27.99 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.458 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.2 m -65.36 141.92 58.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.769 0.318 . . . . 0.0 111.157 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.831 HG23 ' O ' ' A' ' 339' ' ' CYS . 79.8 mt -120.26 135.41 60.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 66.4 p -99.45 -36.55 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.6 t -137.81 122.62 18.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . 0.456 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -137.16 124.18 21.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -150.67 149.81 30.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 335' ' ' PHE . 79.5 t -115.38 138.87 44.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.099 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 39.3 mmt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.895 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 82.2 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.9 0.381 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . 0.411 ' HE2' ' CZ ' ' A' ' 335' ' ' PHE . 22.7 mtpt -65.24 -47.07 78.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.39 27.45 0.62 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.488 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.463 ' O ' HG13 ' A' ' 325' ' ' VAL . 7.8 p90 -174.98 165.72 3.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.883 0.373 . . . . 0.0 110.893 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -167.41 -163.31 21.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -144.16 138.98 28.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.377 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.666 ' CG2' HD21 ' A' ' 310' ' ' LEU . 53.7 t -130.73 142.46 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . 0.831 ' O ' HG23 ' A' ' 320' ' ' ILE . 74.0 m -114.29 145.7 41.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -120.83 174.55 6.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.5 t -73.58 -42.0 62.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.85 145.88 38.49 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.645 0.736 . . . . 0.0 110.837 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.568 ' N ' HG12 ' A' ' 294' ' ' VAL . 71.5 Cg_exo -46.41 -56.18 3.15 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.699 2.266 . . . . 0.0 112.332 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 343' ' ' PRO . 3.6 mm-40 -37.56 -63.52 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -47.75 -45.89 29.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.762 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -60.92 -44.06 97.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 92.8 m -45.9 -61.67 1.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.167 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 349' ' ' ALA . 15.4 ttmt -46.94 -61.95 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -37.52 -50.35 1.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.499 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 57.7 t -41.16 -57.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.113 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 94.2 m -77.48 -55.33 5.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.154 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.572 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 25.6 mm-40 -43.24 -30.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . 0.448 ' O ' ' C ' ' A' ' 354' ' ' ASN . 72.8 mmm -100.82 -53.66 3.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 2.9 t30 -34.02 115.95 0.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 81.03 27.18 50.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.478 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -99.98 118.24 35.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.868 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . 0.504 HD13 ' CA ' ' A' ' 362' ' ' PRO . 27.0 mm -91.51 117.49 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 97.0 t -106.83 -45.01 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -118.55 -72.83 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.093 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.0 p -132.14 -51.74 0.96 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -100.32 148.84 35.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.549 0.69 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.504 ' CA ' HD13 ' A' ' 357' ' ' ILE . 62.9 Cg_endo -77.97 137.34 15.58 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.702 2.268 . . . . 0.0 112.374 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.511 HD21 HD13 ' A' ' 305' ' ' ILE . 62.5 mt -74.5 91.93 2.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -64.19 105.15 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 363' ' ' LEU . 47.0 t -108.79 133.11 54.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.094 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -152.48 151.23 30.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.115 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 73.7 mt -58.79 136.49 57.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 179.825 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.8 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.909 0.385 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 343' ' ' PRO . 19.2 m -118.45 -25.12 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -77.21 143.85 38.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.651 HD12 ' CE1' ' A' ' 340' ' ' PHE . 35.4 mt -131.3 135.87 47.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -94.93 123.83 38.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.2 t -105.07 130.82 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.139 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 34.4 tttp -129.54 162.24 28.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.872 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . 0.479 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.8 m-20 63.86 52.25 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.582 HD12 ' C ' ' A' ' 335' ' ' PHE . 27.7 mt -93.51 91.16 6.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -40.52 135.34 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -41.08 -41.62 1.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -57.3 -38.72 88.04 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.506 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 57.8 mt -65.89 127.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.831 0.348 . . . . 0.0 111.168 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.4 178.51 4.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.828 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -54.8 -41.49 70.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.847 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -63.43 -57.61 9.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -42.36 -51.76 4.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.474 HD13 HD21 ' A' ' 301' ' ' LEU . 49.5 tp -57.28 -70.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -47.91 -27.63 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 10.7 mtpp -74.3 -32.06 62.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -91.66 18.4 7.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.746 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.3 m-85 -127.11 -29.56 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.594 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -54.51 -45.35 99.44 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.673 0.749 . . . . 0.0 110.858 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.1 Cg_exo -47.92 -17.1 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.666 2.244 . . . . 0.0 112.38 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 61.7 m-85 -99.87 -57.6 2.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -155.94 167.66 33.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.479 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 8.1 m -65.82 143.88 57.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.0 111.102 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.746 HD11 ' HB3' ' A' ' 314' ' ' PHE . 80.2 mt -123.81 139.43 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.7 p -110.74 -38.86 5.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.136 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 14.8 m -127.32 111.12 13.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . 0.557 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -145.4 126.01 14.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.161 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 12.5 tptm -165.05 149.73 9.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.534 HG22 HD13 ' A' ' 301' ' ' LEU . 93.7 t -98.13 139.47 20.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 37.7 mmt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 179.95 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 333' ' ' LYS . 37.6 t . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.904 0.383 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . 0.532 ' HD3' ' CZ ' ' A' ' 335' ' ' PHE . 22.1 mtpp -35.14 -48.01 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 117.38 36.59 0.99 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.46 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.582 ' C ' HD12 ' A' ' 301' ' ' LEU . 13.3 p90 -174.47 164.45 3.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.896 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -160.99 -166.78 20.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -134.4 144.37 48.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.868 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 49.0 t -137.08 132.13 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . 0.427 ' O ' HG23 ' A' ' 320' ' ' ILE . 7.2 t -115.92 134.76 54.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.651 ' CE1' HD12 ' A' ' 296' ' ' LEU . 16.5 m-85 -110.86 170.19 8.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.916 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 47.9 t -79.97 -43.32 22.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.895 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 3.0 m -125.29 138.48 31.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.666 0.746 . . . . 0.0 110.84 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.485 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.1 Cg_exo -47.43 -60.02 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.643 2.229 . . . . 0.0 112.37 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 343' ' ' PRO . 42.6 mt-10 -37.44 -58.7 0.83 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -47.35 -45.06 24.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.626 ' O ' HG23 ' A' ' 350' ' ' VAL . . . -61.41 -43.18 99.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.071 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.7 m -51.07 -67.64 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.216 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 349' ' ' ALA . 26.3 tttt -41.32 -63.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.96 -52.93 0.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.641 HG22 HD22 ' A' ' 296' ' ' LEU . 60.9 t -40.06 -54.25 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 81.0 m -79.76 -54.49 5.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.149 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.573 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 17.5 mm-40 -46.42 -25.64 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . 0.435 ' O ' ' C ' ' A' ' 354' ' ' ASN . 73.4 mmm -104.26 -52.23 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 4.2 t-20 -34.89 110.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 91.88 25.88 21.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -99.76 119.99 39.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 8.8 mm -90.66 127.49 43.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.173 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 67.1 t -116.68 -40.98 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.142 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.11 -70.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.128 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.3 p -132.03 -52.91 0.98 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.151 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -99.99 149.44 35.98 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.606 0.717 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.57 136.81 17.69 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.721 2.281 . . . . 0.0 112.295 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 37.0 mt -66.85 100.35 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -73.75 95.4 2.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.403 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 52.7 t -96.95 144.05 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.077 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -157.96 171.7 19.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 28.4 mt -81.14 140.77 34.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.868 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.102 179.788 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 81.4 t . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.866 0.365 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.72 -25.22 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -75.38 128.25 34.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.657 HD21 ' HB1' ' A' ' 346' ' ' ALA . 46.1 mt -118.62 147.84 43.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 299' ' ' LYS . 31.8 t80 -106.76 115.51 30.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 31.8 t -100.46 127.95 52.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.155 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.445 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 42.9 tttp -129.16 160.88 31.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . 0.445 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.5 m120 63.78 50.48 2.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.679 HD21 HD13 ' A' ' 310' ' ' LEU . 24.1 mt -84.28 105.32 15.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.558 ' OD2' ' HB3' ' A' ' 359' ' ' ALA . 62.2 m-20 -45.19 137.42 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -44.97 -40.58 6.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -65.53 -37.97 94.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.479 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.61 107.6 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.822 0.344 . . . . 0.0 111.12 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -95.78 -176.46 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -51.22 -45.91 62.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -66.11 -54.14 29.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -45.27 -42.99 10.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.837 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.679 HD13 HD21 ' A' ' 301' ' ' LEU . 54.0 tp -60.22 -70.29 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.925 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.421 ' NH1' ' HB3' ' A' ' 311' ' ' ARG . 19.3 ttp-105 -53.37 -23.82 10.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -67.96 -35.99 79.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -95.01 20.25 9.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.087 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.878 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.2 m-85 -126.48 -30.38 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.596 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.0 OUTLIER -57.29 -44.79 99.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.62 0.724 . . . . 0.0 110.829 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.7 Cg_exo -48.07 -17.02 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.683 2.255 . . . . 0.0 112.335 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 53.6 m-85 -100.24 -51.48 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.97 163.9 34.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.4 m -63.99 140.7 58.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.124 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.878 HD11 ' HB3' ' A' ' 314' ' ' PHE . 90.9 mt -121.5 143.15 34.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.129 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 69.2 p -117.74 -42.19 2.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.156 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 65.4 m -115.47 105.89 13.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.845 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . 0.445 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -137.52 112.71 9.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.059 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 33.5 tptt -143.54 145.01 32.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.428 ' N ' ' HG3' ' A' ' 324' ' ' LYS . 49.0 t -110.16 117.48 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . 0.411 ' HB3' ' CD ' ' A' ' 333' ' ' LYS . 35.8 mmt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 67.9 p . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.886 0.374 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . 0.569 ' HB3' ' CE2' ' A' ' 335' ' ' PHE . 23.7 mttm -48.59 -52.3 23.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 122.33 33.47 0.89 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.508 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 333' ' ' LYS . 20.1 p90 -173.03 159.67 4.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.924 0.392 . . . . 0.0 110.864 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -162.08 -170.46 26.88 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -131.56 141.02 49.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.882 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 18.5 t -136.51 125.95 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 10.1 t -110.4 134.88 51.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.416 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . 9.4 m-85 -107.59 165.6 11.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 5.0 t -73.36 -39.75 64.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 68.4 m -127.01 139.5 35.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.663 0.744 . . . . 0.0 110.878 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.62 -60.5 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.715 2.276 . . . . 0.0 112.341 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -40.31 -57.67 1.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -46.87 -46.77 21.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.657 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -62.82 -42.65 99.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.081 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 56.5 m -53.2 -63.56 1.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 349' ' ' ALA . 37.8 tttt -43.64 -62.77 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -37.37 -51.65 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 346' ' ' ALA . 58.0 t -40.53 -55.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.151 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 73.4 m -78.74 -55.44 5.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.514 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 2.5 mm-40 -45.01 -27.86 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . 0.484 ' O ' ' CB ' ' A' ' 356' ' ' ARG . 82.3 mmm -102.49 -52.24 3.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.838 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 2.5 t30 -33.96 118.66 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 79.5 18.8 72.76 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.453 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 353' ' ' MET . 22.4 tpp180 -100.12 125.79 46.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.752 0.31 . . . . 0.0 110.872 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 29.2 mm -88.59 139.88 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 90.7 t -128.35 -34.74 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.153 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.558 ' HB3' ' OD2' ' A' ' 302' ' ' ASP . . . -131.27 -69.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.68 -51.2 0.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.177 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.32 155.84 37.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.603 0.716 . . . . 0.0 110.886 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.77 142.67 20.4 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.369 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.587 HD21 HD23 ' A' ' 301' ' ' LEU . 34.4 mt -79.19 92.97 5.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.883 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -65.23 97.69 0.28 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 363' ' ' LEU . 7.6 t -101.17 145.11 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.104 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -158.95 154.64 26.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.093 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.63 140.66 58.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 179.761 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 88.1 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.843 0.354 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.461 HG23 ' SG ' ' A' ' 339' ' ' CYS . 24.2 m -108.85 -34.72 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -59.64 143.74 49.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.573 HD22 HG22 ' A' ' 350' ' ' VAL . 20.2 mt -134.7 153.38 52.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -115.3 118.81 34.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.7 t -100.19 137.06 28.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.076 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -138.92 155.71 47.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 74.78 39.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.477 HD21 HD13 ' A' ' 310' ' ' LEU . 33.9 mt -73.43 90.66 1.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -40.76 139.92 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.4 -41.58 9.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.862 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.85 -38.97 94.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.44 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 66.7 mt -66.52 143.69 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.856 0.36 . . . . 0.0 111.157 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -132.21 -175.03 3.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -57.79 -42.73 84.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -64.65 -63.81 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 74.5 mtt-85 -46.23 -44.56 16.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.477 HD13 HD21 ' A' ' 301' ' ' LEU . 47.5 tp -55.37 -75.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.617 ' HG3' HD13 ' A' ' 320' ' ' ILE . 58.7 ttp180 -48.95 -29.53 4.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -72.14 -33.68 67.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -85.98 20.35 2.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.446 ' HB2' HD11 ' A' ' 320' ' ' ILE . 8.4 m-85 -128.99 -30.73 2.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.83 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.81 -45.34 97.25 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.716 0.769 . . . . 0.0 110.882 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.6 Cg_exo -48.03 -16.73 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.664 2.243 . . . . 0.0 112.351 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 57.9 m-85 -99.84 -46.62 5.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -169.0 165.97 39.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.542 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 42.0 m -62.59 140.19 58.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.116 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.617 HD13 ' HG3' ' A' ' 311' ' ' ARG . 74.5 mt -109.92 145.56 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.112 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 82.4 p -109.98 -45.39 3.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 82.7 p -136.3 116.53 13.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.842 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . 0.576 ' HB3' ' HD3' ' A' ' 311' ' ' ARG . . . -135.2 123.46 23.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -150.61 152.4 33.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.475 HG22 HD22 ' A' ' 310' ' ' LEU . 55.2 t -112.34 130.17 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 37.5 mmt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 179.965 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.895 0.379 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . 0.552 ' HB3' ' CE2' ' A' ' 335' ' ' PHE . 58.2 mttt -52.49 -61.47 2.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 136.9 37.58 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.466 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 333' ' ' LYS . 23.2 p90 -174.82 162.06 3.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 0.0 110.907 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -159.27 -169.16 22.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.477 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -138.8 137.02 36.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.866 0.365 . . . . 0.0 110.912 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 48.8 t -138.04 136.48 44.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.149 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . 0.461 ' SG ' HG23 ' A' ' 294' ' ' VAL . 10.1 t -121.39 133.49 55.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.881 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . 11.4 m-85 -104.13 158.91 16.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.851 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.4 m -64.04 -43.07 96.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 71.0 m -125.38 136.97 28.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.67 0.748 . . . . 0.0 110.859 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.4 -56.87 2.69 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.648 2.232 . . . . 0.0 112.361 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -43.82 -61.33 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -47.66 -46.05 28.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.881 ' HB2' ' HB2' ' A' ' 340' ' ' PHE . . . -61.75 -41.18 97.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.062 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 31.4 m -51.49 -60.9 2.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.108 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -40.96 -58.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -46.48 -53.14 11.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.101 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.573 HG22 HD22 ' A' ' 296' ' ' LEU . 98.6 t -38.48 -58.69 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.162 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 72.4 m -75.36 -59.08 2.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.564 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 39.4 mm-40 -41.54 -28.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.9 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . 0.468 ' HG2' ' CE2' ' A' ' 317' ' ' PHE . 64.1 mmm -100.06 -40.63 7.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -46.1 109.07 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.44 21.93 55.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . 0.419 ' HD3' ' C ' ' A' ' 356' ' ' ARG . 0.0 OUTLIER -98.1 125.19 42.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.762 0.315 . . . . 0.0 110.862 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . 0.458 HD13 ' CA ' ' A' ' 362' ' ' PRO . 27.6 mm -89.42 127.26 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 66.3 t -113.38 -42.89 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -123.0 -74.36 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.089 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 5.2 p -128.9 -49.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.184 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -105.14 150.15 38.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.574 0.702 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.458 ' CA ' HD13 ' A' ' 357' ' ' ILE . 61.5 Cg_endo -76.76 140.98 21.3 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.688 2.259 . . . . 0.0 112.331 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 32.4 mt -80.39 115.87 20.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -83.21 99.66 10.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.476 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 39.0 t -103.37 140.83 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -166.41 152.8 8.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.073 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 26.9 mt -65.93 132.48 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.072 179.802 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.493 HG21 HD22 ' A' ' 367' ' ' LEU . 1.8 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.857 0.361 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 343' ' ' PRO . 23.1 m -117.88 -26.8 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -74.12 114.94 13.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.816 HD21 ' HB1' ' A' ' 346' ' ' ALA . 38.4 mt -105.45 132.97 50.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.955 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.735 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 5.9 t80 -90.28 120.09 31.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.407 HG11 HD21 ' A' ' 301' ' ' LEU . 98.6 t -101.05 137.43 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.116 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.466 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 35.8 tttt -137.03 161.46 36.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . 0.466 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.0 m120 63.53 47.69 3.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.407 HD21 HG11 ' A' ' 298' ' ' VAL . 28.4 mt -80.23 102.46 9.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -45.9 143.9 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -52.39 -39.45 60.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -61.95 -37.11 93.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.79 148.22 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.852 0.358 . . . . 0.0 111.136 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -137.36 179.78 6.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -52.52 -38.67 60.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 309' ' ' ARG . 16.4 mm-40 -68.63 -72.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.888 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 308' ' ' GLU . 61.0 mtt-85 -36.99 -38.89 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.528 HD12 ' CE1' ' A' ' 314' ' ' PHE . 44.0 tp -63.32 -70.72 0.2 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.45 ' HG3' ' CD1' ' A' ' 320' ' ' ILE . 46.3 ttt180 -50.85 -24.98 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -79.4 -32.96 43.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.47 18.88 3.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.081 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.528 ' CE1' HD12 ' A' ' 310' ' ' LEU . 8.4 m-85 -129.36 -30.92 2.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.874 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.584 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.7 OUTLIER -50.79 -45.65 86.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.634 0.73 . . . . 0.0 110.84 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.7 Cg_exo -47.94 -17.05 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.662 2.241 . . . . 0.0 112.353 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . 0.443 ' CE2' ' HG2' ' A' ' 353' ' ' MET . 54.4 m-85 -99.84 -47.45 5.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -166.14 158.61 31.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.484 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 40.8 m -60.7 139.13 57.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.738 0.304 . . . . 0.0 111.163 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 339' ' ' CYS . 46.7 mt -110.99 141.69 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 67.9 p -110.34 -40.39 4.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.068 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 3.5 m -132.12 121.24 23.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.883 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -132.98 125.18 29.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.102 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 22.2 mtpt -142.48 154.99 45.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 31.5 t -129.96 117.57 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.16 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 30.0 mmt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.913 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 9.2 t . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.904 0.383 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . 0.479 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 21.2 mtpp -46.96 -53.31 12.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 300' ' ' ASN . . . 132.59 33.36 0.39 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 333' ' ' LYS . 29.4 p90 -175.15 157.29 2.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -156.89 -161.38 10.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -142.46 131.65 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.386 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 61.7 t -127.36 134.25 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . 0.632 ' O ' HG23 ' A' ' 320' ' ' ILE . 7.3 m -110.26 138.78 46.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.486 ' CE1' HD12 ' A' ' 296' ' ' LEU . 28.8 m-85 -114.14 164.41 13.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.904 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.9 t -67.76 -46.51 71.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 3.5 m -130.69 142.67 46.37 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.638 0.733 . . . . 0.0 110.876 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 344' ' ' GLU . 72.8 Cg_exo -47.05 -59.34 1.28 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.652 2.234 . . . . 0.0 112.36 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 343' ' ' PRO . 39.8 mt-10 -36.09 -61.83 0.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -46.87 -47.28 21.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.816 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -60.89 -41.02 95.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 90.1 m -50.13 -62.8 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 349' ' ' ALA . 27.0 tttm -46.52 -63.94 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.21 -48.96 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.071 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 346' ' ' ALA . 47.0 t -41.66 -56.42 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.187 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 92.9 m -79.58 -51.99 8.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.437 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 20.5 mm-40 -46.3 -29.44 1.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . 0.443 ' HG2' ' CE2' ' A' ' 317' ' ' PHE . 53.4 mmm -101.51 -52.71 3.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 1.8 t30 -34.22 116.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.921 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 82.7 25.57 49.58 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.523 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -100.05 118.27 36.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.723 0.297 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . 0.516 HD13 ' CA ' ' A' ' 362' ' ' PRO . 29.6 mm -86.73 126.43 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 94.9 t -112.18 -48.49 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.172 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -120.75 -68.24 0.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.067 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 6.0 p -130.88 -54.44 1.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.139 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.43 151.17 37.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.561 0.696 . . . . 0.0 110.882 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.516 ' CA ' HD13 ' A' ' 357' ' ' ILE . 63.0 Cg_endo -77.13 143.78 22.96 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.641 2.227 . . . . 0.0 112.353 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 365' ' ' VAL . 33.2 mt -78.68 91.97 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -64.32 101.82 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.47 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 50.8 t -105.66 134.49 47.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.122 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -154.54 153.65 31.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.493 HD22 HG21 ' A' ' 293' ' ' VAL . 79.4 mt -62.26 136.75 58.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . 0.735 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.169 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 99.6 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.857 0.361 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 4.6 m -93.85 -32.54 4.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -64.93 135.84 56.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.928 HD21 ' HB1' ' A' ' 346' ' ' ALA . 48.4 mt -122.33 137.73 54.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -98.75 106.56 18.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.2 t -90.3 135.75 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.164 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.492 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 17.3 ttmm -133.25 164.76 26.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . 0.492 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.7 m-20 63.77 45.34 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 28.4 mt -90.61 98.09 11.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -46.35 163.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.32 -36.62 84.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.26 -43.58 97.13 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.533 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 39.6 mt -60.91 147.49 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.336 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -137.31 -176.82 4.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.823 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -60.14 -34.08 73.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -72.13 -62.25 1.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.878 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -46.82 -42.78 17.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.455 HD12 ' CE1' ' A' ' 314' ' ' PHE . 61.2 tp -62.38 -71.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -48.43 -26.58 2.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -70.48 -33.69 71.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -92.35 18.94 7.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.108 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.472 ' CB ' HD11 ' A' ' 320' ' ' ILE . 6.3 m-85 -123.76 -31.16 3.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.8 OUTLIER -56.85 -45.48 99.95 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.643 0.735 . . . . 0.0 110.846 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.9 Cg_exo -47.95 -17.06 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 0.0 112.385 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . 0.58 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 62.0 m-85 -99.92 -48.91 4.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.26 168.08 37.11 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.455 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.3 m -64.37 139.39 58.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.787 0.327 . . . . 0.0 111.124 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.477 HG21 ' HB2' ' A' ' 323' ' ' ALA . 42.1 mt -115.85 133.93 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 75.2 p -108.15 -40.62 5.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.127 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.9 m -130.09 112.61 13.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.815 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -138.65 124.31 19.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.122 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.447 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 19.2 tptm -163.63 146.55 9.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.447 ' N ' ' HG3' ' A' ' 324' ' ' LYS . 98.9 t -101.05 136.23 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.113 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 37.5 mmt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 179.887 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.963 0.411 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -58.11 -53.62 56.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.899 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 138.78 36.86 0.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.5 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -171.93 152.76 3.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.857 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -154.08 -174.11 23.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.519 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -133.62 143.74 48.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 110.895 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 48.7 t -138.7 147.59 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . 0.424 ' O ' HG23 ' A' ' 320' ' ' ILE . 62.6 m -124.52 149.03 47.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -125.2 175.96 7.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 90.2 p -75.11 -29.79 60.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 43.4 t -156.75 145.05 14.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.717 0.77 . . . . 0.0 110.789 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 346' ' ' ALA . 71.3 Cg_exo -45.06 -54.01 4.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.693 2.262 . . . . 0.0 112.359 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -39.01 -37.92 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -76.2 -38.64 56.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.928 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -65.79 -45.39 82.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 87.5 m -49.3 -67.82 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.172 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.453 ' HG2' ' CG ' ' A' ' 352' ' ' GLU . 19.7 tttm -41.14 -60.71 1.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -40.8 -52.45 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 346' ' ' ALA . 66.2 t -39.47 -59.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 353' ' ' MET . 51.9 m -77.51 -59.6 2.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.159 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.58 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 30.9 mm-40 -37.44 -29.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . 0.468 ' N ' ' O ' ' A' ' 351' ' ' THR . 79.6 mmm -100.24 -61.3 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 353' ' ' MET . 8.0 t30 -36.8 101.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 125.68 -9.26 7.68 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.511 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.42 126.54 35.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 110.878 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . 0.437 HD13 ' CA ' ' A' ' 362' ' ' PRO . 23.4 mm -87.94 135.27 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 65.6 t -113.63 -54.54 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -116.08 -65.39 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.064 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.501 HG23 ' HD3' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -133.76 -52.65 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.501 ' HD3' HG23 ' A' ' 360' ' ' THR . 0.0 OUTLIER -102.81 153.67 38.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.548 0.69 . . . . 0.0 110.893 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.437 ' CA ' HD13 ' A' ' 357' ' ' ILE . 60.0 Cg_endo -73.5 148.24 42.31 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.324 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.477 ' O ' HG23 ' A' ' 365' ' ' VAL . 58.7 mt -70.8 93.61 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -68.08 88.28 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 363' ' ' LEU . 14.3 t -92.66 140.09 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.09 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -155.96 138.32 14.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.478 HD23 ' CD2' ' A' ' 296' ' ' LEU . 60.2 mt -57.76 141.45 48.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.121 179.763 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 98.6 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.864 0.364 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 343' ' ' PRO . 23.9 m -94.55 -23.82 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.175 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -78.35 137.92 38.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.831 HD21 ' HB1' ' A' ' 346' ' ' ALA . 36.2 mt -128.08 142.85 51.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.958 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.64 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 32.9 t80 -99.65 121.87 41.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.54 HG21 HD11 ' A' ' 310' ' ' LEU . 39.3 t -99.57 130.1 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.098 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 16.0 tttm -128.44 157.56 40.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . . . . . . . . . 3.4 m120 63.83 54.94 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.511 HD21 HG11 ' A' ' 298' ' ' VAL . 28.3 mt -92.56 98.07 11.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.939 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 303' ' ' ASP . 14.8 t70 -50.24 131.42 23.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 302' ' ' ASP . 12.9 t70 -35.61 -49.86 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -48.35 -44.98 28.45 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.73 143.15 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.826 0.346 . . . . 0.0 111.125 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.8 -175.76 4.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.828 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.74 -42.94 65.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -62.25 -70.25 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 66.7 mtt-85 -41.66 -40.73 2.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.54 HD11 HG21 ' A' ' 298' ' ' VAL . 43.2 tp -60.72 -70.92 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.653 ' HG3' HD12 ' A' ' 320' ' ' ILE . 54.6 ttt180 -53.2 -23.71 9.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -68.7 -37.97 79.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -91.82 20.09 5.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.098 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.626 ' CB ' HD11 ' A' ' 320' ' ' ILE . 7.1 m-85 -126.19 -30.34 2.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.864 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.589 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.0 OUTLIER -56.9 -45.52 99.95 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.664 0.745 . . . . 0.0 110.822 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 315' ' ' SER . 66.1 Cg_exo -48.0 -17.16 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 0.0 112.354 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 48.6 m-85 -100.8 -52.84 3.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -145.72 170.62 26.94 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.464 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.4 m -85.93 95.19 9.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 0.0 111.143 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.653 HD12 ' HG3' ' A' ' 311' ' ' ARG . 93.4 mt -62.07 143.59 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.181 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 39.1 p -112.13 -28.54 7.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 2.6 t -155.37 109.23 2.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . 0.481 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -123.19 135.77 54.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.135 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -156.57 152.7 27.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 86.7 t -115.96 139.18 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.101 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 35.9 mmt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 59.2 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.907 0.384 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . 0.423 ' HD3' ' CZ ' ' A' ' 335' ' ' PHE . 19.0 mtpt -75.57 -60.77 2.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 149.14 37.72 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.525 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.488 ' CA ' HD12 ' A' ' 301' ' ' LEU . 34.9 p90 -174.02 150.09 1.56 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.899 0.38 . . . . 0.0 110.891 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -158.12 -169.0 21.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.479 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -136.34 143.22 43.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 0.0 110.882 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 41.2 t -134.05 126.84 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.15 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 74.3 m -101.41 127.56 48.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.727 ' CE1' HD12 ' A' ' 296' ' ' LEU . 15.5 m-85 -101.76 168.14 9.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 25.1 t -78.36 -42.24 31.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.9 m -131.24 139.75 36.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.664 0.745 . . . . 0.0 110.875 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 344' ' ' GLU . 72.8 Cg_exo -47.43 -59.01 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.718 2.279 . . . . 0.0 112.332 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 343' ' ' PRO . 27.9 tt0 -36.39 -59.06 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.921 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.43 -48.11 56.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.831 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -55.88 -42.92 76.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.088 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 99.2 m -52.93 -67.15 0.27 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.19 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 349' ' ' ALA . 15.2 ttmt -40.85 -65.06 0.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.6 -48.24 0.51 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.112 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 346' ' ' ALA . 43.4 t -44.38 -52.66 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 53.1 m -81.79 -50.41 9.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.542 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 23.4 mm-40 -49.62 -28.13 5.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 356' ' ' ARG . 83.7 mmm -101.84 -49.0 4.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 3.5 t30 -36.1 110.53 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 87.75 19.83 52.74 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.507 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 353' ' ' MET . 21.8 tpp85 -99.11 120.97 40.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.897 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 9.0 mm -87.11 130.92 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.145 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 85.2 t -116.43 -42.29 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.073 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -126.1 -69.23 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.11 -55.25 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.98 155.68 36.17 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.558 0.694 . . . . 0.0 110.942 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.18 135.55 15.34 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.68 2.253 . . . . 0.0 112.301 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 365' ' ' VAL . 28.0 mt -71.72 88.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -64.48 100.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.94 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 363' ' ' LEU . 28.8 t -100.09 135.25 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -153.94 143.16 21.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 71.7 mt -54.14 145.18 17.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . 0.64 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 74.7 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.882 0.372 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.457 HG12 ' C ' ' A' ' 342' ' ' SER . 16.6 m -87.13 -30.39 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -69.63 123.21 20.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.668 HD21 ' HB1' ' A' ' 346' ' ' ALA . 69.1 mt -112.45 136.84 51.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.966 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -90.21 119.52 30.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.485 HG21 HD11 ' A' ' 310' ' ' LEU . 21.2 t -106.98 129.73 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.119 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.488 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 11.0 tttp -129.61 162.71 27.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . 0.488 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.4 m120 63.8 51.21 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 39.8 mt -85.85 99.41 11.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -46.91 144.26 2.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -47.45 -40.27 17.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -61.28 -36.82 93.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.503 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.591 HD13 HD21 ' A' ' 363' ' ' LEU . 66.9 mt -69.11 135.97 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.826 0.346 . . . . 0.0 111.14 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -136.18 -176.36 4.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -43.04 -63.3 0.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -47.06 -63.83 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -39.59 -52.5 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.515 HD21 ' CG2' ' A' ' 338' ' ' VAL . 53.1 tp -50.22 -74.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.96 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.723 ' HG3' HG21 ' A' ' 320' ' ' ILE . 19.3 ttt180 -54.2 -21.45 8.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -78.41 -29.51 47.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -99.91 17.96 19.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.806 ' CB ' HD11 ' A' ' 320' ' ' ILE . 8.0 m-85 -128.59 -30.39 2.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.73 -45.4 96.81 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.644 0.735 . . . . 0.0 110.82 -179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 315' ' ' SER . 66.0 Cg_exo -48.0 -17.13 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.67 2.247 . . . . 0.0 112.341 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . 0.419 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 52.0 m-85 -99.95 -50.11 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -145.91 169.19 27.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 90.4 m -81.86 88.19 6.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.725 0.298 . . . . 0.0 111.136 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.806 HD11 ' CB ' ' A' ' 314' ' ' PHE . 64.8 mt -65.56 131.57 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.151 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 3.1 t -108.75 -29.65 8.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.1 t -139.98 126.17 19.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -140.24 140.93 35.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.093 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -156.43 150.65 25.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 95.5 t -125.12 135.68 63.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 35.7 mmt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.908 0.385 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -58.22 -56.31 23.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 141.14 36.9 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.471 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -174.2 161.37 3.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.92 0.391 . . . . 0.0 110.846 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -164.85 -167.83 26.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.492 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -144.2 136.13 26.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.902 0.382 . . . . 0.0 110.887 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.515 ' CG2' HD21 ' A' ' 310' ' ' LEU . 60.1 t -123.05 134.82 65.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 64.5 m -107.34 128.58 54.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.517 ' CE1' HD12 ' A' ' 296' ' ' LEU . 21.9 m-85 -105.03 160.86 14.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 95.7 p -67.42 -31.36 71.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.905 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . 0.457 ' C ' HG12 ' A' ' 294' ' ' VAL . 4.8 t -148.48 143.41 17.33 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.681 0.753 . . . . 0.0 110.842 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 344' ' ' GLU . 72.9 Cg_exo -47.28 -58.97 1.42 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.636 2.224 . . . . 0.0 112.368 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 343' ' ' PRO . 22.4 mp0 -36.09 -64.94 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -44.8 -45.47 10.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.668 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -64.1 -42.51 96.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.137 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 97.2 m -45.8 -62.37 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.095 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 349' ' ' ALA . 44.4 tttp -48.41 -63.74 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.65 -48.06 0.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 346' ' ' ALA . 48.3 t -43.19 -54.93 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.106 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 85.8 m -80.65 -48.99 11.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.419 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 17.1 mm-40 -50.7 -26.65 5.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . 0.458 ' O ' ' N ' ' A' ' 356' ' ' ARG . 75.2 mmm -103.31 -50.36 3.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 3.5 t-20 -40.72 105.92 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 95.71 16.78 38.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 353' ' ' MET . 0.0 OUTLIER -98.04 122.0 40.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.762 0.315 . . . . 0.0 110.893 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . 0.42 HD13 ' CA ' ' A' ' 362' ' ' PRO . 23.4 mm -88.76 134.26 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.113 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.86 -59.83 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.13 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -105.72 -70.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.099 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 16.9 p -133.64 -47.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.163 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -104.32 154.85 38.01 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.567 0.698 . . . . 0.0 110.886 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.42 ' CA ' HD13 ' A' ' 357' ' ' ILE . 62.6 Cg_endo -77.7 144.07 21.8 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.674 2.249 . . . . 0.0 112.363 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.591 HD21 HD13 ' A' ' 305' ' ' ILE . 37.8 mt -81.02 92.6 6.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.935 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -61.45 102.65 0.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 363' ' ' LEU . 47.4 t -108.84 137.67 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.091 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -163.38 149.05 11.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.087 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 18.0 mt -60.5 148.38 37.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.105 179.792 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.47 HG21 HD22 ' A' ' 367' ' ' LEU . 1.3 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.872 0.368 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 343' ' ' PRO . 10.1 m -112.12 -22.28 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -75.16 125.9 29.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.784 HD22 ' CG2' ' A' ' 350' ' ' VAL . 49.9 mt -111.37 145.03 39.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.612 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 24.5 t80 -110.99 105.53 14.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 39.1 t -89.5 137.14 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.168 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.564 ' HE2' ' CD1' ' A' ' 364' ' ' TYR . 17.7 ttpt -132.85 162.04 32.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . 0.47 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.8 m-20 64.02 51.72 2.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.524 HD12 ' C ' ' A' ' 335' ' ' PHE . 30.9 mt -90.39 106.63 18.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -52.31 150.29 4.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.842 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -56.64 -34.3 67.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -64.82 -39.73 96.8 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.497 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 60.7 mt -62.82 139.14 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.829 0.347 . . . . 0.0 111.123 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -128.32 174.74 9.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.83 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -49.12 -43.1 41.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -62.86 -64.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 58.5 mtt-85 -42.81 -34.33 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.541 HD12 ' CE1' ' A' ' 314' ' ' PHE . 59.5 tp -67.74 -75.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -48.28 -25.79 1.7 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -70.51 -36.1 73.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -93.82 20.54 7.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.088 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.714 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.3 m-85 -127.06 -29.69 2.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.636 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 2.7 t -58.05 -42.74 96.7 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.665 0.745 . . . . 0.0 110.887 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 315' ' ' SER . 63.4 Cg_exo -47.89 -17.21 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.67 2.247 . . . . 0.0 112.395 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -100.23 -51.94 3.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -158.31 175.65 35.42 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.447 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 92.0 m -77.39 134.25 38.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.728 0.299 . . . . 0.0 111.171 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.714 HD11 ' HB3' ' A' ' 314' ' ' PHE . 84.3 mt -110.32 138.36 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.13 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 82.8 p -108.24 -39.06 5.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 72.7 m -127.56 106.74 9.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.807 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . 0.677 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -131.32 114.37 14.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.084 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.432 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 2.9 tppp? -146.82 145.01 29.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.432 ' N ' ' HG3' ' A' ' 324' ' ' LYS . 44.1 t -106.13 140.4 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 33.8 mmt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.92 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 333' ' ' LYS . 5.4 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.925 0.393 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 332' ' ' SER . 2.9 mtpm? -34.54 -49.67 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 136.79 33.17 0.23 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.524 ' C ' HD12 ' A' ' 301' ' ' LEU . 12.1 p90 -173.35 154.69 2.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 0.0 110.862 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -158.95 179.1 34.82 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.452 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -128.34 129.26 46.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.453 ' CG1' HD13 ' A' ' 320' ' ' ILE . 12.7 t -130.56 130.27 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . 0.545 ' O ' HG23 ' A' ' 320' ' ' ILE . 33.2 t -109.16 154.14 22.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.449 ' CE1' HD12 ' A' ' 296' ' ' LEU . 19.6 m-85 -125.61 177.54 6.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 93.1 p -77.32 -38.08 51.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . 0.42 ' C ' HG12 ' A' ' 294' ' ' VAL . 27.0 t -142.98 146.5 37.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.689 0.756 . . . . 0.0 110.888 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 344' ' ' GLU . 71.6 Cg_exo -46.56 -60.39 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.717 2.278 . . . . 0.0 112.316 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 343' ' ' PRO . 20.8 mt-10 -35.75 -70.04 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 345' ' ' GLU . 0.3 OUTLIER -44.03 -43.86 7.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.827 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.755 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -60.92 -43.63 98.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.086 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.8 m -52.41 -60.31 3.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.149 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -46.27 -52.4 12.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -53.83 -53.08 57.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.784 ' CG2' HD22 ' A' ' 296' ' ' LEU . 76.0 t -39.02 -49.58 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 353' ' ' MET . 50.9 m -82.58 -62.18 1.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -41.04 -24.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 351' ' ' THR . 94.4 mmm -102.06 -43.41 5.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 17.2 t-20 -59.22 109.54 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 108.5 -11.99 36.04 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -87.39 147.45 25.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.772 0.32 . . . . 0.0 110.888 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 6.2 mm -97.47 148.98 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . 0.418 HG21 HD11 ' A' ' 363' ' ' LEU . 61.8 t -131.97 -54.01 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.162 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -113.01 -72.72 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.089 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.447 HG23 ' N ' ' A' ' 361' ' ' LYS . 2.4 t -131.86 -49.08 0.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.447 ' N ' HG23 ' A' ' 360' ' ' THR . 17.2 mttm -101.08 154.0 37.42 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.618 0.723 . . . . 0.0 110.916 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.38 129.14 10.9 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.697 2.265 . . . . 0.0 112.329 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.451 ' CD2' HD23 ' A' ' 301' ' ' LEU . 52.3 mt -67.08 122.55 18.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.914 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.564 ' CD1' ' HE2' ' A' ' 299' ' ' LYS . 25.1 t80 -101.83 93.48 5.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.6 144.22 10.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.126 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -162.43 145.94 11.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.085 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 293' ' ' VAL . 35.9 mt -53.14 145.9 12.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.943 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . 0.612 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.407 HG13 ' O ' ' A' ' 368' ' ' ALA . 97.0 t . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.837 0.351 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.1 m -92.1 -32.5 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.158 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -65.59 136.1 55.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.896 HD21 ' HB1' ' A' ' 346' ' ' ALA . 30.7 mt -123.58 137.2 54.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.967 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -101.62 103.05 13.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 32.2 t -88.45 136.21 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.581 ' HE3' ' CD1' ' A' ' 364' ' ' TYR . 13.2 ttpp -135.41 162.8 31.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . 0.455 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.6 m120 63.97 47.84 3.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 35.7 mt -86.22 98.44 10.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.724 ' OD2' ' HB3' ' A' ' 359' ' ' ALA . 91.6 m-20 -41.47 134.98 2.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -45.83 -36.4 5.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.15 -42.72 97.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.5 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 63.0 mt -60.44 147.65 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.834 0.349 . . . . 0.0 111.173 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -130.34 -174.61 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.23 -28.47 69.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.48 -55.07 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -51.89 -41.89 62.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.533 HD12 ' CE1' ' A' ' 314' ' ' PHE . 62.9 tp -61.89 -72.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.449 ' HD2' ' HB3' ' A' ' 323' ' ' ALA . 13.7 ttt-85 -50.38 -24.89 3.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -80.0 -29.02 39.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -93.34 17.65 10.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.096 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.533 ' CE1' HD12 ' A' ' 310' ' ' LEU . 6.9 m-85 -126.01 -31.49 2.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.49 -45.27 95.67 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.648 0.737 . . . . 0.0 110.799 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.5 Cg_exo -48.03 -16.67 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.716 2.277 . . . . 0.0 112.325 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -99.67 -52.17 3.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.835 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.27 166.56 36.51 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.475 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 23.9 m -64.08 144.48 57.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.743 0.306 . . . . 0.0 111.18 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 339' ' ' CYS . 49.6 mt -119.75 137.73 52.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 68.4 p -100.94 -41.43 6.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.145 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.1 t -142.28 124.53 15.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.825 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . 0.449 ' HB3' ' HD2' ' A' ' 311' ' ' ARG . . . -145.57 124.76 12.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.08 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -149.25 159.0 44.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.32 123.87 71.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.097 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 335' ' ' PHE . 33.5 mmt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.972 0.415 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -69.68 -44.76 69.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.868 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 125.39 34.74 0.65 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.439 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.485 ' CZ ' ' HG3' ' A' ' 326' ' ' MET . 2.5 p90 -174.75 161.13 3.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.913 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -164.7 -172.05 31.69 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.519 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -131.21 146.46 52.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.868 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 50.5 t -142.43 131.9 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.091 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . 0.547 ' O ' HG23 ' A' ' 320' ' ' ILE . 6.5 t -112.94 144.27 42.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -118.52 178.63 4.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.1 t -78.49 -39.88 36.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.3 t -137.53 142.36 36.83 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.671 0.748 . . . . 0.0 110.855 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.99 -54.51 4.9 Favored 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.686 2.258 . . . . 0.0 112.369 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -41.83 -52.05 4.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.93 -46.06 82.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.896 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -59.03 -38.86 80.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.152 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 348' ' ' LYS . 60.9 m -52.04 -74.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 347' ' ' THR . 10.1 ttmm -35.25 -64.8 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.953 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.41 -54.5 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.117 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 346' ' ' ALA . 33.5 t -47.52 -46.25 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.163 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 27.3 m -77.57 -59.48 2.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.133 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -50.49 -22.08 1.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 90.1 mmm -100.22 -43.34 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 9.2 t-20 -58.98 97.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 123.58 -11.49 8.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.492 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -85.15 122.44 29.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . 0.401 HD13 ' CA ' ' A' ' 362' ' ' PRO . 11.5 mm -84.99 149.63 4.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.24 -49.37 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.724 ' HB3' ' OD2' ' A' ' 302' ' ' ASP . . . -120.28 -68.97 0.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.32 -51.25 0.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.185 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.58 151.81 37.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.545 0.688 . . . . 0.0 110.899 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.401 ' CA ' HD13 ' A' ' 357' ' ' ILE . 60.4 Cg_endo -74.15 151.98 44.73 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.728 2.285 . . . . 0.0 112.345 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 63.1 mt -77.09 96.51 4.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . 0.581 ' CD1' ' HE3' ' A' ' 299' ' ' LYS . 10.1 t80 -74.48 85.8 2.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.67 144.41 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.131 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -152.09 168.07 26.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.148 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 29.5 mt -72.35 145.95 47.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 293' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.099 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 93.7 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.883 0.373 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 24.3 m -87.27 -30.32 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -72.69 135.83 45.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.829 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.695 HD21 ' HB1' ' A' ' 346' ' ' ALA . 28.9 mt -129.76 132.99 46.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.916 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.672 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 26.7 t80 -90.81 121.06 32.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.496 HG21 HD11 ' A' ' 310' ' ' LEU . 56.3 t -104.5 132.49 51.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.112 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.49 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 22.3 tttm -132.86 164.05 27.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.898 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . 0.49 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.8 m120 64.14 45.7 3.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.599 HD12 ' C ' ' A' ' 335' ' ' PHE . 32.7 mt -84.31 95.26 8.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -41.24 136.76 1.55 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -45.16 -40.54 7.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -58.97 -35.77 85.03 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.525 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.515 HD13 HD21 ' A' ' 363' ' ' LEU . 65.7 mt -68.36 126.98 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.785 0.326 . . . . 0.0 111.153 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -115.7 175.67 5.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -42.45 -63.82 0.7 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.802 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -47.48 -55.67 8.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.877 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? -45.05 -51.61 9.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.497 HD12 ' CE1' ' A' ' 314' ' ' PHE . 54.7 tp -53.91 -74.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.927 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.481 ' HG3' ' CD1' ' A' ' 320' ' ' ILE . 31.3 ttt180 -45.84 -27.95 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -68.66 -42.78 77.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -83.93 25.1 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.103 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.497 ' CE1' HD12 ' A' ' 310' ' ' LEU . 10.7 m-85 -133.72 -32.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.599 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -51.82 -45.27 92.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.662 0.744 . . . . 0.0 110.867 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.3 Cg_exo -47.95 -17.17 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.642 2.228 . . . . 0.0 112.367 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 46.9 m-85 -100.07 -45.83 5.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -167.8 167.01 39.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.466 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 35.9 m -68.72 141.16 55.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.785 0.326 . . . . 0.0 111.154 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.524 HG21 ' HB2' ' A' ' 323' ' ' ALA . 53.3 mt -113.95 144.09 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 61.6 p -114.12 -38.55 4.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.145 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -133.36 111.05 10.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.825 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . 0.524 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -135.45 122.98 22.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -147.28 152.99 39.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.442 HG22 HD22 ' A' ' 310' ' ' LEU . 81.9 t -119.41 135.85 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.148 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 38.0 mmt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.921 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.956 0.408 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . 0.499 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 55.1 mttp -51.76 -51.25 57.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.936 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 133.02 35.24 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.445 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.599 ' C ' HD12 ' A' ' 301' ' ' LEU . 5.3 p90 -173.04 165.89 5.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.885 0.374 . . . . 0.0 110.906 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -166.71 -171.43 32.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.541 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -136.82 140.03 42.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.883 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.28 133.55 62.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.134 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 8.7 m -111.77 133.2 54.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -109.51 173.3 6.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 13.2 t -87.15 -40.68 14.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.833 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 49.7 m -123.66 130.19 24.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.648 0.737 . . . . 0.0 110.846 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -45.88 -58.57 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.678 2.252 . . . . 0.0 112.345 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -38.62 -52.66 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -54.12 -46.78 72.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.695 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -61.54 -42.38 98.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.115 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.4 m -49.95 -60.35 3.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.125 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 349' ' ' ALA . 46.3 tttt -48.13 -62.94 1.22 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.855 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.62 -48.96 0.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.633 HG22 HD22 ' A' ' 296' ' ' LEU . 57.6 t -42.49 -56.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.163 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 61.2 m -78.33 -54.65 5.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.147 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.481 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 2.2 mm-40 -44.22 -29.54 0.66 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . 0.451 ' O ' ' N ' ' A' ' 356' ' ' ARG . 76.9 mmm -100.06 -51.55 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 1.6 t30 -39.49 103.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 97.66 18.24 28.43 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.501 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 353' ' ' MET . 0.0 OUTLIER -99.04 118.11 35.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.324 . . . . 0.0 110.883 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . 0.503 HD13 ' N ' ' A' ' 362' ' ' PRO . 20.7 mm -85.89 133.75 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.178 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 84.4 t -118.05 -41.99 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -126.26 -65.18 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.065 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.7 p -134.52 -53.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.11 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -101.58 154.22 37.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.569 0.7 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.503 ' N ' HD13 ' A' ' 357' ' ' ILE . 63.1 Cg_endo -78.17 143.46 20.09 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.585 ' O ' HG23 ' A' ' 365' ' ' VAL . 61.8 mt -75.11 90.92 2.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -61.38 99.73 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 363' ' ' LEU . 40.8 t -106.8 141.58 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -161.37 157.8 25.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.059 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 30.8 mt -63.58 141.79 58.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.93 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.089 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.401 HG11 ' HB3' ' A' ' 367' ' ' LEU . 95.9 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.819 0.342 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 343' ' ' PRO . 22.9 m -87.75 -35.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.148 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.42 129.96 43.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.69 HD22 HG22 ' A' ' 350' ' ' VAL . 60.1 mt -118.44 136.3 53.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -94.11 125.96 39.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 310' ' ' LEU . 57.7 t -110.29 143.55 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.154 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.519 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 14.1 ttmm -144.49 164.57 30.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . 0.519 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.5 m120 64.14 44.72 4.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 302' ' ' ASP . 25.5 mt -84.67 99.87 11.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 301' ' ' LEU . 30.0 m-20 -37.52 155.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -31.91 73.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -67.87 -38.32 89.06 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.498 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.583 HG22 ' N ' ' A' ' 306' ' ' ASP . 62.8 mt -56.94 162.94 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.851 0.358 . . . . 0.0 111.104 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.583 ' N ' HG22 ' A' ' 305' ' ' ILE . 8.7 t0 -149.28 -176.75 5.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -59.68 -41.82 91.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -64.86 -57.46 8.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.88 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 29.5 mtt-85 -47.06 -45.17 21.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 298' ' ' VAL . 50.4 tp -57.36 -71.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -49.73 -32.19 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -72.14 -33.73 67.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -85.74 19.31 2.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.059 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.496 ' CB ' HD11 ' A' ' 320' ' ' ILE . 8.2 m-85 -129.73 -30.19 2.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.899 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.18 -45.24 94.1 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.645 0.735 . . . . 0.0 110.866 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.1 Cg_exo -47.94 -16.69 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.71 2.273 . . . . 0.0 112.329 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -99.6 -54.35 2.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.871 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -158.37 170.75 35.11 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.446 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 49.4 m -65.2 144.24 57.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 111.113 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.496 HD11 ' CB ' ' A' ' 314' ' ' PHE . 48.5 mt -124.41 140.91 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 82.6 p -114.16 -46.73 2.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -121.55 111.0 16.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . 0.412 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -138.92 121.33 16.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -155.4 156.27 35.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 48.0 t -110.56 143.33 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . 0.551 ' HG3' ' CE2' ' A' ' 335' ' ' PHE . 38.7 mmt . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.9 0.381 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . 0.578 ' HD3' ' CZ ' ' A' ' 335' ' ' PHE . 28.9 mttm -50.89 -42.27 58.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 128.76 -31.23 3.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.537 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.578 ' CZ ' ' HD3' ' A' ' 333' ' ' LYS . 5.4 p90 -111.64 161.8 15.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.9 0.381 . . . . 0.0 110.881 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -155.37 -174.24 25.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.522 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -136.51 140.63 43.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.928 0.394 . . . . 0.0 110.841 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 51.5 t -136.93 131.52 46.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.164 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . 0.439 ' O ' HG23 ' A' ' 320' ' ' ILE . 4.7 m -111.33 141.33 45.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -115.75 171.85 7.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 62.7 p -71.73 -37.01 70.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.854 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 6.2 t -144.44 143.07 20.57 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.668 0.747 . . . . 0.0 110.828 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.496 ' N ' HG12 ' A' ' 294' ' ' VAL . 71.9 Cg_exo -46.49 -56.07 3.25 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.74 2.294 . . . . 0.0 112.317 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 344' ' ' GLU . 1.2 mp0 -37.21 -61.29 0.59 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -50.3 -43.38 53.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.736 ' O ' HG23 ' A' ' 350' ' ' VAL . . . -63.59 -41.01 98.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 86.2 m -49.29 -60.83 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -47.37 -60.46 2.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -42.51 -48.87 5.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 346' ' ' ALA . 47.1 t -41.49 -55.73 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.111 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 82.7 m -78.74 -55.75 4.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -44.18 -28.96 0.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.886 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 356' ' ' ARG . 79.3 mmm -100.2 -49.81 4.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 9.4 t30 -40.14 110.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 85.29 20.7 56.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.481 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 353' ' ' MET . 19.7 tpp180 -99.94 112.46 24.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.815 0.341 . . . . 0.0 110.885 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . 0.431 HD13 ' CA ' ' A' ' 362' ' ' PRO . 17.6 mm -77.67 150.49 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 95.3 t -132.52 -48.01 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.8 -68.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 19.0 p -130.79 -53.14 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.106 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -100.05 151.42 37.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.576 0.703 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.431 ' CA ' HD13 ' A' ' 357' ' ' ILE . 61.6 Cg_endo -76.58 155.95 35.9 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.706 2.271 . . . . 0.0 112.374 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 365' ' ' VAL . 32.9 mt -94.49 87.44 5.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.944 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -61.48 106.66 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.964 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 363' ' ' LEU . 47.8 t -113.91 134.63 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.104 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -155.27 145.32 21.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.137 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.401 ' HB3' HG11 ' A' ' 293' ' ' VAL . 77.9 mt -54.66 134.18 47.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.757 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 73.8 t . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.86 0.362 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.4 m -86.61 -37.11 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.623 ' O ' HD23 ' A' ' 296' ' ' LEU . 49.7 t30 -52.27 142.17 17.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.973 HD21 ' HB1' ' A' ' 346' ' ' ALA . 32.5 mt -135.48 132.64 37.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -102.08 113.02 25.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . 0.438 HG22 HG13 ' A' ' 365' ' ' VAL . 45.7 t -100.83 145.5 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.132 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 0.0 OUTLIER -132.4 165.84 23.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . 0.537 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 4.0 m-20 63.48 46.57 4.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.92 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.448 HD12 ' C ' ' A' ' 335' ' ' PHE . 32.8 mt -82.43 91.97 6.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.842 ' OD2' ' HB3' ' A' ' 359' ' ' ALA . 86.5 m-20 -36.05 132.09 0.54 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.86 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.58 -41.68 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -60.13 -36.19 89.83 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.468 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' A' ' 309' ' ' ARG . 75.5 mt -64.92 118.49 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.143 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -103.55 -175.74 2.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.37 -45.96 76.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -62.76 -48.96 76.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . 0.415 ' HB3' HG23 ' A' ' 305' ' ' ILE . 4.3 mmm180 -46.68 -49.66 18.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.534 HD12 ' CE1' ' A' ' 314' ' ' PHE . 43.2 tp -56.65 -73.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.416 ' HG3' HD12 ' A' ' 320' ' ' ILE . 15.8 ttp180 -46.89 -26.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -70.01 -41.72 73.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -88.9 21.35 3.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.058 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.565 ' HB3' HD11 ' A' ' 320' ' ' ILE . 8.2 m-85 -129.41 -29.96 2.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -55.38 -44.95 99.9 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.662 0.744 . . . . 0.0 110.883 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.7 Cg_exo -47.97 -16.57 0.59 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.747 2.298 . . . . 0.0 112.288 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -99.64 -51.87 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -163.68 166.07 37.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 64.4 m -67.2 137.91 56.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.785 0.326 . . . . 0.0 111.144 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.734 HG21 ' HB2' ' A' ' 323' ' ' ALA . 93.3 mt -109.65 142.15 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.165 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 70.3 p -111.74 -35.8 5.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.172 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -133.58 104.51 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . 0.734 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -134.58 122.48 22.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.084 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' A' ' 325' ' ' VAL . 44.0 tttp -156.72 152.52 27.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.413 ' N ' ' HG2' ' A' ' 324' ' ' LYS . 59.4 t -107.44 140.33 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . 0.545 ' HG3' ' CE2' ' A' ' 335' ' ' PHE . 34.4 mmt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 89.8 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.918 0.389 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -71.24 -58.13 3.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 139.95 35.76 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.516 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.545 ' CE2' ' HG3' ' A' ' 326' ' ' MET . 25.7 p90 -174.95 163.65 3.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 0.0 110.857 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -162.09 -179.77 36.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -123.88 139.24 54.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 110.897 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.418 HG11 ' CD2' ' A' ' 314' ' ' PHE . 29.9 t -134.59 127.72 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.169 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . 0.548 ' O ' HG23 ' A' ' 320' ' ' ILE . 68.8 m -111.93 134.38 53.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.902 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.534 ' HE1' HD12 ' A' ' 296' ' ' LEU . 43.4 m-85 -111.39 177.18 4.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 6.4 t -78.21 -35.52 48.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.9 t -141.61 141.71 23.56 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.62 0.724 . . . . 0.0 110.885 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.65 -53.65 5.85 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.692 2.261 . . . . 0.0 112.327 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -40.82 -63.74 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -46.09 -44.22 15.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.863 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.973 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -59.15 -59.58 5.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.076 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 28.7 m -41.58 -56.05 2.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.424 ' NZ ' ' HG3' ' A' ' 352' ' ' GLU . 2.3 tmtm? -45.84 -56.31 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -54.51 -51.12 66.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.068 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.419 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 91.9 t -39.38 -53.21 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.143 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 86.7 m -75.29 -59.28 2.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.424 ' HG3' ' NZ ' ' A' ' 348' ' ' LYS . 3.9 mm-40 -49.08 -18.84 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 90.0 mmm -107.28 -35.14 6.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.459 ' OD1' ' C ' ' A' ' 354' ' ' ASN . 5.4 t-20 -59.1 96.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 112.47 -15.86 24.53 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 17.6 tpp85 -73.27 110.19 7.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 20.5 mm -68.12 151.2 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.26 -39.46 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.115 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . 0.842 ' HB3' ' OD2' ' A' ' 302' ' ' ASP . . . -133.22 -71.36 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.095 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 4.9 p -128.96 -55.05 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.95 153.45 37.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.558 0.694 . . . . 0.0 110.873 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.1 153.49 46.61 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.719 2.279 . . . . 0.0 112.332 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 30.5 mt -87.77 99.44 12.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -79.24 91.39 4.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.96 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.438 HG13 HG22 ' A' ' 298' ' ' VAL . 4.2 t -95.33 141.33 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.127 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -159.84 142.98 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.078 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 24.4 mt -52.99 153.43 3.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.094 179.793 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 293' ' ' VAL . 6.5 p . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.855 0.359 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.02 -21.51 5.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.095 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.1 152.05 38.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.69 HD21 ' HB1' ' A' ' 346' ' ' ALA . 14.7 mt -143.87 134.21 24.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -101.85 120.47 40.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.25 145.5 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.113 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.484 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 13.4 ttmm -136.58 162.68 32.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . 0.484 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 6.8 m-20 62.59 51.11 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.543 HD12 ' C ' ' A' ' 335' ' ' PHE . 28.0 mt -88.86 104.52 17.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.452 ' H ' HD12 ' A' ' 305' ' ' ILE . 12.6 t70 -45.92 162.05 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.872 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -64.2 -38.87 92.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.26 -40.59 99.2 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.494 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . 0.452 HD12 ' H ' ' A' ' 302' ' ' ASP . 59.9 mt -57.41 132.64 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 111.176 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.23 -174.82 3.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -49.86 -46.38 51.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -60.69 -61.13 2.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -41.8 -46.05 3.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.895 HD21 HG22 ' A' ' 338' ' ' VAL . 20.4 tp -52.23 -75.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.948 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.721 ' HD2' ' HB3' ' A' ' 323' ' ' ALA . 19.4 mtp180 -53.22 -24.72 11.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -67.58 -39.96 84.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -97.79 19.74 13.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.063 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.554 ' CB ' HD11 ' A' ' 320' ' ' ILE . 7.1 m-85 -127.29 -29.72 2.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.584 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.8 OUTLIER -57.7 -45.61 99.81 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.704 0.764 . . . . 0.0 110.905 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.2 Cg_exo -47.98 -16.63 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.634 2.222 . . . . 0.0 112.377 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . 0.49 ' CE2' ' HG2' ' A' ' 353' ' ' MET . 50.0 m-85 -99.61 -46.92 5.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -165.05 166.31 38.14 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 33.9 m -67.33 133.6 49.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 111.141 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 339' ' ' CYS . 37.7 mt -110.37 139.58 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 41.6 p -109.85 -36.24 5.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 71.0 m -137.42 126.81 24.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . 0.721 ' HB3' ' HD2' ' A' ' 311' ' ' ARG . . . -156.46 119.25 4.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.068 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -150.24 132.25 15.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 49.9 t -82.22 125.2 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.153 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 20.8 mmm . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.878 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 29.9 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.934 0.397 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -53.72 -52.04 61.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 137.63 34.16 0.2 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.543 ' C ' HD12 ' A' ' 301' ' ' LEU . 4.0 p90 -175.39 156.38 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -154.47 172.45 32.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.508 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -117.22 139.41 50.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.895 HG22 HD21 ' A' ' 310' ' ' LEU . 24.1 t -133.85 149.29 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.172 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . 0.584 ' O ' HG23 ' A' ' 320' ' ' ILE . 20.9 t -132.76 134.23 44.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.838 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.501 ' CE1' HD12 ' A' ' 296' ' ' LEU . 6.5 m-85 -113.24 172.46 6.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.882 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.4 p -78.98 -47.94 15.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 54.8 m -121.37 136.12 25.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.691 0.757 . . . . 0.0 110.83 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 346' ' ' ALA . 71.5 Cg_exo -45.87 -63.01 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.72 2.28 . . . . 0.0 112.357 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 343' ' ' PRO . 49.0 tt0 -36.2 -53.62 0.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -52.36 -44.4 65.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.69 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -64.29 -41.91 96.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.08 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 98.1 m -50.77 -64.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 349' ' ' ALA . 31.8 tttm -43.09 -62.91 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.902 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.27 -53.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.108 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.562 HG22 HD22 ' A' ' 296' ' ' LEU . 93.6 t -38.2 -60.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 62.5 m -75.14 -55.27 5.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.444 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 23.5 mm-40 -44.8 -26.26 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . 0.49 ' HG2' ' CE2' ' A' ' 317' ' ' PHE . 83.3 mmm -102.19 -62.03 1.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -40.66 107.22 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 116.15 -5.88 19.65 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -95.74 125.78 40.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 0.0 110.871 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . 0.405 HD13 ' CA ' ' A' ' 362' ' ' PRO . 7.8 mm -85.7 150.31 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.131 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 95.6 t -132.23 -41.06 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -126.64 -71.91 0.67 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.093 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 16.5 p -131.63 -50.16 0.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.18 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.86 152.14 39.51 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.555 0.693 . . . . 0.0 110.909 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.405 ' CA ' HD13 ' A' ' 357' ' ' ILE . 60.5 Cg_endo -74.48 146.77 35.43 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.699 2.266 . . . . 0.0 112.324 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.497 ' O ' HG23 ' A' ' 365' ' ' VAL . 37.3 mt -77.22 88.95 3.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -66.34 94.56 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 363' ' ' LEU . 17.2 t -97.12 150.95 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -164.3 166.24 21.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 58.7 mt -71.32 143.61 50.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.803 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.539 HG11 HD13 ' A' ' 367' ' ' LEU . 6.1 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.874 0.368 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 25.2 m -115.79 -23.98 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -67.13 104.13 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.697 HD22 HG22 ' A' ' 350' ' ' VAL . 45.6 mt -94.85 133.79 38.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.617 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 25.7 t80 -96.45 114.06 25.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.6 t -98.62 139.44 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.114 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.51 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 24.5 tttt -137.33 163.94 29.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . 0.51 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 6.4 m-20 63.19 49.38 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 25.0 mt -87.8 114.88 24.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.36 140.47 27.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -50.5 -42.31 54.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.812 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.26 -30.08 66.96 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.463 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 95.8 mt -72.62 130.78 35.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.34 . . . . 0.0 111.126 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -114.33 -179.11 3.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.96 -45.71 67.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.4 -54.12 47.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -47.03 -47.59 22.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.737 HD11 HG21 ' A' ' 338' ' ' VAL . 16.6 tp -53.96 -75.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . 0.438 ' HG3' HD12 ' A' ' 320' ' ' ILE . 33.5 ttt180 -49.2 -25.4 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -78.81 -32.82 46.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.9 15.72 10.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.083 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.6 ' CZ ' ' SD ' ' A' ' 353' ' ' MET . 10.7 m-85 -128.79 -28.49 2.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -50.25 -46.07 83.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.679 0.752 . . . . 0.0 110.859 -179.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 315' ' ' SER . 63.8 Cg_exo -47.92 -16.89 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.688 2.259 . . . . 0.0 112.367 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -99.66 -41.49 7.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.52 169.0 36.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.492 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 97.0 m -83.21 96.48 8.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.81 0.338 . . . . 0.0 111.17 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.458 HD11 ' CB ' ' A' ' 314' ' ' PHE . 93.5 mt -65.55 145.9 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 73.5 p -117.34 -28.52 6.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.125 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 3.0 p -152.83 109.38 3.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -131.72 142.56 49.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.093 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -154.08 170.24 21.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.13 121.55 54.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.145 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . 0.544 ' HB2' ' CE2' ' A' ' 335' ' ' PHE . 10.2 mmm . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 333' ' ' LYS . 20.2 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.929 0.395 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . 0.473 ' HD3' ' CE1' ' A' ' 335' ' ' PHE . 18.3 mttm -34.57 -55.22 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 128.62 29.95 0.73 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.471 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.544 ' CE2' ' HB2' ' A' ' 326' ' ' MET . 43.7 p90 -164.74 157.15 16.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 0.0 110.907 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -159.63 -167.05 19.73 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.458 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -135.13 122.19 21.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.928 0.394 . . . . 0.0 110.872 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . 0.737 HG21 HD11 ' A' ' 310' ' ' LEU . 46.5 t -116.18 98.1 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.122 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . 0.422 ' O ' HG23 ' A' ' 320' ' ' ILE . 1.7 m -86.9 135.84 33.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . 23.1 m-85 -107.88 178.0 4.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 7.2 t -82.69 -36.48 25.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.813 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.9 m -133.57 133.92 23.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.681 0.753 . . . . 0.0 110.85 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.26 -59.58 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.725 2.283 . . . . 0.0 112.337 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -38.75 -57.32 1.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -54.29 -45.93 72.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.623 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -59.33 -46.89 87.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.066 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 348' ' ' LYS . 14.5 m -45.65 -63.86 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.152 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 347' ' ' THR . 3.9 ttpm? -37.51 -65.93 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -41.13 -53.7 3.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.697 HG22 HD22 ' A' ' 296' ' ' LEU . 46.2 t -39.75 -52.24 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.129 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 82.7 m -78.85 -56.91 4.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -46.69 -24.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . 0.6 ' SD ' ' CZ ' ' A' ' 314' ' ' PHE . 15.7 mtp -104.05 -43.99 5.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 6.8 t-20 -47.91 115.51 1.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 80.76 17.42 72.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.481 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -98.26 121.39 40.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.765 0.317 . . . . 0.0 110.853 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 9.2 mm -87.77 125.7 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.117 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.26 -59.53 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.164 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -109.01 -67.85 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.104 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 361' ' ' LYS . 2.3 t -134.87 -49.06 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.438 ' N ' HG23 ' A' ' 360' ' ' THR . 13.1 mtpp -99.79 151.24 37.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.568 0.699 . . . . 0.0 110.88 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.37 151.59 29.66 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.704 2.269 . . . . 0.0 112.355 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 32.9 mt -89.65 92.97 9.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -70.77 94.74 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.9 t -106.8 141.73 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.086 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -164.69 145.67 7.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.549 HD23 ' CD2' ' A' ' 296' ' ' LEU . 81.3 mt -56.68 137.83 53.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 97.8 t . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.864 0.364 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 343' ' ' PRO . 25.9 m -86.04 -36.9 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -54.72 136.59 45.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.89 HD21 ' HB1' ' A' ' 346' ' ' ALA . 40.6 mt -127.87 144.34 51.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -106.36 110.41 22.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.936 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.1 t -94.4 129.81 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.149 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.484 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 37.0 tttt -130.49 163.25 27.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . 0.484 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.5 m120 63.83 49.45 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.901 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.528 HD12 ' CA ' ' A' ' 335' ' ' PHE . 19.8 mt -87.12 105.98 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . 0.429 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 21.2 t70 -46.12 158.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.877 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -62.15 -37.52 85.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -67.02 -38.75 92.88 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.459 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 83.1 mt -61.65 112.69 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 111.138 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.19 -176.8 3.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.822 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.24 -62.6 1.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.4 ' O ' ' HD3' ' A' ' 312' ' ' LYS . 7.4 pt-20 -52.46 -47.53 66.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -47.28 -34.13 6.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.463 HD12 ' CE1' ' A' ' 314' ' ' PHE . 54.0 tp -77.68 -56.22 4.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -58.33 -24.65 60.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 308' ' ' GLU . 9.2 mptt -84.78 -22.82 29.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -95.18 16.21 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.125 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.463 ' CE1' HD12 ' A' ' 310' ' ' LEU . 7.9 m-85 -129.16 -29.12 2.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.593 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.8 OUTLIER -50.36 -45.54 83.75 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.65 0.738 . . . . 0.0 110.873 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.1 Cg_exo -48.04 -15.51 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.661 2.24 . . . . 0.0 112.342 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 352' ' ' GLU . 55.0 m-85 -99.13 -53.84 3.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.69 -179.1 37.06 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.437 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 28.9 m -74.52 143.39 44.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 111.129 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 339' ' ' CYS . 55.3 mt -115.45 152.53 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.149 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.411 ' N ' HG22 ' A' ' 320' ' ' ILE . 40.9 p -121.11 -41.2 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.5 t -137.38 119.42 15.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -146.35 126.62 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.081 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.474 ' HG2' ' N ' ' A' ' 325' ' ' VAL . 15.7 ttmm -159.99 151.1 19.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.474 ' N ' ' HG2' ' A' ' 324' ' ' LYS . 99.2 t -110.12 132.99 56.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 38.1 mmt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.934 0.397 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . 0.522 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 12.1 mmmt -53.55 -60.95 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.869 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 136.25 34.69 0.22 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.469 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.528 ' CA ' HD12 ' A' ' 301' ' ' LEU . 12.9 p90 -173.39 159.37 3.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -158.91 -171.95 25.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.498 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -135.14 141.1 45.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.36 . . . . 0.0 110.837 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 36.5 t -136.56 140.94 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.112 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . 0.42 ' O ' HG23 ' A' ' 320' ' ' ILE . 65.4 m -117.56 156.57 27.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -130.27 173.89 10.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 51.6 p -80.29 -40.99 25.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . 0.414 ' C ' HG12 ' A' ' 294' ' ' VAL . 22.9 m -130.62 139.23 34.97 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.649 0.738 . . . . 0.0 110.882 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.494 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.3 Cg_exo -47.44 -54.88 4.49 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.688 2.259 . . . . 0.0 112.316 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -41.28 -55.61 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -51.71 -43.75 62.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.862 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.89 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -64.15 -41.5 97.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.09 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 94.6 m -49.71 -63.6 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -47.07 -61.92 1.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -37.71 -50.25 1.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 346' ' ' ALA . 57.8 t -41.69 -55.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 90.2 m -78.7 -55.84 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 317' ' ' PHE . 18.8 mm-40 -44.08 -27.79 0.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . 0.412 ' CB ' HG21 ' A' ' 365' ' ' VAL . 86.4 mmm -101.83 -42.59 6.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 12.9 t-20 -58.14 96.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 121.92 -13.97 9.1 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.469 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -77.12 112.93 14.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.898 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . 0.543 HD13 ' CA ' ' A' ' 362' ' ' PRO . 13.3 mm -78.25 138.29 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.096 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.99 -65.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.112 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -100.79 -75.24 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' A' ' 361' ' ' LYS . 1.0 OUTLIER -123.5 -47.34 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.555 ' N ' ' CG2' ' A' ' 360' ' ' THR . 12.1 pttm -109.39 159.0 33.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.553 0.692 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.543 ' CA ' HD13 ' A' ' 357' ' ' ILE . 60.2 Cg_endo -80.24 154.04 21.7 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.671 2.247 . . . . 0.0 112.369 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 365' ' ' VAL . 31.4 mt -78.13 98.31 5.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -67.8 81.61 0.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 32.2 t -91.14 141.11 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.134 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -160.39 143.33 13.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.096 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.657 ' CD2' HG21 ' A' ' 350' ' ' VAL . 18.8 mt -59.87 141.48 55.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.906 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.801 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 70.9 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.882 0.372 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' VAL . . . . . 0.631 HG12 ' N ' ' A' ' 343' ' ' PRO . 25.8 m -104.02 -35.16 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.54 143.31 57.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.562 HD22 HG22 ' A' ' 350' ' ' VAL . 58.2 mt -131.29 144.99 51.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -99.62 123.47 43.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 17.6 t -107.22 134.75 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.163 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' LYS . . . . . 0.545 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 21.9 ttmt -134.3 165.99 23.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' ASN . . . . . 0.545 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.9 m-20 61.16 51.36 4.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 30.9 mt -91.85 107.54 19.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.39 141.36 24.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -48.4 -34.51 10.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.86 -37.06 94.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.538 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 49.5 mt -70.33 136.91 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 111.164 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -126.49 -178.75 4.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 307' ' ' ASP . 21.5 t0 -51.27 -47.29 62.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -58.44 -66.32 0.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -43.58 -42.1 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 63.2 tp -60.59 -69.35 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -52.32 -27.82 16.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -72.7 -27.52 62.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -95.28 19.23 11.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' PHE . . . . . 0.673 ' CB ' HD11 ' A' ' 320' ' ' ILE . 8.6 m-85 -129.69 -31.31 2.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.854 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' SER . . . . . 0.587 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.2 m -50.89 -45.78 87.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.711 0.767 . . . . 0.0 110.874 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.8 Cg_exo -47.99 -17.25 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.683 2.255 . . . . 0.0 112.314 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' PHE . . . . . 0.574 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 55.5 m-85 -100.05 -49.64 4.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -163.04 160.63 33.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.5 m -60.63 138.28 58.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.311 . . . . 0.0 111.18 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' ILE . . . . . 0.673 HD11 ' CB ' ' A' ' 314' ' ' PHE . 80.3 mt -114.89 130.73 68.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.9 p -103.62 -28.36 11.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 4.7 t -143.19 125.07 15.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -154.64 122.52 5.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -151.93 158.21 42.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.0 134.42 53.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' MET . . . . . 0.548 ' HG3' ' CE2' ' A' ' 335' ' ' PHE . 35.5 mmt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.5 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.008 0.433 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -46.93 -46.81 21.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.68 -28.46 3.39 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.507 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.548 ' CE2' ' HG3' ' A' ' 326' ' ' MET . 3.2 p90 -118.53 160.79 21.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.928 0.394 . . . . 0.0 110.875 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -153.44 -172.45 21.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.531 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -138.44 138.29 38.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.863 0.363 . . . . 0.0 110.884 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 30.9 t -130.27 143.79 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.121 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' CYS . . . . . 0.574 ' O ' HG23 ' A' ' 320' ' ' ILE . 84.3 m -121.6 143.09 49.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -118.19 175.59 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 23.2 t -83.85 -40.79 18.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 70.7 m -130.37 139.33 35.3 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.898 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' PRO . . . . . 0.631 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.2 Cg_exo -47.43 -56.15 3.32 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.694 2.262 . . . . 0.0 112.332 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -41.49 -54.68 3.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -50.55 -45.35 56.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 350' ' ' VAL . . . -61.93 -40.56 95.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.086 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 61.0 m -51.25 -65.7 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.166 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 349' ' ' ALA . 28.6 tttt -44.38 -64.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.06 -48.83 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.114 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 346' ' ' ALA . 49.1 t -42.79 -56.3 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 52.8 m -79.69 -50.71 10.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' GLU . . . . . 0.574 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 24.3 mm-40 -47.66 -29.39 2.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' MET . . . . . 0.601 ' HB3' HG21 ' A' ' 365' ' ' VAL . 75.9 mmm -101.66 -51.75 3.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 7.0 t-20 -35.77 112.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.833 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 87.98 18.87 55.23 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.499 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 353' ' ' MET . 16.5 tpp180 -96.94 126.95 42.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.867 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' ILE . . . . . 0.405 HD13 ' CA ' ' A' ' 362' ' ' PRO . 11.3 mm -93.27 142.62 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 64.6 t -131.84 -38.81 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.65 -72.68 0.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 2.5 p -131.71 -52.22 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.167 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -101.85 153.91 37.66 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.564 0.697 . . . . 0.0 110.931 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.405 ' CA ' HD13 ' A' ' 357' ' ' ILE . 61.1 Cg_endo -75.84 146.38 29.71 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.671 2.248 . . . . 0.0 112.333 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' LEU . . . . . 0.509 ' O ' HG23 ' A' ' 365' ' ' VAL . 43.1 mt -81.68 96.3 7.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -64.52 97.38 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' VAL . . . . . 0.601 HG21 ' HB3' ' A' ' 353' ' ' MET . 37.0 t -103.19 125.35 57.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.153 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -150.6 150.81 31.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' LEU . . . . . 0.529 HD21 HG21 ' A' ' 350' ' ' VAL . 49.5 mt -60.67 139.37 57.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.051 179.824 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.6 m -151.42 123.65 8.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.839 0.352 . . . . 0.0 110.831 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 57.8 m -143.64 174.46 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 174.94 148.77 6.85 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.505 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 2.5 t -104.81 126.23 51.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 0.0 110.857 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 58.5 m -132.63 175.26 9.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.73 69.66 0.45 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.5 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 287' ' ' ARG . 1.2 m-20 -64.53 -51.35 63.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.817 0.342 . . . . 0.0 110.85 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 286' ' ' ASP . 16.8 ptp180 35.49 38.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.507 HD12 ' C ' ' A' ' 288' ' ' ILE . 2.3 pp -83.92 -2.22 6.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.3 t -64.21 139.17 58.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.16 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -171.46 150.47 2.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -50.19 168.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.962 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -59.83 95.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.94 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 83.9 t -128.63 103.13 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.136 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 343' ' ' PRO . 15.4 m -108.72 -26.25 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.135 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -65.59 128.57 36.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.623 ' CD2' HD23 ' A' ' 367' ' ' LEU . 38.5 mt -118.93 145.97 45.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -106.12 115.6 30.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.408 HG21 HD11 ' A' ' 310' ' ' LEU . 58.8 t -103.04 133.13 47.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.554 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 22.1 tttm -130.81 166.39 20.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . 0.554 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 6.7 m-20 63.58 54.55 1.87 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 40.9 mt -91.45 105.44 17.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.949 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -51.4 145.05 9.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.859 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -52.08 -34.01 41.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.913 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -67.55 -35.16 85.99 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.443 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.79 123.92 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.836 0.35 . . . . 0.0 111.121 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -116.0 171.32 7.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.827 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -38.02 -68.38 0.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -40.88 -56.5 2.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -45.91 -58.51 3.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.408 HD11 HG21 ' A' ' 298' ' ' VAL . 64.1 tp -52.7 -62.74 1.45 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.405 ' HG3' ' HB3' ' A' ' 323' ' ' ALA . 2.1 tmm_? -55.86 -24.56 37.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -81.67 -22.2 37.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -96.21 15.12 21.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.1 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.613 ' CD2' HG11 ' A' ' 338' ' ' VAL . 6.2 m-85 -123.73 -32.38 3.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.888 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.7 OUTLIER -50.36 -45.87 83.81 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.627 0.727 . . . . 0.0 110.887 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.4 Cg_exo -47.97 -17.34 0.78 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.724 2.282 . . . . 0.0 112.342 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -100.07 -52.32 3.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.88 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.07 168.26 37.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.486 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 61.6 m -61.88 147.9 45.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 0.0 111.105 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 339' ' ' CYS . 30.9 mt -125.1 134.05 67.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.115 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 71.8 p -110.72 -33.2 6.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.137 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -134.37 109.74 8.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -145.03 122.49 11.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.075 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -160.46 153.33 21.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 93.7 t -111.65 136.86 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 33.4 mmt -70.04 127.04 31.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 35.1 mmm -125.19 140.8 52.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.67 34.31 1.35 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 68.94 85.63 0.11 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.466 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 111.07 -41.2 2.3 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.474 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 19.9 mmm-85 -121.58 167.16 13.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.339 . . . . 0.0 110.845 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 333' ' ' LYS . 68.0 p -101.02 109.11 20.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.496 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 11.8 mmtp -35.7 -58.75 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.8 27.79 0.58 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.508 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.496 ' CE1' ' HB3' ' A' ' 333' ' ' LYS . 42.0 p90 -171.32 147.54 2.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.866 0.365 . . . . 0.0 110.915 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -146.33 -170.37 14.86 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.458 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -134.22 142.09 47.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.899 0.38 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.613 HG11 ' CD2' ' A' ' 314' ' ' PHE . 33.6 t -135.83 132.54 50.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . 0.561 ' O ' HG23 ' A' ' 320' ' ' ILE . 65.5 m -117.61 145.48 44.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.892 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.592 ' HE1' HD12 ' A' ' 296' ' ' LEU . 46.7 m-85 -116.79 174.21 6.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.857 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 4.2 t -75.58 -42.41 52.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.829 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 49.2 m -132.3 143.32 48.37 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.635 0.731 . . . . 0.0 110.917 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.429 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.0 Cg_exo -47.16 -58.24 1.85 Allowed 'Trans proline' 0 N--CA 1.465 -0.17 0 C-N-CA 122.737 2.291 . . . . 0.0 112.344 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -40.6 -56.17 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -53.81 -42.51 68.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.913 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.82 -43.95 91.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.078 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 47.0 m -48.59 -65.21 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.147 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.443 ' O ' ' C ' ' A' ' 349' ' ' ALA . 42.7 tttt -38.6 -64.97 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.888 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -34.52 -55.25 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.122 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.47 HG22 HD22 ' A' ' 296' ' ' LEU . 58.7 t -38.02 -52.84 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 56.0 m -80.6 -53.72 6.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.144 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -49.94 -19.19 0.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . 0.446 ' HB3' HG21 ' A' ' 365' ' ' VAL . 71.8 mmm -107.08 -59.85 1.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 353' ' ' MET . 9.1 t30 -36.3 111.01 0.12 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.895 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 99.01 9.62 51.51 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.478 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -95.86 118.84 33.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 110.89 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . 0.474 HD13 ' N ' ' A' ' 362' ' ' PRO . 11.0 mm -89.27 138.35 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 71.8 t -127.34 -43.64 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -116.43 -73.09 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.579 HG23 ' CD ' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -132.98 -47.62 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.579 ' CD ' HG23 ' A' ' 360' ' ' THR . 0.0 OUTLIER -108.14 156.9 37.56 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.63 0.728 . . . . 0.0 110.875 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.474 ' N ' HD13 ' A' ' 357' ' ' ILE . 62.6 Cg_endo -77.82 139.34 17.55 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.723 2.282 . . . . 0.0 112.341 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 365' ' ' VAL . 65.1 mt -69.47 101.08 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.933 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -68.43 96.82 0.71 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' A' ' 353' ' ' MET . 21.8 t -103.57 131.62 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.105 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -157.44 145.33 18.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.084 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.623 HD23 ' CD2' ' A' ' 296' ' ' LEU . 32.2 mt -63.0 138.87 58.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -95.53 86.83 4.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.059 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -38.49 -57.69 1.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -113.9 151.22 32.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.55 127.37 54.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.937 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -102.2 109.34 21.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.859 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -118.48 84.81 2.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.873 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -121.21 85.64 2.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -68.55 100.0 1.05 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 7.4 t -164.0 173.8 12.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.863 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -175.39 156.18 21.62 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.51 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.04 104.03 1.84 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.665 2.243 . . . . 0.0 112.391 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 77.3 p -60.95 91.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 2.5 m -161.93 163.39 29.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.833 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.485 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 5.5 m -101.56 110.16 22.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 110.883 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 30.6 t -112.04 140.56 46.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -178.45 -52.36 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.454 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 12.4 m -78.0 91.37 4.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.904 0.383 . . . . 0.0 110.864 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 73.0 m -125.48 83.73 2.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.826 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -56.75 130.16 50.07 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.484 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . 0.431 ' CB ' ' HE ' ' A' ' 287' ' ' ARG . 82.5 m-20 -117.41 -50.16 2.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.833 0.349 . . . . 0.0 110.896 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . 0.431 ' HE ' ' CB ' ' A' ' 286' ' ' ASP . 0.0 OUTLIER -77.68 84.0 4.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.903 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.631 ' O ' HD12 ' A' ' 288' ' ' ILE . 2.5 pp -86.67 143.84 10.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.144 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 72.2 p -82.25 140.35 33.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.103 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -107.59 -54.88 2.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.838 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.742 ' O ' HG23 ' A' ' 293' ' ' VAL . 62.7 m-85 -102.41 129.18 48.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -46.8 124.36 6.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 291' ' ' TYR . 58.6 t -129.64 92.81 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.158 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 343' ' ' PRO . 15.1 m -93.07 -34.99 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.086 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -59.01 140.76 55.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.76 HD21 ' HB1' ' A' ' 346' ' ' ALA . 35.6 mt -130.4 135.58 48.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -96.13 106.14 18.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 49.0 t -89.77 131.13 37.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.118 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.462 ' HG2' ' N ' ' A' ' 300' ' ' ASN . 20.5 tttt -135.22 161.82 34.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . 0.462 ' N ' ' HG2' ' A' ' 299' ' ' LYS . 11.1 t-20 74.5 37.87 0.53 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.415 HD12 ' CA ' ' A' ' 335' ' ' PHE . 46.8 mt -79.98 91.32 5.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.485 ' H ' HD12 ' A' ' 305' ' ' ILE . 3.5 t70 -46.26 148.62 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.42 -36.49 9.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.96 -40.62 98.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.509 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.485 HD12 ' H ' ' A' ' 302' ' ' ASP . 41.6 mt -65.99 140.81 18.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.855 0.359 . . . . 0.0 111.113 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -134.15 177.71 7.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.879 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -52.45 -41.66 63.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -65.96 -61.8 1.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 64.8 mtt-85 -49.3 -34.14 14.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.508 HD12 ' CE1' ' A' ' 314' ' ' PHE . 61.5 tp -67.61 -71.12 0.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 45.3 ttt-85 -50.44 -25.45 3.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 27.3 mttm -73.89 -30.26 62.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -94.16 20.28 8.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.128 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.898 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.0 m-85 -126.17 -30.77 2.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.1 t -56.12 -45.32 99.92 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.688 0.756 . . . . 0.0 110.878 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 315' ' ' SER . 66.1 Cg_exo -48.02 -17.04 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.718 2.279 . . . . 0.0 112.324 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 60.0 m-85 -99.93 -52.39 3.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.62 165.91 35.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.418 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.5 m -62.85 138.23 58.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.761 0.315 . . . . 0.0 111.145 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.898 HD11 ' HB3' ' A' ' 314' ' ' PHE . 82.0 mt -118.32 132.1 69.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.134 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 67.2 p -105.77 -40.48 5.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.141 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -126.51 111.14 14.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.81 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . 0.582 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -142.6 119.83 11.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.1 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.455 ' HD2' ' N ' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -153.56 162.36 41.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 78.4 t -121.72 142.98 35.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.136 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 34.1 mmt -68.39 95.58 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 71.3 mmm -109.2 121.2 44.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -145.95 119.42 9.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.904 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 83.86 57.21 2.45 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.476 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 38.45 40.33 0.93 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.443 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.51 169.36 24.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 110.857 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.8 t -106.6 118.83 37.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.825 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -52.2 -47.65 65.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.893 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 123.62 29.93 1.12 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.415 ' CA ' HD12 ' A' ' 301' ' ' LEU . 12.7 p90 -171.32 158.07 5.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.372 . . . . 0.0 110.868 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -161.45 -166.88 21.05 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.501 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -139.04 143.89 38.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 22.7 t -138.96 140.04 39.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 23.7 m -117.54 149.33 40.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -122.84 176.92 5.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.835 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 32.6 t -78.45 -39.2 39.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.885 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 27.2 m -136.87 143.19 41.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.683 0.754 . . . . 0.0 110.843 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.432 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.2 Cg_exo -47.35 -59.15 1.35 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.665 2.243 . . . . 0.0 112.347 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 343' ' ' PRO . 30.9 tt0 -37.63 -59.76 0.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -49.33 -41.39 38.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.76 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -65.08 -42.72 93.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.109 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.4 m -50.72 -67.81 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.167 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -40.55 -56.53 2.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 350' ' ' VAL . . . -44.4 -55.51 4.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.097 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.548 HG22 HD22 ' A' ' 296' ' ' LEU . 84.3 t -36.6 -58.48 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.136 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 353' ' ' MET . 35.2 m -75.94 -60.35 2.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.525 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 3.7 mm-40 -39.99 -27.9 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . 0.505 ' CB ' HG21 ' A' ' 365' ' ' VAL . 77.6 mmm -101.29 -42.33 6.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 26.1 t30 -60.15 106.28 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.859 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 113.92 -3.66 24.23 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.469 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 35.1 ttt-85 -98.88 144.24 28.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.818 0.342 . . . . 0.0 110.894 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . 0.402 HD13 ' CA ' ' A' ' 362' ' ' PRO . 8.3 mm -95.23 152.01 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.129 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.4 ' N ' HG22 ' A' ' 357' ' ' ILE . 45.1 t -131.95 -40.9 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.081 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -130.21 -66.82 0.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.093 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.0 -54.52 0.92 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.15 154.92 36.89 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.564 0.697 . . . . 0.0 110.875 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.402 ' CA ' HD13 ' A' ' 357' ' ' ILE . 61.4 Cg_endo -76.43 134.07 15.13 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 35.7 mt -66.16 123.92 21.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.941 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -95.96 89.44 5.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.919 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.505 HG21 ' CB ' ' A' ' 353' ' ' MET . 2.9 t -90.78 134.53 29.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.061 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -153.87 142.87 21.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.068 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 27.9 mt -60.79 144.88 51.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -105.26 80.02 1.55 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.113 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -46.38 -52.74 12.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -100.81 153.44 19.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -161.86 116.7 1.95 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.874 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -103.11 137.56 41.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.859 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -88.33 133.57 34.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.907 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 14.5 mmt180 -100.01 121.78 41.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.901 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -135.63 152.95 51.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 74.6 m -55.84 155.59 5.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -179.81 74.18 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.511 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.6 150.37 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.642 2.228 . . . . 0.0 112.363 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 72.0 m -150.71 154.68 37.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 1.1 t -153.71 164.01 39.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.853 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.474 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 42.5 t -107.6 99.76 9.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.869 0.366 . . . . 0.0 110.876 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 4.0 m -154.54 152.83 30.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -175.97 113.96 0.46 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.478 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 8.0 m -113.18 131.65 55.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 0.0 110.841 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 41.8 t -100.45 -47.26 4.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.824 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 115.33 124.4 3.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.533 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -84.24 87.97 7.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.776 0.322 . . . . 0.0 110.847 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 16.3 mmt85 -127.8 85.46 2.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 66.3 mt -140.78 130.94 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 82.5 p -98.61 167.41 10.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.141 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -123.56 -48.24 1.94 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -77.85 122.62 25.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -69.68 110.76 5.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 367' ' ' LEU . 84.0 t -119.13 93.39 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.133 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.8 m -93.25 -30.65 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -67.99 133.11 48.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.624 HD22 ' CG2' ' A' ' 350' ' ' VAL . 65.6 mt -121.94 135.84 54.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.668 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 39.5 t80 -94.27 119.93 33.77 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.938 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.411 HG21 HD11 ' A' ' 310' ' ' LEU . 59.3 t -104.14 137.71 31.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.163 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 10.8 tttp -137.22 161.78 35.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.938 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . 0.471 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.1 m120 63.79 53.84 1.9 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.862 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.487 HD13 HG22 ' A' ' 325' ' ' VAL . 32.0 mt -86.67 94.47 9.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.93 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -44.41 149.15 0.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.836 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.81 -36.3 62.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.91 -38.36 95.97 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.468 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 81.6 mt -73.58 121.9 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.836 0.351 . . . . 0.0 111.103 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -116.43 177.91 4.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.851 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -39.28 -46.25 1.52 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.436 ' O ' ' C ' ' A' ' 309' ' ' ARG . 0.2 OUTLIER -65.35 -69.57 0.29 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.925 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 308' ' ' GLU . 10.4 mmt180 -35.19 -36.49 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.492 HD12 ' CE1' ' A' ' 314' ' ' PHE . 47.8 tp -68.05 -75.12 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.447 ' HG3' ' HB3' ' A' ' 323' ' ' ALA . 2.6 tmm_? -48.85 -25.06 1.69 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -79.33 -32.64 43.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.99 21.03 2.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.094 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.624 ' CB ' HD11 ' A' ' 320' ' ' ILE . 8.8 m-85 -130.22 -30.41 1.95 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.597 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.1 t -53.1 -44.92 98.28 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.7 0.762 . . . . 0.0 110.872 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.4 Cg_exo -47.95 -17.59 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.685 2.257 . . . . 0.0 112.351 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -100.22 -54.9 2.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -159.28 163.67 33.51 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.462 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 44.5 m -61.31 143.27 55.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.727 0.298 . . . . 0.0 111.139 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.624 HD11 ' CB ' ' A' ' 314' ' ' PHE . 59.6 mt -117.69 149.37 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.122 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 61.9 p -117.27 -43.83 2.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.157 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 70.8 m -132.69 112.53 12.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . 0.447 ' HB3' ' HG3' ' A' ' 311' ' ' ARG . . . -141.01 119.55 12.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.174 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -153.45 147.78 25.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.487 HG22 HD13 ' A' ' 301' ' ' LEU . 49.0 t -89.87 118.58 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.121 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 335' ' ' PHE . 26.3 mmm -75.29 94.8 3.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.852 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . 0.466 ' CB ' ' HA ' ' A' ' 332' ' ' SER . 5.1 ptp -119.84 179.71 4.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -126.14 91.3 3.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 73.09 -110.31 3.1 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.518 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . 0.418 ' C ' ' HG3' ' A' ' 331' ' ' ARG . . . -108.89 35.36 4.99 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.418 ' HG3' ' C ' ' A' ' 330' ' ' GLY . 18.4 mtm-85 -147.46 115.21 6.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.826 0.346 . . . . 0.0 110.875 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.466 ' HA ' ' CB ' ' A' ' 327' ' ' MET . 47.1 t -71.25 99.0 1.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 14.5 mtmm -38.62 -45.8 1.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.891 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 121.01 43.05 0.46 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.493 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 326' ' ' MET . 2.0 p90 -175.53 160.57 2.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 110.881 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -156.97 177.0 34.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.509 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -127.74 132.74 49.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.871 0.367 . . . . 0.0 110.837 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 37.2 t -133.24 135.3 56.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 9.6 t -117.23 135.96 53.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . 10.9 m-85 -107.98 162.19 14.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.921 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 12.5 t -58.82 -46.92 86.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.85 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.14 146.1 58.31 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.654 0.74 . . . . 0.0 110.861 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' A' ' 344' ' ' GLU . 71.9 Cg_exo -46.16 -57.78 2.02 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.694 2.263 . . . . 0.0 112.356 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 343' ' ' PRO . 17.4 mm-40 -37.09 -64.7 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.413 ' N ' ' CD ' ' A' ' 345' ' ' GLU . 0.2 OUTLIER -49.09 -43.25 41.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.589 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -60.89 -48.05 83.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.102 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 75.1 m -46.08 -63.02 1.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.178 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 349' ' ' ALA . 1.3 ttmp? -40.65 -65.56 0.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.58 -54.93 0.87 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.114 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.624 ' CG2' HD22 ' A' ' 296' ' ' LEU . 59.3 t -41.43 -51.0 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.163 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 66.1 m -79.37 -58.0 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.118 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -45.78 -25.7 0.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.933 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 356' ' ' ARG . 65.3 mmm -102.16 -52.37 3.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 4.7 t-20 -34.25 111.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.916 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.04 20.98 58.28 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.497 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . 0.506 ' N ' ' O ' ' A' ' 353' ' ' MET . 17.5 tpp180 -98.05 123.33 42.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.883 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . 0.489 HD13 ' N ' ' A' ' 362' ' ' PRO . 10.9 mm -93.14 125.35 45.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.108 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 74.8 t -110.52 -51.63 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.133 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -113.22 -69.48 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.09 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 1.4 p -131.6 -53.23 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.099 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.65 153.37 37.95 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.589 0.709 . . . . 0.0 110.861 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.489 ' N ' HD13 ' A' ' 357' ' ' ILE . 62.6 Cg_endo -77.67 145.3 22.97 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.69 2.26 . . . . 0.0 112.344 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.518 ' O ' HG23 ' A' ' 365' ' ' VAL . 48.4 mt -82.74 92.08 7.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -66.82 100.52 0.72 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 363' ' ' LEU . 7.6 t -106.43 136.35 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -158.32 149.18 20.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.442 ' HB3' HG11 ' A' ' 293' ' ' VAL . 34.4 mt -59.31 137.28 58.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . 0.668 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . -114.41 122.48 46.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.148 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -74.49 131.78 41.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -133.71 162.69 31.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.858 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -170.25 105.04 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 44.18 41.66 4.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.939 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -73.96 -45.86 47.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.865 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.411 ' C ' ' HD2' ' A' ' 374' ' ' ARG . 6.4 tmm_? -110.48 109.32 19.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -127.3 127.08 43.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.903 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 5.9 t -141.61 128.65 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -178.29 75.78 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.498 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.02 168.03 24.07 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.671 2.248 . . . . 0.0 112.322 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 50.3 p -116.35 147.67 41.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.897 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 33.3 t -108.7 153.56 23.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.502 -179.967 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 69.6 m -76.77 145.78 38.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.936 0.398 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 43.2 t -81.89 148.12 28.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.831 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 173.49 138.63 2.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.503 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 29.8 t -159.09 148.81 18.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 110.885 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 7.7 t -127.2 83.88 2.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.846 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -169.23 120.71 0.89 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -148.08 122.75 9.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.804 0.335 . . . . 0.0 110.879 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -97.37 144.65 26.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 65.9 mt -125.72 104.95 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.126 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 24.9 m -90.39 91.34 8.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -57.8 -44.04 86.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.903 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -66.55 155.98 36.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -81.76 105.88 13.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 86.8 t -126.58 96.52 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.097 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 343' ' ' PRO . 29.0 m -95.88 -32.24 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.178 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -69.26 126.12 28.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.762 HD21 ' HB1' ' A' ' 346' ' ' ALA . 39.3 mt -114.6 140.17 49.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -95.59 121.16 36.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.725 HG21 HD11 ' A' ' 310' ' ' LEU . 67.0 t -103.01 133.53 46.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.127 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.481 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 26.8 tttm -133.82 162.49 31.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . 0.481 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.4 m120 63.77 48.27 3.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.907 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.501 HD21 HG11 ' A' ' 298' ' ' VAL . 28.9 mt -86.81 99.61 11.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -44.79 157.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -59.14 -42.18 90.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.53 -38.96 94.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.511 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.511 HD13 HD21 ' A' ' 363' ' ' LEU . 77.9 mt -65.92 132.33 31.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.896 0.379 . . . . 0.0 111.123 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -127.68 -174.93 3.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.867 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -46.96 -60.86 2.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.449 ' O ' ' C ' ' A' ' 309' ' ' ARG . 12.5 tt0 -49.65 -65.13 0.62 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.913 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 308' ' ' GLU . 9.8 mmt85 -34.4 -49.08 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.863 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.725 HD11 HG21 ' A' ' 298' ' ' VAL . 67.7 tp -55.42 -74.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 47.0 ttp180 -49.07 -25.05 1.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -74.47 -40.47 61.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.34 19.01 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.109 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.629 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.3 m-85 -127.36 -30.16 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.598 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.2 t -54.02 -45.0 99.16 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.688 0.756 . . . . 0.0 110.872 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.598 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.8 Cg_exo -48.03 -17.88 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.703 2.268 . . . . 0.0 112.351 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . 0.572 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 57.4 m-85 -100.45 -61.09 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.863 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -148.69 159.32 27.99 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.458 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.2 m -65.36 141.92 58.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.769 0.318 . . . . 0.0 111.157 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.831 HG23 ' O ' ' A' ' 339' ' ' CYS . 79.8 mt -120.26 135.41 60.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 66.4 p -99.45 -36.55 9.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.157 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.6 t -137.81 122.62 18.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . 0.456 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -137.16 124.18 21.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.062 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -150.67 149.81 30.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 335' ' ' PHE . 79.5 t -115.38 138.87 44.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.099 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 39.3 mmt -61.45 122.68 15.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . 0.58 ' HE2' ' C ' ' A' ' 331' ' ' ARG . 35.0 mtp -140.8 135.46 31.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -131.87 87.84 2.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 98.64 56.73 1.02 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.493 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 40.71 45.49 3.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.445 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . 0.58 ' C ' ' HE2' ' A' ' 327' ' ' MET . 50.6 ptt85 -152.49 129.57 11.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.864 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 82.2 p -65.3 114.73 4.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.411 ' HE2' ' CZ ' ' A' ' 335' ' ' PHE . 22.7 mtpt -65.24 -47.07 78.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.39 27.45 0.62 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.488 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.463 ' O ' HG13 ' A' ' 325' ' ' VAL . 7.8 p90 -174.98 165.72 3.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.883 0.373 . . . . 0.0 110.893 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -167.41 -163.31 21.06 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.519 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -144.16 138.98 28.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.893 0.377 . . . . 0.0 110.884 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.666 ' CG2' HD21 ' A' ' 310' ' ' LEU . 53.7 t -130.73 142.46 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . 0.831 ' O ' HG23 ' A' ' 320' ' ' ILE . 74.0 m -114.29 145.7 41.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.888 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -120.83 174.55 6.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.5 t -73.58 -42.0 62.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -141.85 145.88 38.49 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.645 0.736 . . . . 0.0 110.837 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.568 ' N ' HG12 ' A' ' 294' ' ' VAL . 71.5 Cg_exo -46.41 -56.18 3.15 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.699 2.266 . . . . 0.0 112.332 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.402 ' C ' ' O ' ' A' ' 343' ' ' PRO . 3.6 mm-40 -37.56 -63.52 0.45 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -47.75 -45.89 29.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.762 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -60.92 -44.06 97.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.113 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 92.8 m -45.9 -61.67 1.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.167 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 349' ' ' ALA . 15.4 ttmt -46.94 -61.95 1.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.878 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -37.52 -50.35 1.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.147 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.499 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 57.7 t -41.16 -57.84 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.113 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 94.2 m -77.48 -55.33 5.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.154 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.572 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 25.6 mm-40 -43.24 -30.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.868 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . 0.448 ' O ' ' C ' ' A' ' 354' ' ' ASN . 72.8 mmm -100.82 -53.66 3.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.9 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 2.9 t30 -34.02 115.95 0.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 81.03 27.18 50.84 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.478 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -99.98 118.24 35.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.868 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . 0.504 HD13 ' CA ' ' A' ' 362' ' ' PRO . 27.0 mm -91.51 117.49 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.173 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 97.0 t -106.83 -45.01 7.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.107 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -118.55 -72.83 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.093 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.0 p -132.14 -51.74 0.96 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.151 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -100.32 148.84 35.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.549 0.69 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.504 ' CA ' HD13 ' A' ' 357' ' ' ILE . 62.9 Cg_endo -77.97 137.34 15.58 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.702 2.268 . . . . 0.0 112.374 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.511 HD21 HD13 ' A' ' 305' ' ' ILE . 62.5 mt -74.5 91.93 2.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -64.19 105.15 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 363' ' ' LEU . 47.0 t -108.79 133.11 54.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.094 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -152.48 151.23 30.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.115 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 73.7 mt -58.79 136.49 57.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.929 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -98.68 172.73 7.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.081 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 8.0 tm0? -101.06 78.72 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.986 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 19.4 mmm-85 -145.83 158.51 43.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 31.5 mttp -106.73 -70.84 0.77 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -147.1 156.91 43.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -113.23 159.59 19.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -129.37 157.09 42.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.905 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -116.94 127.25 54.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 8.7 t -169.8 170.61 7.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -140.12 70.77 0.44 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.503 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.08 -179.08 5.08 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.715 2.277 . . . . 0.0 112.322 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 61.0 m -121.96 143.94 49.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.82 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 30.3 m -126.78 140.61 52.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.819 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.48 179.985 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 280' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 279' ' ' GLY . 92.8 p 35.61 44.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 0.0 110.888 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 66.1 m -140.07 162.13 35.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.85 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -174.57 160.33 29.61 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.525 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 2.6 m -148.57 170.81 17.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.855 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 78.2 p -133.38 172.31 12.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.884 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 136.32 109.39 0.97 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.484 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -173.0 169.26 4.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -109.32 166.99 10.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.849 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.478 HD12 ' C ' ' A' ' 288' ' ' ILE . 2.7 pp -114.17 151.6 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.16 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 68.6 p -118.34 95.42 4.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.106 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 23.3 mmm-85 -63.7 -45.71 88.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -75.14 107.33 7.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -53.58 123.55 12.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 2.8 p -141.66 119.47 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 343' ' ' PRO . 19.2 m -118.45 -25.12 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -77.21 143.85 38.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.651 HD12 ' CE1' ' A' ' 340' ' ' PHE . 35.4 mt -131.3 135.87 47.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -94.93 123.83 38.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.2 t -105.07 130.82 55.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.139 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.479 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 34.4 tttp -129.54 162.24 28.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.872 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . 0.479 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.8 m-20 63.86 52.25 2.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.582 HD12 ' C ' ' A' ' 335' ' ' PHE . 27.7 mt -93.51 91.16 6.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -40.52 135.34 1.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.851 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -41.08 -41.62 1.77 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -57.3 -38.72 88.04 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.506 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 57.8 mt -65.89 127.16 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.831 0.348 . . . . 0.0 111.168 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.4 178.51 4.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.828 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -54.8 -41.49 70.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.847 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -63.43 -57.61 9.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -42.36 -51.76 4.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.842 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.474 HD13 HD21 ' A' ' 301' ' ' LEU . 49.5 tp -57.28 -70.53 0.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 7.8 tmm_? -47.91 -27.63 2.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 10.7 mtpp -74.3 -32.06 62.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.891 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -91.66 18.4 7.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.129 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.746 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.3 m-85 -127.11 -29.56 2.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.882 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.594 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -54.51 -45.35 99.44 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.673 0.749 . . . . 0.0 110.858 -179.797 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.1 Cg_exo -47.92 -17.1 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.666 2.244 . . . . 0.0 112.38 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . 0.573 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 61.7 m-85 -99.87 -57.6 2.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -155.94 167.66 33.29 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.479 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 8.1 m -65.82 143.88 57.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.0 111.102 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.746 HD11 ' HB3' ' A' ' 314' ' ' PHE . 80.2 mt -123.81 139.43 50.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.7 p -110.74 -38.86 5.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.136 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 14.8 m -127.32 111.12 13.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . 0.557 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -145.4 126.01 14.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.161 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 12.5 tptm -165.05 149.73 9.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.895 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.534 HG22 HD13 ' A' ' 301' ' ' LEU . 93.7 t -98.13 139.47 20.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.146 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 37.7 mmt -72.97 96.14 2.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 88.6 mmm -92.64 169.95 10.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.86 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.27 107.59 2.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.862 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 58.6 -111.88 3.59 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.516 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -113.14 41.18 2.29 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.5 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -160.84 171.23 19.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 0.0 110.89 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 333' ' ' LYS . 37.6 t -115.45 108.66 16.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.532 ' HD3' ' CZ ' ' A' ' 335' ' ' PHE . 22.1 mtpp -35.14 -48.01 0.41 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.908 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 117.38 36.59 0.99 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.46 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.582 ' C ' HD12 ' A' ' 301' ' ' LEU . 13.3 p90 -174.47 164.45 3.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.91 0.386 . . . . 0.0 110.896 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -160.99 -166.78 20.4 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.519 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -134.4 144.37 48.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.866 0.365 . . . . 0.0 110.868 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 49.0 t -137.08 132.13 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . 0.427 ' O ' HG23 ' A' ' 320' ' ' ILE . 7.2 t -115.92 134.76 54.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.651 ' CE1' HD12 ' A' ' 296' ' ' LEU . 16.5 m-85 -110.86 170.19 8.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.916 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 47.9 t -79.97 -43.32 22.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.895 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 3.0 m -125.29 138.48 31.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.666 0.746 . . . . 0.0 110.84 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.485 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.1 Cg_exo -47.43 -60.02 1.03 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.643 2.229 . . . . 0.0 112.37 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 343' ' ' PRO . 42.6 mt-10 -37.44 -58.7 0.83 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -47.35 -45.06 24.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.626 ' O ' HG23 ' A' ' 350' ' ' VAL . . . -61.41 -43.18 99.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.071 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.7 m -51.07 -67.64 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.216 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 349' ' ' ALA . 26.3 tttt -41.32 -63.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.96 -52.93 0.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.641 HG22 HD22 ' A' ' 296' ' ' LEU . 60.9 t -40.06 -54.25 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.106 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 81.0 m -79.76 -54.49 5.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.149 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.573 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 17.5 mm-40 -46.42 -25.64 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . 0.435 ' O ' ' C ' ' A' ' 354' ' ' ASN . 73.4 mmm -104.26 -52.23 2.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.926 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 4.2 t-20 -34.89 110.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 91.88 25.88 21.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.505 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -99.76 119.99 39.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.827 0.346 . . . . 0.0 110.883 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 8.8 mm -90.66 127.49 43.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.173 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 67.1 t -116.68 -40.98 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.142 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.11 -70.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.128 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.3 p -132.03 -52.91 0.98 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.151 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -99.99 149.44 35.98 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.606 0.717 . . . . 0.0 110.875 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.57 136.81 17.69 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.721 2.281 . . . . 0.0 112.295 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 37.0 mt -66.85 100.35 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -73.75 95.4 2.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.403 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 52.7 t -96.95 144.05 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.077 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -157.96 171.7 19.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 28.4 mt -81.14 140.77 34.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.868 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -105.18 -61.41 1.48 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.102 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -67.87 137.18 55.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -97.05 -35.85 10.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.825 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -155.81 134.58 11.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.867 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -116.09 139.15 50.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.894 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -44.99 153.59 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.912 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 46.4 ttt180 -73.38 -66.05 0.74 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.865 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.39 178.39 9.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.921 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 64.5 p -161.82 129.79 4.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.829 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 137.6 146.19 5.04 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.458 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.17 156.48 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.702 2.268 . . . . 0.0 112.337 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 41.1 p -118.9 165.95 13.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.89 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 1.3 t -60.19 137.71 58.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.863 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.443 -180.0 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 4.0 m -99.01 160.68 14.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.856 0.36 . . . . 0.0 110.86 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 47.1 m -102.17 -55.93 2.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 70.98 -142.79 35.18 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.494 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 4.6 t -173.06 147.26 1.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.879 0.371 . . . . 0.0 110.809 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 41.9 m -96.61 160.44 14.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.881 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -175.77 115.97 0.55 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.507 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -161.56 160.33 28.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.806 0.336 . . . . 0.0 110.86 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 9.7 tpp85 -143.28 149.48 37.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.826 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 17.7 pt -129.23 135.34 62.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.137 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 14.8 t -174.94 152.41 1.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.182 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 43.9 mtt-85 -140.75 175.44 9.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.857 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -143.42 152.76 41.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.943 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -59.95 113.14 2.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 81.4 t -140.99 111.03 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.132 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.72 -25.22 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.134 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -75.38 128.25 34.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.657 HD21 ' HB1' ' A' ' 346' ' ' ALA . 46.1 mt -118.62 147.84 43.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 299' ' ' LYS . 31.8 t80 -106.76 115.51 30.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 31.8 t -100.46 127.95 52.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.155 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.445 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 42.9 tttp -129.16 160.88 31.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . 0.445 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.5 m120 63.78 50.48 2.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.679 HD21 HD13 ' A' ' 310' ' ' LEU . 24.1 mt -84.28 105.32 15.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.558 ' OD2' ' HB3' ' A' ' 359' ' ' ALA . 62.2 m-20 -45.19 137.42 4.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -44.97 -40.58 6.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -65.53 -37.97 94.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.479 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.61 107.6 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.822 0.344 . . . . 0.0 111.12 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -95.78 -176.46 3.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -51.22 -45.91 62.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.838 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -66.11 -54.14 29.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 7.1 mmt-85 -45.27 -42.99 10.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.837 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.679 HD13 HD21 ' A' ' 301' ' ' LEU . 54.0 tp -60.22 -70.29 0.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.925 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.421 ' NH1' ' HB3' ' A' ' 311' ' ' ARG . 19.3 ttp-105 -53.37 -23.82 10.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -67.96 -35.99 79.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -95.01 20.25 9.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.087 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.878 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.2 m-85 -126.48 -30.38 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.862 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.596 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.0 OUTLIER -57.29 -44.79 99.83 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.62 0.724 . . . . 0.0 110.829 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.7 Cg_exo -48.07 -17.02 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.683 2.255 . . . . 0.0 112.335 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 53.6 m-85 -100.24 -51.48 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.97 163.9 34.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.494 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.4 m -63.99 140.7 58.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.746 0.308 . . . . 0.0 111.124 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.878 HD11 ' HB3' ' A' ' 314' ' ' PHE . 90.9 mt -121.5 143.15 34.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.129 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 69.2 p -117.74 -42.19 2.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.156 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 65.4 m -115.47 105.89 13.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.845 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . 0.445 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -137.52 112.71 9.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.059 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 33.5 tptt -143.54 145.01 32.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.428 ' N ' ' HG3' ' A' ' 324' ' ' LYS . 49.0 t -110.16 117.48 54.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.146 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . 0.411 ' HB3' ' CD ' ' A' ' 333' ' ' LYS . 35.8 mmt -55.49 141.72 35.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.882 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . 0.441 ' N ' ' HD2' ' A' ' 333' ' ' LYS . 50.4 mtp -146.21 165.56 28.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.466 ' HG3' ' CG ' ' A' ' 333' ' ' LYS . 56.4 mt-10 -113.37 64.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.928 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 79.63 -41.35 2.32 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.509 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -152.37 -35.4 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.436 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -85.66 154.23 21.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 110.853 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 67.9 p -89.04 110.53 21.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.819 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.569 ' HB3' ' CE2' ' A' ' 335' ' ' PHE . 23.7 mttm -48.59 -52.3 23.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 122.33 33.47 0.89 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.508 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 333' ' ' LYS . 20.1 p90 -173.03 159.67 4.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.924 0.392 . . . . 0.0 110.864 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -162.08 -170.46 26.88 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.485 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -131.56 141.02 49.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.882 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 18.5 t -136.51 125.95 38.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.108 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 10.1 t -110.4 134.88 51.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.416 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . 9.4 m-85 -107.59 165.6 11.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.92 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 5.0 t -73.36 -39.75 64.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.87 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 68.4 m -127.01 139.5 35.24 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.663 0.744 . . . . 0.0 110.878 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.62 -60.5 0.85 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.715 2.276 . . . . 0.0 112.341 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -40.31 -57.67 1.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -46.87 -46.77 21.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.657 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -62.82 -42.65 99.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.081 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 56.5 m -53.2 -63.56 1.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.13 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 349' ' ' ALA . 37.8 tttt -43.64 -62.77 0.99 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -37.37 -51.65 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.12 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 346' ' ' ALA . 58.0 t -40.53 -55.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.151 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 73.4 m -78.74 -55.44 5.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.151 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.514 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 2.5 mm-40 -45.01 -27.86 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . 0.484 ' O ' ' CB ' ' A' ' 356' ' ' ARG . 82.3 mmm -102.49 -52.24 3.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.838 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 2.5 t30 -33.96 118.66 0.37 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 79.5 18.8 72.76 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.453 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . 0.484 ' CB ' ' O ' ' A' ' 353' ' ' MET . 22.4 tpp180 -100.12 125.79 46.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.752 0.31 . . . . 0.0 110.872 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 29.2 mm -88.59 139.88 16.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 90.7 t -128.35 -34.74 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.153 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.558 ' HB3' ' OD2' ' A' ' 302' ' ' ASP . . . -131.27 -69.76 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.049 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.68 -51.2 0.85 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.177 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.32 155.84 37.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.603 0.716 . . . . 0.0 110.886 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.77 142.67 20.4 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.369 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.587 HD21 HD23 ' A' ' 301' ' ' LEU . 34.4 mt -79.19 92.97 5.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.883 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -65.23 97.69 0.28 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 363' ' ' LEU . 7.6 t -101.17 145.11 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.104 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -158.95 154.64 26.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.093 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.63 140.66 58.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -119.2 100.64 7.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.115 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -114.21 41.59 2.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -88.59 -53.77 4.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.873 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 28.0 tttp -139.54 153.43 47.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -125.75 122.31 35.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.872 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.84 145.29 47.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -146.83 162.83 37.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -90.2 95.17 10.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.904 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 87.9 p -164.12 144.32 8.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.89 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 120.44 98.64 1.68 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.459 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.9 149.2 32.85 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.69 2.26 . . . . 0.0 112.393 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 18.3 m -100.48 133.7 44.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.858 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 34.8 t -164.64 164.63 21.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.868 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.449 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 93.1 p -94.88 123.28 38.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.812 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 3.2 m -67.62 -54.03 23.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.844 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 112.18 135.53 6.56 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.504 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 53.1 p -114.18 161.16 18.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 0.0 110.831 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 28.0 t -123.33 101.66 7.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.845 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 169.0 149.33 6.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.531 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -87.52 95.03 9.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.805 0.336 . . . . 0.0 110.87 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -67.88 -32.72 73.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 61.4 mt -49.47 100.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.121 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 57.8 m -148.7 127.15 12.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.101 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . 0.421 ' O ' ' CG ' ' A' ' 291' ' ' TYR . 59.9 mtp180 -128.1 96.54 4.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.859 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.421 ' CG ' ' O ' ' A' ' 290' ' ' ARG . 45.4 m-85 -161.6 129.9 4.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.917 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -89.16 115.76 26.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 88.1 t -130.63 111.69 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.132 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.461 HG23 ' SG ' ' A' ' 339' ' ' CYS . 24.2 m -108.85 -34.72 2.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.108 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -59.64 143.74 49.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.573 HD22 HG22 ' A' ' 350' ' ' VAL . 20.2 mt -134.7 153.38 52.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -115.3 118.81 34.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 56.7 t -100.19 137.06 28.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.076 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -138.92 155.71 47.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 74.78 39.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.477 HD21 HD13 ' A' ' 310' ' ' LEU . 33.9 mt -73.43 90.66 1.71 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.911 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -40.76 139.92 0.77 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.4 -41.58 9.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.862 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.85 -38.97 94.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.44 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 66.7 mt -66.52 143.69 15.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.856 0.36 . . . . 0.0 111.157 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -132.21 -175.03 3.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -57.79 -42.73 84.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -64.65 -63.81 1.03 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 74.5 mtt-85 -46.23 -44.56 16.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.477 HD13 HD21 ' A' ' 301' ' ' LEU . 47.5 tp -55.37 -75.08 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.617 ' HG3' HD13 ' A' ' 320' ' ' ILE . 58.7 ttp180 -48.95 -29.53 4.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.916 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -72.14 -33.68 67.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.87 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -85.98 20.35 2.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.446 ' HB2' HD11 ' A' ' 320' ' ' ILE . 8.4 m-85 -128.99 -30.73 2.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.83 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.81 -45.34 97.25 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.716 0.769 . . . . 0.0 110.882 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.6 Cg_exo -48.03 -16.73 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.664 2.243 . . . . 0.0 112.351 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 57.9 m-85 -99.84 -46.62 5.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -169.0 165.97 39.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.542 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 42.0 m -62.59 140.19 58.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 111.116 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.617 HD13 ' HG3' ' A' ' 311' ' ' ARG . 74.5 mt -109.92 145.56 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.112 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 82.4 p -109.98 -45.39 3.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.166 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 82.7 p -136.3 116.53 13.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.842 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . 0.576 ' HB3' ' HD3' ' A' ' 311' ' ' ARG . . . -135.2 123.46 23.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -150.61 152.4 33.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.881 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.475 HG22 HD22 ' A' ' 310' ' ' LEU . 55.2 t -112.34 130.17 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.149 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 37.5 mmt -75.48 113.63 13.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . 0.429 ' CB ' ' HA ' ' A' ' 332' ' ' SER . 4.4 ptp -151.37 169.56 21.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -134.3 112.17 10.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.934 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 64.06 -113.75 6.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.49 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -110.44 39.74 2.79 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.452 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -150.17 125.75 10.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.331 . . . . 0.0 110.853 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.429 ' HA ' ' CB ' ' A' ' 327' ' ' MET . 1.4 t -87.62 121.61 30.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.879 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.552 ' HB3' ' CE2' ' A' ' 335' ' ' PHE . 58.2 mttt -52.49 -61.47 2.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 136.9 37.58 0.17 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.466 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 333' ' ' LYS . 23.2 p90 -174.82 162.06 3.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.932 0.396 . . . . 0.0 110.907 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -159.27 -169.16 22.27 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.477 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -138.8 137.02 36.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.866 0.365 . . . . 0.0 110.912 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 48.8 t -138.04 136.48 44.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.149 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . 0.461 ' SG ' HG23 ' A' ' 294' ' ' VAL . 10.1 t -121.39 133.49 55.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.891 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.881 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . 11.4 m-85 -104.13 158.91 16.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.851 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 2.4 m -64.04 -43.07 96.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 71.0 m -125.38 136.97 28.96 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.67 0.748 . . . . 0.0 110.859 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.4 -56.87 2.69 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.648 2.232 . . . . 0.0 112.361 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -43.82 -61.33 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.882 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 62.0 mm-40 -47.66 -46.05 28.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.881 ' HB2' ' HB2' ' A' ' 340' ' ' PHE . . . -61.75 -41.18 97.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.062 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 31.4 m -51.49 -60.9 2.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.108 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -40.96 -58.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -46.48 -53.14 11.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.101 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.573 HG22 HD22 ' A' ' 296' ' ' LEU . 98.6 t -38.48 -58.69 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.162 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 72.4 m -75.36 -59.08 2.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.149 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.564 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 39.4 mm-40 -41.54 -28.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.9 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . 0.468 ' HG2' ' CE2' ' A' ' 317' ' ' PHE . 64.1 mmm -100.06 -40.63 7.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.9 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -46.1 109.07 0.16 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 84.44 21.93 55.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.468 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . 0.419 ' HD3' ' C ' ' A' ' 356' ' ' ARG . 0.0 OUTLIER -98.1 125.19 42.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.762 0.315 . . . . 0.0 110.862 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . 0.458 HD13 ' CA ' ' A' ' 362' ' ' PRO . 27.6 mm -89.42 127.26 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 66.3 t -113.38 -42.89 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.173 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -123.0 -74.36 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.089 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 5.2 p -128.9 -49.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.184 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 10.2 mtmm -105.14 150.15 38.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.574 0.702 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.458 ' CA ' HD13 ' A' ' 357' ' ' ILE . 61.5 Cg_endo -76.76 140.98 21.3 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.688 2.259 . . . . 0.0 112.331 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 32.4 mt -80.39 115.87 20.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -83.21 99.66 10.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.476 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 39.0 t -103.37 140.83 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -166.41 152.8 8.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.073 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 26.9 mt -65.93 132.48 48.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -79.37 173.84 12.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.072 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . 0.438 ' O ' ' C ' ' A' ' 370' ' ' ARG . 49.6 mt-30 -113.29 -42.21 3.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.92 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 369' ' ' GLN . 24.0 mmt-85 -34.51 -45.56 0.24 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.91 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.44 48.53 16.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.911 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.38 153.54 38.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.903 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -135.11 150.18 50.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -135.7 109.35 8.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.833 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -42.54 147.62 0.27 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.962 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 98.0 p -150.63 125.72 9.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.892 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -138.91 145.93 17.43 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.46 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.67 161.05 31.09 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.72 2.28 . . . . 0.0 112.303 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 4.1 m -165.58 176.54 8.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 32.6 p -111.82 99.51 8.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.51 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 4.3 m -115.89 166.67 11.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.918 0.389 . . . . 0.0 110.825 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 25.6 p -141.82 124.13 15.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 128.0 54.11 0.12 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.451 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 77.3 p -128.27 99.52 5.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.879 0.371 . . . . 0.0 110.843 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 43.4 p -143.02 160.72 39.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.845 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 133.78 87.75 0.31 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.508 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -149.43 141.96 24.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.808 0.337 . . . . 0.0 110.84 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -112.29 145.81 39.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 20.3 pt -136.84 164.78 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.572 ' HB ' ' CE2' ' A' ' 291' ' ' TYR . 36.9 p -150.99 109.09 3.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.157 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . 0.434 ' HB3' ' NH1' ' A' ' 290' ' ' ARG . 21.5 ttp-105 -87.56 89.67 8.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.85 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.572 ' CE2' ' HB ' ' A' ' 289' ' ' THR . 36.0 m-85 -141.65 163.12 33.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -77.37 82.24 3.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.953 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.493 HG21 HD22 ' A' ' 367' ' ' LEU . 1.8 p -120.03 112.87 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.13 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 343' ' ' PRO . 23.1 m -117.88 -26.8 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -74.12 114.94 13.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.816 HD21 ' HB1' ' A' ' 346' ' ' ALA . 38.4 mt -105.45 132.97 50.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.955 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.735 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 5.9 t80 -90.28 120.09 31.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.407 HG11 HD21 ' A' ' 301' ' ' LEU . 98.6 t -101.05 137.43 28.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.116 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.466 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 35.8 tttt -137.03 161.46 36.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . 0.466 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 3.0 m120 63.53 47.69 3.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.407 HD21 HG11 ' A' ' 298' ' ' VAL . 28.4 mt -80.23 102.46 9.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -45.9 143.9 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -52.39 -39.45 60.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -61.95 -37.11 93.85 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.489 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 81.6 mt -65.79 148.22 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.852 0.358 . . . . 0.0 111.136 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -137.36 179.78 6.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -52.52 -38.67 60.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 309' ' ' ARG . 16.4 mm-40 -68.63 -72.23 0.19 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.888 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . 0.411 ' C ' ' O ' ' A' ' 308' ' ' GLU . 61.0 mtt-85 -36.99 -38.89 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.528 HD12 ' CE1' ' A' ' 314' ' ' PHE . 44.0 tp -63.32 -70.72 0.2 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.45 ' HG3' ' CD1' ' A' ' 320' ' ' ILE . 46.3 ttt180 -50.85 -24.98 3.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -79.4 -32.96 43.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -87.47 18.88 3.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.081 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.528 ' CE1' HD12 ' A' ' 310' ' ' LEU . 8.4 m-85 -129.36 -30.92 2.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.874 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.584 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.7 OUTLIER -50.79 -45.65 86.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.634 0.73 . . . . 0.0 110.84 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.7 Cg_exo -47.94 -17.05 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.662 2.241 . . . . 0.0 112.353 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . 0.443 ' CE2' ' HG2' ' A' ' 353' ' ' MET . 54.4 m-85 -99.84 -47.45 5.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -166.14 158.61 31.59 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.484 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 40.8 m -60.7 139.13 57.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.738 0.304 . . . . 0.0 111.163 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 339' ' ' CYS . 46.7 mt -110.99 141.69 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.138 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 67.9 p -110.34 -40.39 4.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.068 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 3.5 m -132.12 121.24 23.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.883 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -132.98 125.18 29.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.102 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 22.2 mtpt -142.48 154.99 45.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.895 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 31.5 t -129.96 117.57 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.16 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 30.0 mmt -66.35 107.14 1.91 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 80.5 mtp -110.87 150.34 29.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.891 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -96.18 38.79 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.863 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 68.2 57.88 7.97 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.484 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 121.97 -40.46 2.07 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.478 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 20.3 mtm180 -115.44 102.93 10.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.842 0.353 . . . . 0.0 110.882 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 9.2 t -44.55 116.32 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.479 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 21.2 mtpp -46.96 -53.31 12.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 300' ' ' ASN . . . 132.59 33.36 0.39 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.469 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 333' ' ' LYS . 29.4 p90 -175.15 157.29 2.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -156.89 -161.38 10.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.497 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -142.46 131.65 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.386 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 61.7 t -127.36 134.25 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.136 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . 0.632 ' O ' HG23 ' A' ' 320' ' ' ILE . 7.3 m -110.26 138.78 46.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.86 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.486 ' CE1' HD12 ' A' ' 296' ' ' LEU . 28.8 m-85 -114.14 164.41 13.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.904 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.9 t -67.76 -46.51 71.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.888 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 3.5 m -130.69 142.67 46.37 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.638 0.733 . . . . 0.0 110.876 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 344' ' ' GLU . 72.8 Cg_exo -47.05 -59.34 1.28 Allowed 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.652 2.234 . . . . 0.0 112.36 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 343' ' ' PRO . 39.8 mt-10 -36.09 -61.83 0.47 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -46.87 -47.28 21.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.816 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -60.89 -41.02 95.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 90.1 m -50.13 -62.8 1.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 349' ' ' ALA . 27.0 tttm -46.52 -63.94 0.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.901 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.21 -48.96 0.65 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.071 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 346' ' ' ALA . 47.0 t -41.66 -56.42 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.187 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 92.9 m -79.58 -51.99 8.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.437 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 20.5 mm-40 -46.3 -29.44 1.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . 0.443 ' HG2' ' CE2' ' A' ' 317' ' ' PHE . 53.4 mmm -101.51 -52.71 3.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 1.8 t30 -34.22 116.23 0.29 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.921 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 82.7 25.57 49.58 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.523 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -100.05 118.27 36.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.723 0.297 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . 0.516 HD13 ' CA ' ' A' ' 362' ' ' PRO . 29.6 mm -86.73 126.43 40.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 94.9 t -112.18 -48.49 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.172 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -120.75 -68.24 0.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.067 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 6.0 p -130.88 -54.44 1.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.139 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.43 151.17 37.48 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.561 0.696 . . . . 0.0 110.882 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.516 ' CA ' HD13 ' A' ' 357' ' ' ILE . 63.0 Cg_endo -77.13 143.78 22.96 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.641 2.227 . . . . 0.0 112.353 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 365' ' ' VAL . 33.2 mt -78.68 91.97 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -64.32 101.82 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.47 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 50.8 t -105.66 134.49 47.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.122 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -154.54 153.65 31.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.065 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.493 HD22 HG21 ' A' ' 293' ' ' VAL . 79.4 mt -62.26 136.75 58.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . 0.735 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . -124.31 109.21 13.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.169 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -92.47 128.32 38.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.926 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 10.8 ttm105 -159.7 158.68 31.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.853 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -115.48 169.96 8.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 43.89 43.55 5.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 374' ' ' ARG . 7.5 pt-20 -45.15 -38.18 5.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.411 ' N ' ' HG3' ' A' ' 373' ' ' GLU . 15.9 tpp85 -174.93 127.82 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.1 108.79 2.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.897 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.5 m -151.15 166.99 29.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -136.04 95.61 0.25 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.457 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -77.99 38.81 0.71 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.718 2.279 . . . . 0.0 112.355 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 5.9 p -45.56 -28.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.824 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 12.3 t -113.46 105.55 13.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.536 -179.943 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 7.9 t -111.77 -52.31 2.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.917 0.389 . . . . 0.0 110.869 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 22.9 t -45.43 -45.41 12.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.891 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 46.97 56.02 7.99 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.443 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 3.5 m -72.8 90.16 1.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.929 0.395 . . . . 0.0 110.817 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.8 t -56.67 -60.37 3.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.864 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -132.73 141.05 12.37 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.476 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -43.96 -51.56 7.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.859 0.361 . . . . 0.0 110.85 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 16.2 mtp85 50.51 42.3 26.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.879 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 62.5 mt -91.96 -45.1 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 14.9 t -159.45 152.76 22.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.144 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -125.05 40.69 3.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -146.76 148.34 31.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.879 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . 0.438 ' CD ' ' O ' ' A' ' 292' ' ' GLN . 5.1 pp0? -78.64 118.17 20.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.869 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 99.6 t -126.49 93.53 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 4.6 m -93.85 -32.54 4.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -64.93 135.84 56.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.928 HD21 ' HB1' ' A' ' 346' ' ' ALA . 48.4 mt -122.33 137.73 54.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -98.75 106.56 18.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.937 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.2 t -90.3 135.75 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.164 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.492 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 17.3 ttmm -133.25 164.76 26.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.868 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . 0.492 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.7 m-20 63.77 45.34 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 28.4 mt -90.61 98.09 11.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -46.35 163.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.868 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -65.32 -36.62 84.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.853 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.26 -43.58 97.13 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.533 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 39.6 mt -60.91 147.49 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.807 0.336 . . . . 0.0 111.157 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -137.31 -176.82 4.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.823 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -60.14 -34.08 73.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.844 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -72.13 -62.25 1.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.878 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 65.4 mtt-85 -46.82 -42.78 17.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.455 HD12 ' CE1' ' A' ' 314' ' ' PHE . 61.2 tp -62.38 -71.95 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.921 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -48.43 -26.58 2.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 4.7 mtpm? -70.48 -33.69 71.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -92.35 18.94 7.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.108 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.472 ' CB ' HD11 ' A' ' 320' ' ' ILE . 6.3 m-85 -123.76 -31.16 3.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.8 OUTLIER -56.85 -45.48 99.95 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.643 0.735 . . . . 0.0 110.846 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.9 Cg_exo -47.95 -17.06 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 0.0 112.385 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . 0.58 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 62.0 m-85 -99.92 -48.91 4.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.864 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.26 168.08 37.11 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.455 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.3 m -64.37 139.39 58.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.787 0.327 . . . . 0.0 111.124 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.477 HG21 ' HB2' ' A' ' 323' ' ' ALA . 42.1 mt -115.85 133.93 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.085 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 75.2 p -108.15 -40.62 5.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.127 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.9 m -130.09 112.61 13.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.815 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . 0.477 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -138.65 124.31 19.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.122 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.447 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 19.2 tptm -163.63 146.55 9.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.94 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.447 ' N ' ' HG3' ' A' ' 324' ' ' LYS . 98.9 t -101.05 136.23 33.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.113 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 37.5 mmt -74.8 95.2 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 49.5 mtp -110.04 164.45 12.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.842 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -152.17 132.29 13.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.948 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 49.43 65.1 2.96 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.451 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 42.3 39.15 3.04 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.461 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 54.0 mtp180 -155.57 122.36 5.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.862 0.363 . . . . 0.0 110.881 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 5.6 t -75.85 121.53 22.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -58.11 -53.62 56.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.899 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 138.78 36.86 0.13 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.5 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -171.93 152.76 3.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 0.0 110.857 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -154.08 -174.11 23.85 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.519 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -133.62 143.74 48.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.898 0.38 . . . . 0.0 110.895 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 48.7 t -138.7 147.59 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . 0.424 ' O ' HG23 ' A' ' 320' ' ' ILE . 62.6 m -124.52 149.03 47.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.864 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -125.2 175.96 7.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 90.2 p -75.11 -29.79 60.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.873 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 43.4 t -156.75 145.05 14.42 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.717 0.77 . . . . 0.0 110.789 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 346' ' ' ALA . 71.3 Cg_exo -45.06 -54.01 4.71 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.693 2.262 . . . . 0.0 112.359 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -39.01 -37.92 0.41 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -76.2 -38.64 56.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.928 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -65.79 -45.39 82.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 87.5 m -49.3 -67.82 0.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.172 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.453 ' HG2' ' CG ' ' A' ' 352' ' ' GLU . 19.7 tttm -41.14 -60.71 1.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.915 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -40.8 -52.45 3.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 346' ' ' ALA . 66.2 t -39.47 -59.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 353' ' ' MET . 51.9 m -77.51 -59.6 2.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.159 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.58 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 30.9 mm-40 -37.44 -29.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . 0.468 ' N ' ' O ' ' A' ' 351' ' ' THR . 79.6 mmm -100.24 -61.3 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 353' ' ' MET . 8.0 t30 -36.8 101.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 125.68 -9.26 7.68 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.511 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.42 126.54 35.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 0.0 110.878 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . 0.437 HD13 ' CA ' ' A' ' 362' ' ' PRO . 23.4 mm -87.94 135.27 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.157 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 65.6 t -113.63 -54.54 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.11 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -116.08 -65.39 1.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.064 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.501 HG23 ' HD3' ' A' ' 361' ' ' LYS . 0.1 OUTLIER -133.76 -52.65 0.86 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.138 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.501 ' HD3' HG23 ' A' ' 360' ' ' THR . 0.0 OUTLIER -102.81 153.67 38.06 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.548 0.69 . . . . 0.0 110.893 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.437 ' CA ' HD13 ' A' ' 357' ' ' ILE . 60.0 Cg_endo -73.5 148.24 42.31 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.707 2.271 . . . . 0.0 112.324 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.477 ' O ' HG23 ' A' ' 365' ' ' VAL . 58.7 mt -70.8 93.61 0.97 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -68.08 88.28 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 363' ' ' LEU . 14.3 t -92.66 140.09 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.09 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -155.96 138.32 14.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.478 HD23 ' CD2' ' A' ' 296' ' ' LEU . 60.2 mt -57.76 141.45 48.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -101.71 94.01 5.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.121 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . 0.405 ' O ' ' C ' ' A' ' 370' ' ' ARG . 34.2 mt-30 -100.07 -32.45 10.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . 0.405 ' C ' ' O ' ' A' ' 369' ' ' GLN . 13.4 mtt85 -38.13 -51.91 1.43 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 14.6 tptt -170.49 131.77 0.94 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.841 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -91.07 159.91 15.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -91.35 100.81 13.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -160.35 131.86 5.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.874 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -80.88 134.0 35.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 31.5 m -130.92 -56.79 1.04 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 64.3 95.6 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.488 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -43.96 -51.52 6.41 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.709 2.272 . . . . 0.0 112.33 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 3.4 m -163.64 159.73 22.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.883 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 90.7 p -72.85 117.55 14.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.816 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.488 179.997 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.451 -0.259 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 16.4 t -127.4 140.93 51.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.935 0.397 . . . . 0.0 110.864 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 75.5 m -150.2 177.79 9.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.847 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 133.82 64.24 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.474 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 67.7 m -128.74 165.71 20.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.841 0.353 . . . . 0.0 110.905 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.6 t -103.3 -54.86 2.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.81 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 109.35 170.47 20.52 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.489 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -87.01 116.63 25.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.6 mmm180 -147.83 141.47 25.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 3.2 pt -128.07 133.56 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.123 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 57.5 m -142.05 107.64 5.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.179 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . 0.405 ' O ' ' CG ' ' A' ' 291' ' ' TYR . 7.8 mmt85 -122.96 79.41 1.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.405 ' CG ' ' O ' ' A' ' 290' ' ' ARG . 70.2 m-85 -157.14 159.62 37.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.935 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -93.25 95.43 9.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.922 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 98.6 t -132.89 95.02 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 343' ' ' PRO . 23.9 m -94.55 -23.82 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.175 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -78.35 137.92 38.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.831 HD21 ' HB1' ' A' ' 346' ' ' ALA . 36.2 mt -128.08 142.85 51.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.958 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.64 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 32.9 t80 -99.65 121.87 41.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.54 HG21 HD11 ' A' ' 310' ' ' LEU . 39.3 t -99.57 130.1 49.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.098 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . . . . . . . . . 16.0 tttm -128.44 157.56 40.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . . . . . . . . . 3.4 m120 63.83 54.94 1.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.511 HD21 HG11 ' A' ' 298' ' ' VAL . 28.3 mt -92.56 98.07 11.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.939 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 303' ' ' ASP . 14.8 t70 -50.24 131.42 23.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.851 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 302' ' ' ASP . 12.9 t70 -35.61 -49.86 0.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.892 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -48.35 -44.98 28.45 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 69.4 mt -63.73 143.15 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.826 0.346 . . . . 0.0 111.125 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.8 -175.76 4.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.828 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -52.74 -42.94 65.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.896 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -62.25 -70.25 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 66.7 mtt-85 -41.66 -40.73 2.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.54 HD11 HG21 ' A' ' 298' ' ' VAL . 43.2 tp -60.72 -70.92 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.653 ' HG3' HD12 ' A' ' 320' ' ' ILE . 54.6 ttt180 -53.2 -23.71 9.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -68.7 -37.97 79.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -91.82 20.09 5.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.098 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.626 ' CB ' HD11 ' A' ' 320' ' ' ILE . 7.1 m-85 -126.19 -30.34 2.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.864 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.589 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.0 OUTLIER -56.9 -45.52 99.95 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.664 0.745 . . . . 0.0 110.822 -179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 315' ' ' SER . 66.1 Cg_exo -48.0 -17.16 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.636 2.224 . . . . 0.0 112.354 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 48.6 m-85 -100.8 -52.84 3.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -145.72 170.62 26.94 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.464 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 26.4 m -85.93 95.19 9.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.814 0.34 . . . . 0.0 111.143 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.653 HD12 ' HG3' ' A' ' 311' ' ' ARG . 93.4 mt -62.07 143.59 15.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.181 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 39.1 p -112.13 -28.54 7.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 2.6 t -155.37 109.23 2.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . 0.481 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -123.19 135.77 54.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.135 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 3.2 ttpm? -156.57 152.7 27.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 86.7 t -115.96 139.18 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.101 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 35.9 mmt -70.72 136.99 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 18.4 mtp -133.91 178.17 7.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -116.15 -30.19 6.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.861 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 147.72 41.59 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.459 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 155.41 -42.61 0.57 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.479 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -127.7 159.97 33.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.831 0.348 . . . . 0.0 110.823 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 59.2 p -81.76 140.35 34.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.423 ' HD3' ' CZ ' ' A' ' 335' ' ' PHE . 19.0 mtpt -75.57 -60.77 2.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 149.14 37.72 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.525 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.488 ' CA ' HD12 ' A' ' 301' ' ' LEU . 34.9 p90 -174.02 150.09 1.56 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.899 0.38 . . . . 0.0 110.891 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -158.12 -169.0 21.19 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.479 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -136.34 143.22 43.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.942 0.401 . . . . 0.0 110.882 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 41.2 t -134.05 126.84 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.15 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 74.3 m -101.41 127.56 48.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.727 ' CE1' HD12 ' A' ' 296' ' ' LEU . 15.5 m-85 -101.76 168.14 9.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 25.1 t -78.36 -42.24 31.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.834 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.9 m -131.24 139.75 36.41 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.664 0.745 . . . . 0.0 110.875 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 344' ' ' GLU . 72.8 Cg_exo -47.43 -59.01 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.718 2.279 . . . . 0.0 112.332 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 343' ' ' PRO . 27.9 tt0 -36.39 -59.06 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.921 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.43 -48.11 56.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.91 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.831 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -55.88 -42.92 76.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.088 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 99.2 m -52.93 -67.15 0.27 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.19 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 349' ' ' ALA . 15.2 ttmt -40.85 -65.06 0.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.6 -48.24 0.51 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.112 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 346' ' ' ALA . 43.4 t -44.38 -52.66 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.116 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 53.1 m -81.79 -50.41 9.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.123 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.542 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 23.4 mm-40 -49.62 -28.13 5.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 356' ' ' ARG . 83.7 mmm -101.84 -49.0 4.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.902 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.492 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 3.5 t30 -36.1 110.53 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 87.75 19.83 52.74 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.507 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . 0.476 ' N ' ' O ' ' A' ' 353' ' ' MET . 21.8 tpp85 -99.11 120.97 40.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.746 0.308 . . . . 0.0 110.897 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 9.0 mm -87.11 130.92 36.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.145 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 85.2 t -116.43 -42.29 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.073 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -126.1 -69.23 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.098 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.11 -55.25 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.98 155.68 36.17 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.558 0.694 . . . . 0.0 110.942 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.18 135.55 15.34 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.68 2.253 . . . . 0.0 112.301 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 365' ' ' VAL . 28.0 mt -71.72 88.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -64.48 100.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.94 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 363' ' ' LEU . 28.8 t -100.09 135.25 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -153.94 143.16 21.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 71.7 mt -54.14 145.18 17.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.927 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . 0.64 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . -133.79 176.19 8.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.133 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 7.5 tm0? -84.51 128.57 34.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.865 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -94.67 156.33 16.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -107.83 160.56 15.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -78.76 -47.76 16.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.477 ' HG2' ' N ' ' A' ' 374' ' ' ARG . 29.9 tt0 -167.61 155.67 9.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.843 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . 0.477 ' N ' ' HG2' ' A' ' 373' ' ' GLU . 0.3 OUTLIER -153.34 132.37 12.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.869 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -122.75 140.09 53.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 82.5 p -59.96 -46.92 87.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 40.12 75.26 0.12 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.471 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.13 -20.22 13.02 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.655 2.237 . . . . 0.0 112.39 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 380' ' ' SER . 3.1 m -148.88 131.76 16.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.825 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 379' ' ' SER . 46.6 t -36.93 -53.79 0.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.896 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 72.3 m -68.09 -54.78 15.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.857 0.36 . . . . 0.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 3.5 t -110.88 159.21 17.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.88 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 150.4 50.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.444 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 8.9 t -85.68 153.31 22.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.868 0.366 . . . . 0.0 110.858 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 54.0 p -107.43 156.29 19.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 79.56 67.86 1.54 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.451 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -132.19 94.3 3.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.812 0.339 . . . . 0.0 110.829 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 60.8 mtp85 -85.04 112.85 21.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 21.0 mm -96.44 -55.64 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 14.6 t -147.7 145.3 28.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.85 -13.67 15.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -73.85 133.46 43.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.909 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -62.29 95.77 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.915 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 74.7 t -120.32 88.15 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.457 HG12 ' C ' ' A' ' 342' ' ' SER . 16.6 m -87.13 -30.39 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.077 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -69.63 123.21 20.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.668 HD21 ' HB1' ' A' ' 346' ' ' ALA . 69.1 mt -112.45 136.84 51.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.966 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -90.21 119.52 30.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.485 HG21 HD11 ' A' ' 310' ' ' LEU . 21.2 t -106.98 129.73 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.119 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.488 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 11.0 tttp -129.61 162.71 27.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . 0.488 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.4 m120 63.8 51.21 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 39.8 mt -85.85 99.41 11.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.933 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -46.91 144.26 2.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -47.45 -40.27 17.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -61.28 -36.82 93.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.503 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.591 HD13 HD21 ' A' ' 363' ' ' LEU . 66.9 mt -69.11 135.97 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.826 0.346 . . . . 0.0 111.14 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -136.18 -176.36 4.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -43.04 -63.3 0.83 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -47.06 -63.83 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.886 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -39.59 -52.5 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.515 HD21 ' CG2' ' A' ' 338' ' ' VAL . 53.1 tp -50.22 -74.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.96 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.723 ' HG3' HG21 ' A' ' 320' ' ' ILE . 19.3 ttt180 -54.2 -21.45 8.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -78.41 -29.51 47.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -99.91 17.96 19.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.075 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.806 ' CB ' HD11 ' A' ' 320' ' ' ILE . 8.0 m-85 -128.59 -30.39 2.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.588 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.73 -45.4 96.81 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.644 0.735 . . . . 0.0 110.82 -179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 315' ' ' SER . 66.0 Cg_exo -48.0 -17.13 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.67 2.247 . . . . 0.0 112.341 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . 0.419 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 52.0 m-85 -99.95 -50.11 4.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -145.91 169.19 27.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.509 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 90.4 m -81.86 88.19 6.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.725 0.298 . . . . 0.0 111.136 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.806 HD11 ' CB ' ' A' ' 314' ' ' PHE . 64.8 mt -65.56 131.57 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.151 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 3.1 t -108.75 -29.65 8.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.1 t -139.98 126.17 19.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -140.24 140.93 35.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.093 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 33.7 tttt -156.43 150.65 25.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 95.5 t -125.12 135.68 63.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 35.7 mmt -70.11 106.15 3.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 42.1 mtp -111.65 153.47 26.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.442 ' OE1' ' C ' ' A' ' 328' ' ' GLU . 0.0 OUTLIER -124.03 103.05 8.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 -179.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 65.88 -103.29 0.82 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.499 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -121.38 39.77 2.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.496 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -167.55 140.45 3.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 0.0 110.889 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.9 t -73.98 126.62 30.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.417 ' CG ' ' HB2' ' A' ' 328' ' ' GLU . 94.5 mttt -58.22 -56.31 23.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 141.14 36.9 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.471 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -174.2 161.37 3.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.92 0.391 . . . . 0.0 110.846 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -164.85 -167.83 26.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.492 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -144.2 136.13 26.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.902 0.382 . . . . 0.0 110.887 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.515 ' CG2' HD21 ' A' ' 310' ' ' LEU . 60.1 t -123.05 134.82 65.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.094 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 64.5 m -107.34 128.58 54.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.517 ' CE1' HD12 ' A' ' 296' ' ' LEU . 21.9 m-85 -105.03 160.86 14.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.851 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 95.7 p -67.42 -31.36 71.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.905 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.457 ' C ' HG12 ' A' ' 294' ' ' VAL . 4.8 t -148.48 143.41 17.33 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.681 0.753 . . . . 0.0 110.842 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 344' ' ' GLU . 72.9 Cg_exo -47.28 -58.97 1.42 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.636 2.224 . . . . 0.0 112.368 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 343' ' ' PRO . 22.4 mp0 -36.09 -64.94 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -44.8 -45.47 10.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.668 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -64.1 -42.51 96.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.137 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 97.2 m -45.8 -62.37 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.095 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 349' ' ' ALA . 44.4 tttp -48.41 -63.74 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.65 -48.06 0.51 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 346' ' ' ALA . 48.3 t -43.19 -54.93 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.106 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 85.8 m -80.65 -48.99 11.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.419 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 17.1 mm-40 -50.7 -26.65 5.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . 0.458 ' O ' ' N ' ' A' ' 356' ' ' ARG . 75.2 mmm -103.31 -50.36 3.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.853 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 3.5 t-20 -40.72 105.92 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 95.71 16.78 38.07 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 353' ' ' MET . 0.0 OUTLIER -98.04 122.0 40.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.762 0.315 . . . . 0.0 110.893 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . 0.42 HD13 ' CA ' ' A' ' 362' ' ' PRO . 23.4 mm -88.76 134.26 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.113 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 58.8 t -117.86 -59.83 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.13 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -105.72 -70.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.099 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 16.9 p -133.64 -47.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.163 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -104.32 154.85 38.01 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.567 0.698 . . . . 0.0 110.886 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.42 ' CA ' HD13 ' A' ' 357' ' ' ILE . 62.6 Cg_endo -77.7 144.07 21.8 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.674 2.249 . . . . 0.0 112.363 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.591 HD21 HD13 ' A' ' 305' ' ' ILE . 37.8 mt -81.02 92.6 6.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.935 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 51.5 t80 -61.45 102.65 0.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 363' ' ' LEU . 47.4 t -108.84 137.67 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.091 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -163.38 149.05 11.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.087 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 18.0 mt -60.5 148.38 37.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.929 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -113.84 174.8 5.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.105 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . 0.406 ' C ' ' HD3' ' A' ' 370' ' ' ARG . 24.9 mt-30 -150.85 151.4 32.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . 0.406 ' HD3' ' C ' ' A' ' 369' ' ' GLN . 1.6 mpp_? -140.26 174.51 10.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.913 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -125.15 110.63 14.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -87.29 -64.12 1.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -146.81 159.58 43.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.947 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 19.7 mmt85 -98.02 -58.05 2.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -62.37 147.19 49.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 5.6 t -99.9 -44.15 6.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 145.81 -162.93 28.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.514 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.6 101.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.716 2.277 . . . . 0.0 112.358 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 20.2 p -42.49 -42.27 3.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 43.6 m 49.69 43.29 24.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.489 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 47.5 t -110.56 -56.23 2.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.83 0.348 . . . . 0.0 110.828 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 20.1 m -60.53 114.29 2.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.854 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -131.49 46.78 1.05 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.443 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 33.8 m -131.22 156.32 45.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.916 0.389 . . . . 0.0 110.814 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 16.1 m -94.45 152.86 18.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.843 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.35 117.96 4.34 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.522 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -97.96 -56.93 2.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.844 0.354 . . . . 0.0 110.892 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -84.96 140.74 30.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 288' ' ' ILE . 5.1 mp -88.08 -48.13 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 68.9 p -110.12 44.75 1.18 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 29.1 ttt85 -55.4 -53.4 56.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.824 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -105.67 126.12 51.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.903 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -93.36 102.36 14.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.47 HG21 HD22 ' A' ' 367' ' ' LEU . 1.3 p -125.25 111.57 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.171 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.425 HG12 ' N ' ' A' ' 343' ' ' PRO . 10.1 m -112.12 -22.28 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -75.16 125.9 29.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.853 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.784 HD22 ' CG2' ' A' ' 350' ' ' VAL . 49.9 mt -111.37 145.03 39.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.888 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.612 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 24.5 t80 -110.99 105.53 14.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.896 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 39.1 t -89.5 137.14 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.168 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.564 ' HE2' ' CD1' ' A' ' 364' ' ' TYR . 17.7 ttpt -132.85 162.04 32.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . 0.47 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.8 m-20 64.02 51.72 2.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.874 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.524 HD12 ' C ' ' A' ' 335' ' ' PHE . 30.9 mt -90.39 106.63 18.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -52.31 150.29 4.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.842 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -56.64 -34.3 67.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.883 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -64.82 -39.73 96.8 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.497 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 60.7 mt -62.82 139.14 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.829 0.347 . . . . 0.0 111.123 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -128.32 174.74 9.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.83 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -49.12 -43.1 41.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -62.86 -64.68 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 58.5 mtt-85 -42.81 -34.33 0.92 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.541 HD12 ' CE1' ' A' ' 314' ' ' PHE . 59.5 tp -67.74 -75.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -48.28 -25.79 1.7 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -70.51 -36.1 73.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -93.82 20.54 7.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.088 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.714 ' HB3' HD11 ' A' ' 320' ' ' ILE . 7.3 m-85 -127.06 -29.69 2.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.85 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.636 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 2.7 t -58.05 -42.74 96.7 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.665 0.745 . . . . 0.0 110.887 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.636 ' CD ' ' N ' ' A' ' 315' ' ' SER . 63.4 Cg_exo -47.89 -17.21 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.67 2.247 . . . . 0.0 112.395 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -100.23 -51.94 3.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -158.31 175.65 35.42 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.447 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 92.0 m -77.39 134.25 38.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.728 0.299 . . . . 0.0 111.171 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.714 HD11 ' HB3' ' A' ' 314' ' ' PHE . 84.3 mt -110.32 138.36 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.13 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 82.8 p -108.24 -39.06 5.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.169 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 72.7 m -127.56 106.74 9.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.807 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . 0.677 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -131.32 114.37 14.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.084 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.432 ' HG3' ' N ' ' A' ' 325' ' ' VAL . 2.9 tppp? -146.82 145.01 29.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.896 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.432 ' N ' ' HG3' ' A' ' 324' ' ' LYS . 44.1 t -106.13 140.4 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 33.8 mmt -86.49 90.64 8.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.899 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 2.9 ptp -123.15 176.65 5.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.886 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.55 -62.01 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.841 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 177.78 36.86 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.485 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 166.29 -31.73 0.21 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.484 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 -133.77 116.74 16.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.789 0.328 . . . . 0.0 110.848 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.434 ' O ' ' C ' ' A' ' 333' ' ' LYS . 5.4 t -58.66 112.8 1.74 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.843 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 332' ' ' SER . 2.9 mtpm? -34.54 -49.67 0.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.92 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 136.79 33.17 0.23 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.524 ' C ' HD12 ' A' ' 301' ' ' LEU . 12.1 p90 -173.35 154.69 2.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 0.0 110.862 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -158.95 179.1 34.82 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.452 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -128.34 129.26 46.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 0.0 110.909 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.453 ' CG1' HD13 ' A' ' 320' ' ' ILE . 12.7 t -130.56 130.27 64.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.144 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . 0.545 ' O ' HG23 ' A' ' 320' ' ' ILE . 33.2 t -109.16 154.14 22.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.449 ' CE1' HD12 ' A' ' 296' ' ' LEU . 19.6 m-85 -125.61 177.54 6.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.895 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 93.1 p -77.32 -38.08 51.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.42 ' C ' HG12 ' A' ' 294' ' ' VAL . 27.0 t -142.98 146.5 37.52 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.689 0.756 . . . . 0.0 110.888 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.428 ' O ' ' C ' ' A' ' 344' ' ' GLU . 71.6 Cg_exo -46.56 -60.39 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.717 2.278 . . . . 0.0 112.316 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 343' ' ' PRO . 20.8 mt-10 -35.75 -70.04 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 345' ' ' GLU . 0.3 OUTLIER -44.03 -43.86 7.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.827 -179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.755 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -60.92 -43.63 98.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.086 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.8 m -52.41 -60.31 3.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.149 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 24.3 ttpt -46.27 -52.4 12.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -53.83 -53.08 57.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.784 ' CG2' HD22 ' A' ' 296' ' ' LEU . 76.0 t -39.02 -49.58 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 353' ' ' MET . 50.9 m -82.58 -62.18 1.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -41.04 -24.7 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . 0.46 ' N ' ' O ' ' A' ' 351' ' ' THR . 94.4 mmm -102.06 -43.41 5.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 17.2 t-20 -59.22 109.54 0.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 108.5 -11.99 36.04 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.489 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -87.39 147.45 25.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.772 0.32 . . . . 0.0 110.888 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 6.2 mm -97.47 148.98 5.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.13 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . 0.418 HG21 HD11 ' A' ' 363' ' ' LEU . 61.8 t -131.97 -54.01 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.162 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -113.01 -72.72 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.089 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.447 HG23 ' N ' ' A' ' 361' ' ' LYS . 2.4 t -131.86 -49.08 0.95 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.447 ' N ' HG23 ' A' ' 360' ' ' THR . 17.2 mttm -101.08 154.0 37.42 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.618 0.723 . . . . 0.0 110.916 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.38 129.14 10.9 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.697 2.265 . . . . 0.0 112.329 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.451 ' CD2' HD23 ' A' ' 301' ' ' LEU . 52.3 mt -67.08 122.55 18.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.914 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.564 ' CD1' ' HE2' ' A' ' 299' ' ' LYS . 25.1 t80 -101.83 93.48 5.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.6 144.22 10.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.126 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -162.43 145.94 11.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.085 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.47 HD22 HG21 ' A' ' 293' ' ' VAL . 35.9 mt -53.14 145.9 12.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.943 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . 0.612 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . -130.2 176.31 8.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -123.43 118.3 27.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.959 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 35.5 ttt-85 -147.09 144.52 29.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.897 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 13.2 ttpt -172.74 144.4 1.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -166.16 109.14 0.76 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -131.8 123.88 28.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.897 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -174.55 144.77 0.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -94.96 169.45 10.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.965 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 28.2 t -106.24 153.11 22.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.826 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -130.54 95.24 0.33 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.456 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.31 14.31 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.711 2.274 . . . . 0.0 112.336 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 13.4 t -76.18 95.92 3.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.814 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 1.6 t -56.63 162.11 2.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.479 179.983 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.479 -0.248 . . . . 0.0 112.479 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 37.0 p -116.39 104.64 11.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.896 0.379 . . . . 0.0 110.827 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 56.0 m -159.13 162.97 36.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.828 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 160.34 60.68 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.452 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 41.5 t -122.71 142.27 50.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.898 0.38 . . . . 0.0 110.84 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 72.3 p -150.14 157.97 43.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.86 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 158.96 111.36 0.3 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.471 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.29 97.58 11.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.867 0.365 . . . . 0.0 110.89 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.4 42.83 3.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 5.2 mp -105.36 134.78 45.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.139 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 14.8 t -130.0 147.38 51.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.158 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . 0.46 ' O ' ' CG ' ' A' ' 291' ' ' TYR . 1.0 OUTLIER -134.01 90.88 2.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.846 -179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.781 ' O ' HG23 ' A' ' 293' ' ' VAL . 97.9 m-85 -159.68 126.69 4.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -48.26 96.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 291' ' ' TYR . 97.0 t -122.55 94.82 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.111 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 15.1 m -92.1 -32.5 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.158 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -65.59 136.1 55.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.896 HD21 ' HB1' ' A' ' 346' ' ' ALA . 30.7 mt -123.58 137.2 54.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.967 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -101.62 103.05 13.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 32.2 t -88.45 136.21 23.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.581 ' HE3' ' CD1' ' A' ' 364' ' ' TYR . 13.2 ttpp -135.41 162.8 31.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . 0.455 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.6 m120 63.97 47.84 3.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 35.7 mt -86.22 98.44 10.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.724 ' OD2' ' HB3' ' A' ' 359' ' ' ALA . 91.6 m-20 -41.47 134.98 2.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -45.83 -36.4 5.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.15 -42.72 97.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.5 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 63.0 mt -60.44 147.65 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.834 0.349 . . . . 0.0 111.173 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -130.34 -174.61 3.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.23 -28.47 69.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.863 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.48 -55.07 5.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.9 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 43.4 mtt180 -51.89 -41.89 62.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.533 HD12 ' CE1' ' A' ' 314' ' ' PHE . 62.9 tp -61.89 -72.55 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.449 ' HD2' ' HB3' ' A' ' 323' ' ' ALA . 13.7 ttt-85 -50.38 -24.89 3.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -80.0 -29.02 39.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -93.34 17.65 10.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.096 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.533 ' CE1' HD12 ' A' ' 310' ' ' LEU . 6.9 m-85 -126.01 -31.49 2.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.49 -45.27 95.67 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.648 0.737 . . . . 0.0 110.799 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.5 Cg_exo -48.03 -16.67 0.63 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.716 2.277 . . . . 0.0 112.325 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -99.67 -52.17 3.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.835 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.27 166.56 36.51 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.475 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 23.9 m -64.08 144.48 57.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.743 0.306 . . . . 0.0 111.18 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 339' ' ' CYS . 49.6 mt -119.75 137.73 52.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 68.4 p -100.94 -41.43 6.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.145 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.1 t -142.28 124.53 15.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.825 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . 0.449 ' HB3' ' HD2' ' A' ' 311' ' ' ARG . . . -145.57 124.76 12.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.08 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -149.25 159.0 44.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.32 123.87 71.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.097 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 335' ' ' PHE . 33.5 mmt -59.03 148.0 32.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.883 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . 0.401 ' C ' ' HG3' ' A' ' 333' ' ' LYS . 25.8 mtp -137.21 164.25 28.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -110.95 38.51 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 104.43 -66.55 0.3 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.502 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -113.64 -39.79 1.07 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.503 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -107.63 171.2 7.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.795 0.331 . . . . 0.0 110.876 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.7 m -83.58 139.8 32.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.401 ' HG3' ' C ' ' A' ' 327' ' ' MET . 65.5 mttt -69.68 -44.76 69.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.868 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 125.39 34.74 0.65 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.439 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.485 ' CZ ' ' HG3' ' A' ' 326' ' ' MET . 2.5 p90 -174.75 161.13 3.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.913 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -164.7 -172.05 31.69 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.519 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -131.21 146.46 52.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.868 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 50.5 t -142.43 131.9 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.091 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . 0.547 ' O ' HG23 ' A' ' 320' ' ' ILE . 6.5 t -112.94 144.27 42.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -118.52 178.63 4.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 11.1 t -78.49 -39.88 36.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.3 t -137.53 142.36 36.83 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.671 0.748 . . . . 0.0 110.855 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.99 -54.51 4.9 Favored 'Trans proline' 0 C--O 1.231 0.133 0 C-N-CA 122.686 2.258 . . . . 0.0 112.369 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -41.83 -52.05 4.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.875 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -56.93 -46.06 82.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.896 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -59.03 -38.86 80.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.152 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 348' ' ' LYS . 60.9 m -52.04 -74.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.148 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 347' ' ' THR . 10.1 ttmm -35.25 -64.8 0.26 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.953 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.41 -54.5 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.117 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 346' ' ' ALA . 33.5 t -47.52 -46.25 10.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.163 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 27.3 m -77.57 -59.48 2.76 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.133 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -50.49 -22.08 1.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 90.1 mmm -100.22 -43.34 6.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 9.2 t-20 -58.98 97.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.878 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 123.58 -11.49 8.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.492 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -85.15 122.44 29.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 110.902 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . 0.401 HD13 ' CA ' ' A' ' 362' ' ' PRO . 11.5 mm -84.99 149.63 4.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 42.2 t -129.24 -49.37 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.142 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.724 ' HB3' ' OD2' ' A' ' 302' ' ' ASP . . . -120.28 -68.97 0.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.32 -51.25 0.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.185 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.58 151.81 37.67 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.545 0.688 . . . . 0.0 110.899 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.401 ' CA ' HD13 ' A' ' 357' ' ' ILE . 60.4 Cg_endo -74.15 151.98 44.73 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.728 2.285 . . . . 0.0 112.345 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 63.1 mt -77.09 96.51 4.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . 0.581 ' CD1' ' HE3' ' A' ' 299' ' ' LYS . 10.1 t80 -74.48 85.8 2.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.67 144.41 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.131 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -152.09 168.07 26.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.148 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 29.5 mt -72.35 145.95 47.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.923 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 293' ' ' VAL . . . -123.31 125.81 45.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.099 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . 0.497 ' NE2' HG22 ' A' ' 293' ' ' VAL . 11.1 tp60 -116.81 48.5 1.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.872 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -124.7 82.67 2.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -122.85 115.79 22.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -124.38 40.59 3.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -130.91 125.25 33.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 32.6 mtt180 -110.17 141.99 42.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -133.18 120.24 20.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 51.3 p -146.75 159.58 43.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 168.85 145.12 4.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.51 164.77 25.86 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.752 2.301 . . . . 0.0 112.321 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 58.9 m -136.87 134.48 36.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 13.4 m -164.73 124.34 1.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.83 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.476 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 65.9 p -109.03 174.08 6.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.835 0.35 . . . . 0.0 110.845 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 4.5 m -64.13 -60.03 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.875 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 100.96 126.17 5.76 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.481 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 71.8 p -89.24 126.87 35.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.869 0.366 . . . . 0.0 110.85 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 72.4 p -125.09 151.7 45.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.819 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 162.2 78.3 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.474 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -131.92 151.33 51.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 110.851 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -106.11 145.4 31.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 54.7 mt -58.62 -58.29 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.139 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 14.3 t -168.67 151.44 5.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.186 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . 0.435 ' HB3' ' CE2' ' A' ' 291' ' ' TYR . 56.7 mtt180 -123.28 -46.58 2.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.435 ' CE2' ' HB3' ' A' ' 290' ' ' ARG . 12.2 m-85 -150.25 167.18 27.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.883 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -63.86 114.93 4.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.425 HG13 ' HG3' ' A' ' 369' ' ' GLN . 93.7 t -132.69 94.85 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.171 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 24.3 m -87.27 -30.32 5.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.11 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -72.69 135.83 45.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.829 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.695 HD21 ' HB1' ' A' ' 346' ' ' ALA . 28.9 mt -129.76 132.99 46.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.916 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.672 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 26.7 t80 -90.81 121.06 32.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.496 HG21 HD11 ' A' ' 310' ' ' LEU . 56.3 t -104.5 132.49 51.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.112 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.49 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 22.3 tttm -132.86 164.05 27.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.898 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . 0.49 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.8 m120 64.14 45.7 3.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.599 HD12 ' C ' ' A' ' 335' ' ' PHE . 32.7 mt -84.31 95.26 8.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.892 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -41.24 136.76 1.55 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -45.16 -40.54 7.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -58.97 -35.77 85.03 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.525 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.515 HD13 HD21 ' A' ' 363' ' ' LEU . 65.7 mt -68.36 126.98 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.785 0.326 . . . . 0.0 111.153 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -115.7 175.67 5.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -42.45 -63.82 0.7 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.802 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -47.48 -55.67 8.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.877 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? -45.05 -51.61 9.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.497 HD12 ' CE1' ' A' ' 314' ' ' PHE . 54.7 tp -53.91 -74.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.927 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.481 ' HG3' ' CD1' ' A' ' 320' ' ' ILE . 31.3 ttt180 -45.84 -27.95 0.97 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -68.66 -42.78 77.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -83.93 25.1 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.103 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.497 ' CE1' HD12 ' A' ' 310' ' ' LEU . 10.7 m-85 -133.72 -32.85 1.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.599 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -51.82 -45.27 92.26 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.662 0.744 . . . . 0.0 110.867 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.3 Cg_exo -47.95 -17.17 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.642 2.228 . . . . 0.0 112.367 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 46.9 m-85 -100.07 -45.83 5.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -167.8 167.01 39.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.466 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 35.9 m -68.72 141.16 55.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.785 0.326 . . . . 0.0 111.154 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.524 HG21 ' HB2' ' A' ' 323' ' ' ALA . 53.3 mt -113.95 144.09 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.09 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 61.6 p -114.12 -38.55 4.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.145 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -133.36 111.05 10.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.825 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . 0.524 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -135.45 122.98 22.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.113 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -147.28 152.99 39.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.442 HG22 HD22 ' A' ' 310' ' ' LEU . 81.9 t -119.41 135.85 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.148 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 38.0 mmt -68.4 114.37 6.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 48.1 mtp -123.87 151.89 42.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.413 ' CG ' ' HE3' ' A' ' 333' ' ' LYS . 73.1 mt-10 -107.24 43.41 1.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 67.67 85.51 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.496 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 105.36 -44.36 1.49 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.496 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -116.89 159.14 22.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 5.0 t -102.13 126.22 49.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.826 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.499 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 55.1 mttp -51.76 -51.25 57.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.936 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 133.02 35.24 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.445 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.599 ' C ' HD12 ' A' ' 301' ' ' LEU . 5.3 p90 -173.04 165.89 5.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.885 0.374 . . . . 0.0 110.906 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -166.71 -171.43 32.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.541 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -136.82 140.03 42.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.883 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 43.9 t -131.28 133.55 62.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.134 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . . . . . . . . . 8.7 m -111.77 133.2 54.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -109.51 173.3 6.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.87 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 13.2 t -87.15 -40.68 14.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.833 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 49.7 m -123.66 130.19 24.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.648 0.737 . . . . 0.0 110.846 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -45.88 -58.57 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.678 2.252 . . . . 0.0 112.345 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -38.62 -52.66 1.64 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -54.12 -46.78 72.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.695 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -61.54 -42.38 98.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.115 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 91.4 m -49.95 -60.35 3.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.125 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 349' ' ' ALA . 46.3 tttt -48.13 -62.94 1.22 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.855 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.62 -48.96 0.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.633 HG22 HD22 ' A' ' 296' ' ' LEU . 57.6 t -42.49 -56.98 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.163 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 61.2 m -78.33 -54.65 5.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.147 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.481 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 2.2 mm-40 -44.22 -29.54 0.66 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.913 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . 0.451 ' O ' ' N ' ' A' ' 356' ' ' ARG . 76.9 mmm -100.06 -51.55 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.44 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 1.6 t30 -39.49 103.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 97.66 18.24 28.43 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.501 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 353' ' ' MET . 0.0 OUTLIER -99.04 118.11 35.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.324 . . . . 0.0 110.883 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . 0.503 HD13 ' N ' ' A' ' 362' ' ' PRO . 20.7 mm -85.89 133.75 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.178 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 84.4 t -118.05 -41.99 2.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -126.26 -65.18 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.065 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 18.7 p -134.52 -53.89 0.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.11 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -101.58 154.22 37.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.569 0.7 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.503 ' N ' HD13 ' A' ' 357' ' ' ILE . 63.1 Cg_endo -78.17 143.46 20.09 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.673 2.249 . . . . 0.0 112.332 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.585 ' O ' HG23 ' A' ' 365' ' ' VAL . 61.8 mt -75.11 90.92 2.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.912 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -61.38 99.73 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.931 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 363' ' ' LEU . 40.8 t -106.8 141.58 21.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -161.37 157.8 25.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.059 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 30.8 mt -63.58 141.79 58.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.93 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . 0.672 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . -129.13 74.7 1.6 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.089 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . 0.425 ' HG3' HG13 ' A' ' 293' ' ' VAL . 15.0 mm-40 -151.63 176.08 11.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.968 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -146.42 162.52 38.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.871 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -38.46 141.28 0.26 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -95.9 168.89 10.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.896 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -119.67 -58.75 1.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -169.32 142.11 2.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.831 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -117.28 135.41 53.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 13.6 t -133.34 143.07 48.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.862 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 167.27 84.08 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.449 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.08 98.55 1.23 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.72 2.28 . . . . 0.0 112.361 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 60.3 p -101.19 149.88 23.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.838 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 9.3 t -118.93 160.92 21.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.879 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.483 179.999 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 28.7 t -144.43 158.03 43.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.909 0.385 . . . . 0.0 110.879 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.9 t -106.48 168.78 8.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.882 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -147.81 58.48 0.48 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.446 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 27.0 t -69.32 130.79 43.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.822 0.344 . . . . 0.0 110.857 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 51.4 p -169.37 173.49 6.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -126.39 153.7 18.76 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.476 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -122.29 136.5 54.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.329 . . . . 0.0 110.877 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 30.2 mmt-85 -119.59 92.4 3.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.542 HD11 ' HE ' ' A' ' 290' ' ' ARG . 13.4 tt -63.99 123.77 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.119 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 9.5 t -112.14 -34.47 5.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.166 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . 0.542 ' HE ' HD11 ' A' ' 288' ' ' ILE . 25.3 mmt180 61.06 48.51 6.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -161.71 160.89 29.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.921 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -101.75 114.84 29.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.922 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.401 HG11 ' HB3' ' A' ' 367' ' ' LEU . 95.9 t -134.96 91.79 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 343' ' ' PRO . 22.9 m -87.75 -35.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.148 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.42 129.96 43.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.883 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.69 HD22 HG22 ' A' ' 350' ' ' VAL . 60.1 mt -118.44 136.3 53.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -94.11 125.96 39.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 310' ' ' LEU . 57.7 t -110.29 143.55 20.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.154 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.519 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 14.1 ttmm -144.49 164.57 30.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . 0.519 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.5 m120 64.14 44.72 4.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 302' ' ' ASP . 25.5 mt -84.67 99.87 11.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 301' ' ' LEU . 30.0 m-20 -37.52 155.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.63 -31.91 73.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -67.87 -38.32 89.06 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.498 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.583 HG22 ' N ' ' A' ' 306' ' ' ASP . 62.8 mt -56.94 162.94 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.851 0.358 . . . . 0.0 111.104 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.583 ' N ' HG22 ' A' ' 305' ' ' ILE . 8.7 t0 -149.28 -176.75 5.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.883 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -59.68 -41.82 91.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.905 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -64.86 -57.46 8.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.88 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 29.5 mtt-85 -47.06 -45.17 21.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 298' ' ' VAL . 50.4 tp -57.36 -71.93 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -49.73 -32.19 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -72.14 -33.73 67.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -85.74 19.31 2.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.059 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.496 ' CB ' HD11 ' A' ' 320' ' ' ILE . 8.2 m-85 -129.73 -30.19 2.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.899 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -52.18 -45.24 94.1 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.645 0.735 . . . . 0.0 110.866 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.1 Cg_exo -47.94 -16.69 0.6 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.71 2.273 . . . . 0.0 112.329 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -99.6 -54.35 2.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.871 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -158.37 170.75 35.11 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.446 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 49.4 m -65.2 144.24 57.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.808 0.337 . . . . 0.0 111.113 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.496 HD11 ' CB ' ' A' ' 314' ' ' PHE . 48.5 mt -124.41 140.91 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 82.6 p -114.16 -46.73 2.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -121.55 111.0 16.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.839 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . 0.412 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -138.92 121.33 16.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 68.4 tttt -155.4 156.27 35.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 48.0 t -110.56 143.33 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.112 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . 0.551 ' HG3' ' CE2' ' A' ' 335' ' ' PHE . 38.7 mmt -72.4 135.87 45.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.854 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 27.3 mtp -138.6 171.69 13.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -114.66 -45.8 2.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.877 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 161.84 39.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.447 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 160.19 -37.34 0.45 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.469 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 9.0 ptp85 -124.31 166.45 15.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.817 0.342 . . . . 0.0 110.86 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 7.1 t -85.13 122.22 29.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.578 ' HD3' ' CZ ' ' A' ' 335' ' ' PHE . 28.9 mttm -50.89 -42.27 58.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 128.76 -31.23 3.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.537 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.578 ' CZ ' ' HD3' ' A' ' 333' ' ' LYS . 5.4 p90 -111.64 161.8 15.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.9 0.381 . . . . 0.0 110.881 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -155.37 -174.24 25.02 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.522 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -136.51 140.63 43.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.928 0.394 . . . . 0.0 110.841 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 51.5 t -136.93 131.52 46.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.164 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . 0.439 ' O ' HG23 ' A' ' 320' ' ' ILE . 4.7 m -111.33 141.33 45.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.884 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -115.75 171.85 7.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.854 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 62.7 p -71.73 -37.01 70.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.854 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 6.2 t -144.44 143.07 20.57 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.668 0.747 . . . . 0.0 110.828 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.496 ' N ' HG12 ' A' ' 294' ' ' VAL . 71.9 Cg_exo -46.49 -56.07 3.25 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.74 2.294 . . . . 0.0 112.317 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 344' ' ' GLU . 1.2 mp0 -37.21 -61.29 0.59 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.929 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -50.3 -43.38 53.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.736 ' O ' HG23 ' A' ' 350' ' ' VAL . . . -63.59 -41.01 98.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.086 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 86.2 m -49.29 -60.83 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.14 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 40.2 tttt -47.37 -60.46 2.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -42.51 -48.87 5.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.112 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.736 HG23 ' O ' ' A' ' 346' ' ' ALA . 47.1 t -41.49 -55.73 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.111 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 82.7 m -78.74 -55.75 4.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.159 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -44.18 -28.96 0.56 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.886 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . 0.467 ' O ' ' N ' ' A' ' 356' ' ' ARG . 79.3 mmm -100.2 -49.81 4.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 9.4 t30 -40.14 110.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 85.29 20.7 56.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.481 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 353' ' ' MET . 19.7 tpp180 -99.94 112.46 24.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.815 0.341 . . . . 0.0 110.885 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . 0.431 HD13 ' CA ' ' A' ' 362' ' ' PRO . 17.6 mm -77.67 150.49 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.122 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 95.3 t -132.52 -48.01 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.8 -68.59 0.82 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 19.0 p -130.79 -53.14 1.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.106 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 4.0 mtpm? -100.05 151.42 37.5 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.576 0.703 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.431 ' CA ' HD13 ' A' ' 357' ' ' ILE . 61.6 Cg_endo -76.58 155.95 35.9 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.706 2.271 . . . . 0.0 112.374 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.539 ' O ' HG23 ' A' ' 365' ' ' VAL . 32.9 mt -94.49 87.44 5.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.944 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -61.48 106.66 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.964 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 363' ' ' LEU . 47.8 t -113.91 134.63 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.104 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -155.27 145.32 21.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.137 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.401 ' HB3' HG11 ' A' ' 293' ' ' VAL . 77.9 mt -54.66 134.18 47.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.92 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -107.55 136.83 46.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.123 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -80.44 -48.93 12.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -49.24 132.27 19.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.906 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -132.76 107.13 8.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -61.83 133.72 55.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.928 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -146.88 118.6 8.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -101.16 127.95 47.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.851 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -157.04 142.32 17.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.889 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 3.4 m -136.68 167.1 22.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.828 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 165.17 81.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.504 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.0 125.91 8.31 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.67 2.246 . . . . 0.0 112.332 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 61.2 m -133.22 158.52 42.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.861 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 1.9 t -166.05 124.46 1.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.861 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.466 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.461 -0.256 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 8.9 t -131.26 177.26 7.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.88 0.371 . . . . 0.0 110.891 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 7.1 m -123.17 87.44 2.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 45.89 -124.23 7.07 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.539 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 24.1 p -167.02 166.28 15.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.875 0.369 . . . . 0.0 110.874 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 33.0 p -99.78 144.82 28.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . -136.18 177.88 19.21 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.466 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -133.12 135.93 45.51 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -102.55 98.65 8.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 13.9 pt -134.7 147.05 29.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.09 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 289' ' ' THR . 14.7 t -118.0 37.71 3.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -104.32 176.61 5.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.912 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.621 ' O ' HG23 ' A' ' 293' ' ' VAL . 30.3 m-85 56.11 50.86 12.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.932 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -46.29 125.08 6.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.91 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 291' ' ' TYR . 73.8 t -127.14 92.04 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 6.4 m -86.61 -37.11 11.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.623 ' O ' HD23 ' A' ' 296' ' ' LEU . 49.7 t30 -52.27 142.17 17.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.973 HD21 ' HB1' ' A' ' 346' ' ' ALA . 32.5 mt -135.48 132.64 37.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -102.08 113.02 25.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . 0.438 HG22 HG13 ' A' ' 365' ' ' VAL . 45.7 t -100.83 145.5 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.132 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 0.0 OUTLIER -132.4 165.84 23.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . 0.537 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 4.0 m-20 63.48 46.57 4.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.92 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.448 HD12 ' C ' ' A' ' 335' ' ' PHE . 32.8 mt -82.43 91.97 6.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.842 ' OD2' ' HB3' ' A' ' 359' ' ' ALA . 86.5 m-20 -36.05 132.09 0.54 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.86 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -41.58 -41.68 2.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.885 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -60.13 -36.19 89.83 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.468 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.415 HG23 ' HB3' ' A' ' 309' ' ' ARG . 75.5 mt -64.92 118.49 7.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.0 111.143 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -103.55 -175.74 2.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.37 -45.96 76.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -62.76 -48.96 76.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . 0.415 ' HB3' HG23 ' A' ' 305' ' ' ILE . 4.3 mmm180 -46.68 -49.66 18.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.534 HD12 ' CE1' ' A' ' 314' ' ' PHE . 43.2 tp -56.65 -73.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.416 ' HG3' HD12 ' A' ' 320' ' ' ILE . 15.8 ttp180 -46.89 -26.74 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -70.01 -41.72 73.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -88.9 21.35 3.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.058 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.565 ' HB3' HD11 ' A' ' 320' ' ' ILE . 8.2 m-85 -129.41 -29.96 2.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -55.38 -44.95 99.9 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.662 0.744 . . . . 0.0 110.883 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.7 Cg_exo -47.97 -16.57 0.59 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.747 2.298 . . . . 0.0 112.288 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -99.64 -51.87 3.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -163.68 166.07 37.17 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.483 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 64.4 m -67.2 137.91 56.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.785 0.326 . . . . 0.0 111.144 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.734 HG21 ' HB2' ' A' ' 323' ' ' ALA . 93.3 mt -109.65 142.15 22.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.165 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 70.3 p -111.74 -35.8 5.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.172 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.8 m -133.58 104.51 6.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . 0.734 ' HB2' HG21 ' A' ' 320' ' ' ILE . . . -134.58 122.48 22.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.084 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.413 ' HG2' ' N ' ' A' ' 325' ' ' VAL . 44.0 tttp -156.72 152.52 27.13 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.413 ' N ' ' HG2' ' A' ' 324' ' ' LYS . 59.4 t -107.44 140.33 26.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . 0.545 ' HG3' ' CE2' ' A' ' 335' ' ' PHE . 34.4 mmt -85.73 100.61 12.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 77.9 mtp -97.99 176.5 5.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.48 ' HB3' ' CE ' ' A' ' 333' ' ' LYS . 0.4 OUTLIER -161.07 133.37 5.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 -179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 49.33 32.54 14.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.452 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 88.55 -30.24 5.39 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.506 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -94.54 136.51 34.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.787 0.327 . . . . 0.0 110.877 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 89.8 p -63.14 140.04 58.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.48 ' CE ' ' HB3' ' A' ' 328' ' ' GLU . 89.9 mttt -71.24 -58.13 3.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.902 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 139.95 35.76 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.516 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.545 ' CE2' ' HG3' ' A' ' 326' ' ' MET . 25.7 p90 -174.95 163.65 3.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.931 0.396 . . . . 0.0 110.857 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -162.09 -179.77 36.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.487 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -123.88 139.24 54.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.904 0.383 . . . . 0.0 110.897 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.418 HG11 ' CD2' ' A' ' 314' ' ' PHE . 29.9 t -134.59 127.72 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.169 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . 0.548 ' O ' HG23 ' A' ' 320' ' ' ILE . 68.8 m -111.93 134.38 53.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.902 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.534 ' HE1' HD12 ' A' ' 296' ' ' LEU . 43.4 m-85 -111.39 177.18 4.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 6.4 t -78.21 -35.52 48.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.9 t -141.61 141.71 23.56 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.62 0.724 . . . . 0.0 110.885 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.65 -53.65 5.85 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.692 2.261 . . . . 0.0 112.327 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -40.82 -63.74 0.62 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -46.09 -44.22 15.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.863 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.973 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -59.15 -59.58 5.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.076 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 28.7 m -41.58 -56.05 2.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.424 ' NZ ' ' HG3' ' A' ' 352' ' ' GLU . 2.3 tmtm? -45.84 -56.31 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -54.51 -51.12 66.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.068 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.419 ' O ' ' CB ' ' A' ' 354' ' ' ASN . 91.9 t -39.38 -53.21 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.143 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 86.7 m -75.29 -59.28 2.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.424 ' HG3' ' NZ ' ' A' ' 348' ' ' LYS . 3.9 mm-40 -49.08 -18.84 0.35 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.857 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . . . . . . . . . 90.0 mmm -107.28 -35.14 6.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.459 ' OD1' ' C ' ' A' ' 354' ' ' ASN . 5.4 t-20 -59.1 96.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 112.47 -15.86 24.53 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.464 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 17.6 tpp85 -73.27 110.19 7.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 20.5 mm -68.12 151.2 10.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.26 -39.46 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.115 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . 0.842 ' HB3' ' OD2' ' A' ' 302' ' ' ASP . . . -133.22 -71.36 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.095 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 4.9 p -128.96 -55.05 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.95 153.45 37.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.558 0.694 . . . . 0.0 110.873 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.1 153.49 46.61 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.719 2.279 . . . . 0.0 112.332 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 30.5 mt -87.77 99.44 12.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -79.24 91.39 4.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.96 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.438 HG13 HG22 ' A' ' 298' ' ' VAL . 4.2 t -95.33 141.33 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.127 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -159.84 142.98 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.078 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 24.4 mt -52.99 153.43 3.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -112.75 132.02 55.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.094 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -100.3 86.75 3.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.92 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -115.4 -36.98 4.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.836 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -80.62 -42.84 21.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.88 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -38.49 -65.71 0.33 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.909 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.414 ' C ' ' OE1' ' A' ' 373' ' ' GLU . 0.6 OUTLIER -41.86 -40.47 2.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 -179.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 44.4 ttt85 -80.82 155.37 26.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.856 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 41.58 41.13 1.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 1.5 t -59.14 -52.45 65.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -56.42 -90.24 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.479 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.65 114.3 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.652 2.235 . . . . 0.0 112.337 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 90.9 p -79.73 133.13 36.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 74.6 m -60.04 153.51 21.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.471 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 3.3 t -82.7 159.98 22.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.881 0.372 . . . . 0.0 110.846 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 8.1 t -138.54 167.35 22.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 100.66 118.15 4.23 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.499 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 27.5 p -103.94 157.24 17.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.89 0.376 . . . . 0.0 110.843 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 10.2 m -91.66 -58.89 2.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.868 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 89.65 57.35 1.75 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.503 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -126.13 110.87 13.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.836 0.35 . . . . 0.0 110.875 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . 0.431 ' HD3' ' N ' ' A' ' 287' ' ' ARG . 1.9 mpp_? -122.78 96.0 4.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.853 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . . . . . . . . . 25.2 mm -122.45 139.41 49.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 22.9 m -110.68 -60.33 1.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -173.22 151.84 2.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.901 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -174.85 140.55 0.56 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -104.17 110.31 22.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.929 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 293' ' ' VAL . 6.5 p -132.15 107.47 12.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.02 -21.51 5.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.095 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.1 152.05 38.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.69 HD21 ' HB1' ' A' ' 346' ' ' ALA . 14.7 mt -143.87 134.21 24.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -101.85 120.47 40.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.3 t -103.25 145.5 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.113 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.484 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 13.4 ttmm -136.58 162.68 32.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . 0.484 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 6.8 m-20 62.59 51.11 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.839 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.543 HD12 ' C ' ' A' ' 335' ' ' PHE . 28.0 mt -88.86 104.52 17.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.452 ' H ' HD12 ' A' ' 305' ' ' ILE . 12.6 t70 -45.92 162.05 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.872 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -64.2 -38.87 92.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.26 -40.59 99.2 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.494 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . 0.452 HD12 ' H ' ' A' ' 302' ' ' ASP . 59.9 mt -57.41 132.64 21.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 111.176 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.23 -174.82 3.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -49.86 -46.38 51.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.896 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -60.69 -61.13 2.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -41.8 -46.05 3.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.895 HD21 HG22 ' A' ' 338' ' ' VAL . 20.4 tp -52.23 -75.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.948 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.721 ' HD2' ' HB3' ' A' ' 323' ' ' ALA . 19.4 mtp180 -53.22 -24.72 11.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -67.58 -39.96 84.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -97.79 19.74 13.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.063 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.554 ' CB ' HD11 ' A' ' 320' ' ' ILE . 7.1 m-85 -127.29 -29.72 2.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.584 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.8 OUTLIER -57.7 -45.61 99.81 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.704 0.764 . . . . 0.0 110.905 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.2 Cg_exo -47.98 -16.63 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.634 2.222 . . . . 0.0 112.377 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . 0.49 ' CE2' ' HG2' ' A' ' 353' ' ' MET . 50.0 m-85 -99.61 -46.92 5.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -165.05 166.31 38.14 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.494 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 33.9 m -67.33 133.6 49.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 111.141 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 339' ' ' CYS . 37.7 mt -110.37 139.58 33.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 41.6 p -109.85 -36.24 5.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 71.0 m -137.42 126.81 24.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.867 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . 0.721 ' HB3' ' HD2' ' A' ' 311' ' ' ARG . . . -156.46 119.25 4.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.068 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -150.24 132.25 15.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.91 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 49.9 t -82.22 125.2 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.153 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 20.8 mmm -68.86 86.4 0.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . 0.471 ' CB ' ' HA ' ' A' ' 332' ' ' SER . 21.5 ptm -126.15 159.27 33.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.945 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -116.17 139.26 50.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.861 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 46.67 -105.22 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.502 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -127.51 50.71 0.88 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.512 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.68 124.5 3.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.796 0.331 . . . . 0.0 110.904 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.471 ' HA ' ' CB ' ' A' ' 327' ' ' MET . 29.9 t -77.87 117.7 19.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.855 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -53.72 -52.04 61.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 137.63 34.16 0.2 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.543 ' C ' HD12 ' A' ' 301' ' ' LEU . 4.0 p90 -175.39 156.38 1.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 110.897 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -154.47 172.45 32.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.508 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -117.22 139.41 50.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.865 0.364 . . . . 0.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.895 HG22 HD21 ' A' ' 310' ' ' LEU . 24.1 t -133.85 149.29 30.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.172 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . 0.584 ' O ' HG23 ' A' ' 320' ' ' ILE . 20.9 t -132.76 134.23 44.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.838 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.501 ' CE1' HD12 ' A' ' 296' ' ' LEU . 6.5 m-85 -113.24 172.46 6.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.882 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 40.4 p -78.98 -47.94 15.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 54.8 m -121.37 136.12 25.59 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.691 0.757 . . . . 0.0 110.83 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 346' ' ' ALA . 71.5 Cg_exo -45.87 -63.01 0.36 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.72 2.28 . . . . 0.0 112.357 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 343' ' ' PRO . 49.0 tt0 -36.2 -53.62 0.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -52.36 -44.4 65.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.69 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -64.29 -41.91 96.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.08 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 98.1 m -50.77 -64.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.414 ' O ' ' C ' ' A' ' 349' ' ' ALA . 31.8 tttm -43.09 -62.91 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.902 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -36.27 -53.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.108 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.562 HG22 HD22 ' A' ' 296' ' ' LEU . 93.6 t -38.2 -60.28 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 62.5 m -75.14 -55.27 5.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.444 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 23.5 mm-40 -44.8 -26.26 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . 0.49 ' HG2' ' CE2' ' A' ' 317' ' ' PHE . 83.3 mmm -102.19 -62.03 1.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -40.66 107.22 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 116.15 -5.88 19.65 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -95.74 125.78 40.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 0.0 110.871 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . 0.405 HD13 ' CA ' ' A' ' 362' ' ' PRO . 7.8 mm -85.7 150.31 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.131 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 95.6 t -132.23 -41.06 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -126.64 -71.91 0.67 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.093 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 16.5 p -131.63 -50.16 0.98 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.18 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.86 152.14 39.51 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.555 0.693 . . . . 0.0 110.909 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.405 ' CA ' HD13 ' A' ' 357' ' ' ILE . 60.5 Cg_endo -74.48 146.77 35.43 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.699 2.266 . . . . 0.0 112.324 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.497 ' O ' HG23 ' A' ' 365' ' ' VAL . 37.3 mt -77.22 88.95 3.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -66.34 94.56 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 363' ' ' LEU . 17.2 t -97.12 150.95 4.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -164.3 166.24 21.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.109 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 58.7 mt -71.32 143.61 50.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -110.97 -68.24 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.093 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . 0.532 ' O ' HG23 ' A' ' 293' ' ' VAL . 20.7 tt0 -80.1 112.3 17.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 15.7 ttt85 -65.91 -46.19 79.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -174.07 140.91 0.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -80.27 159.62 25.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -146.39 134.9 22.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -65.13 102.6 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -121.0 142.59 49.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 58.6 p -168.14 124.96 1.08 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.835 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -166.35 146.04 10.57 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.468 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -78.37 -34.68 1.43 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.737 2.291 . . . . 0.0 112.329 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 4.2 m -88.17 126.15 34.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.848 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 12.3 m -85.46 -49.15 8.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.859 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.467 179.99 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 6.1 t -158.92 134.05 8.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.94 0.4 . . . . 0.0 110.818 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 23.4 t -149.85 122.92 8.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.819 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . -107.04 76.35 0.23 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.511 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 4.8 m -73.09 104.11 4.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 110.87 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 2.9 m -54.6 -56.0 23.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.848 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 79.82 153.94 8.76 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.482 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -136.72 107.85 6.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.792 0.33 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 36.8 mtm180 -84.57 97.05 9.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.863 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.419 ' H ' HG22 ' A' ' 288' ' ' ILE . 3.2 tt -74.72 80.9 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.157 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 289' ' ' THR . 15.3 m -92.45 44.49 1.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.166 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 34.1 mtt180 -58.27 -56.11 26.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.865 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -91.3 143.85 26.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 10.0 mm-40 -78.55 114.2 17.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.903 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.539 HG11 HD13 ' A' ' 367' ' ' LEU . 6.1 p -133.14 114.89 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 25.2 m -115.79 -23.98 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 19.8 p-10 -67.13 104.13 1.36 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.697 HD22 HG22 ' A' ' 350' ' ' VAL . 45.6 mt -94.85 133.79 38.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.617 ' HB2' ' HB2' ' A' ' 368' ' ' ALA . 25.7 t80 -96.45 114.06 25.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 60.6 t -98.62 139.44 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.114 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.51 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 24.5 tttt -137.33 163.94 29.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . 0.51 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 6.4 m-20 63.19 49.38 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 25.0 mt -87.8 114.88 24.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.881 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.36 140.47 27.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.865 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -50.5 -42.31 54.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.812 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -59.26 -30.08 66.96 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.463 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 95.8 mt -72.62 130.78 35.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.815 0.34 . . . . 0.0 111.126 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -114.33 -179.11 3.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.96 -45.71 67.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.889 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.4 -54.12 47.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -47.03 -47.59 22.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.737 HD11 HG21 ' A' ' 338' ' ' VAL . 16.6 tp -53.96 -75.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . 0.438 ' HG3' HD12 ' A' ' 320' ' ' ILE . 33.5 ttt180 -49.2 -25.4 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -78.81 -32.82 46.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -90.9 15.72 10.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.083 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.6 ' CZ ' ' SD ' ' A' ' 353' ' ' MET . 10.7 m-85 -128.79 -28.49 2.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.578 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.9 OUTLIER -50.25 -46.07 83.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.679 0.752 . . . . 0.0 110.859 -179.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 315' ' ' SER . 63.8 Cg_exo -47.92 -16.89 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.688 2.259 . . . . 0.0 112.367 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -99.66 -41.49 7.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -160.52 169.0 36.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.492 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 97.0 m -83.21 96.48 8.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.81 0.338 . . . . 0.0 111.17 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.458 HD11 ' CB ' ' A' ' 314' ' ' PHE . 93.5 mt -65.55 145.9 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.12 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 73.5 p -117.34 -28.52 6.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.125 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 3.0 p -152.83 109.38 3.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.892 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -131.72 142.56 49.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.093 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -154.08 170.24 21.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 74.5 t -129.13 121.55 54.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.145 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . 0.544 ' HB2' ' CE2' ' A' ' 335' ' ' PHE . 10.2 mmm -75.46 117.01 16.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . 0.462 ' CA ' ' HD2' ' A' ' 333' ' ' LYS . 37.9 mtp -127.8 169.19 14.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.878 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.419 ' CG ' ' HE2' ' A' ' 333' ' ' LYS . 15.0 mt-10 -93.14 -66.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.925 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -159.88 -52.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.469 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -132.39 30.19 3.19 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.483 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -168.34 115.0 0.67 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.819 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.45 ' O ' ' C ' ' A' ' 333' ' ' LYS . 20.2 t -54.95 104.87 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.873 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.473 ' HD3' ' CE1' ' A' ' 335' ' ' PHE . 18.3 mttm -34.57 -55.22 0.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 128.62 29.95 0.73 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.471 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.544 ' CE2' ' HB2' ' A' ' 326' ' ' MET . 43.7 p90 -164.74 157.15 16.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 0.0 110.907 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -159.63 -167.05 19.73 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.458 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -135.13 122.19 21.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.928 0.394 . . . . 0.0 110.872 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.737 HG21 HD11 ' A' ' 310' ' ' LEU . 46.5 t -116.18 98.1 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.122 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . 0.422 ' O ' HG23 ' A' ' 320' ' ' ILE . 1.7 m -86.9 135.84 33.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.875 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . 23.1 m-85 -107.88 178.0 4.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 7.2 t -82.69 -36.48 25.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.813 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 1.9 m -133.57 133.92 23.09 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.681 0.753 . . . . 0.0 110.85 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -46.26 -59.58 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.725 2.283 . . . . 0.0 112.337 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -38.75 -57.32 1.22 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.927 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -54.29 -45.93 72.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.623 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -59.33 -46.89 87.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.066 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . 0.4 ' O ' ' C ' ' A' ' 348' ' ' LYS . 14.5 m -45.65 -63.86 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.152 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 347' ' ' THR . 3.9 ttpm? -37.51 -65.93 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -41.13 -53.7 3.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.087 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.697 HG22 HD22 ' A' ' 296' ' ' LEU . 46.2 t -39.75 -52.24 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.129 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 82.7 m -78.85 -56.91 4.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.118 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -46.69 -24.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . 0.6 ' SD ' ' CZ ' ' A' ' 314' ' ' PHE . 15.7 mtp -104.05 -43.99 5.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 6.8 t-20 -47.91 115.51 1.2 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 80.76 17.42 72.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.481 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -98.26 121.39 40.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.765 0.317 . . . . 0.0 110.853 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . . . . . . . . . 9.2 mm -87.77 125.7 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.117 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.26 -59.53 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.164 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -109.01 -67.85 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.104 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 361' ' ' LYS . 2.3 t -134.87 -49.06 0.75 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.438 ' N ' HG23 ' A' ' 360' ' ' THR . 13.1 mtpp -99.79 151.24 37.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.568 0.699 . . . . 0.0 110.88 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -77.37 151.59 29.66 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.704 2.269 . . . . 0.0 112.355 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 32.9 mt -89.65 92.97 9.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -70.77 94.74 1.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . . . . . . . . . 13.9 t -106.8 141.73 21.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.086 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -164.69 145.67 7.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.113 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.549 HD23 ' CD2' ' A' ' 296' ' ' LEU . 81.3 mt -56.68 137.83 53.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' A' ' 297' ' ' TYR . . . -110.9 178.37 4.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.106 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -136.61 105.47 5.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . 0.436 ' HD3' ' N ' ' A' ' 371' ' ' LYS . 0.0 OUTLIER -172.0 132.28 0.68 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . 0.436 ' N ' ' HD3' ' A' ' 370' ' ' ARG . 0.3 OUTLIER -106.7 135.7 47.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.902 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.42 155.66 24.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.896 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -153.59 124.49 7.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -109.44 173.37 6.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -133.36 123.62 25.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.956 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 52.4 p -85.57 137.06 33.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 174.3 81.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.485 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.96 111.36 3.22 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.681 2.254 . . . . 0.0 112.362 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 34.5 t -77.55 104.95 8.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 3.3 m -166.87 137.23 3.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.865 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.464 -179.99 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 87.8 p -164.27 162.4 22.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.888 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.2 t -86.84 -46.76 9.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 88.07 -164.17 33.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.5 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 3.1 m -114.57 170.43 8.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.922 0.391 . . . . 0.0 110.857 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 8.6 t -105.35 -54.4 2.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.855 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . . . . . . . . . . . 106.91 -171.41 16.92 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -147.7 126.53 12.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.827 0.346 . . . . 0.0 110.884 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -102.58 130.08 49.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.917 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.737 ' H ' HD13 ' A' ' 288' ' ' ILE . 0.1 OUTLIER -138.86 142.82 33.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.107 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 10.0 t -115.93 153.17 32.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.168 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -104.96 -59.4 1.75 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -63.65 147.26 52.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.915 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -62.24 108.94 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 97.8 t -129.06 95.47 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.174 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 343' ' ' PRO . 25.9 m -86.04 -36.9 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.107 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -54.72 136.59 45.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.913 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.89 HD21 ' HB1' ' A' ' 346' ' ' ALA . 40.6 mt -127.87 144.34 51.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -106.36 110.41 22.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.936 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 41.1 t -94.4 129.81 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.149 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.484 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 37.0 tttt -130.49 163.25 27.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . 0.484 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.5 m120 63.83 49.45 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.901 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.528 HD12 ' CA ' ' A' ' 335' ' ' PHE . 19.8 mt -87.12 105.98 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.429 ' HA ' ' NZ ' ' A' ' 361' ' ' LYS . 21.2 t70 -46.12 158.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.877 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -62.15 -37.52 85.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -67.02 -38.75 92.88 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.459 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 83.1 mt -61.65 112.69 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.803 0.335 . . . . 0.0 111.138 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.19 -176.8 3.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.822 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.24 -62.6 1.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.4 ' O ' ' HD3' ' A' ' 312' ' ' LYS . 7.4 pt-20 -52.46 -47.53 66.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 9.1 mmt180 -47.28 -34.13 6.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.463 HD12 ' CE1' ' A' ' 314' ' ' PHE . 54.0 tp -77.68 -56.22 4.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -58.33 -24.65 60.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . 0.4 ' HD3' ' O ' ' A' ' 308' ' ' GLU . 9.2 mptt -84.78 -22.82 29.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -95.18 16.21 17.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.125 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.463 ' CE1' HD12 ' A' ' 310' ' ' LEU . 7.9 m-85 -129.16 -29.12 2.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.593 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 0.8 OUTLIER -50.36 -45.54 83.75 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.65 0.738 . . . . 0.0 110.873 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 315' ' ' SER . 65.1 Cg_exo -48.04 -15.51 0.42 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.661 2.24 . . . . 0.0 112.342 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . 0.525 ' CZ ' ' HB3' ' A' ' 352' ' ' GLU . 55.0 m-85 -99.13 -53.84 3.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -162.69 -179.1 37.06 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.437 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 28.9 m -74.52 143.39 44.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 111.129 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 339' ' ' CYS . 55.3 mt -115.45 152.53 17.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.149 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.411 ' N ' HG22 ' A' ' 320' ' ' ILE . 40.9 p -121.11 -41.2 2.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 1.5 t -137.38 119.42 15.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -146.35 126.62 13.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.081 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.474 ' HG2' ' N ' ' A' ' 325' ' ' VAL . 15.7 ttmm -159.99 151.1 19.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.474 ' N ' ' HG2' ' A' ' 324' ' ' LYS . 99.2 t -110.12 132.99 56.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.188 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . . . . . . . . . 38.1 mmt -65.41 125.19 24.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 21.2 mtp -122.62 162.43 21.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -119.77 38.9 3.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 70.35 87.49 0.11 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.515 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . 99.61 -43.27 1.84 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.511 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -112.82 162.27 15.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 110.857 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.2 t -104.74 127.4 52.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . 0.522 ' HB3' ' CE1' ' A' ' 335' ' ' PHE . 12.1 mmmt -53.55 -60.95 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.869 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 136.25 34.69 0.22 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.469 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.528 ' CA ' HD12 ' A' ' 301' ' ' LEU . 12.9 p90 -173.39 159.37 3.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.868 0.366 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -158.91 -171.95 25.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.498 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -135.14 141.1 45.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.36 . . . . 0.0 110.837 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 36.5 t -136.56 140.94 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.112 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . 0.42 ' O ' HG23 ' A' ' 320' ' ' ILE . 65.4 m -117.56 156.57 27.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -130.27 173.89 10.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 51.6 p -80.29 -40.99 25.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.414 ' C ' HG12 ' A' ' 294' ' ' VAL . 22.9 m -130.62 139.23 34.97 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.649 0.738 . . . . 0.0 110.882 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.494 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.3 Cg_exo -47.44 -54.88 4.49 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.688 2.259 . . . . 0.0 112.316 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -41.28 -55.61 2.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -51.71 -43.75 62.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.862 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.89 ' HB1' HD21 ' A' ' 296' ' ' LEU . . . -64.15 -41.5 97.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.09 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 94.6 m -49.71 -63.6 1.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . . . . . . . . . 58.1 tttt -47.07 -61.92 1.65 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -37.71 -50.25 1.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.128 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 346' ' ' ALA . 57.8 t -41.69 -55.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 90.2 m -78.7 -55.84 4.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 317' ' ' PHE . 18.8 mm-40 -44.08 -27.79 0.42 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . 0.412 ' CB ' HG21 ' A' ' 365' ' ' VAL . 86.4 mmm -101.83 -42.59 6.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.879 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 12.9 t-20 -58.14 96.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 121.92 -13.97 9.1 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.469 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . . . . . . . . . 20.3 tpp85 -77.12 112.93 14.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.898 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . 0.543 HD13 ' CA ' ' A' ' 362' ' ' PRO . 13.3 mm -78.25 138.29 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.096 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.99 -65.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.112 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -100.79 -75.24 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.116 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . 0.555 ' CG2' ' N ' ' A' ' 361' ' ' LYS . 1.0 OUTLIER -123.5 -47.34 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 -179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.555 ' N ' ' CG2' ' A' ' 360' ' ' THR . 12.1 pttm -109.39 159.0 33.01 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.553 0.692 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.543 ' CA ' HD13 ' A' ' 357' ' ' ILE . 60.2 Cg_endo -80.24 154.04 21.7 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.671 2.247 . . . . 0.0 112.369 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 365' ' ' VAL . 31.4 mt -78.13 98.31 5.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.926 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -67.8 81.61 0.19 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.89 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.468 ' CG1' ' HA ' ' A' ' 350' ' ' VAL . 32.2 t -91.14 141.11 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.134 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -160.39 143.33 13.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.096 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.657 ' CD2' HG21 ' A' ' 350' ' ' VAL . 18.8 mt -59.87 141.48 55.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.906 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . . . . . . . . . . . -105.93 86.51 2.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' A' ' 370' ' ' ARG . 7.5 pt20 -64.82 -46.0 83.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.903 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 369' ' ' GLN . 6.8 tpt180 -34.61 102.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.73 132.94 47.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -119.71 138.88 53.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -155.49 139.5 16.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.838 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -146.97 151.93 37.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.881 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 -145.9 171.02 15.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 48.2 m -122.49 -60.55 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . 69.63 95.57 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.532 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.05 125.51 9.34 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.693 2.262 . . . . 0.0 112.347 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 38.3 t -167.0 117.37 0.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 34.8 t -167.63 131.48 1.76 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.904 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.503 -179.975 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' SER . . . . . . . . . . . . . 22.2 m -150.39 144.91 25.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.875 0.369 . . . . 0.0 110.862 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 82.9 p -152.58 142.43 22.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.866 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' GLY . . . . . . . . . . . . . . . 149.2 -140.78 8.39 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.493 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' SER . . . . . . . . . . . . . 4.4 t -170.86 154.07 4.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.907 0.384 . . . . 0.0 110.795 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 19.2 m -128.73 131.89 47.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.876 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' A' ' 286' ' ' ASP . . . -165.93 83.1 0.1 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.516 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 285' ' ' GLY . 1.1 p-10 -35.3 150.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 0.0 110.829 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' ARG . . . . . 0.428 ' HB2' ' NH1' ' A' ' 287' ' ' ARG . 11.0 ttm105 -132.31 160.61 35.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.902 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' ILE . . . . . 0.564 ' H ' HD13 ' A' ' 288' ' ' ILE . 0.3 OUTLIER -131.09 158.0 43.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 10.1 t -105.08 142.28 35.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' ARG . . . . . 0.432 ' O ' ' C ' ' A' ' 291' ' ' TYR . 35.6 mmt180 -153.71 178.15 10.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.907 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' TYR . . . . . 0.432 ' C ' ' O ' ' A' ' 290' ' ' ARG . 4.7 t80 35.43 35.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.97 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 290' ' ' ARG . 31.6 mt-30 36.31 46.17 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.904 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 70.9 t -66.61 93.06 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.144 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . 0.631 HG12 ' N ' ' A' ' 343' ' ' PRO . 25.8 m -104.02 -35.16 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.116 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -63.54 143.31 57.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.906 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.562 HD22 HG22 ' A' ' 350' ' ' VAL . 58.2 mt -131.29 144.99 51.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -99.62 123.47 43.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' VAL . . . . . . . . . . . . . 17.6 t -107.22 134.75 47.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.163 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.545 ' CG ' ' N ' ' A' ' 300' ' ' ASN . 21.9 ttmt -134.3 165.99 23.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' ASN . . . . . 0.545 ' N ' ' CG ' ' A' ' 299' ' ' LYS . 2.9 m-20 61.16 51.36 4.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 30.9 mt -91.85 107.54 19.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.947 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.39 141.36 24.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -48.4 -34.51 10.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.865 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . -63.86 -37.06 94.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.538 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' ILE . . . . . . . . . . . . . 49.5 mt -70.33 136.91 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.832 0.349 . . . . 0.0 111.164 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -126.49 -178.75 4.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.852 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' ASP . . . . . 0.445 ' OD1' ' C ' ' A' ' 307' ' ' ASP . 21.5 t0 -51.27 -47.29 62.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 58.9 tt0 -58.44 -66.32 0.51 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -43.58 -42.1 4.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.839 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 63.2 tp -60.59 -69.35 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -52.32 -27.82 16.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -72.7 -27.52 62.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -95.28 19.23 11.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' PHE . . . . . 0.673 ' CB ' HD11 ' A' ' 320' ' ' ILE . 8.6 m-85 -129.69 -31.31 2.0 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.854 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' SER . . . . . 0.587 ' N ' ' CD ' ' A' ' 316' ' ' PRO . 1.2 m -50.89 -45.78 87.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.711 0.767 . . . . 0.0 110.874 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' PRO . . . . . 0.587 ' CD ' ' N ' ' A' ' 315' ' ' SER . 64.8 Cg_exo -47.99 -17.25 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.683 2.255 . . . . 0.0 112.314 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' PHE . . . . . 0.574 ' CE1' ' HB3' ' A' ' 352' ' ' GLU . 55.5 m-85 -100.05 -49.64 4.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . -163.04 160.63 33.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.476 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.5 m -60.63 138.28 58.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.752 0.311 . . . . 0.0 111.18 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' ILE . . . . . 0.673 HD11 ' CB ' ' A' ' 314' ' ' PHE . 80.3 mt -114.89 130.73 68.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.108 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.9 p -103.62 -28.36 11.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 4.7 t -143.19 125.07 15.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.842 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' ALA . . . . . . . . . . . . . . . -154.64 122.52 5.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.125 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.427 ' HD3' ' N ' ' A' ' 324' ' ' LYS . 0.0 OUTLIER -151.93 158.21 42.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.0 134.42 53.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' MET . . . . . 0.548 ' HG3' ' CE2' ' A' ' 335' ' ' PHE . 35.5 mmt -61.16 145.02 52.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.852 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' MET . . . . . . . . . . . . . 13.1 mtp -146.23 171.13 15.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.854 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -124.33 -51.47 1.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.936 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -159.61 -51.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.55 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' GLY . . . . . . . . . . . . . . . -149.08 38.6 0.96 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.512 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -168.36 144.29 3.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.863 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 14.5 t -69.3 116.58 9.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' LYS . . . . . . . . . . . . . 14.9 mmtp -46.93 -46.81 21.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.912 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 132.68 -28.46 3.39 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.507 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.548 ' CE2' ' HG3' ' A' ' 326' ' ' MET . 3.2 p90 -118.53 160.79 21.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.928 0.394 . . . . 0.0 110.875 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' GLY . . . . . . . . . . . . . . . -153.44 -172.45 21.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.531 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -138.44 138.29 38.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.863 0.363 . . . . 0.0 110.884 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . . . . . . . . . 30.9 t -130.27 143.79 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.121 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' CYS . . . . . 0.574 ' O ' HG23 ' A' ' 320' ' ' ILE . 84.3 m -121.6 143.09 49.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -118.19 175.59 5.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' SER . . . . . . . . . . . . . 23.2 t -83.85 -40.79 18.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.847 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 70.7 m -130.37 139.33 35.3 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.635 0.731 . . . . 0.0 110.898 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' PRO . . . . . 0.631 ' N ' HG12 ' A' ' 294' ' ' VAL . 73.2 Cg_exo -47.43 -56.15 3.32 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.694 2.262 . . . . 0.0 112.332 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -41.49 -54.68 3.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 50.6 mm-40 -50.55 -45.35 56.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.669 ' O ' HG23 ' A' ' 350' ' ' VAL . . . -61.93 -40.56 95.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.086 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' THR . . . . . . . . . . . . . 61.0 m -51.25 -65.7 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.166 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 349' ' ' ALA . 28.6 tttt -44.38 -64.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 348' ' ' LYS . . . -35.06 -48.83 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.114 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 346' ' ' ALA . 49.1 t -42.79 -56.3 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.122 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' THR . . . . . . . . . . . . . 52.8 m -79.69 -50.71 10.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.146 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' GLU . . . . . 0.574 ' HB3' ' CE1' ' A' ' 317' ' ' PHE . 24.3 mm-40 -47.66 -29.39 2.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' MET . . . . . 0.601 ' HB3' HG21 ' A' ' 365' ' ' VAL . 75.9 mmm -101.66 -51.75 3.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' ASN . . . . . 0.493 ' CB ' ' O ' ' A' ' 350' ' ' VAL . 7.0 t-20 -35.77 112.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.833 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' GLY . . . . . . . . . . . . . . . 87.98 18.87 55.23 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.499 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 353' ' ' MET . 16.5 tpp180 -96.94 126.95 42.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.867 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' ILE . . . . . 0.405 HD13 ' CA ' ' A' ' 362' ' ' PRO . 11.3 mm -93.27 142.62 12.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 64.6 t -131.84 -38.81 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.145 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -125.65 -72.68 0.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.085 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' THR . . . . . . . . . . . . . 2.5 p -131.71 -52.22 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.167 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -101.85 153.91 37.66 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.564 0.697 . . . . 0.0 110.931 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.405 ' CA ' HD13 ' A' ' 357' ' ' ILE . 61.1 Cg_endo -75.84 146.38 29.71 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.671 2.248 . . . . 0.0 112.333 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . 0.509 ' O ' HG23 ' A' ' 365' ' ' VAL . 43.1 mt -81.68 96.3 7.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -64.52 97.38 0.2 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.94 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' VAL . . . . . 0.601 HG21 ' HB3' ' A' ' 353' ' ' MET . 37.0 t -103.19 125.35 57.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.153 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' ALA . . . . . . . . . . . . . . . -150.6 150.81 31.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.529 HD21 HG21 ' A' ' 350' ' ' VAL . 49.5 mt -60.67 139.37 57.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 369' ' ' GLN . . . -84.4 -44.09 14.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.051 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 368' ' ' ALA . 59.6 mt-30 32.43 47.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.94 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -114.57 -43.15 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -157.35 160.13 38.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.97 159.08 16.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.56 169.09 8.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.883 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -127.51 -59.11 1.23 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.826 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -42.22 130.07 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' SER . . . . . . . . . . . . . 23.0 t -113.67 -59.81 1.97 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' GLY . . . . . . . . . . . . . . . -141.9 -167.17 11.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.08 162.31 31.87 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.652 2.235 . . . . 0.0 112.376 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 32.3 t -108.21 -43.95 4.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.858 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 37.8 t -98.04 139.44 33.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.84 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.506 179.953 . . . . . . . . 0 0 . 1 stop_ save_